[{"category":"Human","active_substances_in_scope_of_procedure":"varicella vaccine (live)","active_substance":"varicella vaccine (live)","related_medicines":"","procedure_number":"PSUSA/00010473/202503","regulatory_outcome":"Maintenance","first_published_date":"19/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010473-202503-0"},{"category":"Human","active_substances_in_scope_of_procedure":"varicella vaccine (live)","active_substance":"varicella vaccine (live)","related_medicines":"","procedure_number":"PSUSA/00010473/202503","regulatory_outcome":"Variation","first_published_date":"19/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010473-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"selegiline","active_substance":"selegiline","related_medicines":"","procedure_number":"PSUSA/00002688/202503","regulatory_outcome":"Variation","first_published_date":"19/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002688-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"Rocuronium","active_substance":"rocuronium","related_medicines":"","procedure_number":"PSUSA/00002656/202502","regulatory_outcome":"Variation","first_published_date":"19/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002656-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"rifampicin","active_substance":"rifampicin","related_medicines":"","procedure_number":"PSUSA/00002640/202503","regulatory_outcome":"Variation","first_published_date":"19/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002640-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"metoprolol","active_substance":"metoprolol","related_medicines":"","procedure_number":"PSUSA/00002039/202503","regulatory_outcome":"Variation","first_published_date":"19/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002039-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"prazepam","active_substance":"prazepam","related_medicines":"","procedure_number":"PSUSA/00002502/202503","regulatory_outcome":"Variation","first_published_date":"18/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002502-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"amlodipine / atorvastatin","active_substance":"amlodipine;atorvastatin","related_medicines":"","procedure_number":"PSUSA/00000177/202501","regulatory_outcome":"Variation","first_published_date":"11/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000177-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"caspofungin","active_substance":"caspofungin","related_medicines":"","procedure_number":"PSUSA/00000576/202412","regulatory_outcome":"Variation","first_published_date":"03/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000576-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"tibolone","active_substance":"tibolone","related_medicines":"","procedure_number":"PSUSA/00002947/202412","regulatory_outcome":"Maintenance","first_published_date":"03/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002947-202412"},{"category":"","active_substances_in_scope_of_procedure":"propylthiouracil","active_substance":"propylthiouracil","related_medicines":"","procedure_number":"PSUSA/00002558/202501","regulatory_outcome":"Variation","first_published_date":"02/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002558-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"carvedilol / ivabradine","active_substance":"carvedilol;ivabradine","related_medicines":"","procedure_number":"PSUSA/00010883/202504","regulatory_outcome":"Maintenance","first_published_date":"01/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010883-202504"},{"category":"Human","active_substances_in_scope_of_procedure":"vancomycin","active_substance":"vancomycin","related_medicines":"","procedure_number":"PSUSA/00003097/202501","regulatory_outcome":"Variation","first_published_date":"01/12/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003097-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"reboxetine","active_substance":"reboxetine","related_medicines":"","procedure_number":"PSUSA/00002615/202504","regulatory_outcome":"Maintenance","first_published_date":"28/11/2025","last_updated_date":"28/11/2025","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002615-202504"},{"category":"Human","active_substances_in_scope_of_procedure":"ofloxacin (systemic use)","active_substance":"ofloxacin","related_medicines":"","procedure_number":"PSUSA/00002203/202504","regulatory_outcome":"Maintenance","first_published_date":"28/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-202504"},{"category":"Human","active_substances_in_scope_of_procedure":"ivermectin (systemic use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010377/202504","regulatory_outcome":"Maintenance","first_published_date":"28/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010377-202504"},{"category":"Human","active_substances_in_scope_of_procedure":"triamcinolone (intraocular formulations)","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00010292/202503","regulatory_outcome":"Maintenance","first_published_date":"27/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"codeine","active_substance":"Codeine","related_medicines":"","procedure_number":"PSUSA/00000843/202501","regulatory_outcome":"Variation","first_published_date":"27/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000843-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"gabapentin","active_substance":"gabapentin","related_medicines":"","procedure_number":"PSUSA/00001499/202502","regulatory_outcome":"Variation","first_published_date":"26/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001499-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"Rosuvastatin / Omega-3-acid ethyl esters","active_substance":"rosuvastatin;omega-3-acid ethyl esters 90","related_medicines":"","procedure_number":"PSUSA/00010915/202501","regulatory_outcome":"Maintenance","first_published_date":"26/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010915-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"atenolol","active_substance":"atenolol","related_medicines":"","procedure_number":"PSUSA/00000259/202502","regulatory_outcome":"Variation","first_published_date":"26/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000259-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"dorzolamide","active_substance":"dorzolamide","related_medicines":"","procedure_number":"PSUSA/00003168/202502","regulatory_outcome":"Variation","first_published_date":"26/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003168-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"prednisone","active_substance":"prednisone","related_medicines":"","procedure_number":"PSUSA/00002510/202501","regulatory_outcome":"Variation","first_published_date":"24/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002510-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"trimethoprim","active_substance":"trimethoprim","related_medicines":"","procedure_number":"PSUSA/00003045/202501","regulatory_outcome":"Variation","first_published_date":"24/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003045-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"sodium citrate / sodium lauryl sulfoacetate, sodium citrate / sodium lauryl sulfoacetate / sorbitol","active_substance":"sodium citrate / sodium lauryl sulfoacetate, sodium citrate / sodium lauryl sulfoacetate / sorbitol","related_medicines":"","procedure_number":"PSUSA/00002735/202501","regulatory_outcome":"Variation","first_published_date":"18/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002735-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"estradiol (17-beta) / progesterone","active_substance":"17 beta-estradiol;progesterone","related_medicines":"","procedure_number":"PSUSA/00009145/202412","regulatory_outcome":"Maintenance","first_published_date":"12/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009145-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"botulinum toxin a (except for centrally authorised products)","active_substance":"botulinum toxin a (except for centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00000426/202412","regulatory_outcome":"Variation","first_published_date":"05/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000426-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"alprazolam","active_substance":"alprazolam","related_medicines":"","procedure_number":"PSUSA/00000109/202503","regulatory_outcome":"Maintenance","first_published_date":"05/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000109-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"clobetasol","active_substance":"clobetasol","related_medicines":"","procedure_number":"PSUSA/00000799/202502","regulatory_outcome":"Maintenance","first_published_date":"05/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000799-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"cyamemazine","active_substance":"cyamemazine","related_medicines":"","procedure_number":"PSUSA/00000886/202503","regulatory_outcome":"Maintenance","first_published_date":"05/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000886-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"ethyl loflazepate","active_substance":"ethyl loflazepate","related_medicines":"","procedure_number":"PSUSA/00001317/202503","regulatory_outcome":"Maintenance","first_published_date":"05/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001317-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"fomepizole","active_substance":"Fomepizole","related_medicines":"","procedure_number":"PSUSA/00001466/202503","regulatory_outcome":"Maintenance","first_published_date":"05/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001466-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"diazepam","active_substance":"diazepam","related_medicines":"","procedure_number":"PSUSA/00001029/202503","regulatory_outcome":"Maintenance","first_published_date":"04/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001029-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"erythromycin (systemic use)","active_substance":"erythromycin","related_medicines":"","procedure_number":"PSUSA/00010808/202503","regulatory_outcome":"Maintenance","first_published_date":"04/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010808-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"hepatitis B vaccine (rDNA)","active_substance":"hepatitis B vaccine (rDNA)","related_medicines":"","procedure_number":"PSUSA/00001597/202502","regulatory_outcome":"Maintenance","first_published_date":"03/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001597-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"bupropion","active_substance":"bupropion","related_medicines":"","procedure_number":"PSUSA/00000461/202412","regulatory_outcome":"Variation","first_published_date":"03/11/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000461-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"niflumic acid","active_substance":"niflumic acid","related_medicines":"","procedure_number":"PSUSA/00002157/202412","regulatory_outcome":"Variation","first_published_date":"31/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002157-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"urokinase","active_substance":"urokinase","related_medicines":"","procedure_number":"PSUSA/00003083/202503","regulatory_outcome":"Maintenance","first_published_date":"31/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003083-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"ethinylestradiol","active_substance":"ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00001306/202503","regulatory_outcome":"Maintenance","first_published_date":"31/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001306-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"Mannitol (all indications apart from cystic fibrosis)","active_substance":"mannitol","related_medicines":"","procedure_number":"PSUSA/00010005/202502","regulatory_outcome":"Maintenance","first_published_date":"31/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010005-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"thiamazole","active_substance":"thiamazole","related_medicines":"","procedure_number":"PSUSA/00002922/202503","regulatory_outcome":"Maintenance","first_published_date":"31/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002922-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"trandolapril / verapamil","active_substance":"trandolapril;verapamil","related_medicines":"","procedure_number":"PSUSA/00003005/202503","regulatory_outcome":"Maintenance","first_published_date":"31/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003005-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"doxycycline","active_substance":"doxycycline","related_medicines":"","procedure_number":"PSUSA/00001173/202503","regulatory_outcome":"Maintenance","first_published_date":"31/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001173-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"milrinone","active_substance":"milrinone","related_medicines":"","procedure_number":"PSUSA/00002064/202410","regulatory_outcome":"Maintenance","first_published_date":"31/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002064-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"glipizide","active_substance":"glipizide","related_medicines":"","procedure_number":"PSUSA/00001535/202501","regulatory_outcome":"Maintenance","first_published_date":"30/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001535-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"dermatan sulfate","active_substance":"dermatan sulfate","related_medicines":"","procedure_number":"PSUSA/00000957/202411","regulatory_outcome":"Maintenance","first_published_date":"30/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000957-202411"},{"category":"","active_substances_in_scope_of_procedure":"testosterone (all formulations apart from topical use)","active_substance":"testosterone","related_medicines":"","procedure_number":"PSUSA/00010631/202412","regulatory_outcome":"Variation","first_published_date":"27/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010631-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"dexketoprofen / tramadol","active_substance":"dexketoprofen;tramadol","related_medicines":"","procedure_number":"PSUSA/00010468/202501","regulatory_outcome":"Variation","first_published_date":"23/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010468-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"botulinum neurotoxin type a (150 kd) free from complexing proteins","active_substance":"botulinum neurotoxin type a (150 kd) free from complexing proteins","related_medicines":"","procedure_number":"PSUSA/00009084/202412","regulatory_outcome":"Variation","first_published_date":"23/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009084-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"ciclosporin (systemic use)","active_substance":"ciclosporin","related_medicines":"","procedure_number":"PSUSA/00000745/202412","regulatory_outcome":"Variation","first_published_date":"23/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000745-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"disodium hydrogen phosphate / sodium dihydrogen phosphate, phosphate sodium","active_substance":"","related_medicines":"","procedure_number":"PSUSA/00002737/202501","regulatory_outcome":"Variation","first_published_date":"23/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002737-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"bisoprolol / hydrochlorothiazide","active_substance":"bisoprolol;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000420/202411","regulatory_outcome":"Variation","first_published_date":"22/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000420-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"Sevoflurane","active_substance":"sevoflurane","related_medicines":"","procedure_number":"PSUSA/00002698/202501","regulatory_outcome":"Maintenance","first_published_date":"14/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002698-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"potassium para-aminobenzoate","active_substance":"potassium para-aminobenzoate","related_medicines":"","procedure_number":"PSUSA/00010130/202502","regulatory_outcome":"Maintenance","first_published_date":"07/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010130-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"pimozide","active_substance":"pimozide","related_medicines":"","procedure_number":"PSUSA/00002413/202502","regulatory_outcome":"Maintenance","first_published_date":"06/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002413-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"warfarin","active_substance":"warfarin","related_medicines":"","procedure_number":"PSUSA/00003129/202501","regulatory_outcome":"Maintenance","first_published_date":"06/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003129-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"hydroxyethyl starch / sodium chloride","active_substance":"hydroxyethyl starch;sodium chloride","related_medicines":"","procedure_number":"PSUSA/00001694/202503","regulatory_outcome":"Maintenance","first_published_date":"03/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/202503","regulatory_outcome":"Maintenance","first_published_date":"03/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202503"},{"category":"Human","active_substances_in_scope_of_procedure":"mesterolone","active_substance":"mesterolone","related_medicines":"","procedure_number":"PSUSA/00010551/202501","regulatory_outcome":"Maintenance","first_published_date":"03/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010551-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"xipamide, triamterene / xipamide","active_substance":"xipamide;triamterene","related_medicines":"","procedure_number":"PSUSA/00003133/202501","regulatory_outcome":"Maintenance","first_published_date":"03/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003133-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"lorazepam","active_substance":"lorazepam","related_medicines":"","procedure_number":"PSUSA/00001909/202501","regulatory_outcome":"Maintenance","first_published_date":"03/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-202501"},{"category":"","active_substances_in_scope_of_procedure":"lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/202502","regulatory_outcome":"Maintenance","first_published_date":"03/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202502"},{"category":"Human","active_substances_in_scope_of_procedure":"tofisopam","active_substance":"tofisopam","related_medicines":"","procedure_number":"PSUSA/00002982/202501","regulatory_outcome":"Maintenance","first_published_date":"03/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002982-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"cyclophosphamide","active_substance":"cyclophosphamide","related_medicines":"","procedure_number":"PSUSA/00000901/202501","regulatory_outcome":"Maintenance","first_published_date":"03/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000901-202501"},{"category":"","active_substances_in_scope_of_procedure":"interferon gamma","active_substance":"Interferon gamma","related_medicines":"","procedure_number":"PSUSA/00001760/202501","regulatory_outcome":"Maintenance","first_published_date":"02/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001760-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"diamorphine","active_substance":"Diamorphine","related_medicines":"","procedure_number":"PSUSA/00001028/202411","regulatory_outcome":"Variation","first_published_date":"02/10/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001028-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"timolol (systemic use)","active_substance":"timolol (systemic use)","related_medicines":"","procedure_number":"PSUSA/00010432/202410","regulatory_outcome":"Variation","first_published_date":"30/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010432-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"omega-3-acid ethyl esters 90","active_substance":"omega-3-acid ethyl esters 90","related_medicines":"","procedure_number":"PSUSA/00010312/202501","regulatory_outcome":"Maintenance","first_published_date":"25/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010312-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"flumazenil","active_substance":"flumazenil","related_medicines":"","procedure_number":"PSUSA/00001413/202412","regulatory_outcome":"Maintenance","first_published_date":"23/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001413-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"haloperidol","active_substance":"haloperidol","related_medicines":"","procedure_number":"PSUSA/00001587/202501","regulatory_outcome":"Maintenance","first_published_date":"23/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001587-202501"},{"category":"","active_substances_in_scope_of_procedure":"phosphocreatine","active_substance":"phosphocreatine","related_medicines":"","procedure_number":"PSUSA/00002398/202411","regulatory_outcome":"Variation","first_published_date":"12/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002398-202411"},{"category":"","active_substances_in_scope_of_procedure":"cyanocobalamin / diclofenac / pyridoxine / thiamine","active_substance":"cyanocobalamin;diclofenac;pyridoxine;thiamine","related_medicines":"","procedure_number":"PSUSA/00001041/202501","regulatory_outcome":"Maintenance","first_published_date":"12/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001041-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"acetylsalicylic acid / bisoprolol","active_substance":"acetylsalicylic acid / bisoprolol","related_medicines":"","procedure_number":"PSUSA/00010287/202411","regulatory_outcome":"Variation","first_published_date":"11/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"botulinum toxin a - haemagglutinin complex","active_substance":"botulinum toxin a - haemagglutinin complex","related_medicines":"","procedure_number":"PSUSA/00000427/202412","regulatory_outcome":"Maintenance","first_published_date":"11/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000427-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"myristalkonium, benzalkonium (vaginal use only)","active_substance":"myristalkonium, benzalkonium (vaginal use only)","related_medicines":"","procedure_number":"PSUSA/00010987/202501","regulatory_outcome":"Maintenance","first_published_date":"10/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010987-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"flunitrazepam","active_substance":"flunitrazepam","related_medicines":"","procedure_number":"PSUSA/00001418/202501","regulatory_outcome":"Maintenance","first_published_date":"10/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001418-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"hydromorphone","active_substance":"hydromorphone","related_medicines":"","procedure_number":"PSUSA/00001686/202411","regulatory_outcome":"Variation","first_published_date":"10/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001686-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"human alfa1-proteinase inhibitor (apart from the centrally authorised product)","active_substance":"human alfa1-proteinase inhibitor (apart from the centrally authorised product)","related_medicines":"","procedure_number":"PSUSA/00000108/202412","regulatory_outcome":"Maintenance","first_published_date":"10/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000108-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"varicella-zoster immunoglobuline","active_substance":"varicella-zoster immunoglobuline","related_medicines":"","procedure_number":"PSUSA/00010266/202412","regulatory_outcome":"Maintenance","first_published_date":"10/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010266-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"typhoid vaccine (live, attenuated)","active_substance":"typhoid vaccine","related_medicines":"","procedure_number":"PSUSA/00003067/202412","regulatory_outcome":"Maintenance","first_published_date":"10/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003067-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"cefotaxime","active_substance":"cefotaxime","related_medicines":"","procedure_number":"PSUSA/00000599/202412","regulatory_outcome":"Maintenance","first_published_date":"10/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000599-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"nitric oxide","active_substance":"nitric oxide","related_medicines":"","procedure_number":"PSUSA/00002172/202412","regulatory_outcome":"Maintenance","first_published_date":"09/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002172-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"amino acid combinations / glucose / triglyceride combinations","active_substance":"amino acid combinations;glucose;triglyceride combinations","related_medicines":"","procedure_number":"PSUSA/00010190/202412","regulatory_outcome":"Maintenance","first_published_date":"09/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"phenylephrine (ophthalmic formulations)","active_substance":"phenylephrine (ophthalmic formulations)","related_medicines":"","procedure_number":"PSUSA/00010402/202501","regulatory_outcome":"Maintenance","first_published_date":"09/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010402-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"metamizole sodium / triacetonamine tosilate","active_substance":"metamizole sodium;triacetonamine tosilate","related_medicines":"","procedure_number":"PSUSA/00001999/202501","regulatory_outcome":"Maintenance","first_published_date":"09/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001999-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"lidocaine / phenazone","active_substance":"lidocaine;phenazone","related_medicines":"","procedure_number":"PSUSA/00002359/202501","regulatory_outcome":"Maintenance","first_published_date":"08/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002359-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"tapentadol","active_substance":"tapentadol","related_medicines":"","procedure_number":"PSUSA/00002849/202411","regulatory_outcome":"Variation","first_published_date":"08/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"bendamustine hydrochloride","active_substance":"bendamustine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00003162/202501","regulatory_outcome":"Maintenance","first_published_date":"08/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"roxithromycin","active_substance":"roxithromycin","related_medicines":"","procedure_number":"PSUSA/00002669/202412","regulatory_outcome":"Maintenance","first_published_date":"05/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"pirenoxine","active_substance":"pirenoxine","related_medicines":"","procedure_number":"PSUSA/00002431/202501","regulatory_outcome":"Maintenance","first_published_date":"04/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002431-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"tizanidine","active_substance":"tizanidine","related_medicines":"","procedure_number":"PSUSA/00002977/202412","regulatory_outcome":"Maintenance","first_published_date":"04/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002977-202412"},{"category":"","active_substances_in_scope_of_procedure":"anthrax vaccine","active_substance":"anthrax vaccine","related_medicines":"","procedure_number":"PSUSA/00010771/202412","regulatory_outcome":"Maintenance","first_published_date":"04/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010771-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"alitretinoin (oral use)","active_substance":"alitretinoin","related_medicines":"","procedure_number":"PSUSA/00010710/202501","regulatory_outcome":"Maintenance","first_published_date":"04/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202501"},{"category":"Human","active_substances_in_scope_of_procedure":"nicotine","active_substance":"nicotine","related_medicines":"","procedure_number":"PSUSA/00002153/202412","regulatory_outcome":"Variation","first_published_date":"03/09/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002153-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"levosimendan","active_substance":"","related_medicines":"","procedure_number":"PSUSA00001858202409","regulatory_outcome":"Variation","first_published_date":"21/08/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa00001858202409"},{"category":"Human","active_substances_in_scope_of_procedure":"domperidone","active_substance":"domperidone","related_medicines":"","procedure_number":"PSUSA/00001158/202411","regulatory_outcome":"Variation","first_published_date":"20/08/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001158-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"isoniazid","active_substance":"isoniazid","related_medicines":"","procedure_number":"PSUSA/00001789/202411","regulatory_outcome":"Variation","first_published_date":"13/08/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001789-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"Miconazole, hydrocortisone / miconazole nitrate, miconazole nitrate / zinc oxide","active_substance":"Miconazole;hydrocortisone;miconazole nitrate;zinc oxide","related_medicines":"","procedure_number":"PSUSA/00002052/202410","regulatory_outcome":"Variation","first_published_date":"12/08/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002052-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"methocarbamol / paracetamol","active_substance":"methocarbamol;paracetamol","related_medicines":"","procedure_number":"PSUSA/00002013/202412","regulatory_outcome":"Maintenance","first_published_date":"05/08/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002013-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"methylphenidate","active_substance":"methylphenidate","related_medicines":"","procedure_number":"PSUSA/00002024/202410","regulatory_outcome":"Variation","first_published_date":"05/08/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"dexketoprofen","active_substance":"dexketoprofen","related_medicines":"","procedure_number":"PSUSA/00000997/202410","regulatory_outcome":"Variation","first_published_date":"05/08/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000997-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"clotrimazole / dexamethasone","active_substance":"clotrimazole;dexamethasone","related_medicines":"","procedure_number":"PSUSA/00000830/202411","regulatory_outcome":"Maintenance","first_published_date":"01/08/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000830-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"clotrimazole / hydrocortisone","active_substance":"clotrimazole;hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00000831/202411","regulatory_outcome":"Maintenance","first_published_date":"01/08/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000831-202411"},{"category":"","active_substances_in_scope_of_procedure":"rabbit anti-human thymocyte immunoglobulin","active_substance":"rabbit anti-human thymocyte immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00010184/202406","regulatory_outcome":"Maintenance","first_published_date":"13/02/2025","last_updated_date":"01/08/2025","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010184-202406"},{"category":"Human","active_substances_in_scope_of_procedure":"clotrimazole / metronidazole","active_substance":"clotrimazole;Metronidazole","related_medicines":"","procedure_number":"PSUSA/00000832/202411","regulatory_outcome":"Maintenance","first_published_date":"31/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000832-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"benzydamine","active_substance":"benzydamine","related_medicines":"","procedure_number":"PSUSA/00000375/202410","regulatory_outcome":"Variation","first_published_date":"29/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000375-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"lornoxicam","active_substance":"lornoxicam","related_medicines":"","procedure_number":"PSUSA/00001911/202412","regulatory_outcome":"Maintenance","first_published_date":"29/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001911-202412"},{"category":"","active_substances_in_scope_of_procedure":"ketamine","active_substance":"ketamine","related_medicines":"","procedure_number":"PSUSA/00001804/202412","regulatory_outcome":"Maintenance","first_published_date":"17/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001804-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"neomycin sulfate / nystatin / polymyxin b sulfate","active_substance":"neomycin sulfate;nystatin;polymyxin b sulfate","related_medicines":"","procedure_number":"PSUSA/00002139/202411","regulatory_outcome":"Maintenance","first_published_date":"17/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002139-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"metoclopramide","active_substance":"metoclopramide","related_medicines":"","procedure_number":"PSUSA/00002036/202411","regulatory_outcome":"Maintenance","first_published_date":"17/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002036-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"methocarbamol","active_substance":"methocarbamol","related_medicines":"","procedure_number":"PSUSA/00002011/202412","regulatory_outcome":"Maintenance","first_published_date":"17/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002011-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"paracetamol / pseudoephedrine hydrochloride / triprolidine hydrochloride","active_substance":"paracetamol;pseudoephedrine hydrocholoride;triprolidine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010270/202411","regulatory_outcome":"Maintenance","first_published_date":"17/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010270-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"acetylsalicylic acid / caffeine / paracetamol","active_substance":"acetylsalicylic acid;Caffeine;paracetamol","related_medicines":"","procedure_number":"PSUSA/00002291/202412","regulatory_outcome":"Maintenance","first_published_date":"15/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002291-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"natamycin","active_substance":"natamycin","related_medicines":"","procedure_number":"PSUSA/00003179/202411","regulatory_outcome":"Maintenance","first_published_date":"15/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003179-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"metamizole sodium / pitofenone hydrochloride","active_substance":"metamizole sodium;pitofenone hydrochloride","related_medicines":"","procedure_number":"PSUSA/00002443/202412","regulatory_outcome":"Maintenance","first_published_date":"15/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002443-202412"},{"category":"","active_substances_in_scope_of_procedure":"ceftobiprole","active_substance":"ceftobiprole","related_medicines":"","procedure_number":"PSUSA/00010734/202411","regulatory_outcome":"Maintenance","first_published_date":"15/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010734-202411"},{"category":"","active_substances_in_scope_of_procedure":"cinolazepam","active_substance":"cinolazepam","related_medicines":"","procedure_number":"PSUSA/00000769/202412","regulatory_outcome":"Maintenance","first_published_date":"15/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000769-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"antazoline / tetryzoline","active_substance":"antazoline;tetryzoline","related_medicines":"","procedure_number":"PSUSA/00000219/202412","regulatory_outcome":"Maintenance","first_published_date":"15/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000219-202412"},{"category":"","active_substances_in_scope_of_procedure":"dextromethorphan hydrobromide / paracetamol / promethazine hydrochloride","active_substance":"dextromethorphan hydrobromide;paracetamol;promethazine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00002300/202411","regulatory_outcome":"Maintenance","first_published_date":"15/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002300-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"chlorphenamine / dextromethorphan hydrobromide/ paracetamol","active_substance":"chlorphenamine;dextromethorphan hydrobromide;paracetamol","related_medicines":"","procedure_number":"PSUSA/00000699/202411","regulatory_outcome":"Maintenance","first_published_date":"14/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000699-202411"},{"category":"","active_substances_in_scope_of_procedure":"dextromethorphan / paracetamol / phenylephrine","active_substance":"dextromethorphan;paracetamol;phenylephrine","related_medicines":"","procedure_number":"PSUSA/00009247/202411","regulatory_outcome":"Maintenance","first_published_date":"14/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009247-202411"},{"category":"","active_substances_in_scope_of_procedure":"dextromethorphan hydrobromide / pseudoephedrine hydrochloride / triprolidine hydrochloride","active_substance":"dextromethorphan hydrobromide;pseudoephedrine hydrocholoride;triprolidine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00001021/202411","regulatory_outcome":"Maintenance","first_published_date":"14/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001021-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"urea hydrogen peroxide","active_substance":"urea hydrogen peroxide","related_medicines":"","procedure_number":"PSUSA/00009326/202411","regulatory_outcome":"Maintenance","first_published_date":"14/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009326-202411"},{"category":"","active_substances_in_scope_of_procedure":"mexazolam","active_substance":"mexazolam","related_medicines":"","procedure_number":"PSUSA/00002047/202412","regulatory_outcome":"Maintenance","first_published_date":"11/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002047-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"dextromethorphan hydrobromide / diphenhydramine hydrochloride / levomenthol","active_substance":"dextromethorphan hydrobromide;diphenhydramine hydrochloride;Levomenthol","related_medicines":"","procedure_number":"PSUSA/00001013/202411","regulatory_outcome":"Maintenance","first_published_date":"11/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001013-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"oxygen","active_substance":"oxygen","related_medicines":"","procedure_number":"PSUSA/00002257/202412","regulatory_outcome":"Maintenance","first_published_date":"11/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002257-202412"},{"category":"Human","active_substances_in_scope_of_procedure":"dihydroxyaluminum sodium carbonate, dihydroxyaluminum sodium carbonate / dimeticone","active_substance":"dihydroxyaluminum sodium carbonate;dimeticone","related_medicines":"","procedure_number":"PSUSA/00001098/202411","regulatory_outcome":"Maintenance","first_published_date":"10/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001098-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"cyanocobalamin / folic acid / pyridoxine","active_substance":"cyanocobalamin;folic acid;pyridoxine","related_medicines":"","procedure_number":"PSUSA/00000893/202411","regulatory_outcome":"Maintenance","first_published_date":"10/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000893-202411"},{"category":"","active_substances_in_scope_of_procedure":"acrivastine, acrivastine / pseudoephedrine","active_substance":"acrivastine;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00000054/202412","regulatory_outcome":"Maintenance","first_published_date":"10/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000054-202412"},{"category":"","active_substances_in_scope_of_procedure":"diphenhydramine / paracetamol","active_substance":"diphenhydramine;paracetamol","related_medicines":"","procedure_number":"PSUSA/00001110/202411","regulatory_outcome":"Maintenance","first_published_date":"10/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001110-202411"},{"category":"Human","active_substances_in_scope_of_procedure":"sumatriptan, naproxen / sumatriptan","active_substance":"sumatriptan;naproxen","related_medicines":"","procedure_number":"PSUSA/00002832/202409","regulatory_outcome":"Variation","first_published_date":"08/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002832-202409"},{"category":"Human","active_substances_in_scope_of_procedure":"diclofenac (systemic formulations)","active_substance":"diclofenac","related_medicines":"","procedure_number":"PSUSA/00001048/202409","regulatory_outcome":"Variation","first_published_date":"07/07/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001048-202409"},{"category":"Human","active_substances_in_scope_of_procedure":"etonogestrel","active_substance":"etonogestrel","related_medicines":"","procedure_number":"PSUSA/00001331/202409","regulatory_outcome":"Variation","first_published_date":"13/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001331-202409"},{"category":"Human","active_substances_in_scope_of_procedure":"azelastine / fluticasone","active_substance":"azelastine;fluticasone","related_medicines":"","procedure_number":"PSUSA/00010067/202410","regulatory_outcome":"Maintenance","first_published_date":"12/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010067-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"meropenem","active_substance":"Meropenem","related_medicines":"","procedure_number":"PSUSA/00001989/202408","regulatory_outcome":"Variation","first_published_date":"11/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001989-202408"},{"category":"Human","active_substances_in_scope_of_procedure":"fluticasone / salmeterol (for nationally authorised products)","active_substance":"fluticasone;salmeterol","related_medicines":"","procedure_number":"PSUSA/00001455/202410","regulatory_outcome":"Maintenance","first_published_date":"11/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001455-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"colecalciferol, colecalciferol / calcium, ergocalciferol, ergocalciferol / calcium","active_substance":"colecalciferol;calcium;ergocalciferol","related_medicines":"","procedure_number":"PSUSA/00010386/202410","regulatory_outcome":"Maintenance","first_published_date":"11/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010386-202410"},{"category":"","active_substances_in_scope_of_procedure":"ascorbic acid / magnesium aspartate / leucine L / lysine L / phenylalanine L / valine L","active_substance":"ascorbic acid;magnesium aspartate;leucine L;lysine L;phenylalanine L;valine L","related_medicines":"","procedure_number":"PSUSA/00010988/202410","regulatory_outcome":"Maintenance","first_published_date":"10/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010988-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"letrozole","active_substance":"letrozole","related_medicines":"","procedure_number":"PSUSA/00001842/202410","regulatory_outcome":"Maintenance","first_published_date":"06/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-202410"},{"category":"","active_substances_in_scope_of_procedure":"clindamycin","active_substance":"clindamycin","related_medicines":"","procedure_number":"PSUSA/00000795/202410","regulatory_outcome":"Maintenance","first_published_date":"05/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000795-202410"},{"category":"","active_substances_in_scope_of_procedure":"acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/202410","regulatory_outcome":"Maintenance","first_published_date":"05/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"hydrocortisone (systemic formulations except for products indicated in adrenal insufficiency in a modified release tablet formulation and except for centrally authorised products for adrenal insufficiency, paediatric use only)","active_substance":"hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00010855/202408","regulatory_outcome":"Variation","first_published_date":"04/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010855-202408"},{"category":"Human","active_substances_in_scope_of_procedure":"Alfentanil","active_substance":"alfentanil","related_medicines":"","procedure_number":"PSUSA/00000082/202409","regulatory_outcome":"Maintenance","first_published_date":"02/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-202409"},{"category":"Human","active_substances_in_scope_of_procedure":"oxcarbazepine","active_substance":"oxcarbazepine","related_medicines":"","procedure_number":"PSUSA/00002235/202408","regulatory_outcome":"Variation","first_published_date":"02/06/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-202408"},{"category":"Human","active_substances_in_scope_of_procedure":"anastrozole","active_substance":"anastrozole","related_medicines":"","procedure_number":"PSUSA/00000210/202408","regulatory_outcome":"Variation","first_published_date":"28/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000210-202408"},{"category":"Human","active_substances_in_scope_of_procedure":"chlorocresol / chlorhexidine / hexamidine","active_substance":"chlorocresol (4-chloro-3-methylphenol);hexamidine;chlorhexidine digluconate","related_medicines":"","procedure_number":"PSUSA/00001603/202408","regulatory_outcome":"Variation","first_published_date":"28/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001603-202408"},{"category":"Human","active_substances_in_scope_of_procedure":"phloroglucinol, phloroglucinol / trimethylphloroglucinol","active_substance":"phloroglucinol;trimethylphloroglucinol","related_medicines":"","procedure_number":"PSUSA/00010355/202409","regulatory_outcome":"Maintenance","first_published_date":"27/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010355-202409"},{"category":"Human","active_substances_in_scope_of_procedure":"pramiracetam","active_substance":"pramiracetam","related_medicines":"","procedure_number":"PSUSA/00002492/202409","regulatory_outcome":"Maintenance","first_published_date":"19/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002492-202409"},{"category":"Human","active_substances_in_scope_of_procedure":"hexaminolevulinate hydrochloride","active_substance":"hexaminolevulinate hydrochloride","related_medicines":"","procedure_number":"PSUSA/00001606/202409","regulatory_outcome":"Maintenance","first_published_date":"13/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001606-202409"},{"category":"","active_substances_in_scope_of_procedure":"trifarotene","active_substance":"trifarotene","related_medicines":"","procedure_number":"PSUSA/00010929/202410","regulatory_outcome":"Maintenance","first_published_date":"13/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010929-202410"},{"category":"Human","active_substances_in_scope_of_procedure":"carmustine (implant)","active_substance":"carmustine (implant)","related_medicines":"","procedure_number":"PSUSA/00010348/202409","regulatory_outcome":"Maintenance","first_published_date":"13/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010348-202409"},{"category":"","active_substances_in_scope_of_procedure":"naphazoline, naphazoline, zinc sulphate","active_substance":"naphazoline;zinc sulfate","related_medicines":"","procedure_number":"PSUSA/00010571/202407","regulatory_outcome":"Variation","first_published_date":"12/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010571-202407"},{"category":"","active_substances_in_scope_of_procedure":"zidovudine","active_substance":"zidovudine","related_medicines":"","procedure_number":"PSUSA/00003143/202409","regulatory_outcome":"Maintenance","first_published_date":"12/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003143-202409"},{"category":"","active_substances_in_scope_of_procedure":"rilmenidine","active_substance":"rilmenidine","related_medicines":"","procedure_number":"PSUSA/00002643/202408","regulatory_outcome":"Maintenance","first_published_date":"12/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002643-202408"},{"category":"Human","active_substances_in_scope_of_procedure":"betamethasone / tetryzoline","active_substance":"betamethasone;tetryzoline","related_medicines":"","procedure_number":"PSUSA/00010072/202409","regulatory_outcome":"Maintenance","first_published_date":"12/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010072-202409"},{"category":"","active_substances_in_scope_of_procedure":"opium","active_substance":"opium","related_medicines":"","procedure_number":"PSUSA/00010670/202409","regulatory_outcome":"Maintenance","first_published_date":"12/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-202409"},{"category":"Human","active_substances_in_scope_of_procedure":"magnesium sulfate / sodium sulfate / potassium sulfate","active_substance":"magnesium sulfate;sodium sulfate;potassium sulfate","related_medicines":"","procedure_number":"PSUSA/00010239/202408","regulatory_outcome":"Variation","first_published_date":"07/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-202408"},{"category":"","active_substances_in_scope_of_procedure":"everolimus (indicated for rejection of transplanted organs)","active_substance":"everolimus","related_medicines":"","procedure_number":"PSUSA/00010269/202407","regulatory_outcome":"Maintenance","first_published_date":"06/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010269-202407"},{"category":"Human","active_substances_in_scope_of_procedure":"cinchocaine hydrochloride / hydrocortisone","active_substance":"cinchocaine hydrochloride;hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00000761/202408","regulatory_outcome":"Maintenance","first_published_date":"06/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000761-202408"},{"category":"","active_substances_in_scope_of_procedure":"thiocolchicoside, paracetamol / thiocolchicoside","active_substance":"thiocolchicoside;paracetamol","related_medicines":"","procedure_number":"PSUSA/00010464/202407","regulatory_outcome":"Variation","first_published_date":"06/05/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010464-202407"},{"category":"Human","active_substances_in_scope_of_procedure":"sotalol","active_substance":"sotalol","related_medicines":"","procedure_number":"PSUSA/00002774/202408","regulatory_outcome":"Maintenance","first_published_date":"16/04/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002774-202408"},{"category":"Human","active_substances_in_scope_of_procedure":"acenocoumarol","active_substance":"acenocoumarol","related_medicines":"","procedure_number":"PSUSA/00000027/202407","regulatory_outcome":"Variation","first_published_date":"16/04/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000027-202407"},{"category":"","active_substances_in_scope_of_procedure":"thallium [201TL]","active_substance":"thallium [201TL]","related_medicines":"","procedure_number":"PSUSA/00002920/202408","regulatory_outcome":"Maintenance","first_published_date":"15/04/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002920-202408"},{"category":"","active_substances_in_scope_of_procedure":"busulfan","active_substance":"busulfan","related_medicines":"","procedure_number":"PSUSA/00000464/202407","regulatory_outcome":"Variation","first_published_date":"15/04/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000464-202407"},{"category":"Human","active_substances_in_scope_of_procedure":"ciclesonide","active_substance":"ciclesonide","related_medicines":"","procedure_number":"PSUSA/00000742/202408","regulatory_outcome":"Maintenance","first_published_date":"11/04/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000742-202408"},{"category":"Human","active_substances_in_scope_of_procedure":"dexamfetamine","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"PSUSA/00000986/202409","regulatory_outcome":"Maintenance","first_published_date":"11/04/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202409"},{"category":"","active_substances_in_scope_of_procedure":"hydrocortisone (all formulations apart from systemic use)","active_substance":"hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00010856/202408","regulatory_outcome":"Maintenance","first_published_date":"10/04/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010856-202408"},{"category":"","active_substances_in_scope_of_procedure":"tiagabine","active_substance":"tiagabine","related_medicines":"","procedure_number":"PSUSA/00002942/202406","regulatory_outcome":"Variation","first_published_date":"04/04/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002942-202406"},{"category":"","active_substances_in_scope_of_procedure":"benperidol","active_substance":"benperidol","related_medicines":"","procedure_number":"PSUSA/00000329/202407","regulatory_outcome":"Maintenance","first_published_date":"20/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000329-202407"},{"category":"Human","active_substances_in_scope_of_procedure":"budesonide / salmeterol","active_substance":"Budesonide;salmeterol","related_medicines":"","procedure_number":"PSUSA/00010511/202407","regulatory_outcome":"Maintenance","first_published_date":"19/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010511-202407"},{"category":"Human","active_substances_in_scope_of_procedure":"tiapride","active_substance":"tiapride","related_medicines":"","procedure_number":"PSUSA/00002944/202407","regulatory_outcome":"Maintenance","first_published_date":"19/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002944-202407"},{"category":"Human","active_substances_in_scope_of_procedure":"montelukast","active_substance":"montelukast","related_medicines":"","procedure_number":"PSUSA/00002087/202407","regulatory_outcome":"Maintenance","first_published_date":"19/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002087-202407"},{"category":"Human","active_substances_in_scope_of_procedure":"neomycin / triamcinolone","active_substance":"neomycin;triamcinolone","related_medicines":"","procedure_number":"PSUSA/00000081/202408","regulatory_outcome":"Maintenance","first_published_date":"19/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000081-202408"},{"category":"","active_substances_in_scope_of_procedure":"bibrocathol","active_substance":"bibrocathol","related_medicines":"","procedure_number":"PSUSA/00000406/202408","regulatory_outcome":"Maintenance","first_published_date":"14/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000406-202408"},{"category":"","active_substances_in_scope_of_procedure":"lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide","related_medicines":"","procedure_number":"PSUSA/00010390/202407","regulatory_outcome":"Maintenance","first_published_date":"13/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-202407"},{"category":"","active_substances_in_scope_of_procedure":"lactobacillus all subspecies and combinations of subspecies","active_substance":"lactobacillus all subspecies and combinations of subspecies","related_medicines":"","procedure_number":"PSUSA/00010598/202407","regulatory_outcome":"Maintenance","first_published_date":"13/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010598-202407"},{"category":"","active_substances_in_scope_of_procedure":"oxycodone hydrochloride / paracetamol","active_substance":"oxycodone hydrochloride;paracetamol","related_medicines":"","procedure_number":"PSUSA/00002256/202407","regulatory_outcome":"Variation","first_published_date":"13/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002256-202407"},{"category":"","active_substances_in_scope_of_procedure":"bismuth subcitrate potassium / metronidazole / tetracycline","active_substance":"bismuth subcitrate potassium;Metronidazole;tetracycline","related_medicines":"","procedure_number":"PSUSA/00010199/202405","regulatory_outcome":"Variation","first_published_date":"07/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-202405"},{"category":"","active_substances_in_scope_of_procedure":"iobitridol","active_substance":"iobitridol","related_medicines":"","procedure_number":"PSUSA/00001761/202404","regulatory_outcome":"Variation","first_published_date":"07/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001761-202404"},{"category":"","active_substances_in_scope_of_procedure":"aciclovir","active_substance":"aciclovir","related_medicines":"","procedure_number":"PSUSA/00000048/202406","regulatory_outcome":"Variation","first_published_date":"07/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000048-202406"},{"category":"","active_substances_in_scope_of_procedure":"phenylpropanolamine","active_substance":"phenylpropanolamine","related_medicines":"","procedure_number":"PSUSA/00010483/202406","regulatory_outcome":"Variation","first_published_date":"06/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010483-202406"},{"category":"","active_substances_in_scope_of_procedure":"tianeptine","active_substance":"tianeptine","related_medicines":"","procedure_number":"PSUSA/00002943/202406","regulatory_outcome":"Maintenance","first_published_date":"03/03/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002943-202406"},{"category":"Human","active_substances_in_scope_of_procedure":"propranolol (except for centrally authorised product)","active_substance":"propranolol (except for centrally authorised product)","related_medicines":"","procedure_number":"PSUSA/00000434/202407","regulatory_outcome":"Maintenance","first_published_date":"25/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000434-202407-0"},{"category":"","active_substances_in_scope_of_procedure":"brivudine","active_substance":"brivudine","related_medicines":"","procedure_number":"PSUSA/00000434/202407","regulatory_outcome":"Maintenance","first_published_date":"19/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000434-202407"},{"category":"","active_substances_in_scope_of_procedure":"clebopride","active_substance":"clebopride","related_medicines":"","procedure_number":"PSUSA/00000789/202406","regulatory_outcome":"Maintenance","first_published_date":"14/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000789-202406"},{"category":"","active_substances_in_scope_of_procedure":"dexchlorpheniramine","active_substance":"dexchlorpheniramine","related_medicines":"","procedure_number":"PSUSA/00000989/202406","regulatory_outcome":"Maintenance","first_published_date":"14/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000989-202406"},{"category":"","active_substances_in_scope_of_procedure":"nilutamide","active_substance":"nilutamide","related_medicines":"","procedure_number":"PSUSA/00002163/202407","regulatory_outcome":"Maintenance","first_published_date":"14/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002163-202407"},{"category":"","active_substances_in_scope_of_procedure":"human plasma proteins with no less than 95% albumin","active_substance":"human plasma proteins with no less than 95% albumin","related_medicines":"","procedure_number":"PSUSA/00010605/202407","regulatory_outcome":"Maintenance","first_published_date":"13/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010605-202407"},{"category":"","active_substances_in_scope_of_procedure":"anti-t lymphocyte immunoglobulin for human use, rabbit","active_substance":"anti-t lymphocyte immunoglobulin for human use, rabbit","related_medicines":"","procedure_number":"PSUSA/00010252/202406","regulatory_outcome":"Maintenance","first_published_date":"13/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010252-202406"},{"category":"Human","active_substances_in_scope_of_procedure":"nimesulide (systemic formulations)","active_substance":"nimesulide","related_medicines":"","procedure_number":"PSUSA/00009236/202406","regulatory_outcome":"Maintenance","first_published_date":"13/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009236-202406"},{"category":"Human","active_substances_in_scope_of_procedure":"benzalkonium chloride / ethyl alcohol, benzalkonium chloride / isopropyl alcohol","active_substance":"benzalkonium chloride;ethyl alcohol;isopropyl alcohol","related_medicines":"","procedure_number":"PSUSA/00000342/202407","regulatory_outcome":"Maintenance","first_published_date":"13/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000342-202407"},{"category":"","active_substances_in_scope_of_procedure":"hydrochlorothiazide / zofenopril","active_substance":"hydrochlorothiazide;zofenopril","related_medicines":"","procedure_number":"PSUSA/00003148/202405","regulatory_outcome":"Maintenance","first_published_date":"07/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003148-202405"},{"category":"","active_substances_in_scope_of_procedure":"oxaliplatin","active_substance":"oxaliplatin","related_medicines":"","procedure_number":"PSUSA/00002229/202404","regulatory_outcome":"Variation","first_published_date":"05/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002229-202404"},{"category":"","active_substances_in_scope_of_procedure":"amlodipine besilate / ramipril, amlodipine / hydrochlorothiazide / ramipril, hydrochlorothiazide / ramipril","active_substance":"amlodipine besilate;amlodipine;hydrochlorothiazide;hydrochlorothiazide;ramipril","related_medicines":"","procedure_number":"PSUSA/00010774/202403","regulatory_outcome":"Maintenance","first_published_date":"05/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010774-202403"},{"category":"","active_substances_in_scope_of_procedure":"biclotymol","active_substance":"biclotymol","related_medicines":"","procedure_number":"PSUSA/00000408/202405","regulatory_outcome":"Maintenance","first_published_date":"03/02/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000408-202405"},{"category":"","active_substances_in_scope_of_procedure":"olodaterol / tiotropium","active_substance":"olodaterol;tiotropium","related_medicines":"","procedure_number":"PSUSA/00010489/202405","regulatory_outcome":"Maintenance","first_published_date":"29/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010489-202405"},{"category":"","active_substances_in_scope_of_procedure":"promethazine","active_substance":"promethazine","related_medicines":"","procedure_number":"PSUSA/00002545/202404","regulatory_outcome":"Variation","first_published_date":"27/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002545-202404"},{"category":"","active_substances_in_scope_of_procedure":"nebivolol","active_substance":"nebivolol","related_medicines":"","procedure_number":"PSUSA/00002129/202403","regulatory_outcome":"Variation","first_published_date":"23/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002129-202403"},{"category":"","active_substances_in_scope_of_procedure":"tolperisone","active_substance":"tolperisone","related_medicines":"","procedure_number":"PSUSA/00002991/202406","regulatory_outcome":"Maintenance","first_published_date":"23/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002991-202406"},{"category":"","active_substances_in_scope_of_procedure":"flunarizine","active_substance":"flunarizine","related_medicines":"","procedure_number":"PSUSA/00001416/202405","regulatory_outcome":"Maintenance","first_published_date":"23/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001416-202405"},{"category":"","active_substances_in_scope_of_procedure":"enalapril maleate / lercanidipine","active_substance":"enalapril maleate;lercanidipine","related_medicines":"","procedure_number":"PSUSA/00001215/202406","regulatory_outcome":"Maintenance","first_published_date":"22/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001215-202406"},{"category":"","active_substances_in_scope_of_procedure":"buspirone","active_substance":"buspirone","related_medicines":"","procedure_number":"PSUSA/00000463/202404","regulatory_outcome":"Maintenance","first_published_date":"22/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000463-202404"},{"category":"Human","active_substances_in_scope_of_procedure":"loteprednol","active_substance":"loteprednol","related_medicines":"","procedure_number":"PSUSA/00001913/202405","regulatory_outcome":"Maintenance","first_published_date":"22/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001913-202405"},{"category":"","active_substances_in_scope_of_procedure":"Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure)","active_substance":"ambrosia artemisii folia","related_medicines":"","procedure_number":"PSUSA/00010693/202404","regulatory_outcome":"Variation","first_published_date":"22/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010693-202404"},{"category":"","active_substances_in_scope_of_procedure":"acemetacin","active_substance":"acemetacin","related_medicines":"","procedure_number":"PSUSA/00000026/202405","regulatory_outcome":"Maintenance","first_published_date":"21/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000026-202405"},{"category":"Human","active_substances_in_scope_of_procedure":"fentanyl (transdermal patches, solution for injection - nationally authorised product only)","active_substance":"fentanyl (transdermal patches, solution for injection - nationally authorised product only)","related_medicines":"","procedure_number":"PSUSA/00001370/202404","regulatory_outcome":"Variation","first_published_date":"21/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-202404"},{"category":"Human","active_substances_in_scope_of_procedure":"ranitidine","active_substance":"ranitidine","related_medicines":"","procedure_number":"PSUSA/00002610/202405","regulatory_outcome":"Maintenance","first_published_date":"21/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002610-202405"},{"category":"","active_substances_in_scope_of_procedure":"metyrapone","active_substance":"metyrapone","related_medicines":"","procedure_number":"PSUSA/00002046/202406","regulatory_outcome":"Maintenance","first_published_date":"20/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002046-202406"},{"category":"","active_substances_in_scope_of_procedure":"praziquantel","active_substance":"praziquantel","related_medicines":"","procedure_number":"PSUSA/00002503/202404","regulatory_outcome":"Maintenance","first_published_date":"20/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002503-202404"},{"category":"Human","active_substances_in_scope_of_procedure":"loperamide, loperamide / simethicone","active_substance":"loperamide;simethicone","related_medicines":"","procedure_number":"PSUSA/00010665/202405","regulatory_outcome":"Maintenance","first_published_date":"17/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010665-202405"},{"category":"Human","active_substances_in_scope_of_procedure":"deoxycholic acid","active_substance":"Deoxycholic acid","related_medicines":"","procedure_number":"PSUSA/00010525/202404","regulatory_outcome":"Maintenance","first_published_date":"17/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-202404"},{"category":"","active_substances_in_scope_of_procedure":"metformin","active_substance":"metformin","related_medicines":"","procedure_number":"PSUSA/00002001/202404","regulatory_outcome":"Variation","first_published_date":"17/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002001-202404"},{"category":"","active_substances_in_scope_of_procedure":"tafluprost","active_substance":"tafluprost","related_medicines":"","procedure_number":"PSUSA/00002843/202404","regulatory_outcome":"Maintenance","first_published_date":"17/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002843-202404"},{"category":"","active_substances_in_scope_of_procedure":"daunorubicin","active_substance":"daunorubicin","related_medicines":"","procedure_number":"PSUSA/00000936/202406","regulatory_outcome":"Maintenance","first_published_date":"16/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000936-202406"},{"category":"Human","active_substances_in_scope_of_procedure":"ferucarbotran","active_substance":"Ferucarbotran","related_medicines":"","procedure_number":"PSUSA/00001382/202406","regulatory_outcome":"Maintenance","first_published_date":"16/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001382-202406"},{"category":"Human","active_substances_in_scope_of_procedure":"indocyanine green","active_substance":"indocyanine green","related_medicines":"","procedure_number":"PSUSA/00001737/202405","regulatory_outcome":"Maintenance","first_published_date":"16/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001737-202405"},{"category":"","active_substances_in_scope_of_procedure":"yohimbine","active_substance":"yohimbine","related_medicines":"","procedure_number":"PSUSA/00003136/202405","regulatory_outcome":"Maintenance","first_published_date":"16/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003136-202405"},{"category":"","active_substances_in_scope_of_procedure":"alginic acid / aluminium oxide hydrated / sodium hydrogen carbonate, alginic acid / aluminium hydroxide / calcium carbonate / sodium carbonate","active_substance":"alginic acid;aluminium oxide hydrated;aluminium hydroxide;calcium carbonate;sodium carbonate","related_medicines":"","procedure_number":"PSUSA/00000123/202406","regulatory_outcome":"Maintenance","first_published_date":"16/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000123-202406"},{"category":"Human","active_substances_in_scope_of_procedure":"iodine (131i) iobenguane","active_substance":"Iodine (131I) iobenguane","related_medicines":"","procedure_number":"PSUSA/00001764/202405","regulatory_outcome":"Maintenance","first_published_date":"16/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001764-202405"},{"category":"","active_substances_in_scope_of_procedure":"bilastine","active_substance":"bilastine","related_medicines":"","procedure_number":"PSUSA/00003163/202403","regulatory_outcome":"Variation","first_published_date":"07/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003163-202403"},{"category":"","active_substances_in_scope_of_procedure":"chlorphenamine maleate / paracetamol","active_substance":"chlorphenamine maleate;paracetamol","related_medicines":"","procedure_number":"PSUSA/00000703/202403","regulatory_outcome":"Variation","first_published_date":"06/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000703-202403"},{"category":"","active_substances_in_scope_of_procedure":"lanthanum","active_substance":"lanthanum","related_medicines":"","procedure_number":"PSUSA/00003175/202403","regulatory_outcome":"Variation","first_published_date":"06/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003175-202403"},{"category":"","active_substances_in_scope_of_procedure":"oxycodone","active_substance":"oxycodone","related_medicines":"","procedure_number":"PSUSA/00002254/202404","regulatory_outcome":"Variation","first_published_date":"06/01/2025","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-202404"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofloxacin / fluocinolone acetonide","active_substance":"ciprofloxacin;Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00000772/202404","regulatory_outcome":"Maintenance","first_published_date":"04/12/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000772-202404"},{"category":"","active_substances_in_scope_of_procedure":"Ofloxacin (topical use)","active_substance":"ofloxacin","related_medicines":"","procedure_number":"PSUSA/00002204/202404","regulatory_outcome":"Maintenance","first_published_date":"02/12/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002204-202404"},{"category":"","active_substances_in_scope_of_procedure":"Dihydroergotamine","active_substance":"dihydroergotamine","related_medicines":"","procedure_number":"PSUSA/00001075/202404","regulatory_outcome":"Maintenance","first_published_date":"29/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001075-202404"},{"category":"","active_substances_in_scope_of_procedure":"chlorprothixene","active_substance":"chlorprothixene","related_medicines":"","procedure_number":"PSUSA/00000717/202403","regulatory_outcome":"Maintenance","first_published_date":"29/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000717-202403"},{"category":"","active_substances_in_scope_of_procedure":"isotretinoin (oral formulations)","active_substance":"isotretinoin (oral formulations)","related_medicines":"","procedure_number":"PSUSA/00010488/202405","regulatory_outcome":"Maintenance","first_published_date":"28/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202405"},{"category":"Human","active_substances_in_scope_of_procedure":"bupivacaine, bupivacaine / epinephrine","active_substance":"bupivacaine;bupivacaine / epinephrine","related_medicines":"","procedure_number":"PSUSA/00010335/202404","regulatory_outcome":"Maintenance","first_published_date":"28/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010335-202404"},{"category":"","active_substances_in_scope_of_procedure":"Carteolol","active_substance":"carteolol","related_medicines":"","procedure_number":"PSUSA/00000574/202403","regulatory_outcome":"Maintenance","first_published_date":"28/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000574-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"mesalazine","active_substance":"Mesalazine","related_medicines":"","procedure_number":"PSUSA/00001990/202402","regulatory_outcome":"Variation","first_published_date":"22/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001990-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"zofenopril","active_substance":"zofenopril","related_medicines":"","procedure_number":"PSUSA/00003147/202401","regulatory_outcome":"Variation","first_published_date":"22/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003147-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"terazosin","active_substance":"terazosin","related_medicines":"","procedure_number":"PSUSA/00002895/202311","regulatory_outcome":"Variation","first_published_date":"22/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002895-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"amiodarone","active_substance":"amiodarone","related_medicines":"","procedure_number":"PSUSA/00000166/202312","regulatory_outcome":"Variation","first_published_date":"21/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000166-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"levonorgestrel / ethinylestradiol, ethinylestradiol (combination pack)","active_substance":"levonorgestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010442/202401","regulatory_outcome":"Variation","first_published_date":"13/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"liothyronine","active_substance":"liothyronine","related_medicines":"","procedure_number":"PSUSA/00001890/202401","regulatory_outcome":"Variation","first_published_date":"12/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001890-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"zoledronic acid","active_substance":"zoledronic acid","related_medicines":"","procedure_number":"PSUSA/00003149/202308","regulatory_outcome":"Variation","first_published_date":"07/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003149-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"barnidipine","active_substance":"barnidipine","related_medicines":"","procedure_number":"PSUSA/00000300/202403","regulatory_outcome":"Maintenance","first_published_date":"06/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000300-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"5 fluorouracil (IV use)","active_substance":"5 fluorouracil","related_medicines":"","procedure_number":"PSUSA/00000007/202312","regulatory_outcome":"Variation","first_published_date":"05/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000007-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"nitrazepam","active_substance":"nitrazepam","related_medicines":"","procedure_number":"PSUSA/00002170/202403","regulatory_outcome":"Maintenance","first_published_date":"04/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002170-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"highly refined fish oil, glycerol, purified egg phosphatide","active_substance":"highly refined fish oil;glycerol;purified egg phosphatide","related_medicines":"","procedure_number":"PSUSA/00010802/202403","regulatory_outcome":"Maintenance","first_published_date":"04/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010802-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide","active_substance":"calcium chloride;glutamic acid;Glutathione;histidine;lactobionic acid;magnesium chloride;mannitol;potassium chloride;sodium hydroxide","related_medicines":"","procedure_number":"PSUSA/00009162/202403","regulatory_outcome":"Maintenance","first_published_date":"04/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009162-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"metamizole","active_substance":"metamizole","related_medicines":"","procedure_number":"PSUSA/00001997/202403","regulatory_outcome":"Maintenance","first_published_date":"04/11/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"fluprednidene","active_substance":"fluprednidene","related_medicines":"","procedure_number":"PSUSA/00010097/202403","regulatory_outcome":"Maintenance","first_published_date":"31/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010097-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"olodaterol","active_substance":"olodaterol","related_medicines":"","procedure_number":"PSUSA/00010245/202403","regulatory_outcome":"Maintenance","first_published_date":"31/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"erythromycin (topical use)","active_substance":"erythromycin","related_medicines":"","procedure_number":"PSUSA/00010809/202403","regulatory_outcome":"","first_published_date":"31/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010809-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"fluprednidene / gentamicin","active_substance":"fluprednidene;gentamicin","related_medicines":"","procedure_number":"PSUSA/00010098/202403","regulatory_outcome":"Maintenance","first_published_date":"31/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010098-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"human anti-d immunoglobulin","active_substance":"human anti-d immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00001614/202403","regulatory_outcome":"Maintenance","first_published_date":"31/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001614-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"fluorodopa (18F)","active_substance":"fluorodopa (18F)","related_medicines":"","procedure_number":"PSUSA/00010002/202403","regulatory_outcome":"Maintenance","first_published_date":"31/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010002-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"amantadine","active_substance":"amantadine","related_medicines":"","procedure_number":"PSUSA/00000126/202401","regulatory_outcome":"Variation","first_published_date":"29/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000126-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"valproic acid, sodium valproate, valproate pivoxil, valproate semisodium, valpromide, valproate bismuth, calcium valproate, valproate magnesium","active_substance":"valproic acid;sodium valproate;valproate pivoxil;valproate semisodium;valpromide;valproate bismuth;calcium valproate;valproate magnesium","related_medicines":"","procedure_number":"PSUSA/00003090/202401","regulatory_outcome":"Variation","first_published_date":"28/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003090-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"amitriptyline, amitriptyline / amitriptylinoxide, amitriptylinoxide","active_substance":"amitriptyline;amitriptylinoxide","related_medicines":"","procedure_number":"PSUSA/00010374/202401","regulatory_outcome":"Variation","first_published_date":"28/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010374-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"macrogol 3350 combinations (oral use)","active_substance":"Macrogol 3350","related_medicines":"","procedure_number":"PSUSA/00010705/202401","regulatory_outcome":"Variation","first_published_date":"25/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010705-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"amitriptyline / perphenazine","active_substance":"amitriptyline;perphenazine","related_medicines":"","procedure_number":"PSUSA/00000170/202401","regulatory_outcome":"Variation","first_published_date":"25/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000170-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"allopurinol","active_substance":"allopurinol","related_medicines":"","procedure_number":"PSUSA/00000095/202312","regulatory_outcome":"Variation","first_published_date":"24/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"galantamine","active_substance":"galantamine","related_medicines":"","procedure_number":"PSUSA/00001512/202403","regulatory_outcome":"Maintenance","first_published_date":"17/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001512-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"protirelin","active_substance":"protirelin","related_medicines":"","procedure_number":"PSUSA/00009273/202401","regulatory_outcome":"Maintenance","first_published_date":"17/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009273-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"Amlodipine\r\nLosartan","active_substance":"amlodipine;losartan","related_medicines":"","procedure_number":"PSUSA/00010512/202401","regulatory_outcome":"Maintenance","first_published_date":"17/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010512-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"cilazapril, cilazapril / hydrochlorothiazide","active_substance":"cilazapril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000749/202402","regulatory_outcome":"Maintenance","first_published_date":"16/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000749-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"human coagulation factor VIII (inhibitor bypassing fraction)","active_substance":"human coagulation factor VIII","related_medicines":"","procedure_number":"PSUSA/00009174/202402","regulatory_outcome":"Maintenance","first_published_date":"11/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"ferric carboxymaltose (parenteral use)","active_substance":"ferric carboxymaltose","related_medicines":"","procedure_number":"PSUSA/00010865/202401","regulatory_outcome":"Maintenance","first_published_date":"11/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010865-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"pentoxyverine","active_substance":"pentoxyverine","related_medicines":"","procedure_number":"PSUSA/00002345/202312","regulatory_outcome":"Maintenance","first_published_date":"11/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002345-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"rupatadine","active_substance":"rupatadine","related_medicines":"","procedure_number":"PSUSA/00002673/202312","regulatory_outcome":"Maintenance","first_published_date":"09/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"iron dextran","active_substance":"iron dextran","related_medicines":"","procedure_number":"PSUSA/00010696/202401","regulatory_outcome":"Maintenance","first_published_date":"09/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010696-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"iron sucrose (parenteral use)","active_substance":"iron sucrose","related_medicines":"","procedure_number":"PSUSA/00010864/202401","regulatory_outcome":"Maintenance","first_published_date":"09/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010864-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"aprotinin","active_substance":"aprotinin","related_medicines":"","procedure_number":"PSUSA/00000230/202402","regulatory_outcome":"Maintenance","first_published_date":"09/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000230-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"ferric derisomaltose (parenteral use)","active_substance":"ferric derisomaltose","related_medicines":"","procedure_number":"PSUSA/00010866/202401","regulatory_outcome":"Maintenance","first_published_date":"08/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010866-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"dorzolamide / timolol","active_substance":"dorzolamide;timolol","related_medicines":"","procedure_number":"PSUSA/00001166/202402","regulatory_outcome":"Maintenance","first_published_date":"07/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001166-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"sodium iron gluconate (parenteral use)","active_substance":"sodium iron gluconate (parenteral preparations)","related_medicines":"","procedure_number":"PSUSA/00010867/202401","regulatory_outcome":"Maintenance","first_published_date":"07/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010867-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"chlormadinone acetate / ethinylestradiol","active_substance":"chlormadinone acetate;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00000679/202401","regulatory_outcome":"Maintenance","first_published_date":"07/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000679-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"sterculia, frangula / sterculia","active_substance":"sterculia, frangula;sterculia","related_medicines":"","procedure_number":"PSUSA/00010428/202402","regulatory_outcome":"Maintenance","first_published_date":"07/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010428-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"chlormadinone","active_substance":"chlormadinone","related_medicines":"","procedure_number":"PSUSA/00000677/202401","regulatory_outcome":"Maintenance","first_published_date":"03/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000677-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/202402","regulatory_outcome":"Maintenance","first_published_date":"03/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"ondansetron","active_substance":"ondansetron","related_medicines":"","procedure_number":"PSUSA/00002217/202402","regulatory_outcome":"Maintenance","first_published_date":"03/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002217-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/202403","regulatory_outcome":"Maintenance","first_published_date":"03/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"nomegestrol","active_substance":"nomegestrol","related_medicines":"","procedure_number":"PSUSA/00002181/202401","regulatory_outcome":"Maintenance","first_published_date":"03/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002181-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"flubendazole","active_substance":"flubendazole","related_medicines":"","procedure_number":"PSUSA/00001400/202402","regulatory_outcome":"Maintenance","first_published_date":"03/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001400-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/202403","regulatory_outcome":"Maintenance","first_published_date":"03/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202403"},{"category":"Human","active_substances_in_scope_of_procedure":"ampicillin / sulbactam","active_substance":"ampicillin;sulbactam","related_medicines":"","procedure_number":"PSUSA/00000197/202402","regulatory_outcome":"Maintenance","first_published_date":"03/10/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000197-202402"},{"category":"Human","active_substances_in_scope_of_procedure":"bendroflumethiazide, bendroflumethiazide / potassium chloride","active_substance":"bendroflumethiazide;potassium chloride","related_medicines":"","procedure_number":"PSUSA/00010583/202401","regulatory_outcome":"Maintenance","first_published_date":"01/10/2024","last_updated_date":"01/10/2024","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010583-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"cefpodoxim","active_substance":"cefpodoxim","related_medicines":"","procedure_number":"PSUSA/00000604/202312","regulatory_outcome":"Variation","first_published_date":"25/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000604-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"meropenem","active_substance":"Meropenem","related_medicines":"","procedure_number":"PSUSA/00001989/202108","regulatory_outcome":"Maintenance","first_published_date":"19/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001989-202108"},{"category":"Human","active_substances_in_scope_of_procedure":"dexpanthenol","active_substance":"dexpanthenol","related_medicines":"","procedure_number":"PSUSA/00000999/202401","regulatory_outcome":"Maintenance","first_published_date":"19/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000999-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"cyproheptadine","active_substance":"cyproheptadine","related_medicines":"","procedure_number":"PSUSA/00000902/202312","regulatory_outcome":"Maintenance","first_published_date":"13/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000902-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"levodropropizine","active_substance":"levodropropizine","related_medicines":"","procedure_number":"PSUSA/00001853/202401","regulatory_outcome":"Maintenance","first_published_date":"12/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001853-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"betahistine","active_substance":"betahistine","related_medicines":"","procedure_number":"PSUSA/00000389/202312","regulatory_outcome":"Maintenance","first_published_date":"12/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000389-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"dydrogesterone-estradiol","active_substance":"dydrogesterone-estradiol","related_medicines":"","procedure_number":"PSUSA-00001276-202312","regulatory_outcome":"Variation","first_published_date":"12/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001276-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"doxazosin","active_substance":"doxazosin","related_medicines":"","procedure_number":"PSUSA/00001169/232312","regulatory_outcome":"Maintenance","first_published_date":"12/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001169-232312"},{"category":"Human","active_substances_in_scope_of_procedure":"lormetazepam","active_substance":"lormetazepam","related_medicines":"","procedure_number":"PSUSA/00001910/202312","regulatory_outcome":"Maintenance","first_published_date":"10/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001910-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"pseudoephedrine / triprolidine","active_substance":"pseudoephedrine;triprolidine","related_medicines":"","procedure_number":"PSUSA/00003047/202312","regulatory_outcome":"Maintenance","first_published_date":"10/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003047-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"ketotifen (oral formulations)","active_substance":"ketotifen","related_medicines":"","procedure_number":"PSUSA/00001813/202310","regulatory_outcome":"Maintenance","first_published_date":"10/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001813-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"azelastine","active_substance":"azelastine","related_medicines":"","procedure_number":"PSUSA/00000277/202312","regulatory_outcome":"Maintenance","first_published_date":"10/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000277-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"calcium carbonate / famotidine / magnesium hydroxide","active_substance":"calcium carbonate;Famotidine;magnesium hydroxide","related_medicines":"","procedure_number":"PSUSA/00001351/202309","regulatory_outcome":"Maintenance","first_published_date":"10/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001351-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"ketoprofen / sucralfate","active_substance":"ketoprofen;sucralfate","related_medicines":"","procedure_number":"PSUSA/00002797/202312","regulatory_outcome":"Maintenance","first_published_date":"10/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002797-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"hydrochlorothiazide / spironolactone","active_substance":"hydrochlorothiazide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00001662/202401","regulatory_outcome":"Maintenance","first_published_date":"09/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001662-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"povidone iodinated","active_substance":"povidone iodinated","related_medicines":"","procedure_number":"PSUSA/00002487/202401","regulatory_outcome":"Maintenance","first_published_date":"09/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002487-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"hepatitis A vaccines (inactivated, adsorbed)","active_substance":"hepatitis A vaccines","related_medicines":"","procedure_number":"PSUSA/00001596/202401","regulatory_outcome":"Maintenance","first_published_date":"09/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001596-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"caffeine / drotaverine hydrochloride / metamizole sodium","active_substance":"Caffeine;drotaverine hydrochloride;metamizole sodium","related_medicines":"","procedure_number":"PSUSA/00001996/202401","regulatory_outcome":"Maintenance","first_published_date":"06/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001996-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"celecoxib","active_substance":"celecoxib","related_medicines":"","procedure_number":"PSUSA/00000616/202312","regulatory_outcome":"Maintenance","first_published_date":"06/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000616-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"altizide / spironolactone","active_substance":"altizide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00002781/202401","regulatory_outcome":"Maintenance","first_published_date":"06/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002781-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"balsalazide","active_substance":"balsalazide","related_medicines":"","procedure_number":"PSUSA/00009074/202401","regulatory_outcome":"Maintenance","first_published_date":"06/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009074-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"salicylic acid (topical use)","active_substance":"salicylic acid","related_medicines":"","procedure_number":"PSUSA/00002680/202312","regulatory_outcome":"Variation","first_published_date":"06/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002680-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"dapoxetine","active_substance":"dapoxetine","related_medicines":"","procedure_number":"PSUSA/00000928/202312","regulatory_outcome":"Maintenance","first_published_date":"06/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000928-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"alitretinoin (oral use)","active_substance":"alitretinoin","related_medicines":"","procedure_number":"PSUSA/00010710/202401","regulatory_outcome":"Maintenance","first_published_date":"06/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202401"},{"category":"Human","active_substances_in_scope_of_procedure":"Codeine/ibuprofen","active_substance":"Codeine;Ibuprofen","related_medicines":"","procedure_number":"PSUSA/00000850/202312","regulatory_outcome":"Variation","first_published_date":"06/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000850-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"atomoxetine","active_substance":"atomoxetine","related_medicines":"","procedure_number":"PSUSA/00000262/202311","regulatory_outcome":"Variation","first_published_date":"03/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000262-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"glatiramer","active_substance":"glatiramer","related_medicines":"","procedure_number":"PSUSA/00001529/202311","regulatory_outcome":"Variation","first_published_date":"02/09/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001529-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"methylprednisolone","active_substance":"methylprednisolone","related_medicines":"","procedure_number":"PSUSA/00002026/202311","regulatory_outcome":"Variation","first_published_date":"29/08/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002026-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"hydroxycarbamide (except for centrally authorised product)","active_substance":"hydroxycarbamide","related_medicines":"","procedure_number":"PSUSA/00009182/202312","regulatory_outcome":"Variation","first_published_date":"27/08/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"hydrochlorothiazide / nebivolol","active_substance":"hydrochlorothiazide;nebivolol","related_medicines":"","procedure_number":"PSUSA/00001658/202311","regulatory_outcome":"Variation","first_published_date":"23/08/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001658-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"atorvastatin","active_substance":"atorvastatin","related_medicines":"","procedure_number":"PSUSA/00010347/202310","regulatory_outcome":"Variation","first_published_date":"13/08/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010347-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"Minoxidil (topical formulation)","active_substance":"minoxidil","related_medicines":"","procedure_number":"PSUSA/00002067/202310","regulatory_outcome":"Variation","first_published_date":"13/08/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002067-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/202311","regulatory_outcome":"Variation","first_published_date":"09/08/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"nimodipine","active_substance":"nimodipine","related_medicines":"","procedure_number":"PSUSA/00002166/202311","regulatory_outcome":"Variation","first_published_date":"07/08/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002166-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"ceftazidime","active_substance":"ceftazidime","related_medicines":"","procedure_number":"PSUSA/00000608/202310","regulatory_outcome":"Variation","first_published_date":"02/08/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000608-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"lisinopril / torasemide","active_substance":"lisinopril;torasemide","related_medicines":"","procedure_number":"PSUSA/00010685/202312","regulatory_outcome":"Maintenance","first_published_date":"19/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010685-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)","active_substance":"diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)","related_medicines":"","procedure_number":"PSUSA/00001124/202311","regulatory_outcome":"Maintenance","first_published_date":"19/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"nabilone","active_substance":"nabilone","related_medicines":"","procedure_number":"PSUSA/00002100/202312","regulatory_outcome":"Maintenance","first_published_date":"19/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002100-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"Ethanol extracts of: Iberis amara L., planta tota recens / Angelica archangelica L., radix / Matricaria recutita L., flos / Carum carvi L., fructus / Silybum marianum (L.) Gaertn., fructus / Melissa officinalis L., folium / Mentha piperita L., folium / Chelidonium majus L., herba / Glycyrrhiza glabra L., radix","active_substance":"iberis amara L., planta tota recens;angelica archangelica L., radix;matricaria recutita L., flos;carum carvi L., fructus;silybum marianum (L.) gaertn., fructus;melissa officinalis L., folium;mentha piperita L., folium;chelidonium majus L., herba;glycyrrhiza glabra L., radix","related_medicines":"","procedure_number":"PSUSA/00010800/202311","regulatory_outcome":"Maintenance","first_published_date":"16/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010800-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"levofloxacin (intravenous and oral use)","active_substance":"levofloxacin","related_medicines":"","procedure_number":"PSUSA/00010767/202310","regulatory_outcome":"Variation","first_published_date":"16/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010767-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"flupentixol / melitracene","active_substance":"flupentixol;melitracene","related_medicines":"","procedure_number":"PSUSA/00001445/202311","regulatory_outcome":"Maintenance","first_published_date":"16/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001445-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"tafluprost / timolol","active_substance":"tafluprost;timolol","related_medicines":"","procedure_number":"PSUSA/00010324/202312","regulatory_outcome":"Maintenance","first_published_date":"16/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010324-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"flupentixol","active_substance":"flupentixol","related_medicines":"","procedure_number":"PSUSA/00001444/202311","regulatory_outcome":"Maintenance","first_published_date":"16/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001444-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"sulfasalazine","active_substance":"sulfasalazine","related_medicines":"","procedure_number":"PSUSA/00002816/202312","regulatory_outcome":"Maintenance","first_published_date":"15/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002816-202312"},{"category":"Human","active_substances_in_scope_of_procedure":"baclofen (oral use, for muscle spasticity indication)","active_substance":"baclofen","related_medicines":"","procedure_number":"PSUSA/00000294/202309","regulatory_outcome":"Variation","first_published_date":"12/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000294-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/202310","regulatory_outcome":"Variation","first_published_date":"12/07/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"diclofenac (topical formulations)","active_substance":"diclofenac","related_medicines":"","procedure_number":"PSUSA/00010342/202309","regulatory_outcome":"Variation","first_published_date":"05/07/2024","last_updated_date":"05/07/2024","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010342-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"adapalene / benzoyl peroxide","active_substance":"adapalene;benzoyl peroxide","related_medicines":"","procedure_number":"PSUSA/00000059/202309","regulatory_outcome":"Variation","first_published_date":"05/07/2024","last_updated_date":"05/07/2024","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000059-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"tetrabenazine","active_substance":"tetrabenazine","related_medicines":"","procedure_number":"PSUSA/00002911/202310","regulatory_outcome":"Maintenance","first_published_date":"19/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"bromocriptine","active_substance":"bromocriptine","related_medicines":"","procedure_number":"PSUSA/00000438/202310","regulatory_outcome":"Maintenance","first_published_date":"19/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000438-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"Etifoxine","active_substance":"etifoxine","related_medicines":"","procedure_number":"PSUSA/00001321/202310","regulatory_outcome":"Maintenance","first_published_date":"18/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001321-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"methacholine","active_substance":"methacholine","related_medicines":"","procedure_number":"PSUSA/00010891/202310","regulatory_outcome":"Maintenance","first_published_date":"18/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010891-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"citric acid / potassium salts, potassium citrate","active_substance":"citric acid;potassium salts;potassium citrate","related_medicines":"","procedure_number":"PSUSA/00000783/202311","regulatory_outcome":"Maintenance","first_published_date":"18/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000783-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"flutamide","active_substance":"flutamide","related_medicines":"","procedure_number":"PSUSA/00001453/202310","regulatory_outcome":"Maintenance","first_published_date":"17/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001453-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"hydroxyzine, hydroxyzine combination","active_substance":"hydroxyzine","related_medicines":"","procedure_number":"PSUSA/00001696/202311","regulatory_outcome":"Maintenance","first_published_date":"17/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"ascorbic acid / chlorphenamine maleate / paracetamol","active_substance":"ascorbic acid;chlorphenamine maleate;paracetamol","related_medicines":"","procedure_number":"PSUSA/00000696/202311","regulatory_outcome":"Maintenance","first_published_date":"17/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000696-202311"},{"category":"Human","active_substances_in_scope_of_procedure":"ramipril","active_substance":"ramipril","related_medicines":"","procedure_number":"PSUSA/00002607/202308","regulatory_outcome":"Maintenance","first_published_date":"12/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002607-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"lithium","active_substance":"lithium","related_medicines":"","procedure_number":"PSUSA/00001897/202308","regulatory_outcome":"Variation","first_published_date":"11/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001897-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"naproxen","active_substance":"naproxen","related_medicines":"","procedure_number":"PSUSA/00002125/202308","regulatory_outcome":"Variation","first_published_date":"11/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002125-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"trimetazidine","active_substance":"trimetazidine","related_medicines":"","procedure_number":"PSUSA/00003043/202308","regulatory_outcome":"Variation","first_published_date":"06/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"vincristine","active_substance":"vincristine","related_medicines":"","procedure_number":"PSUSA/00003121/202308","regulatory_outcome":"Variation","first_published_date":"05/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003121-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"naloxone / oxycodone","active_substance":"naloxone;oxycodone","related_medicines":"","procedure_number":"PSUSA/00002114/202308","regulatory_outcome":"Variation","first_published_date":"04/06/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002114-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"dexibuprofen","active_substance":"dexibuprofen","related_medicines":"","procedure_number":"PSUSA/00000996/202308","regulatory_outcome":"Variation","first_published_date":"30/05/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000996-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"human von willebrand factor","active_substance":"human von willebrand factor","related_medicines":"","procedure_number":"PSUSA/00001642/202309","regulatory_outcome":"Maintenance","first_published_date":"28/05/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001642-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"desflurane","active_substance":"desflurane","related_medicines":"","procedure_number":"PSUSA/00000958/202309","regulatory_outcome":"Maintenance","first_published_date":"21/05/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000958-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"levofloxacin (ocular use)","active_substance":"levofloxacin","related_medicines":"","procedure_number":"PSUSA/00010768/202310","regulatory_outcome":"Maintenance","first_published_date":"17/05/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010768-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"prulifloxacin","active_substance":"prulifloxacin","related_medicines":"","procedure_number":"PSUSA/00002569/202309","regulatory_outcome":"Maintenance","first_published_date":"16/05/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002569-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"acetylcysteine","active_substance":"acetylcysteine","related_medicines":"","procedure_number":"PSUSA/00000034/202309","regulatory_outcome":"Maintenance","first_published_date":"16/05/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000034-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"rubidium (82Rb) chloride","active_substance":"rubidium (82Rb) chloride","related_medicines":"","procedure_number":"PSUSA/00010806/202310","regulatory_outcome":"Maintenance","first_published_date":"16/05/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010806-202310"},{"category":"Human","active_substances_in_scope_of_procedure":"paracetamol/tramadol","active_substance":"paracetamol;tramadol","related_medicines":"","procedure_number":"PSUSA/00002310/202308","regulatory_outcome":"Variation","first_published_date":"06/05/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002310-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"quetiapine","active_substance":"quetiapine","related_medicines":"","procedure_number":"PSUSA/00002589/202307","regulatory_outcome":"Variation","first_published_date":"03/05/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002589-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"mirtazapine","active_substance":"mirtazapine","related_medicines":"","procedure_number":"PSUSA/00002068/202308","regulatory_outcome":"Maintenance","first_published_date":"25/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002068-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"inosine pranobex","active_substance":"inosine pranobex","related_medicines":"","procedure_number":"PSUSA/00010425/202308","regulatory_outcome":"Maintenance","first_published_date":"22/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010425-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"human plasma protease C1 inhibitor (nationally authorised products)","active_substance":"human plasma protease C1 inhibitor","related_medicines":"","procedure_number":"PSUSA/00010163/202308","regulatory_outcome":"Maintenance","first_published_date":"22/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010163-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"rosuvastatin/ perindopril /indapamide","active_substance":"rosuvastatin;perindopril;Indapamide","related_medicines":"","procedure_number":"PSUSA/00010752/202308","regulatory_outcome":"Maintenance","first_published_date":"19/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010752-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"dienogest / estradiol (contraception indication)","active_substance":"Dienogest;estradiol","related_medicines":"","procedure_number":"PSUSA/00010444/202309","regulatory_outcome":"Maintenance","first_published_date":"17/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010444-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"ipratropium / xylometazoline","active_substance":"ipratropium;xylometazoline","related_medicines":"","procedure_number":"PSUSA/00009201/202308","regulatory_outcome":"Maintenance","first_published_date":"17/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009201-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"fluocinolone acetonide (intravitreal implant in applicator)","active_substance":"Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00010224/202308","regulatory_outcome":"Maintenance","first_published_date":"15/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"modafinil","active_substance":"modafinil","related_medicines":"","procedure_number":"PSUSA/00010242/202308","regulatory_outcome":"Maintenance","first_published_date":"15/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010242-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"zolpidem","active_substance":"zolpidem","related_medicines":"","procedure_number":"PSUSA/00003151/202308","regulatory_outcome":"","first_published_date":"15/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003151-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"bromazepam","active_substance":"bromazepam","related_medicines":"","procedure_number":"PSUSA/00000435/202308","regulatory_outcome":"Maintenance","first_published_date":"15/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000435-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"pefloxacin","active_substance":"pefloxacin","related_medicines":"","procedure_number":"PSUSA/00002322/202308","regulatory_outcome":"Maintenance","first_published_date":"15/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002322-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"phenytoin","active_substance":"phenytoin","related_medicines":"","procedure_number":"PSUSA/00002392/202308","regulatory_outcome":"Maintenance","first_published_date":"15/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002392-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"trazodone","active_substance":"trazodone","related_medicines":"","procedure_number":"PSUSA/00003012/202308","regulatory_outcome":"Maintenance","first_published_date":"15/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003012-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"suxamethonium","active_substance":"suxamethonium","related_medicines":"","procedure_number":"PSUSA/00002834/202308","regulatory_outcome":"Maintenance","first_published_date":"15/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002834-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"dexamfetamine","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"PSUSA/00000986/202309","regulatory_outcome":"Maintenance","first_published_date":"15/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202309"},{"category":"Human","active_substances_in_scope_of_procedure":"prednisolone","active_substance":"prednisolone","related_medicines":"","procedure_number":"PSUSA/00002506/202308","regulatory_outcome":"Maintenance","first_published_date":"12/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002506-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"colchicine","active_substance":"colchicine","related_medicines":"","procedure_number":"PSUSA/00000858/202307","regulatory_outcome":"Maintenance","first_published_date":"12/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000858-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"levocetirizine","active_substance":"levocetirizine","related_medicines":"","procedure_number":"PSUSA/00001850/202307","regulatory_outcome":"Maintenance","first_published_date":"12/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001850-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"diclofenac / misoprostol","active_substance":"diclofenac;misoprostol","related_medicines":"","procedure_number":"PSUSA/00001040/202307","regulatory_outcome":"Maintenance","first_published_date":"12/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001040-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"xylometazoline","active_substance":"xylometazoline","related_medicines":"","procedure_number":"PSUSA/00003134/202305","regulatory_outcome":"Maintenance","first_published_date":"12/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003134-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"pimecrolimus","active_substance":"pimecrolimus","related_medicines":"","procedure_number":"PSUSA/00002411/202303","regulatory_outcome":"Maintenance","first_published_date":"12/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"aztreonam (parenteral use)","active_substance":"aztreonam","related_medicines":"","procedure_number":"PSUSA/00010178/202308","regulatory_outcome":"Maintenance","first_published_date":"12/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010178-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"finasteride","active_substance":"Finasteride","related_medicines":"","procedure_number":"PSUSA/00001392/202308","regulatory_outcome":"Maintenance","first_published_date":"11/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"paracetamol / pseudoephedrine","active_substance":"paracetamol;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00002307/202306","regulatory_outcome":"Variation","first_published_date":"04/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002307-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"ibuprofen / pseudoephedrine","active_substance":"Ibuprofen;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001711/202307","regulatory_outcome":"Variation","first_published_date":"04/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"rizatriptan","related_medicines":"","procedure_number":"PSUSA/00002655/202306","regulatory_outcome":"Variation","first_published_date":"04/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002655-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"ibutilide","active_substance":"ibutilide","related_medicines":"","procedure_number":"PSUSA/00001713/202212","regulatory_outcome":"Maintenance","first_published_date":"04/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001713-202212"},{"category":"Human","active_substances_in_scope_of_procedure":"felodipine","active_substance":"felodipine","related_medicines":"","procedure_number":"PSUSA/00001356/202212","regulatory_outcome":"Maintenance","first_published_date":"04/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001356-202212"},{"category":"Human","active_substances_in_scope_of_procedure":"rosuvastatin","active_substance":"rosuvastatin","related_medicines":"","procedure_number":"PSUSA/00002664/202211","regulatory_outcome":"Maintenance","first_published_date":"04/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002664-202211"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"tramadol","related_medicines":"","procedure_number":"PSUSA/00003002/202306","regulatory_outcome":"Variation","first_published_date":"04/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003002-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"oxycodone hydrochloride / paracetamol","active_substance":"oxycodone hydrochloride;paracetamol","related_medicines":"","procedure_number":"PSUSA/00002256/202307","regulatory_outcome":"Variation","first_published_date":"03/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002256-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"nimesulide (topical formulations)","active_substance":"nimesulide","related_medicines":"","procedure_number":"PSUSA/00002165/202306","regulatory_outcome":"Variation","first_published_date":"02/04/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002165-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"Dienogest;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00001057/202303","regulatory_outcome":"Maintenance","first_published_date":"26/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001057-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010378/202305","regulatory_outcome":"Variation","first_published_date":"25/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010378-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"fenofibrate","active_substance":"fenofibrate","related_medicines":"","procedure_number":"PSUSA/00001362/202307","regulatory_outcome":"Maintenance","first_published_date":"25/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001362-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"cyproterone","active_substance":"cyproterone","related_medicines":"","procedure_number":"PSUSA/00000905/202307","regulatory_outcome":"Maintenance","first_published_date":"25/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000905-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"lanreotide","active_substance":"lanreotide","related_medicines":"","procedure_number":"PSUSA/00001826/202305","regulatory_outcome":"Maintenance","first_published_date":"25/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"estradiol, estradiol /prednisolone (only cream/balm/emulsion for application in the female genital area)","active_substance":"estradiol;prednisolone","related_medicines":"","procedure_number":"PSUSA/00010441/202304","regulatory_outcome":"Maintenance","first_published_date":"25/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010441-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"misoprostol (gynaecological indication - termination of pregnancy)","related_medicines":"","procedure_number":"PSUSA/00010354/202305","regulatory_outcome":"Variation","first_published_date":"21/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010354-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"mifepristone","active_substance":"mifepristone","related_medicines":"","procedure_number":"PSUSA/00002060/202305","regulatory_outcome":"Variation","first_published_date":"15/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002060-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"ezetimibe;rosuvastatin","related_medicines":"","procedure_number":"PSUSA/00010271/202307","regulatory_outcome":"Maintenance","first_published_date":"14/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010271-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"cyproterone / ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00000906/202305","regulatory_outcome":"Maintenance","first_published_date":"12/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000906-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"oxytocin (systemic use)","related_medicines":"","procedure_number":"PSUSA/00010913/202306","regulatory_outcome":"Maintenance","first_published_date":"12/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010913-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"Ribavirin (oral formulations)","active_substance":"ribavirin","related_medicines":"","procedure_number":"PSUSA/00010007/202307","regulatory_outcome":"Maintenance","first_published_date":"08/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010007-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"indometacin","active_substance":"indometacin","related_medicines":"","procedure_number":"PSUSA/00001738/202307","regulatory_outcome":"Maintenance","first_published_date":"08/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001738-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"niclosamide","active_substance":"niclosamide","related_medicines":"","procedure_number":"PSUSA/00002151/202308","regulatory_outcome":"Maintenance","first_published_date":"07/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002151-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"donepezil / memantine","active_substance":"donepezil;memantine","related_medicines":"","procedure_number":"PSUSA/00011039/202307","regulatory_outcome":"Maintenance","first_published_date":"07/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00011039-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"Anastrozole","active_substance":"anastrozole","related_medicines":"","procedure_number":"PSUSA/00000210/202308","regulatory_outcome":"Maintenance","first_published_date":"07/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000210-202308"},{"category":"Human","active_substances_in_scope_of_procedure":"gadopentetic acid","active_substance":"gadopentetic acid","related_medicines":"","procedure_number":"PSUSA/00001504/202304","regulatory_outcome":"Variation","first_published_date":"06/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001504-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"gadoteric acid (IV and intravascular formulations)","active_substance":"gadoteric acid (IV and intravascular formulations)","related_medicines":"","procedure_number":"PSUSA/00001506/202304","regulatory_outcome":"Variation","first_published_date":"04/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001506-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"nalbuphine","active_substance":"nalbuphine","related_medicines":"","procedure_number":"PSUSA-00002110-202305","regulatory_outcome":"Variation","first_published_date":"01/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002110-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"ceftriaxone","active_substance":"ceftriaxone","related_medicines":"","procedure_number":"PSUSA/00000613/202305","regulatory_outcome":"Variation","first_published_date":"01/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000613-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"gadobenic acid","active_substance":"gadobenic acid","related_medicines":"","procedure_number":"PSUSA/00001500/202304","regulatory_outcome":"Variation","first_published_date":"01/03/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001500-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"moxifloxacin (systemic use)","active_substance":"moxifloxacin","related_medicines":"","procedure_number":"PSUSA/00009231/202305","regulatory_outcome":"Variation","first_published_date":"29/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009231-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"Gadobutrol","active_substance":"Gadobutrol","related_medicines":"","procedure_number":"PSUSA/00001502/202304","regulatory_outcome":"Variation","first_published_date":"29/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001502-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"gadoxetic acid disodium","active_substance":"gadoxetic acid disodium","related_medicines":"","procedure_number":"PSUSA/00001509/202304","regulatory_outcome":"Variation","first_published_date":"29/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001509-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"gadoteridol","active_substance":"gadoteridol","related_medicines":"","procedure_number":"PSUSA/00001507/202304","regulatory_outcome":"Variation","first_published_date":"29/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001507-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"octreotide","active_substance":"octreotide","related_medicines":"","procedure_number":"PSUSA/00002201/202306","regulatory_outcome":"Maintenance","first_published_date":"27/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002201-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"phentermine;topiramate","related_medicines":"","procedure_number":"PSUSA/00010956/202307","regulatory_outcome":"Maintenance","first_published_date":"15/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010956-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"pseudoephedrine, acetylsalicylic acid / pseudoephedrine","active_substance":"pseudoephedrine;acetylsalicylic acid","related_medicines":"","procedure_number":"PSUSA/00010667/202306","regulatory_outcome":"Maintenance","first_published_date":"12/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010667-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"almotriptan","active_substance":"almotriptan","related_medicines":"","procedure_number":"PSUSA/00000101/202306","regulatory_outcome":"Maintenance","first_published_date":"12/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000101-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"Ferucarbotran","active_substance":"Ferucarbotran","related_medicines":"","procedure_number":"PSUSA/00001382/202306","regulatory_outcome":"Maintenance","first_published_date":"09/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001382-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)","active_substance":"hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)","related_medicines":"","procedure_number":"PSUSA/00001594/202306","regulatory_outcome":"Maintenance","first_published_date":"09/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001594-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"misoprostol (gastrointestinal indication)","active_substance":"misoprostol (gastrointestinal indication)","related_medicines":"","procedure_number":"PSUSA/00010291/202306","regulatory_outcome":"Maintenance","first_published_date":"09/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"allergen for therapy: betula verrucosa (sublingual use)","active_substance":"allergen for therapy: betula verrucosa (sublingual use)","related_medicines":"","procedure_number":"PSUSA/00010815/202307","regulatory_outcome":"Maintenance","first_published_date":"09/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202307"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"epirubicin","related_medicines":"","procedure_number":"PSUSA/00001234/202306","regulatory_outcome":"Maintenance","first_published_date":"08/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001234-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"fentanyl (transdermal patches, solution for injection - nationally authorised product only)","active_substance":"fentanyl (transdermal patches, solution for injection - nationally authorised product only)","related_medicines":"","procedure_number":"PSUSA/00001370/202304","regulatory_outcome":"","first_published_date":"06/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"gentamicin (systemic use)","related_medicines":"","procedure_number":"PSUSA/00009159/202303","regulatory_outcome":"Variation","first_published_date":"01/02/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009159-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"racecadotril","related_medicines":"","procedure_number":"PSUSA/00002602/202303","regulatory_outcome":"Variation","first_published_date":"30/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002602-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"aceclofenac","related_medicines":"","procedure_number":"PSUSA/00000022/202303","regulatory_outcome":"Variation","first_published_date":"25/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000022-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"piroxicam","active_substance":"piroxicam","related_medicines":"","procedure_number":"PSUSA/00002438/202304","regulatory_outcome":"Variation","first_published_date":"24/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002438-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"clarithromycin","active_substance":"clarithromycin","related_medicines":"","procedure_number":"PSUSA/00000788/202304","regulatory_outcome":"Variation","first_published_date":"24/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000788-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"venlafaxine","active_substance":"venlafaxine","related_medicines":"","procedure_number":"PSUSA/00003104/202305","regulatory_outcome":"Variation","first_published_date":"24/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003104-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"pravastatin","active_substance":"pravastatin","related_medicines":"","procedure_number":"PSUSA/00002500/202303","regulatory_outcome":"Variation","first_published_date":"24/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002500-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"mometasone","active_substance":"mometasone","related_medicines":"","procedure_number":"PSUSA/00002085/202305","regulatory_outcome":"Maintenance","first_published_date":"24/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002085-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"nortriptyline","active_substance":"nortriptyline","related_medicines":"","procedure_number":"PSUSA/00002192/202303","regulatory_outcome":"Variation","first_published_date":"19/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002192-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"Zuclopenthixol","active_substance":"zuclopenthixol","related_medicines":"","procedure_number":"PSUSA/00003155/202305","regulatory_outcome":"Maintenance","first_published_date":"16/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003155-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"patent blue V sodium","related_medicines":"","procedure_number":"PSUSA/00002320/202304v","regulatory_outcome":"","first_published_date":"16/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002320-202304v"},{"category":"Human","active_substances_in_scope_of_procedure":"chlorpromazine","active_substance":"chlorpromazine","related_medicines":"","procedure_number":"PSUSA/00000715/202305","regulatory_outcome":"Maintenance","first_published_date":"15/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000715-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"latanoprost (products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001834/202304","regulatory_outcome":"Maintenance","first_published_date":"15/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"norfloxacin","active_substance":"norfloxacin","related_medicines":"","procedure_number":"PSUSA/00002190/202306","regulatory_outcome":"Maintenance","first_published_date":"12/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002190-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"ebastine","active_substance":"ebastine","related_medicines":"","procedure_number":"PSUSA/00001191/202305","regulatory_outcome":"Maintenance","first_published_date":"12/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001191-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"pelargonium sidoides dc and-or pelargonium reniforme curt-radix","related_medicines":"","procedure_number":"PSUSA/00002329/202306","regulatory_outcome":"Maintenance","first_published_date":"11/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002329-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"aciclovir","related_medicines":"","procedure_number":"PSUSA/00000048/202306","regulatory_outcome":"Maintenance","first_published_date":"11/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000048-202306"},{"category":"Human","active_substances_in_scope_of_procedure":"Thiamphenicol","active_substance":"thiamphenicol","related_medicines":"","procedure_number":"PSUSA/00002925/202305","regulatory_outcome":"Maintenance","first_published_date":"11/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002925-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"Irinotecan (except for liposomal formulations)","active_substance":"irinotecan","related_medicines":"","procedure_number":"PSUSA/00001783/202305","regulatory_outcome":"Maintenance","first_published_date":"11/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001783-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"azithromycin (ocular use formulations)","related_medicines":"","procedure_number":"PSUSA/00010492/202304","regulatory_outcome":"Maintenance","first_published_date":"11/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010492-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"Azithromycin (systemic use formulations)","active_substance":"azithromycin","related_medicines":"","procedure_number":"PSUSA/00010491/202304","regulatory_outcome":"Maintenance","first_published_date":"11/01/2024","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010491-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"fluconazole","related_medicines":"","procedure_number":"PSUSA/00001404/202303","regulatory_outcome":"Variation","first_published_date":"22/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001404-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"doxylamine","related_medicines":"","procedure_number":"PSUSA/00001174/202304","regulatory_outcome":"Maintenance","first_published_date":"22/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001174-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"piribedil","related_medicines":"","procedure_number":"PSUSA/00002436/202303","regulatory_outcome":"Maintenance","first_published_date":"22/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002436-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"lavender oil","related_medicines":"","procedure_number":"PSUSA/00010810/202304","regulatory_outcome":"Maintenance","first_published_date":"22/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010810-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"furosemide-spironolactone","related_medicines":"","procedure_number":"PSUSA/00001493/202303","regulatory_outcome":"Variation","first_published_date":"22/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001493-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"","related_medicines":"","procedure_number":"PSUSA/00002254/202304","regulatory_outcome":"Variation","first_published_date":"21/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"ibuprofen, ibuprofen lysine (not indicated in ductus arteriosus), ibuprofen / caffeine","active_substance":"Ibuprofen;ibuprofen lysine;Caffeine","related_medicines":"","procedure_number":"PSUSA/00010649/202302","regulatory_outcome":"Variation","first_published_date":"29/11/2023","last_updated_date":"11/12/2023","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010649-202302"},{"category":"Human","active_substances_in_scope_of_procedure":"ofloxacin (systemic use)","active_substance":"ofloxacin","related_medicines":"","procedure_number":"PSUSA/00002203/202304","regulatory_outcome":"Maintenance","first_published_date":"07/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"Dronabinol;cannabidiol","related_medicines":"","procedure_number":"PSUSA/00010844/202304","regulatory_outcome":"Maintenance","first_published_date":"07/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010844-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"rifamyciun","related_medicines":"","procedure_number":"PSUSA-00002641-202304","regulatory_outcome":"Maintenance","first_published_date":"07/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002641-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"cytarabine","active_substance":"cytarabine","related_medicines":"","procedure_number":"PSUSA/00000911/202303","regulatory_outcome":"Maintenance","first_published_date":"06/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000911-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"porfimer","active_substance":"porfimer","related_medicines":"","procedure_number":"PSUSA/00010332/202304","regulatory_outcome":"Maintenance","first_published_date":"06/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010332-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"ivabradine / metoprolol","active_substance":"ivabradine;metoprolol","related_medicines":"","procedure_number":"PSUSA/00010381/202304","regulatory_outcome":"Maintenance","first_published_date":"06/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"Tretinoin (topical formulations)","active_substance":"tretinoin;tetrabenazine (ADV6979)","related_medicines":"","procedure_number":"PSUSA/00003016/202208","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003016-202208"},{"category":"","active_substances_in_scope_of_procedure":"Tapentadol","active_substance":"tapentadol","related_medicines":"","procedure_number":"PSUSA/00002849/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-201411"},{"category":"","active_substances_in_scope_of_procedure":"ceftobiprole","active_substance":"ceftobiprole","related_medicines":"","procedure_number":"PSUSA/00010734/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010734-202111"},{"category":"Human","active_substances_in_scope_of_procedure":"xylometazoline","active_substance":"xylometazoline","related_medicines":"","procedure_number":"PSUSA/00003134/202005","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003134-202005"},{"category":"","active_substances_in_scope_of_procedure":"acarbose","active_substance":"acarbose","related_medicines":"","procedure_number":"PSUSA/00000017/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000017-201503"},{"category":"","active_substances_in_scope_of_procedure":"acarbose","active_substance":"acarbose","related_medicines":"","procedure_number":"PSUSA/0000017/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0000017-201803"},{"category":"","active_substances_in_scope_of_procedure":"acebutolol","active_substance":"acebutolol","related_medicines":"","procedure_number":"PSUSA/00000018/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000018-201712"},{"category":"","active_substances_in_scope_of_procedure":"aceclofenac","active_substance":"aceclofenac","related_medicines":"","procedure_number":"PSUSA/00000022/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000022-201703"},{"category":"","active_substances_in_scope_of_procedure":"aceclofenac","active_substance":"aceclofenac","related_medicines":"","procedure_number":"PSUSA/00000022/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000022-202003"},{"category":"","active_substances_in_scope_of_procedure":"acenocoumarol","active_substance":"acenocoumarol","related_medicines":"","procedure_number":"PSUSA/00000027/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000027-202107"},{"category":"","active_substances_in_scope_of_procedure":"acemetacin","active_substance":"acemetacin","related_medicines":"","procedure_number":"PSUSA/00000026/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000026-201805"},{"category":"","active_substances_in_scope_of_procedure":"Acetyl salicylic acid / atorvastatin / ramipril","active_substance":"acetyl salicylic acid;atorvastatin;ramipril","related_medicines":"","procedure_number":"PSUSA/00010280/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010280-201702"},{"category":"","active_substances_in_scope_of_procedure":"Acetyl salicylic acid / atorvastatin / ramipril","active_substance":"acetyl salicylic acid;atorvastatin;ramipril","related_medicines":"","procedure_number":"PSUSA/00010280/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010280-202002"},{"category":"","active_substances_in_scope_of_procedure":"Acetylcysteine","active_substance":"acetylcysteine","related_medicines":"","procedure_number":"PSUSA/00000034/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000034-201509"},{"category":"","active_substances_in_scope_of_procedure":"Acetylcysteine","active_substance":"acetylcysteine","related_medicines":"","procedure_number":"PSUSA/00000034/201809","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000034-201809"},{"category":"","active_substances_in_scope_of_procedure":"Acetylsalicylic acid / bisoprolol","active_substance":"acetylsalicylic acid;bisoprolol","related_medicines":"","procedure_number":"PSUSA/00010287/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-202111"},{"category":"","active_substances_in_scope_of_procedure":"Acetylsalicylic acid / bisoprolol","active_substance":"acetylsalicylic acid;bisoprolol","related_medicines":"","procedure_number":"PSUSA/00010287/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-201811"},{"category":"","active_substances_in_scope_of_procedure":"Acetylsalicylic acid / bisoprolol","active_substance":"acetylsalicylic acid;bisoprolol","related_medicines":"","procedure_number":"PSUSA/00010287/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-201505"},{"category":"","active_substances_in_scope_of_procedure":"Acetylsalicylic acid / bisoprolol","active_substance":"acetylsalicylic acid;bisoprolol","related_medicines":"","procedure_number":"PSUSA/00010287/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-201511"},{"category":"","active_substances_in_scope_of_procedure":"acetylsalicylic acid","active_substance":"acetylsalicylic acid","related_medicines":"","procedure_number":"PSUSA/00000039/201902","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000039-201902"},{"category":"","active_substances_in_scope_of_procedure":"(18f) fludeoxyglucose","active_substance":"fludeoxyglucose (18F)","related_medicines":"","procedure_number":"PSUSA/00001437/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001437-201411"},{"category":"","active_substances_in_scope_of_procedure":"1-propanol / 2-propanol / lactic acid","active_substance":"1-propanol;2-propanol;lactic acid","related_medicines":"","procedure_number":"PSUSA/00010414/201909","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010414-201909"},{"category":"","active_substances_in_scope_of_procedure":"acetylsalicylic acid","active_substance":"acetylsalicylic acid","related_medicines":"","procedure_number":"PSUSA/00000039/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000039-201602"},{"category":"","active_substances_in_scope_of_procedure":"Aciclovir / hydrocortisone","active_substance":"aciclovir;hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00009004/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009004-201707"},{"category":"","active_substances_in_scope_of_procedure":"Aciclovir / hydrocortisone","active_substance":"aciclovir;hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00009004/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009004-202007"},{"category":"","active_substances_in_scope_of_procedure":"Aciclovir","active_substance":"aciclovir","related_medicines":"","procedure_number":"PSUSA 00000048/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000048-201506"},{"category":"","active_substances_in_scope_of_procedure":"Aciclovir","active_substance":"aciclovir","related_medicines":"","procedure_number":"PSUSA/00000048/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000048-201806"},{"category":"","active_substances_in_scope_of_procedure":"Acipimox","active_substance":"acipimox","related_medicines":"","procedure_number":"PSUSA/00000050/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000050-202105"},{"category":"","active_substances_in_scope_of_procedure":"Acipimox","active_substance":"acipimox","related_medicines":"","procedure_number":"PSUSA/00000050/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000050-201512"},{"category":"","active_substances_in_scope_of_procedure":"Acipimox","active_substance":"acipimox","related_medicines":"","procedure_number":"PSUSA/00000050/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000050-201805"},{"category":"","active_substances_in_scope_of_procedure":"Acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202010"},{"category":"","active_substances_in_scope_of_procedure":"Acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202110"},{"category":"","active_substances_in_scope_of_procedure":"Acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201610"},{"category":"","active_substances_in_scope_of_procedure":"Acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/201810","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201810"},{"category":"","active_substances_in_scope_of_procedure":"Acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/201510","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201510"},{"category":"","active_substances_in_scope_of_procedure":"Acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201710"},{"category":"","active_substances_in_scope_of_procedure":"Acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201910"},{"category":"","active_substances_in_scope_of_procedure":"Adapalene / benzoyl peroxide","active_substance":"adapalene;benzoyl peroxide","related_medicines":"","procedure_number":"PSUSA/00000059/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000059-202009"},{"category":"","active_substances_in_scope_of_procedure":"Adapalene / benzoyl peroxide","active_substance":"adapalene;benzoyl peroxide","related_medicines":"","procedure_number":"PSUSA/00000059/201709","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000059-201709"},{"category":"","active_substances_in_scope_of_procedure":"Adapalene / benzoyl peroxide","active_substance":"adapalene;benzoyl peroxide","related_medicines":"","procedure_number":"PSUSA/00000059/201409","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000059-201409"},{"category":"","active_substances_in_scope_of_procedure":"Adapalene","active_substance":"adapalene","related_medicines":"","procedure_number":"PSUSA/0058/201807","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0058-201807"},{"category":"","active_substances_in_scope_of_procedure":"Adenosine","active_substance":"adenosine","related_medicines":"","procedure_number":"PSUSA/00000062/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000062-201708"},{"category":"","active_substances_in_scope_of_procedure":"Ajmaline","active_substance":"ajmaline","related_medicines":"","procedure_number":"PSUSA/00000072/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000072-201608"},{"category":"","active_substances_in_scope_of_procedure":"Alanine / arginine / aspartic acid / cysteine / glucose anhydrous / glutamic acid / glycine / histidine / isoleucine / leucine / lysine / methionine / olive oil refined / ornithine / phenylalanine / proline / serine / sodium chloride / sodium glycerophosphate hydrated / soya bean oil / taurine / threonine / tryptophan / tyrosine / valine / potassium acetate / calcium chloride dihydrate / magnesium acetate tetrahydrate / olive oil","active_substance":"alanine;arginine;aspartic acid;cysteine;glucose anhydrous;glutamic acid;glycine;histidine;isoleucine;leucine;lysine;methionine;ornithine;phenylalanine;proline;serine;sodium chloride;sodium glycerophosphate hydrated;soya bean oil;taurine;threonine;tryptophan;tyrosine;valine;potassium acetate;calcium chloride dihydrate;magnesium acetate tetrahydrate;olive oil","related_medicines":"","procedure_number":"PSUSA/00010190/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201506"},{"category":"","active_substances_in_scope_of_procedure":"Alanine / arginine / aspartic acid / cysteine / glucose anhydrous / glutamic acid / glycine / histidine / isoleucine / leucine / lysine / methionine / olive oil refined / ornithine / phenylalanine / proline / serine / sodium chloride / sodium glycerophosphate hydrated / soya bean oil / taurine / threonine / tryptophan / tyrosine / valine / potassium acetate / calcium chloride dihydrate / magnesium acetate tetrahydrate / olive oil","active_substance":"alanine;arginine;aspartic acid;cysteine;glucose anhydrous;glutamic acid;glycine;histidine;isoleucine;leucine;lysine;methionine;ornithine;phenylalanine;proline;serine;sodium chloride;sodium glycerophosphate hydrated;soya bean oil;taurine;threonine;tryptophan;tyrosine;valine;potassium acetate;calcium chloride dihydrate;magnesium acetate tetrahydrate;olive oil","related_medicines":"","procedure_number":"PSUSA/00010190/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201512"},{"category":"","active_substances_in_scope_of_procedure":"Albendazole","active_substance":"albendazole","related_medicines":"","procedure_number":"PSUSA/00000073/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000073-202007"},{"category":"","active_substances_in_scope_of_procedure":"Aldesleukin","active_substance":"aldesleukin","related_medicines":"","procedure_number":"PSUSA/00000076/201712","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000076-201712"},{"category":"","active_substances_in_scope_of_procedure":"Alendronate / alfacalcidol","active_substance":"alendronate;alfacalcidol","related_medicines":"","procedure_number":"PSUSA/00010308/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010308-201512"},{"category":"","active_substances_in_scope_of_procedure":"Alendronate","active_substance":"alendronate","related_medicines":"","procedure_number":"PSUSA/00000078/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000078-202101"},{"category":"","active_substances_in_scope_of_procedure":"Alendronate","active_substance":"alendronate","related_medicines":"","procedure_number":"PSUSA/00000078/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000078-201601"},{"category":"","active_substances_in_scope_of_procedure":"Alfacalcidol","active_substance":"alfacalcidol","related_medicines":"","procedure_number":"PSUSA/00000080/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000080-202006"},{"category":"","active_substances_in_scope_of_procedure":"1-propanol / 2-propanol / orthophenylphenol","active_substance":"1-propanol;2-propanol;orthophenylphenol","related_medicines":"","procedure_number":"PSUSA/00010406/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010406-201910"},{"category":"","active_substances_in_scope_of_procedure":"13C-methacetin","active_substance":"methacetin (13C)","related_medicines":"","procedure_number":"PSUSA/00010846/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010846-202010"},{"category":"","active_substances_in_scope_of_procedure":"13C-methacetin","active_substance":"methacetin (13C)","related_medicines":"","procedure_number":"PSUSA/00010846/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010846-202110"},{"category":"","active_substances_in_scope_of_procedure":"5 fluorouracil (i.v. application)","active_substance":"5 fluorouracil","related_medicines":"","procedure_number":"PSUSA/00000007/202012","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000007-202012"},{"category":"","active_substances_in_scope_of_procedure":"5 fluorouracil (i.v. application)","active_substance":"5 fluorouracil","related_medicines":"","procedure_number":"PSUSA/00000007/201712","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000007-201712"},{"category":"","active_substances_in_scope_of_procedure":"5 fluorouracil (i.v. application)","active_substance":"5 fluorouracil","related_medicines":"","procedure_number":"PSUSA/00000007/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000007-201412"},{"category":"","active_substances_in_scope_of_procedure":"5 fluorouracil (topical application)","active_substance":"5 fluorouracil","related_medicines":"","procedure_number":"PSUSA/00010000/201901","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010000-201901"},{"category":"","active_substances_in_scope_of_procedure":"5 Fluorouracil (topical application)","active_substance":"5 fluorouracil","related_medicines":"","procedure_number":"PSUSA/00010000/201412","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010000-201412"},{"category":"","active_substances_in_scope_of_procedure":"5 fluorouracil (topical application)","active_substance":"5 fluorouracil","related_medicines":"","procedure_number":"PSUSA/00010000/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010000-201712"},{"category":"","active_substances_in_scope_of_procedure":"5 fluorouracil / salicylic acid","active_substance":"5 fluorouracil;salicylic acid","related_medicines":"","procedure_number":"PSUSA/00000008/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000008-202105"},{"category":"","active_substances_in_scope_of_procedure":"5 fluorouracil / salicylic acid","active_substance":"5 fluorouracil;salicylic acid","related_medicines":"","procedure_number":"PSUSA/00000008/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000008-201805"},{"category":"","active_substances_in_scope_of_procedure":"5 fluorouracil / salicylic acid","active_substance":"5 fluorouracil;salicylic acid","related_medicines":"","procedure_number":"PSUSA/00000008/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000008-201505"},{"category":"","active_substances_in_scope_of_procedure":"allopurinol","active_substance":"allopurinol","related_medicines":"","procedure_number":"PSUSA/00000095/201612","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-201612"},{"category":"","active_substances_in_scope_of_procedure":"allopurinol","active_substance":"allopurinol","related_medicines":"","procedure_number":"PSUSA/00000095/202012","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-202012"},{"category":"","active_substances_in_scope_of_procedure":"allopurinol","active_substance":"allopurinol","related_medicines":"","procedure_number":"PSUSA/00000095/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-201512"},{"category":"","active_substances_in_scope_of_procedure":"allopurinol","active_substance":"allopurinol","related_medicines":"","procedure_number":"PSUSA/00000095/201712","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-201712"},{"category":"","active_substances_in_scope_of_procedure":"almagate","active_substance":"almagate","related_medicines":"","procedure_number":"PSUSA/00000097/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000097-201505"},{"category":"","active_substances_in_scope_of_procedure":"almotriptan","active_substance":"almotriptan","related_medicines":"","procedure_number":"PSUSA/00000101/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000101-201706"},{"category":"","active_substances_in_scope_of_procedure":"almotriptan","active_substance":"almotriptan","related_medicines":"","procedure_number":"PSUSA/00000101/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000101-202006"},{"category":"","active_substances_in_scope_of_procedure":"alpha-1-antitrypsin","active_substance":"alpha-1-antitrypsin","related_medicines":"","procedure_number":"PSUSA/00000108/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000108-201412"},{"category":"","active_substances_in_scope_of_procedure":"alprazolam","active_substance":"alprazolam","related_medicines":"","procedure_number":"PSUSA/00000109/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000109-201903"},{"category":"","active_substances_in_scope_of_procedure":"alprazolam","active_substance":"alprazolam","related_medicines":"","procedure_number":"PSUSA/00000109/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000109-201603"},{"category":"","active_substances_in_scope_of_procedure":"Alprostadil (erectile dysfunction)","active_substance":"alprostadil","related_medicines":"","procedure_number":"PSUSA/00000110/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000110-202101"},{"category":"","active_substances_in_scope_of_procedure":"Alprostadil (erectile dysfunction)","active_substance":"alprostadil","related_medicines":"","procedure_number":"PSUSA/00000110/201601","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000110-201601"},{"category":"","active_substances_in_scope_of_procedure":"Alprostadil (indicated in peripheral arterial occlusive diseases)","active_substance":"alprostadil","related_medicines":"","procedure_number":"PSUSA/00000111/201707","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000111-201707"},{"category":"","active_substances_in_scope_of_procedure":"Alprostadil (patency of the ductus arteriosus)","active_substance":"alprostadil","related_medicines":"","procedure_number":"PSUSA/00010021/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010021-202107"},{"category":"","active_substances_in_scope_of_procedure":"Alprostadil (patency of the ductus arteriosus)","active_substance":"alprostadil","related_medicines":"","procedure_number":"PSUSA/00010021/201807","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010021-201807"},{"category":"","active_substances_in_scope_of_procedure":"Alprostadil (patency of the ductus arteriosus)","active_substance":"alprostadil","related_medicines":"","procedure_number":"PSUSA/00010021/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010021-201507"},{"category":"","active_substances_in_scope_of_procedure":"alteplase","active_substance":"alteplase","related_medicines":"","procedure_number":"PSUSA/00000112/201705","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000112-201705"},{"category":"","active_substances_in_scope_of_procedure":"altizide / spironolactone","active_substance":"altizide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00002781/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002781-202101"},{"category":"","active_substances_in_scope_of_procedure":"altizide / spironolactone","active_substance":"altizide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00002781/201501","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002781-201501"},{"category":"","active_substances_in_scope_of_procedure":"altizide / spironolactone","active_substance":"altizide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00002781/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002781-201801"},{"category":"","active_substances_in_scope_of_procedure":"amantadine","active_substance":"amantadine","related_medicines":"","procedure_number":"PSUSA/00000126/201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000126-201801"},{"category":"","active_substances_in_scope_of_procedure":"Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure)","active_substance":"","related_medicines":"","procedure_number":"PSUSA/00010693/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010693-201901"},{"category":"","active_substances_in_scope_of_procedure":"Ambroxol / clenbuterol","active_substance":"ambroxol;clenbuterol","related_medicines":"","procedure_number":"PSUSA/00000131/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000131-201609"},{"category":"","active_substances_in_scope_of_procedure":"Ambroxol / clenbuterol","active_substance":"ambroxol;clenbuterol","related_medicines":"","procedure_number":"PSUSA/00000131/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000131-201909"},{"category":"","active_substances_in_scope_of_procedure":"Ambroxol","active_substance":"ambroxol","related_medicines":"","procedure_number":"PSUSA/00000130/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000130-201609"},{"category":"","active_substances_in_scope_of_procedure":"Ambroxol","active_substance":"ambroxol","related_medicines":"","procedure_number":"PSUSA/00000130/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000130-201909"},{"category":"","active_substances_in_scope_of_procedure":"amfepramone","active_substance":"amfepramone","related_medicines":"","procedure_number":"PSUSA/00000138/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000138-202006"},{"category":"","active_substances_in_scope_of_procedure":"amikacin","active_substance":"amikacin","related_medicines":"","procedure_number":"PSUSA/00000143/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000143-201706"},{"category":"","active_substances_in_scope_of_procedure":"Amino acid combinations (only combinations of pure amino acids or combination of amino acids with mineral compounds/electrolytes, i.v. application)","active_substance":"amino acid combinations","related_medicines":"","procedure_number":"PSUSA/00010187/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010187-201901"},{"category":"","active_substances_in_scope_of_procedure":"Amino acid combinations / glucose / triglyceride combinations / with or without electrolytes / mineral compounds - only for the drug Numeta","active_substance":"amino acid combinations;glucose;triglyceride combinations","related_medicines":"","procedure_number":"PSUSA/00010190/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201612"},{"category":"","active_substances_in_scope_of_procedure":"Amino acid combinations / glucose / triglyceride combinations / with or without electrolytes / mineral compounds - only for the drug Numeta","active_substance":"amino acid combinations;glucose;triglyceride combinations","related_medicines":"","procedure_number":"PSUSA/00010190/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201712"},{"category":"","active_substances_in_scope_of_procedure":"Amino acid combinations / glucose / triglyceride combinations / with or without electrolytes / mineral compounds - only for the drug Numeta","active_substance":"amino acid combinations;glucose;triglyceride combinations","related_medicines":"","procedure_number":"PSUSA/00010190/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201812"},{"category":"","active_substances_in_scope_of_procedure":"Amino acid combinations / glucose / triglyceride combinations","active_substance":"amino acid combinations;glucose;triglyceride combinations","related_medicines":"","procedure_number":"PSUSA/00010565/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010565-202106"},{"category":"","active_substances_in_scope_of_procedure":"Amino acid combinations/ glucose/ with or without electrolytes / mineral compounds","active_substance":"amino acid combinations;glucose;triglyceride combinations","related_medicines":"","procedure_number":"PSUSA/00010566/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010566-202106"},{"category":"","active_substances_in_scope_of_procedure":"aminosalicylate sodium","active_substance":"aminosalicylate sodium","related_medicines":"","procedure_number":"PSUSA/00000165/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000165-201610"},{"category":"","active_substances_in_scope_of_procedure":"aminosalicylate sodium","active_substance":"aminosalicylate sodium","related_medicines":"","procedure_number":"PSUSA/00000165/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000165-201910"},{"category":"","active_substances_in_scope_of_procedure":"amiodarone","active_substance":"amiodarone","related_medicines":"","procedure_number":"PSUSA/00000166/202012","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000166-202012"},{"category":"","active_substances_in_scope_of_procedure":"amiodarone","active_substance":"amiodarone","related_medicines":"","procedure_number":"PSUSA/00000166/201412","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000166-201412"},{"category":"","active_substances_in_scope_of_procedure":"amiodarone","active_substance":"amiodarone","related_medicines":"","procedure_number":"PSUSA/00000166/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000166-201712"},{"category":"","active_substances_in_scope_of_procedure":"amisulpride","active_substance":"amisulpride","related_medicines":"","procedure_number":"PSUSA/00000167/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000167-201701"},{"category":"","active_substances_in_scope_of_procedure":"amisulpride","active_substance":"amisulpride","related_medicines":"","procedure_number":"PSUSA/00000167/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000167-202001"},{"category":"","active_substances_in_scope_of_procedure":"amisulpride","active_substance":"amisulpride","related_medicines":"","procedure_number":"PSUSA/00000167/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000167-201501"},{"category":"","active_substances_in_scope_of_procedure":"amisulpride","active_substance":"amitriptyline;perphenazine","related_medicines":"","procedure_number":"PSUSA/00000170/202101","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000170-202101"},{"category":"","active_substances_in_scope_of_procedure":"amisulpride","active_substance":"amitriptyline;perphenazine","related_medicines":"","procedure_number":"PSUSA/00000170/201501","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000170-201501"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline hydrochloride / chlordiazepoxide","active_substance":"amitriptyline hydrochloride;chlordiazepoxide","related_medicines":"","procedure_number":"PSUSA/00000171/201602","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-201602"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline hydrochloride / chlordiazepoxide","active_substance":"amitriptyline hydrochloride;chlordiazepoxide","related_medicines":"","procedure_number":"PSUSA/00000171/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-201702"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline hydrochloride / chlordiazepoxide","active_substance":"amitriptyline hydrochloride;chlordiazepoxide","related_medicines":"","procedure_number":"PSUSA/00000171/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-201802"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline hydrochloride / chlordiazepoxide","active_substance":"amitriptyline hydrochloride;chlordiazepoxide","related_medicines":"","procedure_number":"PSUSA/00000171/201902","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-201902"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline hydrochloride / chlordiazepoxide","active_substance":"amitriptyline hydrochloride;chlordiazepoxide","related_medicines":"","procedure_number":"PSUSA/00000171/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-202002"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline hydrochloride / chlordiazepoxide","active_substance":"amitriptyline hydrochloride;chlordiazepoxide","related_medicines":"","procedure_number":"PSUSA/00000171/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-202102"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline, amitriptyline / amitriptylinoxide, amitriptylinoxide","active_substance":"amitriptyline;amitriptylinoxide","related_medicines":"","procedure_number":"PSUSA/00010374/202101","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010374-202101"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline, amitriptyline / amitriptylinoxide, amitriptylinoxide","active_substance":"amitriptyline;amitriptylinoxide","related_medicines":"","procedure_number":"PSUSA/00010374/201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010374-201801"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline / perphenazine","active_substance":"amitriptyline;perphenazine","related_medicines":"","procedure_number":"PSUSA/00000170/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000170-201801"},{"category":"","active_substances_in_scope_of_procedure":"Amitriptyline","active_substance":"amitriptyline","related_medicines":"","procedure_number":"PSUSA/00000168/201501","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000168-201501"},{"category":"","active_substances_in_scope_of_procedure":"AmitriptylineAmlodipine / atorvastatin / perindopril","active_substance":"amlodipine;atorvastatin;perindopril","related_medicines":"","procedure_number":"PSUSA/00010431/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010431-202010"},{"category":"","active_substances_in_scope_of_procedure":"alfentanil","active_substance":"alfentanil","related_medicines":"","procedure_number":"PSUSA/00000082/202109","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-202109"},{"category":"","active_substances_in_scope_of_procedure":"alfentanil","active_substance":"alfentanil","related_medicines":"","procedure_number":"PSUSA/00000082/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-201509"},{"category":"","active_substances_in_scope_of_procedure":"alfentanil","active_substance":"alfentanil","related_medicines":"","procedure_number":"PSUSA/00000082/201809","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-201809"},{"category":"","active_substances_in_scope_of_procedure":"alfuzosin","active_substance":"alfuzosin","related_medicines":"","procedure_number":"PSUSA/00000084/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000084-201711"},{"category":"","active_substances_in_scope_of_procedure":"alitretinoin (oral use)","active_substance":"alitretinoin","related_medicines":"","procedure_number":"PSUSA/00010710/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202101"},{"category":"","active_substances_in_scope_of_procedure":"alitretinoin (oral use)","active_substance":"alitretinoin","related_medicines":"","procedure_number":"PSUSA/00010710/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-201901"},{"category":"","active_substances_in_scope_of_procedure":"alitretinoin (oral use)","active_substance":"alitretinoin","related_medicines":"","procedure_number":"PSUSA/00010710/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202001"},{"category":"","active_substances_in_scope_of_procedure":"alizapride","active_substance":"alizapride","related_medicines":"","procedure_number":"PSUSA/00000091/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000091-202101"},{"category":"","active_substances_in_scope_of_procedure":"alizapride","active_substance":"alizapride","related_medicines":"","procedure_number":"PSUSA/00000082/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-201509-0"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for diagnostic - skin prick test containing only Phleum Pratense (product authorised via mutually recognition procedure)","active_substance":"Phleum pratense","related_medicines":"","procedure_number":"PSUSA/00010466/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010466-201610"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure)","active_substance":"","related_medicines":"","procedure_number":"PSUSA/00010693/201904","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010693-201904"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure)","active_substance":"","related_medicines":"","procedure_number":"PSUSA/00010693/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010693-202110"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: betula verrucosa (sublingual tablet)","active_substance":"Betula verrucosa","related_medicines":"","procedure_number":"PSUSA/00010815/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202101"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: betula verrucosa (sublingual tablet)","active_substance":"Betula verrucosa","related_medicines":"","procedure_number":"PSUSA/00010815/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202107"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis L. (sublingual tablet)","active_substance":"Dactylis glomerata L.;Phleum pratense L.;Anthoxanthum odoratum L.;Poa pratensis L.;Lolium perenne L.","related_medicines":"","procedure_number":"PSUSA/00010465/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010465-201912"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis","active_substance":"Dactylis glomerata L.;Phleum pratense L.;Anthoxanthum odoratum L.;Poa pratensis L.;Lolium perenne L.","related_medicines":"","procedure_number":"PSUSA/00010465/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010465-201612"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Dermatophagoides pteronyssinus / Dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)","active_substance":"Dermatophagoides pteronyssinus;Dermatophagoides farina","related_medicines":"","procedure_number":"PSUSA/00010582/202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-202109"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Dermatophagoides pteronyssinus / Dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)","active_substance":"Dermatophagoides pteronyssinus;Dermatophagoides farina","related_medicines":"","procedure_number":"PSUSA/00010582/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-201909"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Dermatophagoides pteronyssinus / Dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)","active_substance":"Dermatophagoides pteronyssinus;Dermatophagoides farina","related_medicines":"","procedure_number":"PSUSA/00010582/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-201803"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Phleum Pratense (oromucosal use, product authorised via mutually recognition procedure)","active_substance":"Phleum pratense L.","related_medicines":"","procedure_number":"PSUSA/00010475/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010475-201607"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Phleum Pratense (oromucosal use, product authorised via mutually recognition procedure)","active_substance":"Phleum pratense L.","related_medicines":"","procedure_number":"PSUSA/00010475/201907","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010475-201907"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / atorvastatine","active_substance":"amlodipine;atorvastatin","related_medicines":"","procedure_number":"PSUSA/00000177/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000177-201601"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / indapamide, amlodipine / indapamide / perindopril","active_substance":"amlodipine;Indapamide;perindopril","related_medicines":"","procedure_number":"PSUSA/00010358/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010358-201711"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / losartan","active_substance":"amlodipine;losartan","related_medicines":"","procedure_number":"PSUSA/00010512/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010512-201901"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / perindopril","active_substance":"amlodipine;perindopril","related_medicines":"","procedure_number":"PSUSA/00000179/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000179-202110"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / perindopril","active_substance":"amlodipine;perindopril","related_medicines":"","procedure_number":"PSUSA/00000179/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000179-201610"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / rosuvastatin, perindopril / amlodipine / rosuvastatin","active_substance":"amlodipine;perindopril;rosuvastatin","related_medicines":"","procedure_number":"PSUSA/00010434/202107","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010434-202107"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / rosuvastatin","active_substance":"amlodipine;rosuvastatin","related_medicines":"","procedure_number":"PSUSA/00010434/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010434-201807"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine besilate / ramipril, amlodipine / hydrochlorothiazide / ramipril, hydrochlorothiazide / ramipril","active_substance":"amlodipine besilate;amlodipine;hydrochlorothiazide;hydrochlorothiazide;ramipril","related_medicines":"","procedure_number":"PSUSA/00010774/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010774-202103"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine besilate / ramipril","active_substance":"amlodipine besilate;ramipril","related_medicines":"","procedure_number":"PSUSA/00000181/201503","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000181-201503"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine besilate / ramipril","active_substance":"amlodipine besilate;ramipril","related_medicines":"","procedure_number":"PSUSA/00000181/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000181-201803"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine besilate / hydrochlorothiazide / olmesartan medoxomil","active_substance":"amlodipine besilate;hydrochlorothiazide;olmesartan medoxomil","related_medicines":"","procedure_number":"PSUSA/00002210/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002210-201704"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine lisinopril","active_substance":"amlodipine;lisinopril","related_medicines":"","procedure_number":"PSUSA/00010192/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010192-201612"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / candesartan","active_substance":"amlodipine;Candesartan","related_medicines":"","procedure_number":"PSUSA/00010191/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010191-201704"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / olmesartan","active_substance":"amlodipine;olmesartan","related_medicines":"","procedure_number":"PSUSA/00002208/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002208-201704"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine","active_substance":"amlodipine","related_medicines":"","procedure_number":"PSUSA/00000174/201703","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000174-201703"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine","active_substance":"amlodipine","related_medicines":"","procedure_number":"PSUSA/00000174/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000174-201603"},{"category":"","active_substances_in_scope_of_procedure":"Amorolfine","active_substance":"amorolfine","related_medicines":"","procedure_number":"PSUSA/00000185/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000185-201706"},{"category":"","active_substances_in_scope_of_procedure":"Amoxicillin / clavulanate","active_substance":"amoxicillin;clavulanate","related_medicines":"","procedure_number":"PSUSA/00000188/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000188-201703"},{"category":"","active_substances_in_scope_of_procedure":"Amoxicillin","active_substance":"amoxicillin","related_medicines":"","procedure_number":"PSUSA/00000187/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000187-201703"},{"category":"","active_substances_in_scope_of_procedure":"Ampicillin / sulbactam","active_substance":"ampicillin;sulbactam","related_medicines":"","procedure_number":"PSUSA/00000197/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000197-202102"},{"category":"","active_substances_in_scope_of_procedure":"Ampicillin / sulbactam","active_substance":"ampicillin;sulbactam","related_medicines":"","procedure_number":"PSUSA/00000197/201502","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000197-201502"},{"category":"","active_substances_in_scope_of_procedure":"Ampicillin / sulbactam","active_substance":"ampicillin;sulbactam","related_medicines":"","procedure_number":"PSUSA/00000197/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000197-201802"},{"category":"","active_substances_in_scope_of_procedure":"Amsacrine","active_substance":"amsacrine","related_medicines":"","procedure_number":"PSUSA/00000199/201906","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000199-201906"},{"category":"","active_substances_in_scope_of_procedure":"Anastrozole","active_substance":"anastrozole","related_medicines":"","procedure_number":"PSUSA/00000210/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000210-201708"},{"category":"","active_substances_in_scope_of_procedure":"Androstanolone","active_substance":"androstanolone","related_medicines":"","procedure_number":"PSUSA/00000212/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000212-201412"},{"category":"","active_substances_in_scope_of_procedure":"Aniracetam","active_substance":"aniracetam","related_medicines":"","procedure_number":"PSUSA/00010790/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010790-202108"},{"category":"","active_substances_in_scope_of_procedure":"Anthrax vaccine","active_substance":"anthrax vaccine","related_medicines":"","procedure_number":"PSUSA/00010771/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010771-202012"},{"category":"","active_substances_in_scope_of_procedure":"Anthrax vaccine","active_substance":"anthrax vaccine","related_medicines":"","procedure_number":"PSUSA/00010771/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010771-201912"},{"category":"","active_substances_in_scope_of_procedure":"Anti-T lymphocyte immunoglobulin for human use, horse","active_substance":"anti-T lymphocyte immunoglobulin for human use, horse","related_medicines":"","procedure_number":"PSUSA/00010433/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010433-201811"},{"category":"","active_substances_in_scope_of_procedure":"Antithrombin iii","active_substance":"antithrombin iii","related_medicines":"","procedure_number":"PSUSA/00003159/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003159-202012"},{"category":"","active_substances_in_scope_of_procedure":"Antithrombin iii","active_substance":"antithrombin iii","related_medicines":"","procedure_number":"PSUSA/00003159/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003159-201612"},{"category":"","active_substances_in_scope_of_procedure":"Antithrombin iii","active_substance":"antithrombin iii","related_medicines":"","procedure_number":"PSUSA/00003159/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003159-201712"},{"category":"","active_substances_in_scope_of_procedure":"Antithrombin iii","active_substance":"antithrombin iii","related_medicines":"","procedure_number":"PSUSA/00003159/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003159-201512"},{"category":"","active_substances_in_scope_of_procedure":"Apomorphine","active_substance":"apomorphine","related_medicines":"","procedure_number":"PSUSA/00000227/201505","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-201505"},{"category":"","active_substances_in_scope_of_procedure":"Apomorphine","active_substance":"apomorphine","related_medicines":"","procedure_number":"PSUSA/00000227/201511","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-201511"},{"category":"","active_substances_in_scope_of_procedure":"Apomorphine","active_substance":"apomorphine","related_medicines":"","procedure_number":"PSUSA/00000227/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-201611"},{"category":"","active_substances_in_scope_of_procedure":"Apomorphine","active_substance":"apomorphine","related_medicines":"","procedure_number":"PSUSA/00000227/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-201911"},{"category":"","active_substances_in_scope_of_procedure":"Aprotinin / calcium chloride / human factor XIII / ...","active_substance":"aprotinin;calcium chloride;human factor XIII;human fibrinogen;human thrombin, aprotinin;fibrinogen;fibronectin;human coagulation factor XIII;plasma protein fraction;plasminogen;thrombin, aprotinin;human fibrinogen;thrombin;calcium chloride, aprotinin;calcium chloride;factor XIII;human thrombin;human clottable protein containing mainly fibrinogen and fibronectin, calcium chloride;human fibrinogen;bovine aprotinin, calcium chloride;bovine aprotinin, human fibrinogen;calcium chloride dihydrate;plasma fibronectin;bovine aprotinin;human coagulation factor XIII, human fibrinogen;calcium chloride dihydrate;plasma protein fraction;fibronectin","related_medicines":"","procedure_number":"PSUSA/00010346/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010346-201611"},{"category":"","active_substances_in_scope_of_procedure":"Aprotinin","active_substance":"aprotinin","related_medicines":"","procedure_number":"PSUSA-00000230-201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000230-201802"},{"category":"","active_substances_in_scope_of_procedure":"Aprotinin","active_substance":"aprotinin","related_medicines":"","procedure_number":"PSUSA/00000230/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000230-201602"},{"category":"","active_substances_in_scope_of_procedure":"Argatroban","active_substance":"argatroban","related_medicines":"","procedure_number":"PSUSA/ 00009057/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009057-202101"},{"category":"","active_substances_in_scope_of_procedure":"Argatroban","active_substance":"argatroban","related_medicines":"","procedure_number":"PSUSA/00009057/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009057-201801"},{"category":"","active_substances_in_scope_of_procedure":"Argatroban","active_substance":"argatroban","related_medicines":"","procedure_number":"PSUSA/00009057/201501","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009057-201501"},{"category":"","active_substances_in_scope_of_procedure":"Argipressin","active_substance":"argipressin","related_medicines":"","procedure_number":"PSUSA/00010749/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010749-202103"},{"category":"","active_substances_in_scope_of_procedure":"Artemether / lumefantrin (apart from the dispersible tablet)","active_substance":"artemether;lumefantrin","related_medicines":"","procedure_number":"PSUSA/00000236/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000236-201610"},{"category":"","active_substances_in_scope_of_procedure":"Artemether / lumefantrin (dispersible tablet)","active_substance":"artemether;lumefantrin","related_medicines":"","procedure_number":"PSUSA/00009060/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009060-201510"},{"category":"","active_substances_in_scope_of_procedure":"Artemether / lumefantrin (dispersible tablet)","active_substance":"artemether;lumefantrin","related_medicines":"","procedure_number":"PSUSA/0009060/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0009060-201504"},{"category":"","active_substances_in_scope_of_procedure":"Artemether-lumefantrin (apart from the dispersible tablet)","active_substance":"artemether;lumefantrin","related_medicines":"","procedure_number":"PSUSA/00000236/201910","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000236-201910"},{"category":"","active_substances_in_scope_of_procedure":"Ascorbic acid / paracetamol / pheniramine maleate","active_substance":"ascorbic acid;paracetamol;pheniramine maleate","related_medicines":"","procedure_number":"PSUSA/00002368/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002368-202003"},{"category":"","active_substances_in_scope_of_procedure":"Ascorbic acid / paracetamol / phenylephrine hydrochloride","active_substance":"ascorbic acid;paracetamol;phenylephrine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00000255/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000255-202006"},{"category":"","active_substances_in_scope_of_procedure":"Asparaginase, crisantaspase (nationally authorised products)","active_substance":"asparaginase;crisantaspase","related_medicines":"","procedure_number":"PSUSA/00003161/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003161-202108"},{"category":"","active_substances_in_scope_of_procedure":"Asparaginase, crisantaspase, pegaspargase (nationally authorised products)","active_substance":"asparaginase;crisantaspase;pegaspargase","related_medicines":"","procedure_number":"PSUSA/00003161/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003161-201808"},{"category":"","active_substances_in_scope_of_procedure":"Asparaginase","active_substance":"asparaginase","related_medicines":"","procedure_number":"PSUSA/00003161/201508","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003161-201508"},{"category":"","active_substances_in_scope_of_procedure":"Atenolol / chlortalidone","active_substance":"atenolol;chlortalidone","related_medicines":"","procedure_number":"PSUSA/00000260/201409","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000260-201409"},{"category":"","active_substances_in_scope_of_procedure":"Atenolol / chlortalidone","active_substance":"atenolol;chlortalidone","related_medicines":"","procedure_number":"PSUSA/00000260/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000260-201909"},{"category":"","active_substances_in_scope_of_procedure":"Atomoxetine","active_substance":"atomoxetine","related_medicines":"","procedure_number":"PSUSA/00000262/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000262-201411"},{"category":"","active_substances_in_scope_of_procedure":"Atomoxetine","active_substance":"atomoxetine","related_medicines":"","procedure_number":"PSUSA/00000262/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000262-201511"},{"category":"","active_substances_in_scope_of_procedure":"Atorvastatin / perindopril","active_substance":"atorvastatin;perindopril","related_medicines":"","procedure_number":"PSUSA/00010679/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010679-202010"},{"category":"","active_substances_in_scope_of_procedure":"Atorvastatin / ezetimibe","active_substance":"atorvastatin;ezetimibe","related_medicines":"","procedure_number":"PSUSA/00010385/201807","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010385-201807"},{"category":"","active_substances_in_scope_of_procedure":"Atorvastatin","active_substance":"atorvastatin","related_medicines":"","procedure_number":"PSUSA/00010347/201710","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010347-201710"},{"category":"","active_substances_in_scope_of_procedure":"Atovaquone / proguanil","active_substance":"atovaquone;proguanil","related_medicines":"","procedure_number":"PSUSA/00000266/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000266-201710"},{"category":"","active_substances_in_scope_of_procedure":"Atovaquone","active_substance":"atovaquone","related_medicines":"","procedure_number":"PSUSA/00000265/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000265-201411"},{"category":"","active_substances_in_scope_of_procedure":"Azathioprine","active_substance":"azathioprine","related_medicines":"","procedure_number":"PSUSA/00000275/201812","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000275-201812"},{"category":"","active_substances_in_scope_of_procedure":"Azelastin","active_substance":"azelastine","related_medicines":"","procedure_number":"PSUSA/00000277/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000277-201712"},{"category":"","active_substances_in_scope_of_procedure":"Azelastin","active_substance":"azelastine","related_medicines":"","procedure_number":"PSUSA/00000277/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000277-202012"},{"category":"","active_substances_in_scope_of_procedure":"Azelastine / fluticasone","active_substance":"azelastine;fluticasone","related_medicines":"","procedure_number":"PSUSA/00010067/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010067-202110"},{"category":"","active_substances_in_scope_of_procedure":"Azelastine / fluticasone","active_substance":"azelastine;fluticasone","related_medicines":"","procedure_number":"PSUSA/00010067/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010067-201510"},{"category":"","active_substances_in_scope_of_procedure":"Azelastine / fluticasone","active_substance":"azelastine;fluticasone","related_medicines":"","procedure_number":"PSUSA/00010067/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010067-201810"},{"category":"","active_substances_in_scope_of_procedure":"Azelastine","active_substance":"azelastine","related_medicines":"","procedure_number":"PSUSA/00000277/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000277-201412"},{"category":"","active_substances_in_scope_of_procedure":"Azithromycin (ocular use formulations)","active_substance":"azithromycin","related_medicines":"","procedure_number":"PSUSA/00010492/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010492-201704"},{"category":"","active_substances_in_scope_of_procedure":"Azithromycin (systemic use formulations)","active_substance":"azithromycin","related_medicines":"","procedure_number":"PSUSA/00010491/201704","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010491-201704"},{"category":"","active_substances_in_scope_of_procedure":"Azithromycin","active_substance":"azithromycin","related_medicines":"","procedure_number":"PSUSA/00010491/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010491-202004"},{"category":"","active_substances_in_scope_of_procedure":"Azithromycin","active_substance":"azithromycin","related_medicines":"","procedure_number":"PSUSA/00010492/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010492-202004"},{"category":"","active_substances_in_scope_of_procedure":"Aztreonam","active_substance":"aztreonam","related_medicines":"","procedure_number":"PSUSA/00010178/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010178-201808"},{"category":"","active_substances_in_scope_of_procedure":"Bacillus clausii multi-antibioresistant spores","active_substance":"bacillus clausii multi-antibioresistant spores","related_medicines":"","procedure_number":"PSUSA/00000284/201611","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000284-201611"},{"category":"","active_substances_in_scope_of_procedure":"Bacillus clausii multi-antibioresistant spores","active_substance":"bacillus clausii multi-antibioresistant spores","related_medicines":"","procedure_number":"PSUSA/00000284/201911","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000284-201911"},{"category":"","active_substances_in_scope_of_procedure":"Baclofen (intrathecal)","active_substance":"baclofen","related_medicines":"","procedure_number":"PSUSA/00000293/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000293-202101"},{"category":"","active_substances_in_scope_of_procedure":"Baclofen (oral)","active_substance":"baclofen","related_medicines":"","procedure_number":"PSUSA/00000294/202009","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000294-202009"},{"category":"","active_substances_in_scope_of_procedure":"Baclofen (oral)","active_substance":"baclofen","related_medicines":"","procedure_number":"PSUSA/00000294/201609","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000294-201609"},{"category":"","active_substances_in_scope_of_procedure":"Baclofen (oral)","active_substance":"baclofen","related_medicines":"","procedure_number":"PSUSA/00000294/201809","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000294-201809"},{"category":"","active_substances_in_scope_of_procedure":"Baclofen","active_substance":"baclofen","related_medicines":"","procedure_number":"PSUSA/00000293/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000293-201601"},{"category":"","active_substances_in_scope_of_procedure":"Bacterial lysate of haemophilus influenzae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus mitis / streptococcus pneumoniae / streptococcus pyogenes, bacterial lysate of haemophilus influenzae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus pneumoniae / streptococcus pyogenes, streptococcus pneumoniae / streptococcus aga","active_substance":"bacterial lysate of haemophilus influenzae;klebsiella pneumoniae;moraxella catarrhalis;staphylococcus aureus;streptococcus mitis;streptococcus pneumoniae;streptococcus pyogenes;klebsiella pneumoniae;moraxella catarrhalis;staphylococcus aureus;streptococcus aga","related_medicines":"","procedure_number":"PSUSA/00002786/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002786-202103"},{"category":"","active_substances_in_scope_of_procedure":"Bacterial lysate of haemophilus influenzae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus mitis / streptococcus pneumoniae / streptococcus pyogenes, bacterial lysate of haemophilus influenzae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus pneumoniae / streptococcus pyogenes","active_substance":"bacterial lysate of haemophilus influenzae;klebsiella pneumoniae;moraxella catarrhalis;staphylococcus aureus;streptococcus mitis;streptococcus pneumoniae;streptococcus pyogenes;klebsiella pneumoniae;moraxella catarrhalis;staphylococcus aureus;streptococcus pneumoniae;streptococcus aga","related_medicines":"","procedure_number":"PSUSA/00002786/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002786-201603"},{"category":"","active_substances_in_scope_of_procedure":"Bambuterol","active_substance":"bambuterol","related_medicines":"","procedure_number":"PSUSA/00000295/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000295-201712"},{"category":"","active_substances_in_scope_of_procedure":"BCG (bacillus calmette-gurin) for immunotherapy","active_substance":"bacillus calmette-gurin (BCG)","related_medicines":"","procedure_number":"PSUSA/00000303/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000303-201803"},{"category":"","active_substances_in_scope_of_procedure":"BCG vaccine (freeze-dried)","active_substance":"bacillus calmette-gurin (BCG)","related_medicines":"","procedure_number":"PSUSA/00000304/201803","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000304-201803"},{"category":"","active_substances_in_scope_of_procedure":"Beclometasone / formoterol (inhalative application)","active_substance":"beclometasone;formoterol","related_medicines":"","procedure_number":"PSUSA/00010068/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010068-201607"},{"category":"","active_substances_in_scope_of_procedure":"Beclometasone / formoterol (inhalative application)","active_substance":"beclometasone;formoterol","related_medicines":"","procedure_number":"PSUSA/00010068/201907","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010068-201907"},{"category":"","active_substances_in_scope_of_procedure":"Beclometasone / salbutamol","active_substance":"beclometasone;salbutamol","related_medicines":"","procedure_number":"PSUSA/00000309/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000309-201701"},{"category":"","active_substances_in_scope_of_procedure":"Beclometasone","active_substance":"beclometasone","related_medicines":"","procedure_number":"PSUSA/00000306/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000306-201612"},{"category":"","active_substances_in_scope_of_procedure":"Bemetizide / triamterene","active_substance":"beclometasone;triamterene","related_medicines":"","procedure_number":"PSUSA/00009076/201506","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009076-201506"},{"category":"","active_substances_in_scope_of_procedure":"Bemiparin","active_substance":"bemiparin","related_medicines":"","procedure_number":"PSUSA/00000312/201604","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000312-201604"},{"category":"","active_substances_in_scope_of_procedure":"Bemiparin","active_substance":"bemiparin","related_medicines":"","procedure_number":"PSUSA/00000312/201904","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000312-201904"},{"category":"","active_substances_in_scope_of_procedure":"Benazepril / hydrochlorothiazide","active_substance":"benazepril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000314/202105","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000314-202105"},{"category":"","active_substances_in_scope_of_procedure":"Benazepril / hydrochlorothiazide","active_substance":"hydrochlorothiazide;benazepril","related_medicines":"","procedure_number":"PSUSA/00000314/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000314-201605"},{"category":"","active_substances_in_scope_of_procedure":"Bendamustine hydrochloride","active_substance":"bendamustine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00003162/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-201801"},{"category":"","active_substances_in_scope_of_procedure":"Benazepril","active_substance":"benazepril","related_medicines":"","procedure_number":"PSUSA/00000313/202011","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000313-202011"},{"category":"","active_substances_in_scope_of_procedure":"Benazepril","active_substance":"benazepril","related_medicines":"","procedure_number":"PSUSA/00000313/201511","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000313-201511"},{"category":"","active_substances_in_scope_of_procedure":"Bendamustine hydrochloride","active_substance":"bendamustine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00003162/201601","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-201601"},{"category":"","active_substances_in_scope_of_procedure":"Bendamustine hydrochloride","active_substance":"bendamustine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00003162/201701","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-201701"},{"category":"","active_substances_in_scope_of_procedure":"Bendamustine hydrochloride","active_substance":"bendamustine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00003162/202001","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-202001"},{"category":"","active_substances_in_scope_of_procedure":"Bendroflumethiazide, bendroflumethiazide/potassium chloride","active_substance":"bendroflumethiazide;potassium chloride","related_medicines":"","procedure_number":"PSUSA-00010583-201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010583-201801"},{"category":"","active_substances_in_scope_of_procedure":"Benzydamine","active_substance":"benzydamine","related_medicines":"","procedure_number":"PSUSA/00000375/201510","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000375-201510"},{"category":"","active_substances_in_scope_of_procedure":"Benserazide / levodopa","active_substance":"benserazide;levodopa","related_medicines":"","procedure_number":"PSUSA/00000330/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000330-201706"},{"category":"","active_substances_in_scope_of_procedure":"Benzalkonium chloride / chlorhexidine digluconate","active_substance":"benzalkonium chloride;chlorhexidine digluconate","related_medicines":"","procedure_number":"PSUSA/00010070/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010070-202111"},{"category":"","active_substances_in_scope_of_procedure":"Benzalkonium chloride / chlorhexidine digluconate","active_substance":"benzalkonium chloride;chlorhexidine digluconate","related_medicines":"","procedure_number":"PSUSA/00010070/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010070-201611"},{"category":"","active_substances_in_scope_of_procedure":"Benzydamine / cetylpyridine","active_substance":"benzydamine;cetylpyridine","related_medicines":"","procedure_number":"PSUSA/00000378/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000378-201901"},{"category":"","active_substances_in_scope_of_procedure":"Benzydamine","active_substance":"benzydamine","related_medicines":"","procedure_number":"PSUSA/00000375/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000375-201810"},{"category":"","active_substances_in_scope_of_procedure":"Benzydamine","active_substance":"benzydamine","related_medicines":"","procedure_number":"PSUSA/00000375/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000375-202110"},{"category":"","active_substances_in_scope_of_procedure":"Benzyl nicotinate / camphor / dimethyl sulfoxide / nonivamide / turpentine oil","active_substance":"benzyl nicotinate;camphor;Dimethyl sulfoxide;nonivamide;turpentine oil","related_medicines":"","procedure_number":"PSUSA/00010584/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010584-201803"},{"category":"","active_substances_in_scope_of_procedure":"Benzylpenicillin","active_substance":"benzylpenicillin","related_medicines":"","procedure_number":"PSUSA/00000383/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000383-202006"},{"category":"","active_substances_in_scope_of_procedure":"Beractant","active_substance":"beractant","related_medicines":"","procedure_number":"PSUSA/00000384/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000384-202010"},{"category":"","active_substances_in_scope_of_procedure":"Beractant","active_substance":"beractant","related_medicines":"","procedure_number":"PSUSA/00000384/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000384-201510"},{"category":"","active_substances_in_scope_of_procedure":"Beta-alanine","active_substance":"beta-alanine","related_medicines":"","procedure_number":"PSUSA/00010510/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010510-201701"},{"category":"","active_substances_in_scope_of_procedure":"Beta-alanine","active_substance":"beta-alanine","related_medicines":"","procedure_number":"PSUSA/00010510/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010510-202001"},{"category":"","active_substances_in_scope_of_procedure":"Betahistine","active_substance":"betahistine","related_medicines":"","procedure_number":"PSUSA/00000389/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000389-202012"},{"category":"","active_substances_in_scope_of_procedure":"Betahistine","active_substance":"betahistine","related_medicines":"","procedure_number":"PSUSA/00000389/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000389-201712"},{"category":"","active_substances_in_scope_of_procedure":"Betahistine","active_substance":"betahistine","related_medicines":"","procedure_number":"PSUSA/0000389/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0000389-201412"},{"category":"","active_substances_in_scope_of_procedure":"Betamethasone / tetryzoline","active_substance":"betamethasone;tetryzoline","related_medicines":"","procedure_number":"PSUSA/00010072/201409","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010072-201409"},{"category":"","active_substances_in_scope_of_procedure":"Betamethasone / tetryzoline","active_substance":"betamethasone;tetryzoline","related_medicines":"","procedure_number":"PSUSA/00010072/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010072-201909"},{"category":"","active_substances_in_scope_of_procedure":"Betamethasone","active_substance":"betamethasone","related_medicines":"","procedure_number":"PSUSA/00000391/202101","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000391-202101"},{"category":"","active_substances_in_scope_of_procedure":"Betamethasone dipropionate clotrimazole","active_substance":"betamethasone dipropionate clotrimazole","related_medicines":"","procedure_number":"PSUSA/00000394/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000394-202101"},{"category":"","active_substances_in_scope_of_procedure":"Betamethasone valerate / clioquinol","active_substance":"betamethasone valerate;clioquinol","related_medicines":"","procedure_number":"PSUSA/00000398/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000398-202101"},{"category":"","active_substances_in_scope_of_procedure":"Betamethasone valerate / fusidic acid","active_substance":"betamethasone valerate;fusidic acid","related_medicines":"","procedure_number":"PSUSA/00000399/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000399-202101"},{"category":"","active_substances_in_scope_of_procedure":"Betaxolol","active_substance":"betaxolol","related_medicines":"","procedure_number":"PSUSA/00000401/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000401-201705"},{"category":"","active_substances_in_scope_of_procedure":"Bethanechol","active_substance":"bethanechol","related_medicines":"","procedure_number":"PSUSA/00000402/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000402-202006"},{"category":"","active_substances_in_scope_of_procedure":"Betula verrucosa","active_substance":"Betula verrucosa","related_medicines":"","procedure_number":"PSUSA/00010815/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202007"},{"category":"","active_substances_in_scope_of_procedure":"Bezafibrate","active_substance":"bezafibrate","related_medicines":"","procedure_number":"PSUSA/00000405/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000405-201901"},{"category":"","active_substances_in_scope_of_procedure":"Bicalutamide","active_substance":"bicalutamide","related_medicines":"","procedure_number":"PSUSA/00000407/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000407-201702"},{"category":"","active_substances_in_scope_of_procedure":"Bilastine","active_substance":"bilastine","related_medicines":"","procedure_number":"PSUSA/00003163/201603","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003163-201603"},{"category":"","active_substances_in_scope_of_procedure":"Bilastine","active_substance":"bilastine","related_medicines":"","procedure_number":"PSUSA/00003163/201703","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003163-201703"},{"category":"","active_substances_in_scope_of_procedure":"Biotin","active_substance":"biotin","related_medicines":"","procedure_number":"PSUSA/00000414/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000414-201901"},{"category":"","active_substances_in_scope_of_procedure":"Biperiden","active_substance":"biperiden","related_medicines":"","procedure_number":"PSUSA/00000415/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000415-201608"},{"category":"","active_substances_in_scope_of_procedure":"Biperiden","active_substance":"biperiden","related_medicines":"","procedure_number":"PSUSA/00000415/201908","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000415-201908"},{"category":"","active_substances_in_scope_of_procedure":"Bismuth subcitrate potassium / metronidazole / tetracycline","active_substance":"bismuth subcitrate potassium;Metronidazole;tetracycline","related_medicines":"","procedure_number":"PSUSA/00010199/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-202105"},{"category":"","active_substances_in_scope_of_procedure":"Bismuth subcitrate potassium / metronidazole / tetracycline","active_substance":"bismuth subcitrate potassium;Metronidazole;tetracycline","related_medicines":"","procedure_number":"PSUSA/00010199/201505","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-201505"},{"category":"","active_substances_in_scope_of_procedure":"Bismuth subcitrate potassium / metronidazole / tetracycline","active_substance":"bismuth subcitrate potassium;Metronidazole;tetracycline","related_medicines":"","procedure_number":"PSUSA/00010199/201705","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-201705"},{"category":"","active_substances_in_scope_of_procedure":"Bismuth subcitrate potassium / metronidazole / tetracycline","active_substance":"bismuth subcitrate potassium;Metronidazole;tetracycline","related_medicines":"","procedure_number":"PSUSA/00010199/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-201605"},{"category":"","active_substances_in_scope_of_procedure":"Bismuth subcitrate potassium / metronidazole / tetracycline","active_substance":"bismuth subcitrate potassium;Metronidazole;tetracycline","related_medicines":"","procedure_number":"PSUSA/00010199/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-201805"},{"category":"","active_substances_in_scope_of_procedure":"Bisoprolol","active_substance":"bisoprolol","related_medicines":"","procedure_number":"PSUSA/00000419/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000419-202009"},{"category":"","active_substances_in_scope_of_procedure":"Bisoprolol / hydrochlorothiazide","active_substance":"bisoprolol;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000420/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000420-202111"},{"category":"","active_substances_in_scope_of_procedure":"Bisoprolol / hydrochlorothiazide","active_substance":"bisoprolol;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000420/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000420-201511"},{"category":"","active_substances_in_scope_of_procedure":"Bisoprolol / hydrochlorothiazide","active_substance":"bisoprolol;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000420/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000420-201811"},{"category":"","active_substances_in_scope_of_procedure":"Bisoprolol / perindopril","active_substance":"bisoprolol;perindopril","related_medicines":"","procedure_number":"PSUSA/00010462/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010462-202010"},{"category":"","active_substances_in_scope_of_procedure":"Bisoprolol","active_substance":"bisoprolol","related_medicines":"","procedure_number":"PSUSA/00000419/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000419-201509"},{"category":"","active_substances_in_scope_of_procedure":"Bivalrudin","active_substance":"bivalrudin","related_medicines":"","procedure_number":"PSUSA/00000421/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000421-202009"},{"category":"","active_substances_in_scope_of_procedure":"Botulinum neurotoxin type a (150 kd) free from complexing proteins","active_substance":"botulinum neurotoxin type a (150 kd) free from complexing proteins","related_medicines":"","procedure_number":"PSUSA/00009084/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009084-201512"},{"category":"","active_substances_in_scope_of_procedure":"Botulinum neurotoxin type a (150 kd) free from complexing proteins","active_substance":"botulinum neurotoxin type a (150 kd) free from complexing proteins","related_medicines":"","procedure_number":"PSUSA/00009084/201812","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009084-201812"},{"category":"","active_substances_in_scope_of_procedure":"Botulinum toxin a - haemagglutinin complex","active_substance":"botulinum toxin a - haemagglutinin complex","related_medicines":"","procedure_number":"PSUSA/00000427/201812","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000427-201812"},{"category":"","active_substances_in_scope_of_procedure":"Botulinum toxin a - haemagglutinin complex","active_substance":"botulinum toxin a - haemagglutinin complex","related_medicines":"","procedure_number":"PSUSA/00000427/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000427-201512"},{"category":"","active_substances_in_scope_of_procedure":"Botulinum toxin a","active_substance":"botulinum toxin a","related_medicines":"","procedure_number":"PSUSA/00000426/201812","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000426-201812"},{"category":"","active_substances_in_scope_of_procedure":"Bovine lung phospholipid","active_substance":"bovine lung phospholipid","related_medicines":"","procedure_number":"PSUSA/00010791/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010791-202106"},{"category":"","active_substances_in_scope_of_procedure":"Brimonidine (except for the centrally authorised product)","active_substance":"brimonidine","related_medicines":"","procedure_number":"PSUSA/00000430/202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000430-202109"},{"category":"","active_substances_in_scope_of_procedure":"Brimonidine (except for the centrally authorised product)","active_substance":"brimonidine","related_medicines":"","procedure_number":"PSUSA/00000430/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000430-201609"},{"category":"","active_substances_in_scope_of_procedure":"Brimonidine / timolol","active_substance":"brimonidine;timolol","related_medicines":"","procedure_number":"PSUSA/00000431/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000431-201609"},{"category":"","active_substances_in_scope_of_procedure":"Brimonidine / timolol","active_substance":"brimonidine;timolol","related_medicines":"","procedure_number":"PSUSA/00000431/202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000431-202109"},{"category":"","active_substances_in_scope_of_procedure":"Brivudine","active_substance":"brivudine","related_medicines":"","procedure_number":"PSUSA/00000434/201907","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000434-201907"},{"category":"","active_substances_in_scope_of_procedure":"Bromazepam","active_substance":"bromazepam","related_medicines":"","procedure_number":"PSUSA/00000435/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000435-201708"},{"category":"","active_substances_in_scope_of_procedure":"Bromazepam","active_substance":"bromazepam","related_medicines":"","procedure_number":"PSUSA/00000435/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000435-202008"},{"category":"","active_substances_in_scope_of_procedure":"Bromhexine","active_substance":"bromhexine","related_medicines":"","procedure_number":"PSUSA/00000437/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000437-201609"},{"category":"","active_substances_in_scope_of_procedure":"Bromocriptine","active_substance":"bromocriptine","related_medicines":"","procedure_number":"PSUSA/00000438/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000438-201810"},{"category":"","active_substances_in_scope_of_procedure":"Bromocriptine","active_substance":"bromocriptine","related_medicines":"","procedure_number":"PSUSA/00000438/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000438-201510"},{"category":"","active_substances_in_scope_of_procedure":"Bromperidol","active_substance":"bromperidol","related_medicines":"","procedure_number":"PSUSA/00000439/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000439-201711"},{"category":"","active_substances_in_scope_of_procedure":"Brotizolam","active_substance":"brotizolam","related_medicines":"","procedure_number":"PSUSA/00000444/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000444-201612"},{"category":"","active_substances_in_scope_of_procedure":"Brotizolam","active_substance":"brotizolam","related_medicines":"","procedure_number":"PSUSA/00000444/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000444-201912"},{"category":"","active_substances_in_scope_of_procedure":"Budesonide / formoterol (apart from centrally authorised products)","active_substance":"Budesonide;formoterol","related_medicines":"","procedure_number":"PSUSA/00000450/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000450-201608"},{"category":"","active_substances_in_scope_of_procedure":"Budesonide / salmeterol","active_substance":"Budesonide;salmeterol","related_medicines":"","procedure_number":"PSUSA/00010511/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010511-202107"},{"category":"","active_substances_in_scope_of_procedure":"Budesonide","active_substance":"Budesonide","related_medicines":"","procedure_number":"PSUSA/00000449/201604","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000449-201604"},{"category":"","active_substances_in_scope_of_procedure":"Budesonide","active_substance":"Budesonide","related_medicines":"","procedure_number":"PSUSA/00000449/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000449-202104"},{"category":"","active_substances_in_scope_of_procedure":"Buprenorphine","active_substance":"buprenorphine","related_medicines":"","procedure_number":"PSUSA/00000459/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000459-201707"},{"category":"","active_substances_in_scope_of_procedure":"Bupropion","active_substance":"bupropion","related_medicines":"","procedure_number":"PSUSA/00000461/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000461-201512"},{"category":"","active_substances_in_scope_of_procedure":"Bupropion","active_substance":"bupropion","related_medicines":"","procedure_number":"PSUSA/00000461/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000461-201812"},{"category":"","active_substances_in_scope_of_procedure":"Buserelin","active_substance":"buserelin","related_medicines":"","procedure_number":"PSUSA/00000462/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000462-202108"},{"category":"","active_substances_in_scope_of_procedure":"Buserelin","active_substance":"buserelin","related_medicines":"","procedure_number":"PSUSA/00000462/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000462-201608"},{"category":"","active_substances_in_scope_of_procedure":"Buspirone","active_substance":"buspirone","related_medicines":"","procedure_number":"PSUSA/00000463/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000463-201704"},{"category":"","active_substances_in_scope_of_procedure":"Busulfan","active_substance":"busulfan","related_medicines":"","procedure_number":"PSUSA/0464/201907","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0464-201907"},{"category":"","active_substances_in_scope_of_procedure":"Butoconazole","active_substance":"butoconazole","related_medicines":"","procedure_number":"PSUSA/00000471/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000471-202102"},{"category":"","active_substances_in_scope_of_procedure":"Butoconazole","active_substance":"butoconazole","related_medicines":"","procedure_number":"PSUSA/00000471/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000471-201602"},{"category":"","active_substances_in_scope_of_procedure":"Cabergoline","active_substance":"cabergoline","related_medicines":"","procedure_number":"PSUSA/00000477/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000477-201503"},{"category":"","active_substances_in_scope_of_procedure":"Cabergoline","active_substance":"cabergoline","related_medicines":"","procedure_number":"PSUSA/00000477/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000477-201803"},{"category":"","active_substances_in_scope_of_procedure":"Cabergoline","active_substance":"cabergoline","related_medicines":"","procedure_number":"PSUSA/00000477/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000477-201903"},{"category":"","active_substances_in_scope_of_procedure":"Caffeine (apnea)","active_substance":"Caffeine","related_medicines":"","procedure_number":"PSUSA/00000482/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000482-201707"},{"category":"","active_substances_in_scope_of_procedure":"Caffeine / drotaverine hydrochloride / metamizol sodium","active_substance":"Caffeine;drotaverine hydrochloride;metamizol sodium","related_medicines":"","procedure_number":"PSUSA/00001996/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001996-202101"},{"category":"","active_substances_in_scope_of_procedure":"Caffeine / drotaverine hydrochloride / metamizol sodium","active_substance":"Caffeine;drotaverine hydrochloride;metamizol sodium","related_medicines":"","procedure_number":"PSUSA/00001996/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001996-201711"},{"category":"","active_substances_in_scope_of_procedure":"Caffeine / ergotamine","active_substance":"Caffeine;ergotamine","related_medicines":"","procedure_number":"PSUSA/00000485/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000485-202111"},{"category":"","active_substances_in_scope_of_procedure":"Caffeine / ergotamine","active_substance":"Caffeine;ergotamine","related_medicines":"","procedure_number":"PSUSA/00000485/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000485-201511"},{"category":"","active_substances_in_scope_of_procedure":"Caffeine / ergotamine","active_substance":"Caffeine;ergotamine","related_medicines":"","procedure_number":"PSUSA/00000485/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000485-201811"},{"category":"","active_substances_in_scope_of_procedure":"Calcifediol","active_substance":"calcifediol","related_medicines":"","procedure_number":"PSUSA/00000491/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000491-202106"},{"category":"","active_substances_in_scope_of_procedure":"Calcitonin salmon, synthetic analogue of eel calcitonin","active_substance":"calcitonin salmon;synthetic analogue of eel calcitonin","related_medicines":"","procedure_number":"PSUSA/00000494/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000494-202106"},{"category":"","active_substances_in_scope_of_procedure":"Calcitonin salmon, synthetic analogue of eel calcitonin","active_substance":"calcitonin salmon;synthetic analogue of eel calcitonin","related_medicines":"","procedure_number":"PSUSA/00000494/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000494-201506"},{"category":"","active_substances_in_scope_of_procedure":"Calcitonin salmon, synthetic analogue of eel calcitonin","active_substance":"calcitonin salmon;synthetic analogue of eel calcitonin","related_medicines":"","procedure_number":"PSUSA/00000494/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000494-201806"},{"category":"","active_substances_in_scope_of_procedure":"Calcitriol","active_substance":"calcitriol","related_medicines":"","procedure_number":"PSUSA/00000495/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000495-202101"},{"category":"","active_substances_in_scope_of_procedure":"Calcitriol","active_substance":"calcitriol","related_medicines":"","procedure_number":"PSUSA/00000495/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000495-201801"},{"category":"","active_substances_in_scope_of_procedure":"Calcitriol","active_substance":"calcitriol","related_medicines":"","procedure_number":"PSUSA/00000495/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000495-201501"},{"category":"","active_substances_in_scope_of_procedure":"Calcitriol","active_substance":"calcium carbonate;Famotidine;magnesium hydroxide","related_medicines":"","procedure_number":"PSUSA/00001351/201409","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001351-201409"},{"category":"","active_substances_in_scope_of_procedure":"Calcitriol","active_substance":"calcium carbonate;Famotidine;magnesium hydroxide","related_medicines":"","procedure_number":"PSUSA/00001351/201709","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001351-201709"},{"category":"","active_substances_in_scope_of_procedure":"Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide","active_substance":"calcium chloride;glutamic acid;Glutathione;histidine;lactobionic acid;magnesium chloride;mannitol;potassium chloride;sodium hydroxide","related_medicines":"","procedure_number":"PSUSA/0009162202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0009162202103"},{"category":"","active_substances_in_scope_of_procedure":"Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide","active_substance":"calcium chloride;glutamic acid;Glutathione;histidine;lactobionic acid;magnesium chloride;mannitol;potassium chloride;sodium hydroxide","related_medicines":"","procedure_number":"PSUSA/00009162/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009162-201803"},{"category":"","active_substances_in_scope_of_procedure":"Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide","active_substance":"calcium chloride;glutamic acid;Glutathione;histidine;lactobionic acid;magnesium chloride;mannitol;potassium chloride;sodium hydroxide","related_medicines":"","procedure_number":"PSUSA/00009162/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009162-201503"},{"category":"","active_substances_in_scope_of_procedure":"Calcium salts / colecalciferol","active_substance":"colecalciferol;calcium salts","related_medicines":"","procedure_number":"PSUSA/00010386/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010386-201610"},{"category":"","active_substances_in_scope_of_procedure":"Calcium salts / colecalciferol","active_substance":"colecalciferol;calcium salts","related_medicines":"","procedure_number":"PSUSA/00010386/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010386-201910"},{"category":"","active_substances_in_scope_of_procedure":"Camellia sinensis, Leaf, Dry extract refined (derived from Camellia sinensis, L. O.KUNTZE) (topical use)","active_substance":"camellia sinensis","related_medicines":"","procedure_number":"PSUSA/00010569/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010569-201812"},{"category":"","active_substances_in_scope_of_procedure":"Candesartan, candesartan / hydrochlorothiazide","active_substance":"hydrochlorothiazide;Candesartan","related_medicines":"","procedure_number":"PSUSA/00000527/201704","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000527-201704"},{"category":"","active_substances_in_scope_of_procedure":"Captopril / hydrochlorothiazide","active_substance":"captopril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000536/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000536-202104"},{"category":"","active_substances_in_scope_of_procedure":"carbomers","active_substance":"carbomers","related_medicines":"","procedure_number":"PSUSA/00000557/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000557-201701"},{"category":"","active_substances_in_scope_of_procedure":"Captopril / hydrochlorothiazide","active_substance":"captopril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000536/201604","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000536-201604"},{"category":"","active_substances_in_scope_of_procedure":"Captopril","active_substance":"captopril","related_medicines":"","procedure_number":"PSUSA/00000535/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000535-201504"},{"category":"","active_substances_in_scope_of_procedure":"Captopril","active_substance":"captopril","related_medicines":"","procedure_number":"PSUSA/00000535/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000535-202004"},{"category":"","active_substances_in_scope_of_procedure":"carboplatin","active_substance":"carboplatin","related_medicines":"","procedure_number":"PSUSA/00000559/201601","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000559-201601"},{"category":"","active_substances_in_scope_of_procedure":"Carbamazepine","active_substance":"carbamazepine","related_medicines":"","procedure_number":"PSUSA/00000539/202012","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000539-202012"},{"category":"","active_substances_in_scope_of_procedure":"Carbetocin","active_substance":"carbetocin","related_medicines":"","procedure_number":"PSUSA/00000546/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000546-201706"},{"category":"","active_substances_in_scope_of_procedure":"Carbidopa / levodopa","active_substance":"carbidopa;levodopa","related_medicines":"","procedure_number":"PSUSA/00000548/201910","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000548-201910"},{"category":"","active_substances_in_scope_of_procedure":"carboplatin","active_substance":"carboplatin","related_medicines":"","procedure_number":"PSUSA/00000559/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000559-201901"},{"category":"","active_substances_in_scope_of_procedure":"Carbidopa / levodopa (except for centrally authorised product)","active_substance":"carbidopa;levodopa","related_medicines":"","procedure_number":"PSUSA/00000548/201610","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000548-201610"},{"category":"","active_substances_in_scope_of_procedure":"carboprost","active_substance":"carboprost","related_medicines":"","procedure_number":"PSUSA/00000560/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000560-202101"},{"category":"","active_substances_in_scope_of_procedure":"carboprost","active_substance":"carboprost","related_medicines":"","procedure_number":"PSUSA/00000560/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000560-201601"},{"category":"","active_substances_in_scope_of_procedure":"carmustine","active_substance":"carmustine (implant)","related_medicines":"","procedure_number":"PSUSA/00010348/202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010348-202109"},{"category":"","active_substances_in_scope_of_procedure":"carmustine","active_substance":"carmustine (implant)","related_medicines":"","procedure_number":"PSUSA/00010348/201809","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010348-201809"},{"category":"","active_substances_in_scope_of_procedure":"carmustine","active_substance":"carmustine (implant)","related_medicines":"","procedure_number":"PSUSA/00010348/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010348-201509"},{"category":"","active_substances_in_scope_of_procedure":"Carmustine (powder and solvent for solution for infusion)","active_substance":"carmustine","related_medicines":"","procedure_number":"PSUSA/00010349/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010349-201504"},{"category":"","active_substances_in_scope_of_procedure":"carmustine (powder and solvent for solution for infusion)","active_substance":"carmustine","related_medicines":"","procedure_number":"PSUSA/00010349/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010349-202104"},{"category":"Human","active_substances_in_scope_of_procedure":"Carrageenin / titanium dioxide / zinc oxide, carrageenin / lidocaine / titanium dioxide / zinc oxide, titanium dioxide / zinc oxide / tetracaine hydrochloride","active_substance":"carrageenin;titanium dioxide;lidocaine;zinc oxide;tetracaine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00001869/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001869-202006"},{"category":"","active_substances_in_scope_of_procedure":"Dacarbazine","active_substance":"dacarbazine","related_medicines":"","procedure_number":"PSUSA/00000919/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000919-201802"},{"category":"","active_substances_in_scope_of_procedure":"Dalteparin sodium","active_substance":"dalteparin sodium","related_medicines":"","procedure_number":"PSUSA/00000922/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000922-201508"},{"category":"","active_substances_in_scope_of_procedure":"Dalteparin sodium","active_substance":"dalteparin sodium","related_medicines":"","procedure_number":"PSUSA/00000922/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000922-202008"},{"category":"","active_substances_in_scope_of_procedure":"Danaparoid","active_substance":"danaparoid","related_medicines":"","procedure_number":"PSUSA/00000923/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000923-201812"},{"category":"","active_substances_in_scope_of_procedure":"Dapoxetine","active_substance":"dapoxetine","related_medicines":"","procedure_number":"PSUSA/00000928/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000928-202012"},{"category":"","active_substances_in_scope_of_procedure":"Dapoxetine","active_substance":"dapoxetine","related_medicines":"","procedure_number":"PSUSA/00000928/201712","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000928-201712"},{"category":"","active_substances_in_scope_of_procedure":"Dapoxetine","active_substance":"dapoxetine","related_medicines":"","procedure_number":"PSUSA/00000928/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000928-201412"},{"category":"","active_substances_in_scope_of_procedure":"Daunorubicin","active_substance":"daunorubicin","related_medicines":"","procedure_number":"PSUSA/00000936/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000936-202106"},{"category":"","active_substances_in_scope_of_procedure":"Daunorubicin","active_substance":"daunorubicin","related_medicines":"","procedure_number":"PSUSA/00000936/201506","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000936-201506"},{"category":"","active_substances_in_scope_of_procedure":"Daunorubicin","active_substance":"daunorubicin","related_medicines":"","procedure_number":"PSUSA/0000936/201806","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0000936-201806"},{"category":"","active_substances_in_scope_of_procedure":"Delapril / manidipine, delapril / indapamide","active_substance":"delapril;manidipine;Indapamide","related_medicines":"","procedure_number":"PSUSA/00010496/201706","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010496-201706"},{"category":"","active_substances_in_scope_of_procedure":"Delapril","active_substance":"delapril","related_medicines":"","procedure_number":"PSUSA/00000946/201501","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000946-201501"},{"category":"","active_substances_in_scope_of_procedure":"Demeclocycline / triamcinolone","active_substance":"triamcinolone;demeclocycline","related_medicines":"","procedure_number":"PSUSA/00010415/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010415-201707"},{"category":"","active_substances_in_scope_of_procedure":"Deoxycholic acid","active_substance":"Deoxycholic acid","related_medicines":"","procedure_number":"PSUSA/00010525/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-201704"},{"category":"","active_substances_in_scope_of_procedure":"Deoxycholic acid","active_substance":"Deoxycholic acid","related_medicines":"","procedure_number":"PSUSA/00010525/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-202104"},{"category":"","active_substances_in_scope_of_procedure":"Deoxycholic acid","active_substance":"Deoxycholic acid","related_medicines":"","procedure_number":"PSUSA/00010525/201710","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-201710"},{"category":"","active_substances_in_scope_of_procedure":"Deoxycholic acid","active_substance":"Deoxycholic acid","related_medicines":"","procedure_number":"PSUSA/00010525/201804","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-201804"},{"category":"","active_substances_in_scope_of_procedure":"Deoxycholic acid","active_substance":"Deoxycholic acid","related_medicines":"","procedure_number":"PSUSA/00010525/202004","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-202004"},{"category":"","active_substances_in_scope_of_procedure":"Carvedilol / ivabradine","active_substance":"carvedilol;ivabradine","related_medicines":"","procedure_number":"PSUSA/00010586/201904","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010586-201904"},{"category":"","active_substances_in_scope_of_procedure":"Carteolol","active_substance":"carteolol","related_medicines":"","procedure_number":"PSUSA/00000574/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000574-201903"},{"category":"","active_substances_in_scope_of_procedure":"Carvedilol / ivabradine","active_substance":"carvedilol;ivabradine","related_medicines":"","procedure_number":"PSUSA/00010586/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010586-201711"},{"category":"","active_substances_in_scope_of_procedure":"Carvedilol","active_substance":"carvedilol","related_medicines":"","procedure_number":"PSUSA/00000575/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000575-201704"},{"category":"","active_substances_in_scope_of_procedure":"Ce (conjugated estrogens) / mpa (medroxyprogesterone acetate)","active_substance":"conjugated estrogens;medroxyprogesterone acetate","related_medicines":"","procedure_number":"PSUSA/00000582/201908","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000582-201908"},{"category":"","active_substances_in_scope_of_procedure":"Cefadroxil","active_substance":"cefadroxil","related_medicines":"","procedure_number":"PSUSA/00000584/201707","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000584-201707"},{"category":"","active_substances_in_scope_of_procedure":"Cefazolin","active_substance":"cefazolin","related_medicines":"","procedure_number":"PSUSA/00000589/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000589-202111"},{"category":"","active_substances_in_scope_of_procedure":"Cefazolin","active_substance":"cefazolin","related_medicines":"","procedure_number":"PSUSA/00000589/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000589-201611"},{"category":"","active_substances_in_scope_of_procedure":"Cefepime","active_substance":"cefepime","related_medicines":"","procedure_number":"PSUSA/00000593/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000593-202106"},{"category":"","active_substances_in_scope_of_procedure":"Cefepime","active_substance":"cefepime","related_medicines":"","procedure_number":"PSUSA/00000593/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000593-201506"},{"category":"","active_substances_in_scope_of_procedure":"Cefepime","active_substance":"cefepime","related_medicines":"","procedure_number":"PSUSA/00000593/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000593-201806"},{"category":"","active_substances_in_scope_of_procedure":"Cefodizime","active_substance":"cefodizime","related_medicines":"","procedure_number":"PSUSA/00000595/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000595-201703"},{"category":"","active_substances_in_scope_of_procedure":"Cefoperazone","active_substance":"cefoperazone","related_medicines":"","procedure_number":"PSUSA/00000597/202101","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000597-202101"},{"category":"Human","active_substances_in_scope_of_procedure":"cefoperazone / sulbactam","active_substance":"cefoperazone;sulbactam","related_medicines":"","procedure_number":"PSUSA/00000598/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000598-202101"},{"category":"","active_substances_in_scope_of_procedure":"cefoperazone / sulbactam","active_substance":"cefoperazone;sulbactam","related_medicines":"","procedure_number":"PSUSA/00000598/201601","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000598-201601"},{"category":"","active_substances_in_scope_of_procedure":"Cefoperazone","active_substance":"cefoperazone","related_medicines":"","procedure_number":"PSUSA/00000597/201601","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000597-201601"},{"category":"","active_substances_in_scope_of_procedure":"Cefotaxime","active_substance":"cefotaxime","related_medicines":"","procedure_number":"PSUSA/00000599/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000599-201812"},{"category":"","active_substances_in_scope_of_procedure":"Cefotaxime","active_substance":"cefotaxime","related_medicines":"","procedure_number":"PSUSA/00000599/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000599-201512"},{"category":"","active_substances_in_scope_of_procedure":"Cefprozil","active_substance":"cefprozil","related_medicines":"","procedure_number":"PSUSA/00000605/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000605-201712"},{"category":"","active_substances_in_scope_of_procedure":"Ceftazidime","active_substance":"cefotaxime","related_medicines":"","procedure_number":"PSUSA/00000608/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000608-201510"},{"category":"","active_substances_in_scope_of_procedure":"Ceftazidime","active_substance":"cefotaxime","related_medicines":"","procedure_number":"PSUSA/00000608/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000608-201810"},{"category":"","active_substances_in_scope_of_procedure":"Ceftibuten","active_substance":"ceftibuten","related_medicines":"","procedure_number":"PSUSA/00000611/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000611-201707"},{"category":"","active_substances_in_scope_of_procedure":"Ceftobiprole","active_substance":"ceftobiprole","related_medicines":"","procedure_number":"PSUSA/00010734/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010734-202111-0"},{"category":"","active_substances_in_scope_of_procedure":"Ceftriaxone","active_substance":"cefotaxime","related_medicines":"","procedure_number":"PSUSA/00000613/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000613-201505"},{"category":"","active_substances_in_scope_of_procedure":"Ceftriaxone","active_substance":"cefotaxime","related_medicines":"","procedure_number":"PSUSA/00000613/201805","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000613-201805"},{"category":"","active_substances_in_scope_of_procedure":"Cefuroxime axetil","active_substance":"cefuroxime axetil","related_medicines":"","procedure_number":"PSUSA/00009099/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009099-201704"},{"category":"","active_substances_in_scope_of_procedure":"Cefuroxime sodium (except for intracameral use)","active_substance":"cefuroxime sodium","related_medicines":"","procedure_number":"PSUSA/00000615/201704","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000615-201704"},{"category":"","active_substances_in_scope_of_procedure":"Cefuroxime sodium (for intracameral use)","active_substance":"cefuroxime sodium","related_medicines":"","procedure_number":"PSUSA/00010206/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010206-202105"},{"category":"","active_substances_in_scope_of_procedure":"Cefuroxime sodium (for intracameral use)","active_substance":"cefuroxime sodium","related_medicines":"","procedure_number":"PSUSA/00010206/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010206-201411"},{"category":"","active_substances_in_scope_of_procedure":"Cefuroxime sodium (for intracameral use)","active_substance":"cefuroxime sodium","related_medicines":"","procedure_number":"PSUSA/00010206/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010206-201505"},{"category":"","active_substances_in_scope_of_procedure":"Cefuroxime sodium (for intracameral use)","active_substance":"cefuroxime sodium","related_medicines":"","procedure_number":"PSUSA/00010206/201805","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010206-201805"},{"category":"","active_substances_in_scope_of_procedure":"Celecoxib","active_substance":"celecoxib","related_medicines":"","procedure_number":"PSUSA/00000616/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000616-202012"},{"category":"","active_substances_in_scope_of_procedure":"Celecoxib","active_substance":"celecoxib","related_medicines":"","procedure_number":"PSUSA/00000616/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000616-201412"},{"category":"","active_substances_in_scope_of_procedure":"Celecoxib","active_substance":"celecoxib","related_medicines":"","procedure_number":"PSUSA/00000616/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000616-201712"},{"category":"","active_substances_in_scope_of_procedure":"Celiprolol","active_substance":"celiprolol","related_medicines":"","procedure_number":"PSUSA/00000617/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000617-202001"},{"category":"","active_substances_in_scope_of_procedure":"Cetirizine / pseudoephedrine","active_substance":"cetirizine;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00000629/201608","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000629-201608"},{"category":"","active_substances_in_scope_of_procedure":"Cetirizine pseudoephedrine","active_substance":"cetirizine pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00000629/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000629-202108"},{"category":"","active_substances_in_scope_of_procedure":"Cetirizine","active_substance":"cetirizine","related_medicines":"","procedure_number":"PSUSA/00000628/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000628-201711"},{"category":"","active_substances_in_scope_of_procedure":"Chlormadinone acetate / ethinylestradiol","active_substance":"chlormadinone acetate;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00000679/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000679-201611"},{"category":"","active_substances_in_scope_of_procedure":"Chlormadinone","active_substance":"chlormadinone","related_medicines":"","procedure_number":"PSUSA/00000677/201611","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000677-201611"},{"category":"","active_substances_in_scope_of_procedure":"Chloroprocaine hydrochloride","active_substance":"chloroprocaine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010078/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010078-201703"},{"category":"","active_substances_in_scope_of_procedure":"Chloroquine","active_substance":"chloroquine","related_medicines":"","procedure_number":"PSUSA/00000685/202104","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000685-202104"},{"category":"","active_substances_in_scope_of_procedure":"Chloroquine phosphate / proguanil hydrochloride","active_substance":"chloroquine phosphate;proguanil hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010207/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010207-201611"},{"category":"","active_substances_in_scope_of_procedure":"Chloroquine phosphate / proguanil hydrochloride","active_substance":"chloroquine phosphate;proguanil hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010207/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010207-201911"},{"category":"","active_substances_in_scope_of_procedure":"Chloroquine","active_substance":"chloroquine","related_medicines":"","procedure_number":"PSUSA/00000685/201508","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000685-201508"},{"category":"","active_substances_in_scope_of_procedure":"Chlorphenoxamine hydrochloride","active_substance":"chlorphenoxamine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010361/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010361-201805"},{"category":"","active_substances_in_scope_of_procedure":"Chlorpromazine","active_substance":"chlorpromazine","related_medicines":"","procedure_number":"PSUSA/00000715/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000715-202005"},{"category":"","active_substances_in_scope_of_procedure":"Chlorpromazine","active_substance":"chlorpromazine","related_medicines":"","procedure_number":"PSUSA/00000715/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000715-201705"},{"category":"","active_substances_in_scope_of_procedure":"Chlorpromazine","active_substance":"chlorpromazine","related_medicines":"","procedure_number":"PSUSA/00000717/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000717-201803"},{"category":"","active_substances_in_scope_of_procedure":"Chlorquinadol (vaginal tablet) / promestriene","active_substance":"chlorquinaldol;promestriene","related_medicines":"","procedure_number":"PSUSA/00009272/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009272-201509"},{"category":"","active_substances_in_scope_of_procedure":"Chlorquinadol (vaginal tablet) / promestriene","active_substance":"chlorquinaldol;promestriene","related_medicines":"","procedure_number":"PSUSA/00009272/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009272-201909"},{"category":"","active_substances_in_scope_of_procedure":"Chlorquinadol (vaginal tablet) / promestriene","active_substance":"chlorquinaldol;promestriene","related_medicines":"","procedure_number":"PSUSA/00009272/201609","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009272-201609"},{"category":"","active_substances_in_scope_of_procedure":"Ciclesonide","active_substance":"ciclesonide","related_medicines":"","procedure_number":"PSUSA/00000742/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000742-202108"},{"category":"","active_substances_in_scope_of_procedure":"Ciclesonide","active_substance":"ciclesonide","related_medicines":"","procedure_number":"PSUSA/00000742/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000742-201808"},{"category":"","active_substances_in_scope_of_procedure":"Ciclesonide","active_substance":"ciclesonide","related_medicines":"","procedure_number":"PSUSA/00000742/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000742-201508"},{"category":"","active_substances_in_scope_of_procedure":"Beclometasone","active_substance":"beclometasone","related_medicines":"","procedure_number":"PSUSA/00000306/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000306-202112"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: betula verrucosa (sublingual use)","active_substance":"allergen for therapy: betula verrucosa (sublingual use)","related_medicines":"","procedure_number":"PSUSA/00010815/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202201"},{"category":"","active_substances_in_scope_of_procedure":"Alitretinoin (oral use)","active_substance":"alitretinoin","related_medicines":"","procedure_number":"PSUSA/00010710/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202201"},{"category":"","active_substances_in_scope_of_procedure":"Ciclosporin (systemic use)","active_substance":"ciclosporin","related_medicines":"","procedure_number":"PSUSA/00000745/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000745-201512"},{"category":"","active_substances_in_scope_of_procedure":"Ciclosporin (systemic use)","active_substance":"ciclosporin","related_medicines":"","procedure_number":"PSUSA/00000745/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000745-201812"},{"category":"","active_substances_in_scope_of_procedure":"Cidofovir","active_substance":"cidofovir","related_medicines":"","procedure_number":"PSUSA/00010558/201906","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-201906"},{"category":"","active_substances_in_scope_of_procedure":"Cidofovir","active_substance":"cidofovir","related_medicines":"","procedure_number":"PSUSA/00010558/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-202006"},{"category":"","active_substances_in_scope_of_procedure":"Cidofovir","active_substance":"cidofovir","related_medicines":"","procedure_number":"PSUSA/00010558/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-202106"},{"category":"","active_substances_in_scope_of_procedure":"Cidofovir","active_substance":"cidofovir","related_medicines":"","procedure_number":"PSUSA/00010558/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-201706"},{"category":"","active_substances_in_scope_of_procedure":"Cidofovir","active_substance":"cidofovir","related_medicines":"","procedure_number":"PSUSA/00010558/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-201806"},{"category":"","active_substances_in_scope_of_procedure":"Cilastatin / Imipenem","active_substance":"cilastatin;imipenem","related_medicines":"","procedure_number":"PSUSA/00000748/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000748-201706"},{"category":"","active_substances_in_scope_of_procedure":"Cilazapril, cilazapril / hydrochlorothiazide","active_substance":"cilazapril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000749/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000749-202102"},{"category":"","active_substances_in_scope_of_procedure":"Cilazapril, cilazapril / hydrochlorothiazide","active_substance":"cilazapril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000749/201802","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000749-201802"},{"category":"","active_substances_in_scope_of_procedure":"Cilazapril, cilazapril / hydrochlorothiazide","active_substance":"cilazapril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000749/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000749-201502"},{"category":"","active_substances_in_scope_of_procedure":"Cilostazol","active_substance":"cilostazol","related_medicines":"","procedure_number":"PSUSA/00010209/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201702"},{"category":"","active_substances_in_scope_of_procedure":"Cilostazol","active_substance":"cilostazol","related_medicines":"","procedure_number":"PSUSA/00010209/201502","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201502"},{"category":"","active_substances_in_scope_of_procedure":"Cilostazol","active_substance":"cilostazol","related_medicines":"","procedure_number":"PSUSA/00010209/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201508"},{"category":"","active_substances_in_scope_of_procedure":"Cilostazol","active_substance":"cilostazol","related_medicines":"","procedure_number":"PSUSA/00010209/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201602"},{"category":"","active_substances_in_scope_of_procedure":"Cilostazol","active_substance":"cilostazol","related_medicines":"","procedure_number":"PSUSA/00010209/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201802"},{"category":"","active_substances_in_scope_of_procedure":"Cilostazol","active_substance":"cilostazol","related_medicines":"","procedure_number":"PSUSA/00010209/201902","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201902"},{"category":"","active_substances_in_scope_of_procedure":"Cilostazol","active_substance":"cilostazol","related_medicines":"","procedure_number":"PSUSA/00010209/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-202002"},{"category":"","active_substances_in_scope_of_procedure":"Cimicifuga racemosa (L.) nutt., rhizome","active_substance":"cimicifuga racemosa (L.) nutt., rhizoma","related_medicines":"","procedure_number":"PSUSA/00000755/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000755-201801"},{"category":"","active_substances_in_scope_of_procedure":"Cinolazepam","active_substance":"cinolazepam","related_medicines":"","procedure_number":"PSUSA/00000769/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000769-201912"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofibrate","active_substance":"ciprofibrate","related_medicines":"","procedure_number":"PSUSA/00000771/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000771-202112"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofibrate","active_substance":"ciprofibrate","related_medicines":"","procedure_number":"PSUSA/00000771/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000771-201612"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofloxacin (systemic use)","active_substance":"ciprofloxacin","related_medicines":"","procedure_number":"PSUSA/00000775/201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000775-201801"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofloxacin (topical use)","active_substance":"ciprofloxacin","related_medicines":"","procedure_number":"PSUSA/00000775/201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000775-201801-0"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofloxacin (topical use)","active_substance":"ciprofloxacin","related_medicines":"","procedure_number":"PSUSA/00000776/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000776-201801"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofloxacin hydrochloride / dexamethasone acetate (ear drops, suspension)","active_substance":"ciprofloxacin hydrochloride;dexamethasone acetate","related_medicines":"","procedure_number":"PSUSA/00010012/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010012-202004"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofloxacin hydrochloride / hydrocortisone","active_substance":"ciprofloxacin hydrochloride;hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00000774/202011","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000774-202011"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofloxacin hydrochloride / hydrocortisone","active_substance":"ciprofloxacin hydrochloride;hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00000774/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000774-201711"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofloxacin hydrochloride, dexamethasone acetate (ear drops, suspension)","active_substance":"ciprofloxacin hydrochloride;dexamethasone acetate","related_medicines":"","procedure_number":"PSUSA/00010012/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010012-201504"},{"category":"","active_substances_in_scope_of_procedure":"Ciprofloxacin hydrochloride, hydrocortisone","active_substance":"ciprofloxacin hydrochloride;hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00000774/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000774-201411"},{"category":"","active_substances_in_scope_of_procedure":"Cisatracurium","active_substance":"cisatracurium","related_medicines":"","procedure_number":"PSUSA/00000777/202007","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000777-202007"},{"category":"","active_substances_in_scope_of_procedure":"Cisatracurium","active_substance":"cisatracurium","related_medicines":"","procedure_number":"PSUSA/00000777/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000777-201507"},{"category":"","active_substances_in_scope_of_procedure":"Cisplatin","active_substance":"cisplatin","related_medicines":"","procedure_number":"PSUSA/00000778/201712","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000778-201712"},{"category":"","active_substances_in_scope_of_procedure":"Citalopram","active_substance":"citalopram","related_medicines":"","procedure_number":"PSUSA/00000779/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000779-201612"},{"category":"","active_substances_in_scope_of_procedure":"Citrulline malate","active_substance":"citrulline malate","related_medicines":"","procedure_number":"PSUSA/00010579/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010579-202103"},{"category":"","active_substances_in_scope_of_procedure":"Citrulline malate","active_substance":"citrulline malate","related_medicines":"","procedure_number":"PSUSA/00010579/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010579-201803"},{"category":"","active_substances_in_scope_of_procedure":"Clarithromycin","active_substance":"clarithromycin","related_medicines":"","procedure_number":"PSUSA/00000788/202004","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000788-202004"},{"category":"","active_substances_in_scope_of_procedure":"Clarithromycin","active_substance":"clarithromycin","related_medicines":"","procedure_number":"PSUSA/00000788/201704","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000788-201704"},{"category":"","active_substances_in_scope_of_procedure":"Clebopride","active_substance":"clebopride","related_medicines":"","procedure_number":"PSUSA/00000789/201906","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000789-201906"},{"category":"","active_substances_in_scope_of_procedure":"Clenbuterol","active_substance":"clenbuterol","related_medicines":"","procedure_number":"PSUSA/00000794/201809","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000794-201809"},{"category":"","active_substances_in_scope_of_procedure":"Clenbuterol","active_substance":"clenbuterol","related_medicines":"","procedure_number":"PSUSA/00000794/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000794-201909"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202111"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/202011","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202011"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202105"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201505"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201511"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201605"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201611"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201705"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201711"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201805"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201811"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201905"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201911"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202005"},{"category":"","active_substances_in_scope_of_procedure":"botulinum toxin a - haemagglutinin complex","active_substance":"botulinum toxin a - haemagglutinin complex","related_medicines":"","procedure_number":"PSUSA/00000427/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000427-202112"},{"category":"","active_substances_in_scope_of_procedure":"niflumic acid","active_substance":"niflumic acid","related_medicines":"","procedure_number":"PSUSA/00002157/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002157-202112"},{"category":"","active_substances_in_scope_of_procedure":"bendamustine hydrochloride","active_substance":"bendamustine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00003162/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-202201"},{"category":"","active_substances_in_scope_of_procedure":"hydromorphone","active_substance":"hydromorphone","related_medicines":"","procedure_number":"PSUSA/00001686/202111","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001686-202111"},{"category":"","active_substances_in_scope_of_procedure":"flunitrazepam","active_substance":"flunitrazepam","related_medicines":"","procedure_number":"PSUSA/00001418/202201","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001418-202201"},{"category":"","active_substances_in_scope_of_procedure":"","active_substance":"citalopram","related_medicines":"","procedure_number":"PSUSA/00000779/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000779-202112"},{"category":"","active_substances_in_scope_of_procedure":"Clindamycin","active_substance":"clindamycin","related_medicines":"","procedure_number":"PSUSA/00000795/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000795-202110"},{"category":"","active_substances_in_scope_of_procedure":"Clindamycin phosphate / tretinoin","active_substance":"clindamycin phosphate;tretinoin","related_medicines":"","procedure_number":"PSUSA/00010080/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010080-201707"},{"category":"","active_substances_in_scope_of_procedure":"Clindamycin","active_substance":"clindamycin","related_medicines":"","procedure_number":"PSUSA/00000795/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000795-201510"},{"category":"","active_substances_in_scope_of_procedure":"Clindamycin","active_substance":"clindamycin","related_medicines":"","procedure_number":"PSUSA/00000795/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000795-201810"},{"category":"","active_substances_in_scope_of_procedure":"Clobazam","active_substance":"clobazam","related_medicines":"","procedure_number":"PSUSA/00000798/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000798-202002"},{"category":"","active_substances_in_scope_of_procedure":"Clobetasol","active_substance":"clobetasol","related_medicines":"","procedure_number":"PSUSA/00000799/202002","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000799-202002"},{"category":"","active_substances_in_scope_of_procedure":"Clobetasol","active_substance":"clobetasol","related_medicines":"","procedure_number":"PSUSA/00000799/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000799-201502"},{"category":"","active_substances_in_scope_of_procedure":"Clodronic acid","active_substance":"clodronic acid","related_medicines":"","procedure_number":"PSUSA/00000804/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000804-201702"},{"category":"","active_substances_in_scope_of_procedure":"clonazepam (56718)","active_substance":"clonazepam","related_medicines":"","procedure_number":"PSUSA/00000812/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000812-201506"},{"category":"","active_substances_in_scope_of_procedure":"clonazepam (56718)","active_substance":"clonazepam","related_medicines":"","procedure_number":"PSUSA/00000812/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000812-202006"},{"category":"","active_substances_in_scope_of_procedure":"Clotiazepam","active_substance":"clotiazepam","related_medicines":"","procedure_number":"PSUSA/00000827/202005","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000827-202005"},{"category":"","active_substances_in_scope_of_procedure":"Clotiazepam","active_substance":"clotiazepam","related_medicines":"","procedure_number":"PSUSA/00000827/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000827-201505"},{"category":"","active_substances_in_scope_of_procedure":"Codeine camphosulphonate / sodium benzoate, codeine camphosulphonate / sulfogaiacol / grindelia soft extract","active_substance":"codeine camphosulphonate;sodium benzoate;sulfogaiacol;grindelia soft extract","related_medicines":"","procedure_number":"PSUSA/00010542/201912","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010542-201912"},{"category":"","active_substances_in_scope_of_procedure":"Colchicine","active_substance":"colchicine","related_medicines":"","procedure_number":"PSUSA/00000858/201807","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000858-201807"},{"category":"","active_substances_in_scope_of_procedure":"Corticorelin","active_substance":"corticorelin","related_medicines":"","procedure_number":"PSUSA/00000876/201410","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000876-201410"},{"category":"","active_substances_in_scope_of_procedure":"Corticorelin","active_substance":"corticorelin","related_medicines":"","procedure_number":"PSUSA/00000876/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000876-201910"},{"category":"","active_substances_in_scope_of_procedure":"Flumazenil","active_substance":"flumazenil","related_medicines":"","procedure_number":"PSUSA/00001413/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001413-202112"},{"category":"","active_substances_in_scope_of_procedure":"pilocarpine (ophthalmic formulation)","active_substance":"pilocarpine","related_medicines":"","procedure_number":"PSUSA/00002410/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002410-202108"},{"category":"","active_substances_in_scope_of_procedure":"Dermatophagoides pteronyssinus / dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)","active_substance":"Dermatophagoides pteronyssinus;Dermatophagoides farina","related_medicines":"","procedure_number":"PSUSA/00010582/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-201709"},{"category":"","active_substances_in_scope_of_procedure":"Desfluran","active_substance":"desfluran","related_medicines":"","procedure_number":"PSUSA/0000958/201409","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0000958-201409"},{"category":"","active_substances_in_scope_of_procedure":"Desflurane","active_substance":"desflurane","related_medicines":"","procedure_number":"PSUSA/00000958/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000958-202009"},{"category":"","active_substances_in_scope_of_procedure":"Desflurane","active_substance":"desflurane","related_medicines":"","procedure_number":"PSUSA/00000958/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000958-201709"},{"category":"","active_substances_in_scope_of_procedure":"Desmopressin","active_substance":"desmopressin","related_medicines":"","procedure_number":"PSUSA/00000964/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000964-202012"},{"category":"","active_substances_in_scope_of_procedure":"Desmopressin","active_substance":"desmopressin","related_medicines":"","procedure_number":"PSUSA/00000964/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000964-201412"},{"category":"","active_substances_in_scope_of_procedure":"Desmopressin","active_substance":"desmopressin","related_medicines":"","procedure_number":"PSUSA/00000964/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000964-201712"},{"category":"","active_substances_in_scope_of_procedure":"Desogestrel / ethinylestradiol","active_substance":"desogestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00000967/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000967-202009"},{"category":"","active_substances_in_scope_of_procedure":"Desogestrel / ethinylestradiol","active_substance":"desogestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00000967/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000967-201509"},{"category":"","active_substances_in_scope_of_procedure":"Desogestrel","active_substance":"desogestrel","related_medicines":"","procedure_number":"PSUSA/00000966/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000966-202107"},{"category":"","active_substances_in_scope_of_procedure":"Desogestrel","active_substance":"desogestrel","related_medicines":"","procedure_number":"PSUSA/00000966/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000966-201607"},{"category":"","active_substances_in_scope_of_procedure":"Dexamethasone (apart from centrally authorised products)","active_substance":"dexamethasone","related_medicines":"","procedure_number":"PSUSA/00000973/201601","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000973-201601"},{"category":"","active_substances_in_scope_of_procedure":"Dexamethasone (apart from centrally authorised products)","active_substance":"dexamethasone","related_medicines":"","procedure_number":"PSUSA/00000973/202101","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000973-202101"},{"category":"","active_substances_in_scope_of_procedure":"Dexamethasone / netilmicin","active_substance":"dexamethasone;netilmicin","related_medicines":"","procedure_number":"PSUSA/00010854/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010854-202104"},{"category":"","active_substances_in_scope_of_procedure":"Dexamethasone / tobramycin","active_substance":"dexamethasone;tobramycin","related_medicines":"","procedure_number":"PSUSA/00000979/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000979-202103"},{"category":"","active_substances_in_scope_of_procedure":"Dexamethasone / tobramycin","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"PSUSA/00000986/202109","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202109"},{"category":"","active_substances_in_scope_of_procedure":"Dexamfetamine","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"EMEA/H/N/PSR/S/0028","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0028"},{"category":"","active_substances_in_scope_of_procedure":"Dexamfetamine","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"EMEA/H/N/PSR/S/0029","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0029"},{"category":"","active_substances_in_scope_of_procedure":"Dexamfetamine","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"PSUSA/00000986/201709","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-201709"},{"category":"","active_substances_in_scope_of_procedure":"Dexamfetamine","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"PSUSA/00000986/201909","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-201909"},{"category":"","active_substances_in_scope_of_procedure":"Dexamfetamine","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"PSUSA/00000986/201809","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-201809"},{"category":"","active_substances_in_scope_of_procedure":"Dexamfetamine","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"PSUSA/00000986/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202009"},{"category":"","active_substances_in_scope_of_procedure":"Dexchlorpheniramine","active_substance":"dexchlorpheniramine","related_medicines":"","procedure_number":"PSUSA/00000989/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000989-202106"},{"category":"","active_substances_in_scope_of_procedure":"Dexchlorpheniramine","active_substance":"dexchlorpheniramine","related_medicines":"","procedure_number":"PSUSA/00000989/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000989-201506"},{"category":"","active_substances_in_scope_of_procedure":"Dexchlorpheniramine","active_substance":"dexchlorpheniramine","related_medicines":"","procedure_number":"PSUSA/00000989/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000989-201806"},{"category":"","active_substances_in_scope_of_procedure":"Dexibuprofen","active_substance":"dexibuprofen","related_medicines":"","procedure_number":"PSUSA/00000996/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000996-201708"},{"category":"","active_substances_in_scope_of_procedure":"Dexibuprofen","active_substance":"dexibuprofen","related_medicines":"","procedure_number":"PSUSA/00000996/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000996-202008"},{"category":"","active_substances_in_scope_of_procedure":"Dexketoprofen / tramadol","active_substance":"dexketoprofen;tramadol","related_medicines":"","procedure_number":"PSUSA/00010468/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010468-201901"},{"category":"","active_substances_in_scope_of_procedure":"Dexketoprofen","active_substance":"dexketoprofen","related_medicines":"","procedure_number":"PSUSA/00000997/202110","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000997-202110"},{"category":"","active_substances_in_scope_of_procedure":"Dexketoprofen / tramadol","active_substance":"dexketoprofen;tramadol","related_medicines":"","procedure_number":"EMEA/H/N/PSR/S/0035","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0035"},{"category":"","active_substances_in_scope_of_procedure":"Dexketoprofen","active_substance":"dexketoprofen","related_medicines":"","procedure_number":"PSUSA/00000997/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000997-201510"},{"category":"","active_substances_in_scope_of_procedure":"Dexlansoprazole / lansoprazole","active_substance":"dexlansoprazole;lansoprazole","related_medicines":"","procedure_number":"PSUSA/00001827/201612","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001827-201612"},{"category":"","active_substances_in_scope_of_procedure":"Dexpanthenol xylometazoline","active_substance":"dexpanthenol xylometazoline","related_medicines":"","procedure_number":"PSUSA/00010030/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010030-202005"},{"category":"","active_substances_in_scope_of_procedure":"Dextromethorphan","active_substance":"dextromethorphan","related_medicines":"","procedure_number":"PSUSA/00001009/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001009-202111"},{"category":"","active_substances_in_scope_of_procedure":"Dextromethorphan","active_substance":"dextromethorphan","related_medicines":"","procedure_number":"PSUSA/00001009/201511","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001009-201511"},{"category":"","active_substances_in_scope_of_procedure":"Dextromethorphan","active_substance":"dextromethorphan","related_medicines":"","procedure_number":"PSUSA/00001009/201811","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001009-201811"},{"category":"","active_substances_in_scope_of_procedure":"Dhydroergocryptine","active_substance":"dihydroergocryptine","related_medicines":"","procedure_number":"PSUSA/00001074/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001074-201507"},{"category":"","active_substances_in_scope_of_procedure":"Diacerein","active_substance":"Diacerein","related_medicines":"","procedure_number":"PSUSA/00001026/201612","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001026-201612"},{"category":"","active_substances_in_scope_of_procedure":"Diacerein","active_substance":"Diacerein","related_medicines":"","procedure_number":"PSUSA/00001026/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001026-201712"},{"category":"","active_substances_in_scope_of_procedure":"Diacerein","active_substance":"Diacerein","related_medicines":"","procedure_number":"PSUSA/0001026/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0001026-201512"},{"category":"","active_substances_in_scope_of_procedure":"Diacerin","active_substance":"diacerin","related_medicines":"","procedure_number":"PSUSA/00001026/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001026-202012"},{"category":"","active_substances_in_scope_of_procedure":"","active_substance":"methohexital","related_medicines":"","procedure_number":"PSUSA/00010656/202201","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010656-202201"},{"category":"","active_substances_in_scope_of_procedure":"Esketamine","active_substance":"Esketamine","related_medicines":"","procedure_number":"PSUSA/00001266/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001266-202108"},{"category":"","active_substances_in_scope_of_procedure":"Diclofenac","active_substance":"diclofenac","related_medicines":"","procedure_number":"PSUSA/00001048/202109","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001048-202109"},{"category":"","active_substances_in_scope_of_procedure":"exemestane","active_substance":"exemestane","related_medicines":"","procedure_number":"PSUSA/00001345/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001345-201512"},{"category":"","active_substances_in_scope_of_procedure":"Ezetimibe / rosuvastatin","active_substance":"ezetimibe;rosuvastatin","related_medicines":"","procedure_number":"PSUSA/00010271/201707","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010271-201707"},{"category":"","active_substances_in_scope_of_procedure":"Ezetimibe / rosuvastatin","active_substance":"ezetimibe;rosuvastatin","related_medicines":"","procedure_number":"PSUSA/00010271/202007","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010271-202007"},{"category":"","active_substances_in_scope_of_procedure":"Domperidone","active_substance":"domperidone","related_medicines":"","procedure_number":"EMEA/H/N/PSR/J/0015","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0015"},{"category":"","active_substances_in_scope_of_procedure":"Dornase alpha","active_substance":"dornase alpha","related_medicines":"","procedure_number":"PSUSA/00001164/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001164-201709"},{"category":"","active_substances_in_scope_of_procedure":"Diclofenac (systemic formulations)","active_substance":"diclofenac","related_medicines":"","procedure_number":"PSUSA/00001048/201509","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001048-201509"},{"category":"","active_substances_in_scope_of_procedure":"Dorzolamide / timolol","active_substance":"dorzolamide;timolol","related_medicines":"","procedure_number":"PSUSA/00001166/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001166-201602"},{"category":"","active_substances_in_scope_of_procedure":"","active_substance":"ivabradine;metoprolol","related_medicines":"","procedure_number":"PSUSA/00010381/202004","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"13/09/2022","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202004"},{"category":"","active_substances_in_scope_of_procedure":"Dorzolamide / timolol","active_substance":"dorzolamide;timolol","related_medicines":"","procedure_number":"PSUSA/00001166/201902","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001166-201902"},{"category":"","active_substances_in_scope_of_procedure":"Erdosteine","active_substance":"Erdosteine","related_medicines":"","procedure_number":"PSUSA/00001248/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001248-201602"},{"category":"","active_substances_in_scope_of_procedure":"Ezetimibe / simvastatin","active_substance":"ezetimibe;simvastatin","related_medicines":"","procedure_number":"PSUSA/00001347/201903","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001347-201903"},{"category":"","active_substances_in_scope_of_procedure":"Ezetimibe","active_substance":"ezetimibe","related_medicines":"","procedure_number":"PSUSA/00001346/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001346-201710"},{"category":"","active_substances_in_scope_of_procedure":"F(ab)2 fragments of equine antirabies immunoglobulin","active_substance":"F(ab)2 fragments of equine antirabies immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00001348/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001348-201605"},{"category":"","active_substances_in_scope_of_procedure":"Famciclovir","active_substance":"famciclovir","related_medicines":"","procedure_number":"PSUSA/00001349/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001349-202012"},{"category":"","active_substances_in_scope_of_procedure":"Famciclovir","active_substance":"famciclovir","related_medicines":"","procedure_number":"PSUSA/00001349/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001349-201712"},{"category":"","active_substances_in_scope_of_procedure":"Famotidine","active_substance":"Famotidine","related_medicines":"","procedure_number":"PSUSA/00001350/201709","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001350-201709"},{"category":"","active_substances_in_scope_of_procedure":"Felbamate","active_substance":"felbamate","related_medicines":"","procedure_number":"PSUSA/00010155/201609","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010155-201609"},{"category":"","active_substances_in_scope_of_procedure":"Felbamate","active_substance":"felbamate","related_medicines":"","procedure_number":"PSUSA/00010155/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010155-201909"},{"category":"","active_substances_in_scope_of_procedure":"Felodipine / metoprolol","active_substance":"felodipine;metoprolol","related_medicines":"","procedure_number":"PSUSA/00001357/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001357-201712"},{"category":"","active_substances_in_scope_of_procedure":"Felodipine / ramipril","active_substance":"felodipine;ramipril","related_medicines":"","procedure_number":"PSUSA/00001358/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001358-201803"},{"category":"","active_substances_in_scope_of_procedure":"Felodipine","active_substance":"felodipine","related_medicines":"","procedure_number":"PSUSA/00001356/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001356-201712"},{"category":"","active_substances_in_scope_of_procedure":"Fenofibrate","active_substance":"fenofibrate","related_medicines":"","procedure_number":"PSUSA/00001362/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001362-202007"},{"category":"","active_substances_in_scope_of_procedure":"Fenofibrate","active_substance":"fenofibrate","related_medicines":"","procedure_number":"PSUSA/00001362/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001362-201707"},{"category":"","active_substances_in_scope_of_procedure":"Fenoterol (obstetric indications)","active_substance":"fenoterol","related_medicines":"","procedure_number":"PSUSA/00010001/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010001-201509"},{"category":"","active_substances_in_scope_of_procedure":"Fenoterol (respiratory indications)","active_substance":"fenoterol","related_medicines":"","procedure_number":"PSUSA/00001366/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001366-201709"},{"category":"","active_substances_in_scope_of_procedure":"Diclofenac (systemic formulations)","active_substance":"diclofenac","related_medicines":"","procedure_number":"PSUSA/00001048/201809","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001048-201809"},{"category":"","active_substances_in_scope_of_procedure":"Fenspiride","active_substance":"fenspiride","related_medicines":"","procedure_number":"PSUSA/00001368/201804","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001368-201804"},{"category":"","active_substances_in_scope_of_procedure":"Fenoterol / ipratropium","active_substance":"fenoterol;ipratropium","related_medicines":"","procedure_number":"PSUSA/00001367/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001367-201802"},{"category":"","active_substances_in_scope_of_procedure":"Fenspiride","active_substance":"fenspiride","related_medicines":"","procedure_number":"PSUSA/00001368/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001368-201704"},{"category":"","active_substances_in_scope_of_procedure":"Fentanyl (transdermal patches, solution for injection - nationally authorised product only)","active_substance":"fentanyl (transdermal patches, solution for injection - nationally authorised product only)","related_medicines":"","procedure_number":"PSUSA/00001370/202104","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-202104"},{"category":"","active_substances_in_scope_of_procedure":"Fentanyl (transdermal patches, solution for injection - nationally authorised product only)","active_substance":"fentanyl","related_medicines":"","procedure_number":"PSUSA/00001370/201804","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-201804"},{"category":"","active_substances_in_scope_of_procedure":"Dorzolamide","active_substance":"dorzolamide","related_medicines":"","procedure_number":"PSUSA/00003168/201602","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003168-201602"},{"category":"","active_substances_in_scope_of_procedure":"Fentanyl (transdermal patches, solution for injection)","active_substance":"fentanyl","related_medicines":"","procedure_number":"PSUSA/00001370/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-201504"},{"category":"","active_substances_in_scope_of_procedure":"Fexofenadine","active_substance":"fexofenadine","related_medicines":"","procedure_number":"PSUSA/00001388/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001388-201703"},{"category":"","active_substances_in_scope_of_procedure":"Finasteride","active_substance":"Finasteride","related_medicines":"","procedure_number":"PSUSA/00001392/201608","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201608"},{"category":"","active_substances_in_scope_of_procedure":"Dorzolamide","active_substance":"dorzolamide","related_medicines":"","procedure_number":"PSUSA/00003168/201902","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003168-201902"},{"category":"","active_substances_in_scope_of_procedure":"Finasteride","active_substance":"Finasteride","related_medicines":"","procedure_number":"PSUSA/00001392/201908","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201908"},{"category":"","active_substances_in_scope_of_procedure":"Finasteride","active_substance":"Finasteride","related_medicines":"","procedure_number":"PSUSA/00001392/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-202108"},{"category":"","active_substances_in_scope_of_procedure":"Diclofenac (topical formulations)","active_substance":"diclofenac","related_medicines":"","procedure_number":"PSUSA/00010342/201809","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010342-201809"},{"category":"","active_substances_in_scope_of_procedure":"Finasteride","active_substance":"Finasteride","related_medicines":"","procedure_number":"PSUSA/00001392/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201508"},{"category":"","active_substances_in_scope_of_procedure":"Finasteride","active_substance":"Finasteride","related_medicines":"","procedure_number":"PSUSA/00001392/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201808"},{"category":"","active_substances_in_scope_of_procedure":"Finasteride","active_substance":"Finasteride","related_medicines":"","procedure_number":"PSUSA/00001392/201708","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201708"},{"category":"","active_substances_in_scope_of_procedure":"Diclofenac (topical formulations)","active_substance":"diclofenac","related_medicines":"","procedure_number":"PSUSA/00010342/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010342-201509"},{"category":"","active_substances_in_scope_of_procedure":"Fish oil/olive oil/soybean oil/triglycerides medium-chain","active_substance":"triglycerides medium-chain;olive oil;Fish oil;soya bean oil","related_medicines":"","procedure_number":"PSUSA/00010223/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010223-201702"},{"category":"","active_substances_in_scope_of_procedure":"Doxazosin","active_substance":"doxazosin","related_medicines":"","procedure_number":"PSUSA/00001169/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001169-202012"},{"category":"","active_substances_in_scope_of_procedure":"Flecainide","active_substance":"flecainide","related_medicines":"","procedure_number":"PSUSA/00001396/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001396-201706"},{"category":"","active_substances_in_scope_of_procedure":"Diclofenac / misoprostol","active_substance":"diclofenac;misoprostol","related_medicines":"","procedure_number":"PSUSA/00001040/201707","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001040-201707"},{"category":"","active_substances_in_scope_of_procedure":"Flubendazole","active_substance":"flubendazole","related_medicines":"","procedure_number":"PSUSA/00001400/201702","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001400-201702"},{"category":"","active_substances_in_scope_of_procedure":"Flucloxacillin","active_substance":"flucloxacillin","related_medicines":"","procedure_number":"PSUSA/00001402/202003","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001402-202003"},{"category":"","active_substances_in_scope_of_procedure":"Doxazosin","active_substance":"doxazosin","related_medicines":"","procedure_number":"PSUSA/00001169/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001169-201512"},{"category":"","active_substances_in_scope_of_procedure":"Fluconazole","active_substance":"fluconazole","related_medicines":"","procedure_number":"PSUSA/00001404/202003","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001404-202003"},{"category":"","active_substances_in_scope_of_procedure":"Diclofenac / omeprazole","active_substance":"diclofenac;omeprazole","related_medicines":"","procedure_number":"PSUSA/00010461/202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010461-202109"},{"category":"","active_substances_in_scope_of_procedure":"Doxylamine","active_substance":"doxylamine","related_medicines":"","procedure_number":"PSUSA/00001174/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001174-201704"},{"category":"","active_substances_in_scope_of_procedure":"Fluconazole","active_substance":"fluconazole","related_medicines":"","procedure_number":"PSUSA/00001404/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001404-201703"},{"category":"","active_substances_in_scope_of_procedure":"Fludarabine","active_substance":"fludarabine","related_medicines":"","procedure_number":"PSUSA/00001406/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001406-201708"},{"category":"","active_substances_in_scope_of_procedure":"Fludeoxyglucose (18f)","active_substance":"fludeoxyglucose (18F)","related_medicines":"","procedure_number":"PSUSA/00001437/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001437-201711"},{"category":"","active_substances_in_scope_of_procedure":"Diclofenac / omeprazole: List of nationally authorised medicinal products - PSUSA/00010461/201809","active_substance":"diclofenac;omeprazole","related_medicines":"","procedure_number":"PSUSA/00010461/201809","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010461-201809"},{"category":"","active_substances_in_scope_of_procedure":"Flumazenil","active_substance":"flumazenil","related_medicines":"","procedure_number":"PSUSA/00001413/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001413-201512"},{"category":"","active_substances_in_scope_of_procedure":"Flunarizine","active_substance":"flunarizine","related_medicines":"","procedure_number":"PSUSA/00001416/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001416-202105"},{"category":"","active_substances_in_scope_of_procedure":"Flunarizine","active_substance":"flunarizine","related_medicines":"","procedure_number":"PSUSA/00001416/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001416-201505"},{"category":"","active_substances_in_scope_of_procedure":"Didanosine","active_substance":"didanosine","related_medicines":"","procedure_number":"PSUSA/00001054/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001054-201510"},{"category":"","active_substances_in_scope_of_procedure":"Flunarizine","active_substance":"flunarizine","related_medicines":"","procedure_number":"PSUSA/00001416/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001416-201805"},{"category":"","active_substances_in_scope_of_procedure":"Drospirenone / estradiol","active_substance":"drospirenone;estradiol","related_medicines":"","procedure_number":"PSUSA/00001184/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001184-201912"},{"category":"","active_substances_in_scope_of_procedure":"Didanosine","active_substance":"didanosine","related_medicines":"","procedure_number":"PSUSA/00001054/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001054-201810"},{"category":"","active_substances_in_scope_of_procedure":"Flunitrazepam","active_substance":"flunitrazepam","related_medicines":"","procedure_number":"PSUSA/00001418/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001418-201601"},{"category":"","active_substances_in_scope_of_procedure":"Dienogest / estradiol (contraception indication)","active_substance":"Dienogest;estradiol","related_medicines":"","procedure_number":"PSUSA/00010444/201809","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010444-201809"},{"category":"","active_substances_in_scope_of_procedure":"Flunitrazepam","active_substance":"flunitrazepam","related_medicines":"","procedure_number":"PSUSA/00001418/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001418-201901"},{"category":"","active_substances_in_scope_of_procedure":"Dienogest / estradiol (HRT indication)","active_substance":"Dienogest;estradiol","related_medicines":"","procedure_number":"PSUSA/00010443/201606","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010443-201606"},{"category":"","active_substances_in_scope_of_procedure":"Fluocinolone acetonide (intravitreal implant in applicator)","active_substance":"Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00010224/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-202108"},{"category":"","active_substances_in_scope_of_procedure":"Drospirenone / ethinylestradiol","active_substance":"drospirenone;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010217/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010217-201609"},{"category":"","active_substances_in_scope_of_procedure":"Fluocinolone acetonide (intravitreal implant in applicator)","active_substance":"Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00010224/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201502"},{"category":"","active_substances_in_scope_of_procedure":"Dienogest / estradiol (HRT indication)","active_substance":"Dienogest;estradiol","related_medicines":"","procedure_number":"PSUSA/00010443/201906","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010443-201906"},{"category":"","active_substances_in_scope_of_procedure":"Fluocinolone acetonide (intravitreal implant in applicator)","active_substance":"Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00010224/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201508"},{"category":"","active_substances_in_scope_of_procedure":"Fluocinolone acetonide (intravitreal implant in applicator)","active_substance":"Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00010224/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201602"},{"category":"","active_substances_in_scope_of_procedure":"Fluocinolone acetonide (intravitreal implant in applicator)","active_substance":"Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00010224/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201608"},{"category":"","active_substances_in_scope_of_procedure":"Fluorodopa (18F)","active_substance":"fluorodopa (18F)","related_medicines":"","procedure_number":"PSUSA/00010002/201803","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010002-201803"},{"category":"","active_substances_in_scope_of_procedure":"Fluocinolone acetonide (intravitreal implant in applicator)","active_substance":"Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00010224/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201708"},{"category":"","active_substances_in_scope_of_procedure":"Fluocinolone acetonide (intravitreal implant in applicator)","active_substance":"Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00010224/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201808"},{"category":"","active_substances_in_scope_of_procedure":"Dienogest / ethinylestradiol","active_substance":"Dienogest;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00001057/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001057-201803"},{"category":"","active_substances_in_scope_of_procedure":"Drospirenone / ethinylestradiol","active_substance":"drospirenone;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010217/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010217-201909"},{"category":"","active_substances_in_scope_of_procedure":"Fluocinolone acetonide","active_substance":"Fluocinolone acetonide","related_medicines":"","procedure_number":"PSUSA/00010224/202008","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-202008"},{"category":"","active_substances_in_scope_of_procedure":"Drospirenone","active_substance":"drospirenone","related_medicines":"","procedure_number":"PSUSA/00010853/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010853-202111"},{"category":"","active_substances_in_scope_of_procedure":"Dienogest","active_substance":"Dienogest","related_medicines":"","procedure_number":"PSUSA/00003167/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003167-201612"},{"category":"","active_substances_in_scope_of_procedure":"Dienogest","active_substance":"Dienogest","related_medicines":"","procedure_number":"PSUSA/00003167/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003167-201912"},{"category":"","active_substances_in_scope_of_procedure":"Dihydroergocristine","active_substance":"dihydroergocristine","related_medicines":"","procedure_number":"PSUSA/00001071/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001071-201504"},{"category":"","active_substances_in_scope_of_procedure":"Dihydroergotamine","active_substance":"dihydroergotamine","related_medicines":"","procedure_number":"PSUSA/00001075/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001075-201504"},{"category":"","active_substances_in_scope_of_procedure":"Dihydroergotamine","active_substance":"dihydroergotamine","related_medicines":"","procedure_number":"PSUSA/00001075/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001075-201804"},{"category":"","active_substances_in_scope_of_procedure":"Dihydroergotamine","active_substance":"dihydroergotamine","related_medicines":"","procedure_number":"PSUSA/00001075/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001075-202104"},{"category":"","active_substances_in_scope_of_procedure":"Dihydroergotoxine","active_substance":"dihydroergotoxine","related_medicines":"","procedure_number":"PSUSA/0001079/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0001079-201804"},{"category":"","active_substances_in_scope_of_procedure":"Drospirenone/estradiol","active_substance":"drospirenone;estradiol","related_medicines":"","procedure_number":"PSUSA/00001184/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001184-201412"},{"category":"","active_substances_in_scope_of_procedure":"Dihydroergotoxine","active_substance":"dihydroergotoxine","related_medicines":"","procedure_number":"PSUSA/00001079/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001079-201504"},{"category":"","active_substances_in_scope_of_procedure":"Dutasteride, dutasteride / tamsulosin","active_substance":"dutasteride;tamsulosin","related_medicines":"","procedure_number":"PSUSA/00010506/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010506-201711"},{"category":"","active_substances_in_scope_of_procedure":"Diltiazem","active_substance":"diltiazem","related_medicines":"","procedure_number":"PSUSA/00001084/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001084-201705"},{"category":"","active_substances_in_scope_of_procedure":"Diltiazem","active_substance":"diltiazem","related_medicines":"","procedure_number":"PSUSA/00001084/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001084-201705-0"},{"category":"","active_substances_in_scope_of_procedure":"Ebastine","active_substance":"ebastine","related_medicines":"","procedure_number":"PSUSA/00001191/201805","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001191-201805"},{"category":"","active_substances_in_scope_of_procedure":"Corticorelin","active_substance":"corticorelin","related_medicines":"","procedure_number":"PSUSA/00000876/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000876-201910-0"},{"category":"","active_substances_in_scope_of_procedure":"Cromoglicic acid","active_substance":"cromoglicic acid","related_medicines":"","procedure_number":"PSUSA/00000883/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000883-201702"},{"category":"","active_substances_in_scope_of_procedure":"Cyanocobalamin / diclofenac / pyridoxine / thiamine","active_substance":"cyanocobalamin;diclofenac;pyridoxine;thiamine","related_medicines":"","procedure_number":"PSUSA/00001041/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001041-202001"},{"category":"","active_substances_in_scope_of_procedure":"Dinoprostone","active_substance":"dinoprostone","related_medicines":"","procedure_number":"PSUSA/00001104/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001104-201609"},{"category":"","active_substances_in_scope_of_procedure":"Econazole, econazole nitrate / triamcinolone acetonide,  econazole nitrate / zinc oxide","active_substance":"econazole;econazole nitrate;triamcinolone acetonide;zinc oxide","related_medicines":"","procedure_number":"PSUSA/00001195/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001195-201711"},{"category":"","active_substances_in_scope_of_procedure":"Cyproheptadine","active_substance":"cyproheptadine","related_medicines":"","procedure_number":"PSUSA/00000902/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000902-202012"},{"category":"","active_substances_in_scope_of_procedure":"Cyproheptadine","active_substance":"cyproheptadine","related_medicines":"","procedure_number":"PSUSA/00000902/201412","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000902-201412"},{"category":"","active_substances_in_scope_of_procedure":"Dinoprostone","active_substance":"dinoprostone","related_medicines":"","procedure_number":"PSUSA/00001104/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001104-201909"},{"category":"","active_substances_in_scope_of_procedure":"Ivabradine / metoprolol","active_substance":"ivabradine;metoprolol","related_medicines":"","procedure_number":"PSUSA/00010381/202004","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202004-0"},{"category":"","active_substances_in_scope_of_procedure":"Cyproheptadine","active_substance":"cyproheptadine","related_medicines":"","procedure_number":"PSUSA/00000902/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000902-201712"},{"category":"","active_substances_in_scope_of_procedure":"Eletriptan","active_substance":"eletriptan","related_medicines":"","procedure_number":"PSUSA/00001204/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001204-202102"},{"category":"","active_substances_in_scope_of_procedure":"Cyproterone / ethinylestradiol","active_substance":"cyproterone;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00000906/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000906-202005"},{"category":"","active_substances_in_scope_of_procedure":"Cyproterone / ethinylestradiol","active_substance":"cyproterone;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00000906/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000906-201705"},{"category":"","active_substances_in_scope_of_procedure":"Eletriptan","active_substance":"eletriptan","related_medicines":"","procedure_number":"PSUSA/00001204/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001204-201602"},{"category":"","active_substances_in_scope_of_procedure":"Cyproterone / ethinylestradiol","active_substance":"cyproterone;ethinylestradiol","related_medicines":"","procedure_number":"EMEA/H/N/PSR/J/0003","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0003"},{"category":"","active_substances_in_scope_of_procedure":"Cyproterone / ethinylestradiol","active_substance":"cyproterone;ethinylestradiol","related_medicines":"","procedure_number":"EMEA/H/N/PSR/J/0005","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0005"},{"category":"","active_substances_in_scope_of_procedure":"Cyproterone / ethinylestradiol","active_substance":"cyproterone;ethinylestradiol","related_medicines":"","procedure_number":"EMEA/H/N/PSR/J/0006","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0006"},{"category":"","active_substances_in_scope_of_procedure":"Cytarabine","active_substance":"cytarabine","related_medicines":"","procedure_number":"PSUSA/00000911/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000911-202103"},{"category":"","active_substances_in_scope_of_procedure":"Cytomegalovirus immunoglobulin","active_substance":"cytomegalovirus immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00000914/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000914-202101"},{"category":"","active_substances_in_scope_of_procedure":"Cytomegalovirus immunoglobulin","active_substance":"cytomegalovirus immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00000914/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000914-201601"},{"category":"","active_substances_in_scope_of_procedure":"Enalapril / hydrochlorothiazide","active_substance":"enalapril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00001212/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001212-201707"},{"category":"","active_substances_in_scope_of_procedure":"Enalapril / nitrendipine","active_substance":"enalapril;nitrendipine","related_medicines":"","procedure_number":"PSUSA/00001213/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001213-201801"},{"category":"","active_substances_in_scope_of_procedure":"Enalapril, nitrendipine","active_substance":"enalapril;nitrendipine","related_medicines":"","procedure_number":"PSUSA/00001213/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001213-201501"},{"category":"","active_substances_in_scope_of_procedure":"Enalapril","active_substance":"enalapril","related_medicines":"","procedure_number":"PSUSA/00001211/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001211-201803"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria / tetanus / pertussis (acellular, component) / haemophilus type b conjugate vaccine (adsorbed)","active_substance":"haemophilus type b conjugate vaccine;pertussis (acellular, component);tetanus;diphtheria vaccine","related_medicines":"","procedure_number":"PSUSA/00001121/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001121-201710"},{"category":"","active_substances_in_scope_of_procedure":"Enoxaparin (except for biosimilars)","active_substance":"enoxaparin","related_medicines":"","procedure_number":"PSUSA/00010560/201904","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010560-201904"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)","active_substance":"diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)","related_medicines":"","procedure_number":"PSUSA/00001124/202011","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-202011"},{"category":"","active_substances_in_scope_of_procedure":"Enoxaparin (except for biosimilars)","active_substance":"enoxaparin","related_medicines":"","procedure_number":"PSUSA/00010560/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010560-201804"},{"category":"","active_substances_in_scope_of_procedure":"Epinastine","active_substance":"epinastine","related_medicines":"","procedure_number":"PSUSA/00001231/201710","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001231-201710"},{"category":"","active_substances_in_scope_of_procedure":"Epinephrine / lidocaine","active_substance":"epinephrine;lidocaine","related_medicines":"","procedure_number":"PSUSA/00001233/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001233-202009"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)","active_substance":"haemophilus type b conjugate vaccine (adsorbed);poliomyelitis (inactivated);pertussis (acellular, component);diphtheria vaccine;tetanus","related_medicines":"","procedure_number":"PSUSA/00001124/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-201711"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria / tetanus / pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed), diphtheria / tetanus / pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed) reduce antigens content","active_substance":"diphtheria tetanus pertussis and poliomyelitis inactivated vaccine;diphtheria tetanus pertussis and poliomyelitis inactivated vaccine reduce antigens content","related_medicines":"","procedure_number":"PSUSA/00001126/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001126-201507"},{"category":"","active_substances_in_scope_of_procedure":"Ivabradine / metoprolol","active_substance":"ivabradine;metoprolol","related_medicines":"","procedure_number":"PSUSA/00010381/202004","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202004-1"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria/tetanus/pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed), diphtheria/tetanus/pertussis (acellular, component) and poliomyelitis","active_substance":"diphtheria tetanus pertussis and poliomyelitis inactivated vaccine","related_medicines":"","procedure_number":"PSUSA/00001126/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001126-202007"},{"category":"","active_substances_in_scope_of_procedure":"Ivabradine / metoprolol","active_substance":"ivabradine;metoprolol","related_medicines":"","procedure_number":"PSUSA/00010381/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202004-2"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria / tetanus / pertussis (acellular, component) vaccine (adsorbed), diphtheria / tetanus / pertussis (acellular, component) vaccine (adsorbed) reduced antigens contents","active_substance":"pertussis (acellular, component) vaccine (adsorbed) reduced antigens contents;tetanus;pertussis (acellular, component) vaccine (adsorbed), diphtheria;diphtheria vaccine","related_medicines":"","procedure_number":"PSUSA/00001125/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001125-201703"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria / tetanus / poliomyelitis (inactivated) vaccine (adsorbed, reduced antigens(s) content)","active_substance":"poliomyelitis (inactivated) vaccine (adsorbed, reduced antigens(s) content);tetanus;diphtheria vaccine","related_medicines":"","procedure_number":"PSUSA/00001127/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001127-201708"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria / tetanus vaccines (adsorbed), diphtheria vaccines (adsorbed)","active_substance":"diphtheria vaccine;tetanus vaccine","related_medicines":"","procedure_number":"PSUSA/00001128/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001128-202005"},{"category":"","active_substances_in_scope_of_procedure":"Estradiol (except cream/balm/emulsion for application in female genital area)","active_substance":"estradiol","related_medicines":"","procedure_number":"PSUSA/00010440/202108","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010440-202108"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria tetanus vaccines (adsorbed)","active_substance":"diphtheria tetanus vaccines","related_medicines":"","procedure_number":"PSUSA/00001128/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001128-201505"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria tetanus vaccines (adsorbed)","active_substance":"diphtheria tetanus vaccines","related_medicines":"","procedure_number":"PSUSA/00001128/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001128-201505-0"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated), haemophilus type b conjugate vaccine: List of nationally authorised medicinal products - PSUSA/00001124/201411","active_substance":"diphtheria vaccine;tetanus;pertussis;poliomyelitis;haemophilus type b conjugate vaccine","related_medicines":"","procedure_number":"PSUSA/00001124/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-201411"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated), haemophilus type b conjugate vaccine","active_substance":"diphtheria vaccine;tetanus;pertussis;poliomyelitis;haemophilus type b conjugate vaccine","related_medicines":"","procedure_number":"PSUSA/00001124/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-201411-0"},{"category":"","active_substances_in_scope_of_procedure":"Esketamine","active_substance":"Esketamine","related_medicines":"","procedure_number":"PSUSA/00001266/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001266-201608"},{"category":"","active_substances_in_scope_of_procedure":"Donepezil","active_substance":"donepezil","related_medicines":"","procedure_number":"PSUSA/00001160/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001160-201611"},{"category":"","active_substances_in_scope_of_procedure":"Estradiol (17-beta) / Trimegestone","active_substance":"17 beta-estradiol;trimegestone","related_medicines":"","procedure_number":"PSUSA/00001275/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001275-201703"},{"category":"","active_substances_in_scope_of_procedure":"Domperidone","active_substance":"domperidone","related_medicines":"","procedure_number":"PSUSA/00001158/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001158-201911"},{"category":"","active_substances_in_scope_of_procedure":"Domperidone","active_substance":"domperidone","related_medicines":"","procedure_number":"PSUSA/00001158/201611","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001158-201611"},{"category":"","active_substances_in_scope_of_procedure":"Esomeprazole / Naproxen","active_substance":"esomeprazole;naproxen","related_medicines":"","procedure_number":"PSUSA/00001270/201704","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001270-201704"},{"category":"","active_substances_in_scope_of_procedure":"Domperidone","active_substance":"domperidone","related_medicines":"","procedure_number":"PSUSA/00001158/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001158-201501"},{"category":"","active_substances_in_scope_of_procedure":"Dobutamine","active_substance":"Dobutamine","related_medicines":"","procedure_number":"PSUSA/00001151/202103","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001151-202103"},{"category":"","active_substances_in_scope_of_procedure":"Dobutamine","active_substance":"Dobutamine","related_medicines":"","procedure_number":"PSUSA/00001151/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001151-201503"},{"category":"","active_substances_in_scope_of_procedure":"Dobutamine","active_substance":"Dobutamine","related_medicines":"","procedure_number":"PSUSA/00001151/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001151-201803"},{"category":"","active_substances_in_scope_of_procedure":"Docosanol","active_substance":"docosanol","related_medicines":"","procedure_number":"PSUSA/00010092/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010092-202104"},{"category":"","active_substances_in_scope_of_procedure":"Docosanol","active_substance":"docosanol","related_medicines":"","procedure_number":"PSUSA/00010092/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010092-202104-0"},{"category":"","active_substances_in_scope_of_procedure":"Estradiol (except cream/balm/emulsion for application in female genital area)","active_substance":"estradiol","related_medicines":"","procedure_number":"PSUSA/00010440/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010440-201608"},{"category":"","active_substances_in_scope_of_procedure":"Epinephrine / mepivacaine hydrochloride, mepivacaine /  norepinephrine, mepivacaine","active_substance":"epinephrine;mepivacaine hydrochloride;mepivacaine;norepinephrine","related_medicines":"","procedure_number":"PSUSA/00001979/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001979-201803"},{"category":"","active_substances_in_scope_of_procedure":"Fluoxetine","active_substance":"fluoxetine","related_medicines":"","procedure_number":"PSUSA/00001442/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001442-201709"},{"category":"","active_substances_in_scope_of_procedure":"Flupirtine","active_substance":"flupirtine","related_medicines":"","procedure_number":"PSUSA/00010225/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010225-201501"},{"category":"","active_substances_in_scope_of_procedure":"Epinephrine","active_substance":"epinephrine","related_medicines":"","procedure_number":"PSUSA/00001232/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001232-202007"},{"category":"","active_substances_in_scope_of_procedure":"Flupirtine","active_substance":"flupirtine","related_medicines":"","procedure_number":"PSUSA/00010225/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010225-201710"},{"category":"","active_substances_in_scope_of_procedure":"Flurbiprofen","active_substance":"flurbiprofen","related_medicines":"","procedure_number":"PSUSA/00001450/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001450-201611"},{"category":"","active_substances_in_scope_of_procedure":"Epirubicin","active_substance":"epirubicin","related_medicines":"","procedure_number":"PSUSA/00001234/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001234-201706"},{"category":"","active_substances_in_scope_of_procedure":"Flurbiprofen","active_substance":"flurbiprofen","related_medicines":"","procedure_number":"PSUSA/00001450/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001450-201911"},{"category":"","active_substances_in_scope_of_procedure":"Flutamide","active_substance":"flutamide","related_medicines":"","procedure_number":"PSUSA/00001453/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001453-201810"},{"category":"","active_substances_in_scope_of_procedure":"Fluticasone / salmeterol","active_substance":"fluticasone;salmeterol","related_medicines":"","procedure_number":"PSUSA/00001455/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001455-201910"},{"category":"","active_substances_in_scope_of_procedure":"Fluticasone propionate / formoterol fumarate dehydrate","active_substance":"formoterol fumarate dihydrate;fluticasone propionate","related_medicines":"","procedure_number":"PSUSA/00010339/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-201607"},{"category":"","active_substances_in_scope_of_procedure":"Epirubicin","active_substance":"epirubicin","related_medicines":"","procedure_number":"PSUSA/00001234/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001234-202006"},{"category":"","active_substances_in_scope_of_procedure":"Fluticasone propionate / formoterol fumarate dihydrate","active_substance":"fluticasone propionate;formoterol fumarate dihydrate","related_medicines":"","procedure_number":"PSUSA/00010339/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-202107"},{"category":"","active_substances_in_scope_of_procedure":"Fluticasone propionate / formoterol fumarate dihydrate","active_substance":"fluticasone propionate;formoterol fumarate dihydrate","related_medicines":"","procedure_number":"PSUSA/00010339/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-201507"},{"category":"","active_substances_in_scope_of_procedure":"Fluticasone propionate / formoterol fumarate dihydrate","active_substance":"formoterol fumarate dihydrate;fluticasone propionate","related_medicines":"","procedure_number":"PSUSA/00010339/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-201707"},{"category":"","active_substances_in_scope_of_procedure":"Epoprostenol","active_substance":"epoprostenol","related_medicines":"","procedure_number":"PSUSA/00001242/201703","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001242-201703"},{"category":"","active_substances_in_scope_of_procedure":"Eplerenone","active_substance":"eplerenone","related_medicines":"","procedure_number":"PSUSA/00001236/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001236-201703"},{"category":"","active_substances_in_scope_of_procedure":"Eprosartan / hydrochlorothiazide","active_substance":"hydrochlorothiazide;eprosartan","related_medicines":"","procedure_number":"PSUSA/00001244/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001244-201704"},{"category":"","active_substances_in_scope_of_procedure":"Eprosartan","active_substance":"eprosartan","related_medicines":"","procedure_number":"PSUSA/00001243/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001243-201704"},{"category":"","active_substances_in_scope_of_procedure":"Erythromycin / isotretinoin, isotretinoin (topical  formulations)","active_substance":"erythromycin;isotretinoin;isotretinoin (topical formulations)","related_medicines":"","procedure_number":"PSUSA/00010487/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010487-201808"},{"category":"","active_substances_in_scope_of_procedure":"Erythromycin / isotretinoin","active_substance":"erythromycin;isotretinoin","related_medicines":"","procedure_number":"PSUSA/00001796/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001796-201508"},{"category":"","active_substances_in_scope_of_procedure":"Fluticasone propionate","active_substance":"fluticasone propionate","related_medicines":"","procedure_number":"PSUSA/00001454/201702","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001454-201702"},{"category":"","active_substances_in_scope_of_procedure":"Fluvastatin","active_substance":"fluvastatin","related_medicines":"","procedure_number":"PSUSA-00001457-201708","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001457-201708"},{"category":"","active_substances_in_scope_of_procedure":"Fluvoxamine","active_substance":"fluvoxamine","related_medicines":"","procedure_number":"PSUSA/00001458/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001458-201707"},{"category":"","active_substances_in_scope_of_procedure":"Folic acid","active_substance":"folic acid","related_medicines":"","procedure_number":"PSUSA/00001459/201706","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001459-201706"},{"category":"","active_substances_in_scope_of_procedure":"Formoterol","active_substance":"formoterol","related_medicines":"","procedure_number":"PSUSA/00001469/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001469-202005"},{"category":"","active_substances_in_scope_of_procedure":"Formoterol","active_substance":"formoterol","related_medicines":"","procedure_number":"PSUSA/00001469/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001469-201705"},{"category":"","active_substances_in_scope_of_procedure":"Foscarnet","active_substance":"foscarnet","related_medicines":"","procedure_number":"PSUSA/00001472/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001472-201803"},{"category":"","active_substances_in_scope_of_procedure":"Fosfomycin","active_substance":"fosfomycin","related_medicines":"","procedure_number":"EMA/235643/2017","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/ema-235643-2017"},{"category":"","active_substances_in_scope_of_procedure":"Fosfomycin","active_substance":"fosfomycin","related_medicines":"","procedure_number":"PSUSA/00010336/201907","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010336-201907"},{"category":"","active_substances_in_scope_of_procedure":"Fosfomycin","active_substance":"fosfomycin","related_medicines":"","procedure_number":"PSUSA/00010326/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010326-201607"},{"category":"","active_substances_in_scope_of_procedure":"Erythromycin / tretinoin","active_substance":"erythromycin;tretinoin","related_medicines":"","procedure_number":"PSUSA/00001259/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001259-201610"},{"category":"","active_substances_in_scope_of_procedure":"Fosfomycin","active_substance":"fosfomycin","related_medicines":"","procedure_number":"PSUSA/00010326/201907","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010326-201907"},{"category":"","active_substances_in_scope_of_procedure":"Erythromycin / tretinoin","active_substance":"erythromycin;tretinoin","related_medicines":"","procedure_number":"PSUSA/00001259/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001259-202110"},{"category":"","active_substances_in_scope_of_procedure":"Erythromycin","active_substance":"erythromycin","related_medicines":"","procedure_number":"PSUSA/00001257/201903","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001257-201903"},{"category":"","active_substances_in_scope_of_procedure":"Escherichia coli lysate","active_substance":"escherichia coli lysate","related_medicines":"","procedure_number":"PSUSA/00001263/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001263-202007"},{"category":"","active_substances_in_scope_of_procedure":"Escherichia coli lysate","active_substance":"escherichia coli lysate","related_medicines":"","procedure_number":"PSUSA/00001263/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001263-201507"},{"category":"","active_substances_in_scope_of_procedure":"Escitalopram","active_substance":"escitalopram","related_medicines":"","procedure_number":"PSUSA/00001265/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001265-201612"},{"category":"","active_substances_in_scope_of_procedure":"Fluorescein (systemic use)","active_substance":"fluorescein","related_medicines":"","procedure_number":"PSUSA/00009153/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009153-201704"},{"category":"","active_substances_in_scope_of_procedure":"Fluorescein (systemic use)","active_substance":"fluorescein","related_medicines":"","procedure_number":"PSUSA/00009153/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009153-202004"},{"category":"","active_substances_in_scope_of_procedure":"Fluorodopa (18F)","active_substance":"fluorodopa (18F)","related_medicines":"","procedure_number":"PSUSA/00010002/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010002-202103"},{"category":"","active_substances_in_scope_of_procedure":"Fosinopril / hydrochlorothiazide","active_substance":"fosinopril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00001475/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001475-201507"},{"category":"","active_substances_in_scope_of_procedure":"Fosinopril, fosinopril / hydrochlorothiazide","active_substance":"fosinopril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00010463/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010463-202107"},{"category":"","active_substances_in_scope_of_procedure":"Fosinopril, fosinopril / hydrochlorothiazide","active_substance":"fosinopril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00010463/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010463-201807"},{"category":"","active_substances_in_scope_of_procedure":"Fosinopril","active_substance":"fosinopril","related_medicines":"","procedure_number":"PSUSA/00001474/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001474-201507"},{"category":"","active_substances_in_scope_of_procedure":"Fosphenytoin","active_substance":"fosphenytoin","related_medicines":"","procedure_number":"PSUSA/00001476/202008","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001476-202008"},{"category":"","active_substances_in_scope_of_procedure":"Frovatriptan","active_substance":"frovatriptan","related_medicines":"","procedure_number":"PSUSA/00001484/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001484-201703"},{"category":"","active_substances_in_scope_of_procedure":"Furosemide / spironolactone","active_substance":"Furosemide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00001493/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001493-201612"},{"category":"","active_substances_in_scope_of_procedure":"Furosemide / spironolactone","active_substance":"Furosemide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00001493/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001493-201512"},{"category":"","active_substances_in_scope_of_procedure":"Furosemide","active_substance":"Furosemide","related_medicines":"","procedure_number":"PSUSA/00001491/201501","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001491-201501"},{"category":"","active_substances_in_scope_of_procedure":"Furosemide","active_substance":"Furosemide","related_medicines":"","procedure_number":"PSUSA/00001491/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001491-201801"},{"category":"","active_substances_in_scope_of_procedure":"Fusidic acid (systemic use)","active_substance":"fusidic acid","related_medicines":"","procedure_number":"PSUSA/00010226/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010226-201605"},{"category":"","active_substances_in_scope_of_procedure":"Fusidic acid (systemic use)","active_substance":"fusidic acid","related_medicines":"","procedure_number":"PSUSA/00010226/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010226-201905"},{"category":"","active_substances_in_scope_of_procedure":"Gabapentin","active_substance":"gabapentin","related_medicines":"","procedure_number":"PSUSA/00001499/201602","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001499-201602"},{"category":"","active_substances_in_scope_of_procedure":"Gabapentin","active_substance":"gabapentin","related_medicines":"","procedure_number":"PSUSA/00001499/201902","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001499-201902"},{"category":"","active_substances_in_scope_of_procedure":"Gadobenic acid","active_substance":"gadobenic acid","related_medicines":"","procedure_number":"PSUSA/00001500/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001500-202108"},{"category":"","active_substances_in_scope_of_procedure":"Gadobenic acid","active_substance":"gadobenic acid","related_medicines":"","procedure_number":"PSUSA/00001500/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001500-201504"},{"category":"","active_substances_in_scope_of_procedure":"Gadobenic acid","active_substance":"gadobenic acid","related_medicines":"","procedure_number":"PSUSA/00001500/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001500-202004"},{"category":"","active_substances_in_scope_of_procedure":"Gadobutrol","active_substance":"Gadobutrol","related_medicines":"","procedure_number":"PSUSA/00001502/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001502-202108"},{"category":"","active_substances_in_scope_of_procedure":"Gadobutrol","active_substance":"Gadobutrol","related_medicines":"","procedure_number":"PSUSA/00001502/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001502-201504"},{"category":"","active_substances_in_scope_of_procedure":"Gadodiamide","active_substance":"gadodiamide","related_medicines":"","procedure_number":"PSUSA/00001503/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001503-201504"},{"category":"","active_substances_in_scope_of_procedure":"Gadodiamide","active_substance":"gadodiamide","related_medicines":"","procedure_number":"PSUSA/00001503/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001503-202004"},{"category":"","active_substances_in_scope_of_procedure":"Gadopentetic acid","active_substance":"gadopentetic acid","related_medicines":"","procedure_number":"PSUSA/00001504/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001504-201504"},{"category":"","active_substances_in_scope_of_procedure":"Gadopentetic acid","active_substance":"gadopentetic acid","related_medicines":"","procedure_number":"PSUSA/00001504/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001504-202108"},{"category":"","active_substances_in_scope_of_procedure":"Gadopentetic acid","active_substance":"gadopentetic acid","related_medicines":"","procedure_number":"PSUSA/00001504/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001504-202004"},{"category":"","active_substances_in_scope_of_procedure":"Gadoteric acid (intra articular formulation)","active_substance":"gadoteric acid","related_medicines":"","procedure_number":"PSUSA/00001505/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001505-202004"},{"category":"","active_substances_in_scope_of_procedure":"Gadoteric acid (IV and intravascular formulations)","active_substance":"gadoteric acid (IV and intravascular formulations)","related_medicines":"","procedure_number":"PSUSA/00001506/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001506-202108"},{"category":"","active_substances_in_scope_of_procedure":"Gadoteric acid (IV and intravascular formulations)","active_substance":"gadoteric acid (IV and intravascular formulations)","related_medicines":"","procedure_number":"PSUSA/00001506/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001506-201504"},{"category":"","active_substances_in_scope_of_procedure":"Gadoteric acid (IV and intravascular formulations)","active_substance":"gadoteric acid (IV and intravascular formulations)","related_medicines":"","procedure_number":"PSUSA/00001506/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001506-202004"},{"category":"","active_substances_in_scope_of_procedure":"Gadoteridol","active_substance":"gadoteridol","related_medicines":"","procedure_number":"PSUSA/00001507/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001507-202108"},{"category":"","active_substances_in_scope_of_procedure":"Gadoteridol","active_substance":"gadoteridol","related_medicines":"","procedure_number":"PSUSA/00001507/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001507-201504"},{"category":"","active_substances_in_scope_of_procedure":"Gadoteridol","active_substance":"gadoteridol","related_medicines":"","procedure_number":"PSUSA/00001507/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001507-202004"},{"category":"","active_substances_in_scope_of_procedure":"Gadoxetic acid disodium","active_substance":"gadoxetic acid disodium","related_medicines":"","procedure_number":"PSUSA/00001509/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001509-202108"},{"category":"","active_substances_in_scope_of_procedure":"Gadoxetic acid disodium","active_substance":"gadoxetic acid disodium","related_medicines":"","procedure_number":"PSUSA/00001509/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001509-201504"},{"category":"","active_substances_in_scope_of_procedure":"Gadoxetic acid disodium","active_substance":"gadoxetic acid disodium","related_medicines":"","procedure_number":"PSUSA/00001509/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001509-202004"},{"category":"","active_substances_in_scope_of_procedure":"Galantamine","active_substance":"galantamine","related_medicines":"","procedure_number":"PSUSA/00001512/202003","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001512-202003"},{"category":"","active_substances_in_scope_of_procedure":"Galantamine","active_substance":"galantamine","related_medicines":"","procedure_number":"PSUSA/00001512/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001512-201603"},{"category":"","active_substances_in_scope_of_procedure":"Ganciclovir","active_substance":"ganciclovir","related_medicines":"","procedure_number":"PSUSA/00001516/201606","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001516-201606"},{"category":"","active_substances_in_scope_of_procedure":"Ganciclovir","active_substance":"ganciclovir","related_medicines":"","procedure_number":"PSUSA/00001516/201906","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001516-201906"},{"category":"","active_substances_in_scope_of_procedure":"Gasiloxe","active_substance":"gasiloxe","related_medicines":"","procedure_number":"PSUSA/00010283/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-201501"},{"category":"","active_substances_in_scope_of_procedure":"Gasiloxe","active_substance":"gasiloxe","related_medicines":"","procedure_number":"PSUSA/00010283/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-201507"},{"category":"","active_substances_in_scope_of_procedure":"Gasiloxe","active_substance":"gasiloxe","related_medicines":"","procedure_number":"PSUSA/00010283/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-201601"},{"category":"","active_substances_in_scope_of_procedure":"Gasiloxe","active_substance":"gasiloxe","related_medicines":"","procedure_number":"PSUSA/00010283/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-201701"},{"category":"","active_substances_in_scope_of_procedure":"Gasiloxe","active_substance":"gasiloxe","related_medicines":"","procedure_number":"PSUSA/00010283/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-202001"},{"category":"","active_substances_in_scope_of_procedure":"Gemcitabine","active_substance":"gemcitabine","related_medicines":"","procedure_number":"PSUSA/00001519/201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001519-201801"},{"category":"","active_substances_in_scope_of_procedure":"Gentamicin (systemic use)","active_substance":"gentamicin","related_medicines":"","procedure_number":"PSUSA/00009159/201703","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009159-201703"},{"category":"","active_substances_in_scope_of_procedure":"Gentamicin","active_substance":"gentamicin","related_medicines":"","procedure_number":"PSUSA/00009159/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009159-202003"},{"category":"","active_substances_in_scope_of_procedure":"Germanium (68Ge) chloride / gallium (68Ga) chloride","active_substance":"gallium (68Ga) chloride;germanium (68Ge) chloride","related_medicines":"","procedure_number":"PSUSA/00010364/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201609"},{"category":"","active_substances_in_scope_of_procedure":"Germanium (68Ge) chloride / gallium (68Ga) chloride","active_substance":"gallium (68Ga) chloride;germanium (68Ge) chloride","related_medicines":"","procedure_number":"PSUSA/00010364/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201903"},{"category":"","active_substances_in_scope_of_procedure":"Germanium (68Ge) chloride / gallium (68Ga) chloride","active_substance":"gallium (68Ga) chloride;germanium (68Ge) chloride","related_medicines":"","procedure_number":"PSUSA/00010364/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201509"},{"category":"","active_substances_in_scope_of_procedure":"Germanium (68Ge) chloride / gallium (68Ga) chloride","active_substance":"gallium (68Ga) chloride;germanium (68Ge) chloride","related_medicines":"","procedure_number":"PSUSA/00010364/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201603"},{"category":"","active_substances_in_scope_of_procedure":"Germanium (68Ge) chloride / gallium (68Ga) chloride","active_substance":"gallium (68Ga) chloride;germanium (68Ge) chloride","related_medicines":"","procedure_number":"PSUSA/00010364/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201703"},{"category":"","active_substances_in_scope_of_procedure":"Germanium (68Ge) chloride / gallium (68Ga) chloride","active_substance":"gallium (68Ga) chloride;germanium (68Ge) chloride","related_medicines":"","procedure_number":"PSUSA/00010364/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201803"},{"category":"","active_substances_in_scope_of_procedure":"Glatiramer","active_substance":"glatiramer","related_medicines":"","procedure_number":"PSUSA/00001529/202011","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001529-202011"},{"category":"","active_substances_in_scope_of_procedure":"Glatiramer","active_substance":"glatiramer","related_medicines":"","procedure_number":"PSUSA/00001529/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001529-201411"},{"category":"","active_substances_in_scope_of_procedure":"Glatiramer","active_substance":"glatiramer","related_medicines":"","procedure_number":"PSUSA/00001529/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001529-201711"},{"category":"","active_substances_in_scope_of_procedure":"Glibenclamide / metformin hydrochloride","active_substance":"glibenclamide;metformin hydrochloride","related_medicines":"","procedure_number":"PSUSA/00002002/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002002-202106"},{"category":"","active_substances_in_scope_of_procedure":"Glibenclamide / metformin hydrochloride","active_substance":"glibenclamide;metformin hydrochloride","related_medicines":"","procedure_number":"PSUSA/00002002/201506","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002002-201506"},{"category":"","active_substances_in_scope_of_procedure":"Glibenclamide / metformin hydrochloride","active_substance":"glibenclamide;metformin hydrochloride","related_medicines":"","procedure_number":"PSUSA/00002002/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002002-201806"},{"category":"","active_substances_in_scope_of_procedure":"Gliclazide","active_substance":"gliclazide","related_medicines":"","procedure_number":"PSUSA/00001532/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001532-202102"},{"category":"","active_substances_in_scope_of_procedure":"Gliclazide","active_substance":"gliclazide","related_medicines":"","procedure_number":"PSUSA/00001532/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001532-201602"},{"category":"","active_substances_in_scope_of_procedure":"Glimepiride","active_substance":"glimepiride","related_medicines":"","procedure_number":"PSUSA/00001534/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001534-201706"},{"category":"","active_substances_in_scope_of_procedure":"Glipizide","active_substance":"glipizide","related_medicines":"","procedure_number":"PSUSA/00001535/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001535-201901"},{"category":"","active_substances_in_scope_of_procedure":"Glipizide","active_substance":"glipizide","related_medicines":"","procedure_number":"PSUSA/00001535/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001535-201901-0"},{"category":"","active_substances_in_scope_of_procedure":"Glucosamine","active_substance":"glucosamine","related_medicines":"","procedure_number":"PSUSA/00001539/201703","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001539-201703"},{"category":"","active_substances_in_scope_of_procedure":"Glyceryl trinitrate","active_substance":"glyceryl trinitrate","related_medicines":"","procedure_number":"PSUSA/00001552/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001552-202007"},{"category":"","active_substances_in_scope_of_procedure":"Glycopyrronium / neostigmine","active_substance":"glycopyrronium;neostigmine","related_medicines":"","procedure_number":"PSUSA/00001557/201509","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001557-201509"},{"category":"","active_substances_in_scope_of_procedure":"Glycopyrronium bromide (all indications except for chronic obstructive pulmonary disease)","active_substance":"glycopyrronium bromide","related_medicines":"","procedure_number":"PSUSA/00001556/201509","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001556-201509"},{"category":"","active_substances_in_scope_of_procedure":"Goserelin","active_substance":"goserelin","related_medicines":"","procedure_number":"PSUSA/00001562/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001562-202105"},{"category":"","active_substances_in_scope_of_procedure":"Goserelin","active_substance":"goserelin","related_medicines":"","procedure_number":"PSUSA/00001562/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001562-201605"},{"category":"","active_substances_in_scope_of_procedure":"Granisetron (other formulations except for transdermal patch)","active_substance":"granisetron (other formulations except for transdermal patch)","related_medicines":"","procedure_number":"PSUSA/00001568/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001568-202102"},{"category":"","active_substances_in_scope_of_procedure":"Granisetron","active_substance":"granisetron","related_medicines":"","procedure_number":"PSUSA/00001568/201602","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001568-201602"},{"category":"","active_substances_in_scope_of_procedure":"Haemophilus influenzae / klebsiella ozaenae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus pneumoniae / streptococcus pyogenes / streptococcus viridans vaccine","active_substance":"streptococcus viridans vaccine;streptococcus pyogenes;streptococcus pneumoniae;staphylococcus aureus;moraxella catarrhalis;klebsiella pneumoniae;klebsiella ozaenae;haemophilus influenzae","related_medicines":"","procedure_number":"PSUSA/00001582/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001582-201712"},{"category":"","active_substances_in_scope_of_procedure":"Haemophilus type b and meningococcal group c conjugate vaccine","active_substance":"haemophilus type b and meningococcal group c conjugate vaccine","related_medicines":"","procedure_number":"PSUSA/00001583/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001583-201702"},{"category":"","active_substances_in_scope_of_procedure":"Haemophilus type b and meningococcal group c conjugate vaccine","active_substance":"haemophilus type b conjugate vaccine;meningococcal group c conjugate vaccine","related_medicines":"","procedure_number":"PSUSA/00001583/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001583-202002"},{"category":"","active_substances_in_scope_of_procedure":"Haemophilus type b conjugate vaccines","active_substance":"haemophilus type b conjugate vaccines","related_medicines":"","procedure_number":"PSUSA/00001584/201702","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001584-201702"},{"category":"","active_substances_in_scope_of_procedure":"Haemophilus type b conjugate vaccines","active_substance":"haemophilus type b conjugate vaccines","related_medicines":"","procedure_number":"PSUSA/00001584/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001584-202002"},{"category":"","active_substances_in_scope_of_procedure":"Halofantrine","active_substance":"halofantrine","related_medicines":"","procedure_number":"PSUSA/00001586/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001586-201705"},{"category":"","active_substances_in_scope_of_procedure":"Hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)","active_substance":"typhoid polysaccharide vaccine;hepatitis a","related_medicines":"","procedure_number":"PSUSA/00001594/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001594-201706"},{"category":"","active_substances_in_scope_of_procedure":"Hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)","active_substance":"hepatitis A virus (inactivated);typhoid polysaccharide vaccine","related_medicines":"","procedure_number":"PSUSA/00001594/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001594-202006"},{"category":"","active_substances_in_scope_of_procedure":"Hepatitis A vaccines (inactivated, adsorbed)","active_substance":"hepatitis A vaccines","related_medicines":"","procedure_number":"PSUSA/00001596/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001596-201901"},{"category":"","active_substances_in_scope_of_procedure":"Hexaminolevulinate hydrochloride","active_substance":"hexaminolevulinate hydrochloride","related_medicines":"","procedure_number":"PSUSA/00001606/201409","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001606-201409"},{"category":"","active_substances_in_scope_of_procedure":"Hexoprenaline sulfate","active_substance":"hexoprenaline sulfate","related_medicines":"","procedure_number":"PSUSA/00003170/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003170-202008"},{"category":"","active_substances_in_scope_of_procedure":"Hexoprenaline sulphate","active_substance":"hexoprenaline sulfate","related_medicines":"","procedure_number":"PSUSA/00003170/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003170-201508"},{"category":"","active_substances_in_scope_of_procedure":"Human alpha1-proteinase inhibitor (apart from the centrally authorised product)","active_substance":"human alpha1-proteinase inhibitor","related_medicines":"","procedure_number":"PSUSA/00000108/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000108-201912"},{"category":"","active_substances_in_scope_of_procedure":"Human alpha1-proteinase inhibitor (apart from the centrally authorised product)","active_substance":"human alpha1-proteinase inhibitor","related_medicines":"","procedure_number":"PSUSA/00000108/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000108-201912-0"},{"category":"","active_substances_in_scope_of_procedure":"Human anti-d immunoglobulin","active_substance":"human anti-d immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00001614/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001614-202103"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen / levomenthol","active_substance":"Ibuprofen;Levomenthol","related_medicines":"","procedure_number":"PSUSA/00001708/202007","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001708-202007"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen / pseudoephedrine","active_substance":"Ibuprofen;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001711/202107","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-202107"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen / pseudoephedrine","active_substance":"Ibuprofen;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001711/201807","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201807"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen / pseudoephedrine","active_substance":"Ibuprofen;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001711/201907","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201907"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen / pseudoephedrine","active_substance":"Ibuprofen;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001711/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201507"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen / pseudoephedrine","active_substance":"Ibuprofen;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001711/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201607"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen / pseudoephedrine","active_substance":"Ibuprofen;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001711/201707","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201707"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen / pseudoephedrine","active_substance":"Ibuprofen;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001711/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-202007"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen, ibuprofen lysine (not indicated in ductus arteriosus), ibuprofen / caffeine","active_substance":"Ibuprofen;ibuprofen lysine;Caffeine","related_medicines":"","procedure_number":"PSUSA/00010649/202002","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010649-202002"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen, ibuprofen lysine (not indicated in ductus arteriosus)","active_substance":"Ibuprofen;ibuprofen lysine","related_medicines":"","procedure_number":"PSUSA/00010345/201702","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010345-201702"},{"category":"","active_substances_in_scope_of_procedure":"Ibutilide","active_substance":"ibutilide","related_medicines":"","procedure_number":"PSUSA/00001713/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001713-201712"},{"category":"","active_substances_in_scope_of_procedure":"Idarubicin","active_substance":"idarubicin","related_medicines":"","procedure_number":"PSUSA/00001720/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001720-201611"},{"category":"","active_substances_in_scope_of_procedure":"Idebenone (non centrally authorised products)","active_substance":"idebenone","related_medicines":"","procedure_number":"PSUSA/00001721/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001721-201709"},{"category":"","active_substances_in_scope_of_procedure":"Idebenone (non centrally authorised products)","active_substance":"idebenone","related_medicines":"","procedure_number":"PSUSA/00001721/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001721-202009"},{"category":"","active_substances_in_scope_of_procedure":"Idebenone (non centrally authorised products)","active_substance":"idebenone","related_medicines":"","procedure_number":"PSUSA/00001721/201409","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001721-201409"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor VIII (inhibitor bypassing fraction)","active_substance":"human coagulation factor VIII (inhibitor bypassing fraction)","related_medicines":"","procedure_number":"PSUSA/00009174/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-202102"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor VIII (inhibitor bypassing fraction)","active_substance":"human coagulation factor VIII (inhibitor bypassing fraction)","related_medicines":"","procedure_number":"PSUSA/00009174/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-201802"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor VIII (inhibitor bypassing fraction)","active_substance":"human coagulation factor VIII (inhibitor bypassing fraction)","related_medicines":"","procedure_number":"PSUSA/00009174/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-201602"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor VIII (inhibitor bypassing fraction)","active_substance":"human coagulation factor VIII (inhibitor bypassing fraction)","related_medicines":"","procedure_number":"PSUSA/00009174/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-201702"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor viii / human von willebrand factor","active_substance":"human coagulation factor VIII;human von willebrand factor","related_medicines":"","procedure_number":"PSUSA/00001621/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001621-201810"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor VIII / human von Willebrand factor","active_substance":"human coagulation factor VIII;human von willebrand factor","related_medicines":"","procedure_number":"PSUSA/00001621/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001621-201510"},{"category":"","active_substances_in_scope_of_procedure":"Human fibrinogen","active_substance":"human fibrinogen","related_medicines":"","procedure_number":"PSUSA/00001624/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001624-201506"},{"category":"","active_substances_in_scope_of_procedure":"Human hemin","active_substance":"human hemin","related_medicines":"","procedure_number":"PSUSA/00001629/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-202105"},{"category":"","active_substances_in_scope_of_procedure":"Human hemin","active_substance":"human hemin","related_medicines":"","procedure_number":"PSUSA/00001629/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-201605"},{"category":"","active_substances_in_scope_of_procedure":"Human hemin","active_substance":"human hemin","related_medicines":"","procedure_number":"PSUSA/00001629/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-201705"},{"category":"","active_substances_in_scope_of_procedure":"Human hemin","active_substance":"human hemin","related_medicines":"","procedure_number":"PSUSA/00001629/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-201805"},{"category":"","active_substances_in_scope_of_procedure":"Human hemin","active_substance":"human hemin","related_medicines":"","procedure_number":"PSUSA/00001629/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-201905"},{"category":"","active_substances_in_scope_of_procedure":"Human hemin","active_substance":"human hemin","related_medicines":"","procedure_number":"PSUSA/00001629/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-202005"},{"category":"","active_substances_in_scope_of_procedure":"Human plasma (pooled and treated for virus inactivation)","active_substance":"human plasma (pooled and treated for virus inactivation)","related_medicines":"","procedure_number":"PSUSA/00001635/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001635-201702"},{"category":"","active_substances_in_scope_of_procedure":"Human plasma protease C1 inhibitor (nationally authorised products)","active_substance":"human plasma protease C1 inhibitor","related_medicines":"","procedure_number":"PSUSA/00010163/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010163-201608"},{"category":"","active_substances_in_scope_of_procedure":"Human plasma protease C1 inhibitor","active_substance":"human plasma protease C1 inhibitor","related_medicines":"","procedure_number":"PSUSA/00010163/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010163-202108"},{"category":"","active_substances_in_scope_of_procedure":"Human plasma proteins with not less than 95% albumin","active_substance":"Human plasma proteins","related_medicines":"","procedure_number":"PSUSA/00010605/201907","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010605-201907"},{"category":"","active_substances_in_scope_of_procedure":"Human prothrombin complex","active_substance":"human prothrombin complex","related_medicines":"","procedure_number":"PSUSA/00001638/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001638-202104"},{"category":"","active_substances_in_scope_of_procedure":"Human prothrombin complex","active_substance":"human prothrombin complex","related_medicines":"","procedure_number":"PSUSA/00001638/201604","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001638-201604"},{"category":"","active_substances_in_scope_of_procedure":"Human rabies immunoglobulin","active_substance":"human rabies immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00001639/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001639-201704"},{"category":"","active_substances_in_scope_of_procedure":"Human tetanus immunoglobulin","active_substance":"human tetanus immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00002909/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002909-201708"},{"category":"","active_substances_in_scope_of_procedure":"Human von willebrand factor","active_substance":"human von willebrand factor","related_medicines":"","procedure_number":"PSUSA/00001642/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001642-202009"},{"category":"","active_substances_in_scope_of_procedure":"Human von willebrand factor","active_substance":"human von willebrand factor","related_medicines":"","procedure_number":"PSUSA/00001642/201409","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001642-201409"},{"category":"","active_substances_in_scope_of_procedure":"Human von willebrand factor","active_substance":"human von willebrand factor","related_medicines":"","procedure_number":"PSUSA/00001642/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001642-201709"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide / lisinopril","active_substance":"hydrochlorothiazide;lisinopril","related_medicines":"","procedure_number":"PSUSA/00001654/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001654-201602"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide / losartan","active_substance":"hydrochlorothiazide;losartan","related_medicines":"","procedure_number":"PSUSA/00001655/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001655-201802"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide / olmesartan","active_substance":"hydrochlorothiazide;olmesartan","related_medicines":"","procedure_number":"PSUSA/00002209/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002209-202110"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide / olmesartan","active_substance":"hydrochlorothiazide;olmesartan","related_medicines":"","procedure_number":"PSUSA/00002209/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002209-201610"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide / quinapril","active_substance":"hydrochlorothiazide;quinapril","related_medicines":"","procedure_number":"PSUSA/00002592/202104","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002592-202104"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide / quinapril","active_substance":"hydrochlorothiazide;quinapril","related_medicines":"","procedure_number":"PSUSA/00002592/201604","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002592-201604"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide / ramipril","active_substance":"hydrochlorothiazide;ramipril","related_medicines":"","procedure_number":"PSUSA/00001660/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001660-201801"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide / spironolactone","active_substance":"hydrochlorothiazide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00001662/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001662-201801"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide / spironolactone","active_substance":"hydrochlorothiazide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00001662/202101","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001662-202101"},{"category":"","active_substances_in_scope_of_procedure":"Ifosfamide","active_substance":"ifosfamide","related_medicines":"","procedure_number":"PSUSA/00001723/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001723-202007"},{"category":"","active_substances_in_scope_of_procedure":"Iloprost (i.v. solution only)","active_substance":"iloprost","related_medicines":"","procedure_number":"PSUSA/00009190/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009190-202101"},{"category":"","active_substances_in_scope_of_procedure":"Iloprost (iv solution)","active_substance":"iloprost","related_medicines":"","procedure_number":"PSUSA/00009190/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009190-201501"},{"category":"","active_substances_in_scope_of_procedure":"Iloprost (iv solution)","active_substance":"iloprost","related_medicines":"","procedure_number":"PSUSA/00009190/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009190-201801"},{"category":"","active_substances_in_scope_of_procedure":"Imipramine","active_substance":"imipramine","related_medicines":"","procedure_number":"PSUSA/00001728/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001728-202007"},{"category":"","active_substances_in_scope_of_procedure":"Indapamide","active_substance":"Indapamide","related_medicines":"","procedure_number":"PSUSA/00001731/202011","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001731-202011"},{"category":"","active_substances_in_scope_of_procedure":"Indapamide / perindopril","active_substance":"Indapamide;perindopril","related_medicines":"","procedure_number":"PSUSA/00010230/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010230-202111"},{"category":"","active_substances_in_scope_of_procedure":"Indapamide / perindopril","active_substance":"Indapamide;perindopril","related_medicines":"","procedure_number":"PSUSA/00010230/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010230-201611"},{"category":"","active_substances_in_scope_of_procedure":"Indapamide / perindopril","active_substance":"Indapamide","related_medicines":"","procedure_number":"PSUSA/00001731/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001731-201511"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide moexipril","active_substance":"hydrochlorothiazide moexipril","related_medicines":"","procedure_number":"PSUSA/00002082/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002082-201706"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide, ramipril","active_substance":"hydrochlorothiazide;ramipril","related_medicines":"","procedure_number":"PSUSA/00001660/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001660-201501"},{"category":"","active_substances_in_scope_of_procedure":"Hydrochlorothiazide, spironolactone","active_substance":"hydrochlorothiazide;spironolactone","related_medicines":"","procedure_number":"PSUSA/00001662/201501","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001662-201501"},{"category":"","active_substances_in_scope_of_procedure":"Hydrocortisone (except for products indicated in adrenal insufficiency in a modified release tablet formulation)","active_substance":"hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00010328/201908","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010328-201908"},{"category":"","active_substances_in_scope_of_procedure":"Hydromorphone","active_substance":"hydromorphone","related_medicines":"","procedure_number":"PSUSA/00001686/201511","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001686-201511"},{"category":"","active_substances_in_scope_of_procedure":"Hydromorphone","active_substance":"hydromorphone","related_medicines":"","procedure_number":"PSUSA/00001686/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001686-201811"},{"category":"","active_substances_in_scope_of_procedure":"Hydroquinidine","active_substance":"hydroquinidine","related_medicines":"","procedure_number":"PSUSA/00001688/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001688-201703"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxycarbamide (except for centrally authorised  product)","active_substance":"hydroxycarbamide","related_medicines":"","procedure_number":"PSUSA-00009182-201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-201812"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxycarbamide (except for centrally authorised product)","active_substance":"hydroxycarbamide","related_medicines":"","procedure_number":"PSUSA/00009182/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-201612"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxycarbamide (except for centrally authorised  product)","active_substance":"hydroxycarbamide","related_medicines":"","procedure_number":"PSUSA/00009182/202012","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-202012"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxycarbamide (except for centrally authorised  product)","active_substance":"hydroxycarbamide","related_medicines":"","procedure_number":"PSUSA/00009182/201712","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-201712"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxychloroquine","active_substance":"hydroxychloroquine","related_medicines":"","procedure_number":"PSUSA/00001693/202104","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001693-202104"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyethyl starch","active_substance":"hydroxyethyl starch","related_medicines":"","procedure_number":"PSUSA-00001694-202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202103"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyethyl starch","active_substance":"hydroxyethyl starch","related_medicines":"","procedure_number":"EMEA/H/N/PSR/J/0031","regulatory_outcome":"Suspension","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0031"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyethyl starch","active_substance":"hydroxyethyl starch","related_medicines":"","procedure_number":"PSUSA/00001694/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202003"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyethyl starch","active_substance":"hydroxyethyl starch","related_medicines":"","procedure_number":"PSUSA/00001694/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-201501"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyethyl starch","active_substance":"hydroxyethyl starch","related_medicines":"","procedure_number":"PSUSA/00001694/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-201703"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyethyl starch","active_substance":"hydroxyethyl starch","related_medicines":"","procedure_number":"PSUSA/00001694/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-201803"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyethyl starch","active_substance":"hydroxyethyl starch","related_medicines":"","procedure_number":"PSUSA/00001694/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-201903"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyzine chloride / hydroxyzine pamoate and all fixed  combination, hydroxyzine","active_substance":"hydroxyzine chloride;hydroxyzine pamoate;hydroxyzine","related_medicines":"","procedure_number":"PSUSA/00001696/202011","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-202011"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyzine chloride / hydroxyzine pamoate and all fixed  combination, hydroxyzine","active_substance":"hydroxyzine chloride;hydroxyzine pamoate;hydroxyzine","related_medicines":"","procedure_number":"PSUSA/00001696/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-201605"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyzine chloride / hydroxyzine pamoate and all fixed combination, hydroxyzine","active_substance":"hydroxyzine;hydroxyzine pamoate;hydroxyzine chloride","related_medicines":"","procedure_number":"PSUSA/00001696/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-201711"},{"category":"","active_substances_in_scope_of_procedure":"hydroxyzine chloride, hydroxyzine pamoate and all fixed  combination/ hydroxyzine","active_substance":"hydroxyzine chloride;hydroxyzine pamoate;hydroxyzine","related_medicines":"","procedure_number":"PSUSA/00001696/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-201411"},{"category":"","active_substances_in_scope_of_procedure":"Hypericum perforatum L., herba","active_substance":"hypericum perforatum L., herba","related_medicines":"","procedure_number":"PSUSA/00001701/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001701-201801"},{"category":"","active_substances_in_scope_of_procedure":"Iodine (131i) iobenguane","active_substance":"Iodine (131I) iobenguane","related_medicines":"","procedure_number":"PSUSA/00001764/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001764-202105"},{"category":"","active_substances_in_scope_of_procedure":"Iodine (131i) iobenguane","active_substance":"Iodine (131I) iobenguane","related_medicines":"","procedure_number":"PSUSA/00001764/201505","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001764-201505"},{"category":"","active_substances_in_scope_of_procedure":"Iodixanol","active_substance":"iodixanol","related_medicines":"","procedure_number":"PSUSA/00001766/202004","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001766-202004"},{"category":"","active_substances_in_scope_of_procedure":"Iohexol","active_substance":"iohexol","related_medicines":"","procedure_number":"PSUSA/00001768/202006","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001768-202006"},{"category":"","active_substances_in_scope_of_procedure":"Iomeprol","active_substance":"iomeprol","related_medicines":"","procedure_number":"PSUSA/00001769/202004","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001769-202004"},{"category":"","active_substances_in_scope_of_procedure":"Human anti-d immunoglobulin","active_substance":"human anti-d immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00001614/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001614-201503"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor IX","active_substance":"human coagulation factor IX","related_medicines":"","procedure_number":"PSUSA/00001617/201907","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001617-201907"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor VII","active_substance":"human coagulation factor VII","related_medicines":"","procedure_number":"PSUSA/00001619/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001619-201610"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor VIII","active_substance":"human coagulation factor VIII","related_medicines":"","procedure_number":"PSUSA/00001620/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001620-201911"},{"category":"","active_substances_in_scope_of_procedure":"Iopamidol","active_substance":"iopamidol","related_medicines":"","procedure_number":"PSUSA/00001771/201912","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001771-201912"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor VIII (antihemophilic factor A)","active_substance":"human coagulation factor VIII","related_medicines":"","procedure_number":"PSUSA/00001620/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001620-201411"},{"category":"","active_substances_in_scope_of_procedure":"Iopromide","active_substance":"iopromide","related_medicines":"","procedure_number":"PSUSA/00001773/202006","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001773-202006"},{"category":"","active_substances_in_scope_of_procedure":"Ioxaglic acid","active_substance":"ioxaglic acid","related_medicines":"","procedure_number":"PSUSA/00001777/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001777-201802"},{"category":"","active_substances_in_scope_of_procedure":"Ipratropium salbutamol","active_substance":"ipratropium salbutamol","related_medicines":"","procedure_number":"PSUSA/00001781/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001781-202001"},{"category":"","active_substances_in_scope_of_procedure":"Iron (parenteral preparations, except for iron dextran)","active_substance":"iron","related_medicines":"","procedure_number":"PSUSA/00010236/201901","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010236-201901"},{"category":"","active_substances_in_scope_of_procedure":"iron","active_substance":"","related_medicines":"","procedure_number":"PSUSA/00010236/202001","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010236-202001"},{"category":"","active_substances_in_scope_of_procedure":"Ipratropium / salbutamol","active_substance":"ipratropium;salbutamol","related_medicines":"","procedure_number":"PSUSA-00001781-201701","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001781-201701"},{"category":"","active_substances_in_scope_of_procedure":"Ipratropium","active_substance":"ipratropium","related_medicines":"","procedure_number":"PSUSA/00001780/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001780-201701"},{"category":"","active_substances_in_scope_of_procedure":"Iron / parenteral preparations","active_substance":"iron","related_medicines":"","procedure_number":"PSUSA/00010236/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010236-201701"},{"category":"","active_substances_in_scope_of_procedure":"Irinotecan (except for liposomal formulations)","active_substance":"irinotecan","related_medicines":"","procedure_number":"PSUSA/00001783/201705","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001783-201705"},{"category":"","active_substances_in_scope_of_procedure":"Irinotecan (except for liposomal formulations)","active_substance":"irinotecan","related_medicines":"","procedure_number":"PSUSA/00001783/202005","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001783-202005"},{"category":"","active_substances_in_scope_of_procedure":"Ivabradine/metoprolol","active_substance":"ivabradine;metoprolol","related_medicines":"","procedure_number":"PSUSA/00010381/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-201804"},{"category":"","active_substances_in_scope_of_procedure":"Ivabradine / metoprolol","active_substance":"ivabradine;metoprolol","related_medicines":"","procedure_number":"PSUSA/10381/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-10381-201704"},{"category":"","active_substances_in_scope_of_procedure":"PSUSA/00010381/201604","active_substance":"ivabradine;metoprolol","related_medicines":"","procedure_number":"PSUSA/00010381/201604","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-201604"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (systemic use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010377/201604","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010377-201604"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (systemic use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010377/201904","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010377-201904"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (topical use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010376/201510","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201510"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (topical use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010376/201604","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201604"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (topical use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010376/201704","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201704"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (topical use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010376/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201610"},{"category":"","active_substances_in_scope_of_procedure":"Lenograstim","active_substance":"lenograstim","related_medicines":"","procedure_number":"PSUSA/00001839/201610","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001839-201610"},{"category":"","active_substances_in_scope_of_procedure":"Letrozole","active_substance":"letrozole","related_medicines":"","procedure_number":"PSUSA/00001842/201610","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-201610"},{"category":"","active_substances_in_scope_of_procedure":"Lenograstim","active_substance":"lenograstim","related_medicines":"","procedure_number":"PSUSA/00001839/201910","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001839-201910"},{"category":"","active_substances_in_scope_of_procedure":"Letrozole","active_substance":"letrozole","related_medicines":"","procedure_number":"PSUSA/00001842/201810","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-201810"},{"category":"","active_substances_in_scope_of_procedure":"Leuprorelin (depot formulations)","active_substance":"leuprorelin (depot formulations)","related_medicines":"","procedure_number":"PSUSA/00010877/202107","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010877-202107"},{"category":"","active_substances_in_scope_of_procedure":"Lercanidipine","active_substance":"lercanidipine","related_medicines":"","procedure_number":"PSUSA/00001841/201908","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001841-201908"},{"category":"","active_substances_in_scope_of_procedure":"Letrozole","active_substance":"letrozole","related_medicines":"","procedure_number":"PSUSA/00001842/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-202110"},{"category":"","active_substances_in_scope_of_procedure":"Letrozole","active_substance":"letrozole","related_medicines":"","procedure_number":"PSUSA/00001437/201410","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001437-201410"},{"category":"","active_substances_in_scope_of_procedure":"Letrozole","active_substance":"letrozole","related_medicines":"","procedure_number":"PSUSA/00001842/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-201510"},{"category":"","active_substances_in_scope_of_procedure":"Leuprorelin","active_substance":"leuprorelin","related_medicines":"","procedure_number":"PSUSA/00001844/201707","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001844-201707"},{"category":"","active_substances_in_scope_of_procedure":"Iron dextran","active_substance":"iron dextran","related_medicines":"","procedure_number":"PSUSA/00010696/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010696-202101"},{"category":"","active_substances_in_scope_of_procedure":"Levobunolol","active_substance":"levobunolol","related_medicines":"","procedure_number":"PSUSA/00010109/201701","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010109-201701"},{"category":"","active_substances_in_scope_of_procedure":"Levobupivacaine","active_substance":"levobupivacaine","related_medicines":"","procedure_number":"PSUSA/00001848/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001848-201712"},{"category":"","active_substances_in_scope_of_procedure":"Levocabastine","active_substance":"levocabastine","related_medicines":"","procedure_number":"PSUSA/00001849/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001849-201711"},{"category":"","active_substances_in_scope_of_procedure":"Levocetirizine","active_substance":"levocetirizine","related_medicines":"","procedure_number":"PSUSA/00001850/201707","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001850-201707"},{"category":"","active_substances_in_scope_of_procedure":"Levofloxacin","active_substance":"levofloxacin","related_medicines":"","procedure_number":"PSUSA/00001854/201810","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001854-201810"},{"category":"","active_substances_in_scope_of_procedure":"Levofloxacin/dexamethasone (ocular use)","active_substance":"levofloxacin/dexamethasone (ocular use)","related_medicines":"","procedure_number":"PSUSA/00010881/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010881-202106"},{"category":"","active_substances_in_scope_of_procedure":"Levofloxacin","active_substance":"levofloxacin","related_medicines":"","procedure_number":"PSUSA/00001854/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001854-201510"},{"category":"","active_substances_in_scope_of_procedure":"Levomethadone","active_substance":"levomethadone","related_medicines":"","procedure_number":"PSUSA/00001855/201905","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001855-201905"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel","active_substance":"levonorgestrel","related_medicines":"","procedure_number":"PSUSA/00010828/202105","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010828-202105"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel,  Ethinylestradiol","active_substance":"levonorgestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010442/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201607"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel,  Ethinylestradiol","active_substance":"levonorgestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010442/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201707"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel,  Ethinylestradiol","active_substance":"levonorgestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010442/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201801"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel,  Ethinylestradiol","active_substance":"levonorgestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010442/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201807"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel,  Ethinylestradiol","active_substance":"levonorgestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010442/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201901"},{"category":"","active_substances_in_scope_of_procedure":"levonorgestrel / ethinylestradiol, ethinylestradiol (combination pack)","active_substance":"levonorgestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010442/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-202101"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel,  Ethinylestradiol","active_substance":"levonorgestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010442/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201701"},{"category":"","active_substances_in_scope_of_procedure":"levonorgestrel / ethinylestradiol, ethinylestradiol (combination pack)","active_substance":"levonorgestrel;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010442/202001","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-202001"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel","active_substance":"levonorgestrel","related_medicines":"","procedure_number":"PSUSA/00001856/201712","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001856-201712"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel","active_substance":"levonorgestrel","related_medicines":"","procedure_number":"PSUSA/00001856/201905","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001856-201905"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel","active_substance":"levonorgestrel","related_medicines":"","procedure_number":"PSUSA/00001856/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001856-201412"},{"category":"","active_substances_in_scope_of_procedure":"Levosalbutamol, salbutamol","active_substance":"salbutamol;levosalbutamol","related_medicines":"","procedure_number":"PSUSA/00010330/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010330-201701"},{"category":"","active_substances_in_scope_of_procedure":"Levosalbutamol, salbutamol","active_substance":"levosalbutamol;salbutamol","related_medicines":"","procedure_number":"PSUSA/00010330/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010330-202001"},{"category":"","active_substances_in_scope_of_procedure":"Levosimendan","active_substance":"Levosimendan","related_medicines":"","procedure_number":"PSUSA/00001858/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001858-201609"},{"category":"","active_substances_in_scope_of_procedure":"Levosimendan","active_substance":"Levosimendan","related_medicines":"","procedure_number":"PSUSA/00001858/201909","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001858-201909"},{"category":"","active_substances_in_scope_of_procedure":"Levothyroxine","active_substance":"levothyroxine","related_medicines":"","procedure_number":"PSUSA/00001860/201901","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001860-201901"},{"category":"","active_substances_in_scope_of_procedure":"Levothyroxine","active_substance":"levothyroxine","related_medicines":"","procedure_number":"PSUSA/00001860/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001860-201601"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine, phenazone","active_substance":"lidocaine;phenazone","related_medicines":"","procedure_number":"PSUSA/00002359/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002359-202001"},{"category":"","active_substances_in_scope_of_procedure":"ofloxacin (topical use)","active_substance":"ofloxacin","related_medicines":"","procedure_number":"PSUSA/00002204/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002204-202104"},{"category":"","active_substances_in_scope_of_procedure":"triamcinolone (intraocular formulations)","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00010292/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-202103"},{"category":"","active_substances_in_scope_of_procedure":"iron sucrose (parenteral preparations)","active_substance":"iron sucrose","related_medicines":"","procedure_number":"PSUSA/00010864/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010864-202101"},{"category":"","active_substances_in_scope_of_procedure":"iron parenteral preparations","active_substance":"iron","related_medicines":"","procedure_number":"PSUSA/00010236/201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010236-201801"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine, prilocaine (not centrally authorised product)","active_substance":"lidocaine;prilocaine","related_medicines":"","procedure_number":"PSUSA/00001867/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001867-201703"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine","active_substance":"lidocaine","related_medicines":"","procedure_number":"PSUSA/00001861/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001861-202009"},{"category":"","active_substances_in_scope_of_procedure":"isoflurane","active_substance":"Isoflurane","related_medicines":"","procedure_number":"PSUSA/00001786/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001786-201610"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"tropicamide;phenylephrine hydrochloride;lidocaine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010390/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201607"},{"category":"","active_substances_in_scope_of_procedure":"isoflurane","active_substance":"Isoflurane","related_medicines":"","procedure_number":"PSUSA/00001786/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001786-201910"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide","related_medicines":"","procedure_number":"PSUSA/00010390/202007","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-202007"},{"category":"","active_substances_in_scope_of_procedure":"isoniazid","active_substance":"isoniazid","related_medicines":"","procedure_number":"PSUSA/00001789/201411","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001789-201411"},{"category":"","active_substances_in_scope_of_procedure":"isoniazid","active_substance":"isoniazid","related_medicines":"","procedure_number":"PSUSA/00001789/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001789-201911"},{"category":"","active_substances_in_scope_of_procedure":"isoniazide / rifampicin","active_substance":"isoniazid;rifampicin","related_medicines":"","procedure_number":"PSUSA/00001792/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001792-201605"},{"category":"","active_substances_in_scope_of_procedure":"isoniazide / rifampicin","active_substance":"isoniazid;rifampicin","related_medicines":"","procedure_number":"PSUSA/00001792/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001792-201905"},{"category":"","active_substances_in_scope_of_procedure":"isotretinoin (oral formulations)","active_substance":"isotretinoin (oral formulations)","related_medicines":"","procedure_number":"PSUSA/00010488/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202005"},{"category":"","active_substances_in_scope_of_procedure":"isotretinoin (oral formulations)","active_substance":"isotretinoin (oral formulations)","related_medicines":"","procedure_number":"PSUSA/00010488/202105","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202105"},{"category":"","active_substances_in_scope_of_procedure":"isotretinoin (oral formulations)","active_substance":"isotretinoin (oral formulations)","related_medicines":"","procedure_number":"PSUSA/00010488/201611","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-201611"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide","related_medicines":"","procedure_number":"PSUSA/00010390/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201601"},{"category":"","active_substances_in_scope_of_procedure":"isotretinoin (oral formulations)","active_substance":"isotretinoin (oral formulations)","related_medicines":"","procedure_number":"PSUSA/00010488/201805","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-201805"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide","related_medicines":"","procedure_number":"PSUSA/00010390/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201701"},{"category":"","active_substances_in_scope_of_procedure":"isotretinoin (oral formulations)","active_substance":"isotretinoin (oral formulations)","related_medicines":"","procedure_number":"PSUSA/00010488/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-201705"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"tropicamide;phenylephrine hydrochloride;lidocaine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010390/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201707"},{"category":"","active_substances_in_scope_of_procedure":"isotretinoin (oral formulations)","active_substance":"isotretinoin (oral formulations)","related_medicines":"","procedure_number":"PSUSA/00010488/201905","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-201905"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide","related_medicines":"","procedure_number":"PSUSA/00010390/2018","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-2018"},{"category":"","active_substances_in_scope_of_procedure":"Isotretinoin","active_substance":"isotretinoin","related_medicines":"","procedure_number":"PSUSA/00001795/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001795-201505"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"tropicamide;phenylephrine hydrochloride;lidocaine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010390/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201801"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (topical use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010376/201904","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201904"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"tropicamide;phenylephrine hydrochloride;lidocaine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010390/201907","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201907"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride/methylprednisolone acetate","active_substance":"lidocaine hydrochloride;methylprednisolone acetate","related_medicines":"","procedure_number":"PSUSA/00001879/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001879-202008"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide","active_substance":"lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide","related_medicines":"","procedure_number":"PSUSA/00010390/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-202107"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine, tetracaine","active_substance":"tetracaine;lidocaine","related_medicines":"","procedure_number":"PSUSA/00001868/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001868-202006"},{"category":"","active_substances_in_scope_of_procedure":"Llinezolid","active_substance":"linezolid","related_medicines":"","procedure_number":"PSUSA/00001888/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001888-201704"},{"category":"","active_substances_in_scope_of_procedure":"Lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202102"},{"category":"","active_substances_in_scope_of_procedure":"Lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/202002","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202002"},{"category":"","active_substances_in_scope_of_procedure":"Lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201702"},{"category":"","active_substances_in_scope_of_procedure":"Lisdexamfetamine dimesylate","active_substance":"lisdexamfetamine dimesylate","related_medicines":"","procedure_number":"EMEA/H/N/PSR/S/0033","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0033"},{"category":"","active_substances_in_scope_of_procedure":"Lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/201902","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201902"},{"category":"","active_substances_in_scope_of_procedure":"Lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201502"},{"category":"","active_substances_in_scope_of_procedure":"Lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201508"},{"category":"","active_substances_in_scope_of_procedure":"Lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201802"},{"category":"","active_substances_in_scope_of_procedure":"Lisinopril, lisinopril / hydrochlorothiazide","active_substance":"lisinopril;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00010532/202009","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010532-202009"},{"category":"","active_substances_in_scope_of_procedure":"Lisinopril","active_substance":"lisinopril","related_medicines":"","procedure_number":"PSUSA/00001894/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001894-201509"},{"category":"","active_substances_in_scope_of_procedure":"Loperamide, loperamide / simeticone","active_substance":"loperamide;simeticone","related_medicines":"","procedure_number":"PSUSA/00010665/202105","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010665-202105"},{"category":"","active_substances_in_scope_of_procedure":"Lisuride","active_substance":"lisuride","related_medicines":"","procedure_number":"PSUSA/00001896/201411","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001896-201411"},{"category":"","active_substances_in_scope_of_procedure":"Lomustine","active_substance":"lomustine","related_medicines":"","procedure_number":"PSUSA/00001902/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001902-201801"},{"category":"","active_substances_in_scope_of_procedure":"Loperamide, loperamide / simeticone","active_substance":"loperamide;simeticone","related_medicines":"","procedure_number":"PSUSA/00010665/201805","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010665-201805"},{"category":"","active_substances_in_scope_of_procedure":"Ketamine","active_substance":"ketamine","related_medicines":"","procedure_number":"PSUSA/00001804/201812","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001804-201812"},{"category":"","active_substances_in_scope_of_procedure":"Ketamine","active_substance":"ketamine","related_medicines":"","procedure_number":"PSUSA/00001804/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001804-202112"},{"category":"","active_substances_in_scope_of_procedure":"Ketamine","active_substance":"ketamine","related_medicines":"","procedure_number":"PSUSA/00001804/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001804-201512"},{"category":"","active_substances_in_scope_of_procedure":"Ketobemidone","active_substance":"ketobemidone","related_medicines":"","procedure_number":"PSUSA/00001807/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001807-202005"},{"category":"","active_substances_in_scope_of_procedure":"Loperamide","active_substance":"loperamide","related_medicines":"","procedure_number":"PSUSA/00001903/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001903-201605"},{"category":"","active_substances_in_scope_of_procedure":"Ketoprofen (all formulations except topical)","active_substance":"ketoprofen","related_medicines":"","procedure_number":"PSUSA/00001809/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001809-201707"},{"category":"","active_substances_in_scope_of_procedure":"Ketoprofen (topical use only)","active_substance":"ketoprofen","related_medicines":"","procedure_number":"PSUSA/00009205/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009205-201901"},{"category":"","active_substances_in_scope_of_procedure":"Ketoprofen (topical use only)","active_substance":"ketoprofen","related_medicines":"","procedure_number":"PSUSA/00009205/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009205-201509"},{"category":"","active_substances_in_scope_of_procedure":"Ketoprofen (topical use only)","active_substance":"ketoprofen","related_medicines":"","procedure_number":"PSUSA/00009205/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009205-201609"},{"category":"","active_substances_in_scope_of_procedure":"Loratadine / pseudoephedrine","active_substance":"pseudoephedrine;loratadine","related_medicines":"","procedure_number":"PSUSA/00001908/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001908-201702"},{"category":"","active_substances_in_scope_of_procedure":"Loratadine","active_substance":"loratadine","related_medicines":"","procedure_number":"PSUSA/00001907/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001907-201702"},{"category":"","active_substances_in_scope_of_procedure":"Lorazepam","active_substance":"lorazepam","related_medicines":"","procedure_number":"PSUSA/00001909/201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-201801"},{"category":"","active_substances_in_scope_of_procedure":"Lorazepam","active_substance":"lorazepam","related_medicines":"","procedure_number":"PSUSA/00001909/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-201601"},{"category":"","active_substances_in_scope_of_procedure":"Lorazepam","active_substance":"lorazepam","related_medicines":"","procedure_number":"PSUSA/00001909/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-202001"},{"category":"","active_substances_in_scope_of_procedure":"Lormetazepam","active_substance":"lormetazepam","related_medicines":"","procedure_number":"PSUSA/00001910/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001910-202012"},{"category":"","active_substances_in_scope_of_procedure":"Lormetazepam","active_substance":"lormetazepam","related_medicines":"","procedure_number":"PSUSA/00001910/201412","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001910-201412"},{"category":"","active_substances_in_scope_of_procedure":"Lormetazepam","active_substance":"lormetazepam","related_medicines":"","procedure_number":"PSUSA/00001910/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001910-201712"},{"category":"","active_substances_in_scope_of_procedure":"Losartan","active_substance":"losartan","related_medicines":"","procedure_number":"PSUSA/00001912/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001912-201709"},{"category":"","active_substances_in_scope_of_procedure":"Ketorolac (ophthalmic formulations)","active_substance":"ketorolac","related_medicines":"","procedure_number":"PSUSA/00001810/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001810-201707"},{"category":"","active_substances_in_scope_of_procedure":"Ketorolac (systemic formulations)","active_substance":"ketorolac","related_medicines":"","procedure_number":"PSUSA/00001811/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001811-201707"},{"category":"","active_substances_in_scope_of_procedure":"Ketotifen (ophthalmic formulations)","active_substance":"ketotifen","related_medicines":"","procedure_number":"PSUSA/00001812/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001812-201706"},{"category":"","active_substances_in_scope_of_procedure":"Ketotifen (oral formulations)","active_substance":"ketotifen","related_medicines":"","procedure_number":"PSUSA/00001813/201410","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001813-201410"},{"category":"","active_substances_in_scope_of_procedure":"Ketotifen (oral formulations)","active_substance":"ketotifen","related_medicines":"","procedure_number":"PSUSA/00001813/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001813-201710"},{"category":"","active_substances_in_scope_of_procedure":"Ketotifen (oral formulations)","active_substance":"ketotifen","related_medicines":"","procedure_number":"PSUSA/00001813/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001813-202010"},{"category":"","active_substances_in_scope_of_procedure":"Lovastatin","active_substance":"lovastatin","related_medicines":"","procedure_number":"PSUSA/00010051/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010051-202107"},{"category":"","active_substances_in_scope_of_procedure":"Lovastatin","active_substance":"lovastatin","related_medicines":"","procedure_number":"PSUSA/00010051/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010051-201607"},{"category":"","active_substances_in_scope_of_procedure":"Lubiprostone","active_substance":"Lubiprostone","related_medicines":"","procedure_number":"PSUSA/00010290/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010290-201701"},{"category":"","active_substances_in_scope_of_procedure":"Lubiprostone","active_substance":"Lubiprostone","related_medicines":"","procedure_number":"PSUSA/000010290/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-000010290-201507"},{"category":"","active_substances_in_scope_of_procedure":"Alverine / simeticone","active_substance":"alverine;simeticone","related_medicines":"","procedure_number":"PSUSA/00000125/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000125-202202"},{"category":"","active_substances_in_scope_of_procedure":"Lubiprostone","active_substance":"Lubiprostone","related_medicines":"","procedure_number":"PSUSA/00010290/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010290-201601"},{"category":"Human","active_substances_in_scope_of_procedure":"Alverine","active_substance":"alverine","related_medicines":"","procedure_number":"PSUSA/00000124/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000124-202202"},{"category":"","active_substances_in_scope_of_procedure":"Lubiprostone","active_substance":"Lubiprostone","related_medicines":"","procedure_number":"PSUSA/00010290/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010290-201607"},{"category":"","active_substances_in_scope_of_procedure":"Lubiprostone","active_substance":"Lubiprostone","related_medicines":"","procedure_number":"PSUSA/00010290/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010290-201801"},{"category":"","active_substances_in_scope_of_procedure":"Lysine acetylsalicylate","active_substance":"lysine acetylsalicylate","related_medicines":"","procedure_number":"PSUSA/00001921/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001921-201709"},{"category":"","active_substances_in_scope_of_procedure":"Macrogol 3350","active_substance":"Macrogol 3350","related_medicines":"","procedure_number":"PSUSA/00001924/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001924-201605"},{"category":"","active_substances_in_scope_of_procedure":"Macrogol 3350","active_substance":"Macrogol 3350","related_medicines":"","procedure_number":"PSUSA/00001924/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001924-201905"},{"category":"","active_substances_in_scope_of_procedure":"Macrogol 4000, macrogol 4000 combinations (oral use)","active_substance":"macrogol 4000","related_medicines":"","procedure_number":"PSUSA/00010392/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010392-201905"},{"category":"","active_substances_in_scope_of_procedure":"Macrogol 4000","active_substance":"macrogol 4000","related_medicines":"","procedure_number":"PSUSA/00010392/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010392-201605"},{"category":"","active_substances_in_scope_of_procedure":"","active_substance":"magnesium hydroxide","related_medicines":"","procedure_number":"PSUSA/00001926/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001926-202110"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium hydroxide","active_substance":"magnesium hydroxide","related_medicines":"","procedure_number":"PSUSA/00001926/201610","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001926-201610"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium sulfate","active_substance":"magnesium sulfate","related_medicines":"","procedure_number":"PSUSA/00009225/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009225-201506"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium sulfate","active_substance":"magnesium sulfate","related_medicines":"","procedure_number":"PSUSA/00009225/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009225-202006"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium sulphate / sodium sulphate / potassium sulphate","active_substance":"sodium sulfate;magnesium sulfate;potassium sulfate","related_medicines":"","procedure_number":"PSUSA/00010239/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201508"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium sulphate / sodium sulphate / potassium sulphate","active_substance":"sodium sulfate;magnesium sulfate;potassium sulfate","related_medicines":"","procedure_number":"PSUSA/00010239/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201602"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium sulphate / sodium sulphate / potassium sulphate","active_substance":"sodium sulfate;magnesium sulfate;potassium sulfate","related_medicines":"","procedure_number":"PSUSA/00010239/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201608"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium sulphate / sodium sulphate / potassium sulphate","active_substance":"sodium sulfate;magnesium sulfate;potassium sulfate","related_medicines":"","procedure_number":"PSUSA/00010239/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201708"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium sulphate / sodium sulphate / potassium sulphate","active_substance":"sodium sulfate;magnesium sulfate;potassium sulfate","related_medicines":"","procedure_number":"PSUSA/00010239/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201808"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium sulphate heptahydrate, sodium sulphate anhydrous, potassium sulphate","active_substance":"magnesium sulfate heptahydrate (BLI800);sodium sulfate anhydrous;potassium sulfate","related_medicines":"","procedure_number":"EMEA/H/N/PSR/S/0016","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0016"},{"category":"Human","active_substances_in_scope_of_procedure":"Magnesium sulfate, sodium sulfate, potassium sulfate","active_substance":"magnesium sulfate;sodium sulfate;potassium sulfate","related_medicines":"","procedure_number":"PSUSA 00010239202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239202108"},{"category":"","active_substances_in_scope_of_procedure":"Magnesium sulphate, sodium sulphate, potassium sulphate","active_substance":"sodium sulfate;magnesium sulfate;potassium sulfate","related_medicines":"","procedure_number":"PSUSA/00010239/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201502"},{"category":"","active_substances_in_scope_of_procedure":"Mefloquine","active_substance":"mefloquine","related_medicines":"","procedure_number":"PSUSA/00001955/201702","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001955-201702"},{"category":"","active_substances_in_scope_of_procedure":"Meloxicam","active_substance":"meloxicam","related_medicines":"","procedure_number":"PSUSA/00010474/201607","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010474-201607"},{"category":"","active_substances_in_scope_of_procedure":"Mequitazine","active_substance":"mequitazine","related_medicines":"","procedure_number":"PSUSA/00001986/202001","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001986-202001"},{"category":"","active_substances_in_scope_of_procedure":"Meropenem","active_substance":"Meropenem","related_medicines":"","procedure_number":"PSUSA/00001989/201508","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001989-201508"},{"category":"","active_substances_in_scope_of_procedure":"Zanamivir (except for centrally authorised products)","active_substance":"zanamivir","related_medicines":"","procedure_number":"PSUSA/00003141/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003141-202201"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202203"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202203"},{"category":"","active_substances_in_scope_of_procedure":"Loratadine","active_substance":"loratadine","related_medicines":"","procedure_number":"PSUSA/00001907/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001907-202202"},{"category":"","active_substances_in_scope_of_procedure":"Cromoglicic acid","active_substance":"cromoglicic acid","related_medicines":"","procedure_number":"PSUSA/00000883/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000883-202202"},{"category":"","active_substances_in_scope_of_procedure":"Loratadine / pseudoephedrine","active_substance":"loratadine;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001908/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001908-202202"},{"category":"","active_substances_in_scope_of_procedure":"Manidipine","active_substance":"manidipine","related_medicines":"","procedure_number":"PSUSA/00001932/201806","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001932-201806"},{"category":"","active_substances_in_scope_of_procedure":"Manidipine","active_substance":"manidipine","related_medicines":"","procedure_number":"PSUSA/00001932/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001932-201506"},{"category":"","active_substances_in_scope_of_procedure":"Mannitol","active_substance":"mannitol","related_medicines":"","procedure_number":"PSUSA/00010005/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010005-201702"},{"category":"","active_substances_in_scope_of_procedure":"Mannitol","active_substance":"mannitol","related_medicines":"","procedure_number":"PSUSA/00010005/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010005-202002"},{"category":"","active_substances_in_scope_of_procedure":"Measles vaccine (live attenuated)","active_substance":"measles vaccine (live attenuated)","related_medicines":"","procedure_number":"PSUSA/00001938/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001938-201905"},{"category":"","active_substances_in_scope_of_procedure":"Mefloquine","active_substance":"mefloquine","related_medicines":"","procedure_number":"PSUSA/00001955/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001955-202002"},{"category":"","active_substances_in_scope_of_procedure":"Meningococcal group a and c polysaccharide vaccine","active_substance":"meningococcal group a and c polysaccharide vaccine","related_medicines":"","procedure_number":"PSUSA/00001970/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001970-201602"},{"category":"","active_substances_in_scope_of_procedure":"Meningococcal group a, c, w135, y polysaccharide vaccine","active_substance":"meningococcal group A, C, W-135 and Y conjugate vaccine","related_medicines":"","procedure_number":"PSUSA/00010602/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010602-201803"},{"category":"","active_substances_in_scope_of_procedure":"Meningococcal group c polysaccharide conjugate vaccine","active_substance":"meningococcal group c polysaccharide conjugate vaccine","related_medicines":"","procedure_number":"PSUSA/00001971/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001971-202110"},{"category":"","active_substances_in_scope_of_procedure":"Meningococcal group c polysaccharide conjugate vaccine","active_substance":"meningococcal group c polysaccharide conjugate vaccine","related_medicines":"","procedure_number":"PSUSA/00001971/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001971-201510"},{"category":"","active_substances_in_scope_of_procedure":"Meningococcal group c polysaccharide conjugate vaccine","active_substance":"meningococcal group c polysaccharide conjugate vaccine","related_medicines":"","procedure_number":"PSUSA/00001971/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001971-201810"},{"category":"","active_substances_in_scope_of_procedure":"Meropenem","active_substance":"Meropenem","related_medicines":"","procedure_number":"PSUSA/00001989/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001989-201808"},{"category":"","active_substances_in_scope_of_procedure":"Methadone","active_substance":"methadone","related_medicines":"","procedure_number":"PSUSA/00002004/201905","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002004-201905"},{"category":"","active_substances_in_scope_of_procedure":"Metamizole","active_substance":"metamizole","related_medicines":"","procedure_number":"PSUSA/00001997/202003","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-202003"},{"category":"","active_substances_in_scope_of_procedure":"Mesalazine","active_substance":"Mesalazine","related_medicines":"","procedure_number":"PSUSA/00001990/202002","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001990-202002"},{"category":"","active_substances_in_scope_of_procedure":"Mesalazine","active_substance":"Mesalazine","related_medicines":"","procedure_number":"PSUSA/00001990/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001990-201502"},{"category":"","active_substances_in_scope_of_procedure":"Mesterolone","active_substance":"mesterolone","related_medicines":"","procedure_number":"PSUSA/00010551/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010551-201901"},{"category":"","active_substances_in_scope_of_procedure":"Metamizole","active_substance":"metamizole","related_medicines":"","procedure_number":"PSUSA/00001997/202103","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-202103"},{"category":"","active_substances_in_scope_of_procedure":"Metamizole sodium / triacetonamine tosilate","active_substance":"metamizole sodium;triacetonamine tosilate","related_medicines":"","procedure_number":"PSUSA/00001999/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001999-202001"},{"category":"","active_substances_in_scope_of_procedure":"Metamizole","active_substance":"metamizole","related_medicines":"","procedure_number":"PSUSA/00001997/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-201504"},{"category":"","active_substances_in_scope_of_procedure":"Metamizole","active_substance":"metamizole","related_medicines":"","procedure_number":"PSUSA/00001997/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-201804"},{"category":"","active_substances_in_scope_of_procedure":"Metformin","active_substance":"Metformin","related_medicines":"","procedure_number":"PSUSA/00002001/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002001-202104"},{"category":"","active_substances_in_scope_of_procedure":"Metformin","active_substance":"Metformin","related_medicines":"","procedure_number":"PSUSA/00002001/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002001-201504"},{"category":"","active_substances_in_scope_of_procedure":"Metformin","active_substance":"Metformin","related_medicines":"","procedure_number":"PSUSA/00002001/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002001-201804"},{"category":"","active_substances_in_scope_of_procedure":"Methyl salicylate / levomenthol / DL-camphor","active_substance":"methyl salicylate;Levomenthol;DL-camphor","related_medicines":"","procedure_number":"PSUSA/00010117/201704","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010117-201704"},{"category":"","active_substances_in_scope_of_procedure":"Methyl salicylate / levomenthol","active_substance":"Levomenthol;methyl salicylate","related_medicines":"","procedure_number":"PSUSA/00010241/201704","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010241-201704"},{"category":"","active_substances_in_scope_of_procedure":"Methylaminolevulinate","active_substance":"methylaminolevulinate","related_medicines":"","procedure_number":"PSUSA/00002019/201706","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002019-201706"},{"category":"","active_substances_in_scope_of_procedure":"Methylphenidate","active_substance":"methylphenidate","related_medicines":"","procedure_number":"PSUSA/00002024/202110","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-202110"},{"category":"","active_substances_in_scope_of_procedure":"Methoxyflurane","active_substance":"Methoxyflurane","related_medicines":"","procedure_number":"PSUSA/00010484/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201611"},{"category":"","active_substances_in_scope_of_procedure":"Methoxyflurane","active_substance":"Methoxyflurane","related_medicines":"","procedure_number":"PSUSA/00010484/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201705"},{"category":"","active_substances_in_scope_of_procedure":"Methoxyflurane","active_substance":"Methoxyflurane","related_medicines":"","procedure_number":"PSUSA/00010484/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201711"},{"category":"","active_substances_in_scope_of_procedure":"Methoxyflurane","active_substance":"Methoxyflurane","related_medicines":"","procedure_number":"PSUSA/00010484/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201805"},{"category":"","active_substances_in_scope_of_procedure":"Methoxyflurane","active_substance":"Methoxyflurane","related_medicines":"","procedure_number":"PSUSA/00010484/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201811"},{"category":"","active_substances_in_scope_of_procedure":"Methoxyflurane","active_substance":"Methoxyflurane","related_medicines":"","procedure_number":"PSUSA/00010484/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201905"},{"category":"","active_substances_in_scope_of_procedure":"Methoxyflurane","active_substance":"Methoxyflurane","related_medicines":"","procedure_number":"PSUSA/00010484/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-202005"},{"category":"","active_substances_in_scope_of_procedure":"Methoxyflurane","active_substance":"Methoxyflurane","related_medicines":"","procedure_number":"PSUSA/00010484/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-202105"},{"category":"","active_substances_in_scope_of_procedure":"Methylphenidate","active_substance":"methylphenidate","related_medicines":"","procedure_number":"PSUSA/00002024/201810","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-201810"},{"category":"","active_substances_in_scope_of_procedure":"Methylphenidate","active_substance":"methylphenidate","related_medicines":"","procedure_number":"PSUSA/00002024/201910","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-201910"},{"category":"","active_substances_in_scope_of_procedure":"Methylprednisolone","active_substance":"methylprednisolone","related_medicines":"","procedure_number":"PSUSA/00002026/201411","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002026-201411"},{"category":"","active_substances_in_scope_of_procedure":"Methylphenidate","active_substance":"methylphenidate","related_medicines":"","procedure_number":"PSUSA/00002024/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-201710"},{"category":"","active_substances_in_scope_of_procedure":"Methylphenidate","active_substance":"methylphenidate","related_medicines":"","procedure_number":"PSUSA/00002024/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-201510"},{"category":"","active_substances_in_scope_of_procedure":"Methylphenobarbital","active_substance":"methylphenobarbital","related_medicines":"","procedure_number":"PSUSA/00002025/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002025-201803"},{"category":"","active_substances_in_scope_of_procedure":"Methylprednisolone","active_substance":"methylprednisolone","related_medicines":"","procedure_number":"PSUSA/00002026/202011","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002026-202011"},{"category":"","active_substances_in_scope_of_procedure":"Methylprednisolone","active_substance":"methylprednisolone","related_medicines":"","procedure_number":"PSUSA/00002026/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002026-201711"},{"category":"","active_substances_in_scope_of_procedure":"Methysergide","active_substance":"methysergide","related_medicines":"","procedure_number":"PSUSA/00002030/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002030-201502"},{"category":"","active_substances_in_scope_of_procedure":"Metoclopramide","active_substance":"metoclopramide","related_medicines":"","procedure_number":"PSUSA/00002036/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002036-202111"},{"category":"","active_substances_in_scope_of_procedure":"Metoclopramide","active_substance":"metoclopramide","related_medicines":"","procedure_number":"PSUSA/00002036/201510","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002036-201510"},{"category":"","active_substances_in_scope_of_procedure":"Metoclopramide","active_substance":"metoclopramide","related_medicines":"","procedure_number":"PSUSA/00002036/201811","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002036-201811"},{"category":"","active_substances_in_scope_of_procedure":"Metronidazole / neomycin / nystatin","active_substance":"nystatin;neomycin;Metronidazole","related_medicines":"","procedure_number":"PSUSA/00010508/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010508-201709"},{"category":"","active_substances_in_scope_of_procedure":"Metronidazole / neomycin / nystatin","active_substance":"Metronidazole;neomycin;nystatin","related_medicines":"","procedure_number":"PSUSA/00010508/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010508-202009"},{"category":"","active_substances_in_scope_of_procedure":"Metyrapone","active_substance":"metyrapone","related_medicines":"","procedure_number":"PSUSA/00002046/201806","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002046-201806"},{"category":"","active_substances_in_scope_of_procedure":"Miconazole / hydrocortisone, miconazole nitrate / miconazole nitrate, zinc oxide","active_substance":"Miconazole;hydrocortisone;miconazole nitrate;zinc oxide","related_medicines":"","procedure_number":"PSUSA/00002052/201410","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002052-201410"},{"category":"","active_substances_in_scope_of_procedure":"Midazolam (all pharmaceutical forms and indications apart from oromucosal solution indicated for the treatment of prolonged, acute, convulsive seizures)","active_substance":"midazolam","related_medicines":"","procedure_number":"PSUSA/00002057/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002057-201709"},{"category":"","active_substances_in_scope_of_procedure":"Mifepristone / misoprostol","active_substance":"mifepristone;misoprostol","related_medicines":"","procedure_number":"PSUSA/00010378/201705","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010378-201705"},{"category":"","active_substances_in_scope_of_procedure":"Midodrine","active_substance":"midodrine","related_medicines":"","procedure_number":"PSUSA/00003178/201606","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003178-201606"},{"category":"","active_substances_in_scope_of_procedure":"Mifepristone / misoprostol","active_substance":"mifepristone;misoprostol","related_medicines":"","procedure_number":"PSUSA/00010378/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010378-202005"},{"category":"","active_substances_in_scope_of_procedure":"Mifepristone","active_substance":"mifepristone","related_medicines":"","procedure_number":"PSUSA/00002060/202005","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002060-202005"},{"category":"","active_substances_in_scope_of_procedure":"Mifepristone","active_substance":"mifepristone","related_medicines":"","procedure_number":"PSUSA/00002060/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002060-201705"},{"category":"","active_substances_in_scope_of_procedure":"Miglitol","active_substance":"Miglitol","related_medicines":"","procedure_number":"PSUSA/00002061/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002061-201807"},{"category":"","active_substances_in_scope_of_procedure":"Milnacipran","active_substance":"milnacipran","related_medicines":"","procedure_number":"PSUSA/00002063/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002063-201504"},{"category":"","active_substances_in_scope_of_procedure":"Milnacipran","active_substance":"milnacipran","related_medicines":"","procedure_number":"PSUSA/00002063/201804","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002063-201804"},{"category":"","active_substances_in_scope_of_procedure":"Milnacipran","active_substance":"milnacipran","related_medicines":"","procedure_number":"PSUSA/00002063/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002063-202104"},{"category":"","active_substances_in_scope_of_procedure":"Milrinone","active_substance":"milrinone","related_medicines":"","procedure_number":"PSUSA/00002064/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002064-202110"},{"category":"","active_substances_in_scope_of_procedure":"Milrinone","active_substance":"milrinone","related_medicines":"","procedure_number":"PSUSA/00002064/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002064-201510"},{"category":"","active_substances_in_scope_of_procedure":"Milrinone","active_substance":"milrinone","related_medicines":"","procedure_number":"PSUSA/00002064/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002064-201810"},{"category":"","active_substances_in_scope_of_procedure":"Minocycline","active_substance":"minocycline","related_medicines":"","procedure_number":"PSUSA/00002065/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002065-201708"},{"category":"","active_substances_in_scope_of_procedure":"Minoxidil","active_substance":"minoxidil","related_medicines":"","procedure_number":"PSUSA/0002066/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-0002066-201510"},{"category":"","active_substances_in_scope_of_procedure":"Minoxidil","active_substance":"minoxidil","related_medicines":"","procedure_number":"PSUSA/00002066/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002066-202010"},{"category":"","active_substances_in_scope_of_procedure":"Minoxidil","active_substance":"minoxidil","related_medicines":"","procedure_number":"PSUSA/00002067/201510","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002067-201510"},{"category":"","active_substances_in_scope_of_procedure":"Minoxidil (topical formulation)","active_substance":"minoxidil","related_medicines":"","procedure_number":"PSUSA/00002067/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002067-201710"},{"category":"","active_substances_in_scope_of_procedure":"Minoxidil (topical formulation)","active_substance":"minoxidil","related_medicines":"","procedure_number":"PSUSA-00002067-202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002067-202010"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gastrointestinal indication)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010291/201706","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-201706"},{"category":"","active_substances_in_scope_of_procedure":"Mirtazapine","active_substance":"mirtazapine","related_medicines":"","procedure_number":"PSUSA/00002068/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002068-201808"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gastrointestinal indication)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010291/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-201506"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gastrointestinal indication)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010291/201606","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-201606"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gastrointestinal indication)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010291/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-201806"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gastrointestinal indication)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010291/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-202006"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gynaecological indication - labor induction)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010353/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201505"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gynaecological indication - labour induction)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010353/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-202105"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gynaecological indication - labour induction)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010353/201605","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201605"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gynaecological indication - termination of pregnancy)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010354/201705","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010354-201705"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010353/201805","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201805"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA00010291202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa00010291202106"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gynaecological indication - termination of pregnancy)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010354/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010354-201505"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gynaecological indication - labour induction)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010353/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201705"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gynaecological indication - labour induction)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010353/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201905"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gynaecological indication - labour induction)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010353/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-202005"},{"category":"","active_substances_in_scope_of_procedure":"Misoprostol (gynaecological indication - termination of pregnancy)","active_substance":"misoprostol","related_medicines":"","procedure_number":"PSUSA/00010354/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010354-202005"},{"category":"","active_substances_in_scope_of_procedure":"Mitoxantrone","active_substance":"mitoxantrone","related_medicines":"","procedure_number":"PSUSA/00002076/201606","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002076-201606"},{"category":"","active_substances_in_scope_of_procedure":"Mitoxantrone","active_substance":"mitoxantrone","related_medicines":"","procedure_number":"PSUSA/00002076/201906","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002076-201906"},{"category":"","active_substances_in_scope_of_procedure":"Mivacurium","active_substance":"mivacurium","related_medicines":"","procedure_number":"PSUSA/00002077/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002077-201801"},{"category":"","active_substances_in_scope_of_procedure":"Mizolastine","active_substance":"mizolastine","related_medicines":"","procedure_number":"PSUSA/00002078/201711","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002078-201711"},{"category":"","active_substances_in_scope_of_procedure":"Moclobemide","active_substance":"moclobemide","related_medicines":"","procedure_number":"PSUSA/00002079/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002079-201704"},{"category":"","active_substances_in_scope_of_procedure":"Modafinil","active_substance":"modafinil","related_medicines":"","procedure_number":"PSUSA/00010242/202108","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010242-202108"},{"category":"","active_substances_in_scope_of_procedure":"Modafinil","active_substance":"modafinil","related_medicines":"","procedure_number":"PSUSA/00010242/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010242-202008"},{"category":"","active_substances_in_scope_of_procedure":"Moxifloxacin (systemic use)","active_substance":"moxifloxacin","related_medicines":"","procedure_number":"PSUSA/00009231/201905","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009231-201905"},{"category":"","active_substances_in_scope_of_procedure":"Moxifloxacin (systemic use)","active_substance":"moxifloxacin","related_medicines":"","procedure_number":"PSUSA/00009231/201605","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009231-201605"},{"category":"","active_substances_in_scope_of_procedure":"Morphine morphine-cyclizine","active_substance":"morphine;cyclizine","related_medicines":"","procedure_number":"PSUSA/00010549/201710","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010549-201710"},{"category":"","active_substances_in_scope_of_procedure":"Montelukast","active_substance":"montelukast","related_medicines":"","procedure_number":"PSUSA/00002087/201807","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002087-201807"},{"category":"","active_substances_in_scope_of_procedure":"Montelukast","active_substance":"montelukast","related_medicines":"","procedure_number":"PSUSA/00002087/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002087-201507"},{"category":"","active_substances_in_scope_of_procedure":"Montelukast","active_substance":"montelukast","related_medicines":"","procedure_number":"PSUSA/00002087/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002087-202107"},{"category":"","active_substances_in_scope_of_procedure":"Modafinil","active_substance":"modafinil","related_medicines":"","procedure_number":"PSUSA/00010242/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010242-201708"},{"category":"","active_substances_in_scope_of_procedure":"Mometasone","active_substance":"mometasone","related_medicines":"","procedure_number":"PSUSA/00002085/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002085-201705"},{"category":"","active_substances_in_scope_of_procedure":"Mometasone","active_substance":"mometasone","related_medicines":"","procedure_number":"PSUSA/00002085/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002085-202005"},{"category":"","active_substances_in_scope_of_procedure":"Nefopam","active_substance":"nefopam","related_medicines":"","procedure_number":"PSUSA/00002131/201603","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002131-201603"},{"category":"","active_substances_in_scope_of_procedure":"Naproxen","active_substance":"naproxen","related_medicines":"","procedure_number":"PSUSA/00002125/201708","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002125-201708"},{"category":"","active_substances_in_scope_of_procedure":"Naftifine","active_substance":"naftifine","related_medicines":"","procedure_number":"PSUSA/00002109/202008","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002109-202008"},{"category":"","active_substances_in_scope_of_procedure":"Nafarelin","active_substance":"nafarelin","related_medicines":"","procedure_number":"PSUSA/00002105/202102","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002105-202102"},{"category":"","active_substances_in_scope_of_procedure":"Nadroparin","active_substance":"nadroparin","related_medicines":"","procedure_number":"PSUSA/00002104/201803","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002104-201803"},{"category":"","active_substances_in_scope_of_procedure":"Nadroparin","active_substance":"nadroparin","related_medicines":"","procedure_number":"PSUSA/00002104/202103","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002104-202103"},{"category":"","active_substances_in_scope_of_procedure":"Nadifloxacin","active_substance":"nadifloxacin","related_medicines":"","procedure_number":"PSUSA/00002102/201605","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002102-201605"},{"category":"","active_substances_in_scope_of_procedure":"Moxifloxacin (topical ophthalmic use)","active_substance":"moxifloxacin","related_medicines":"","procedure_number":"PSUSA/00002094/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002094-202105"},{"category":"","active_substances_in_scope_of_procedure":"Moxonidine","active_substance":"moxonidine","related_medicines":"","procedure_number":"PSUSA/00002095/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002095-201701"},{"category":"","active_substances_in_scope_of_procedure":"Mupirocin","active_substance":"mupirocin","related_medicines":"","procedure_number":"PSUSA/00002096/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002096-201703"},{"category":"","active_substances_in_scope_of_procedure":"Mxifloxacin (topical ophthalmic use)","active_substance":"moxifloxacin","related_medicines":"","procedure_number":"PSUSA/00002094/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002094-201605"},{"category":"","active_substances_in_scope_of_procedure":"Mycophenolic acid (apart from mycophenolate mofetil)","active_substance":"mycophenolic acid","related_medicines":"","procedure_number":"PSUSA/00010243/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010243-201510"},{"category":"","active_substances_in_scope_of_procedure":"Mycophenolic acid (apart from mycophenolate mofetil)","active_substance":"mycophenolic acid","related_medicines":"","procedure_number":"PSUSA/00010243/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010243-201605"},{"category":"","active_substances_in_scope_of_procedure":"N(2)-L-alanyl-L-glutamine","active_substance":"N(2)-L-alanyl-L-glutamine","related_medicines":"","procedure_number":"PSUSA/00003158/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003158-202103"},{"category":"","active_substances_in_scope_of_procedure":"N(2)-L-alanyl-L-glutamine","active_substance":"N(2)-L-alanyl-L-glutamine","related_medicines":"","procedure_number":"PSUSA/00003158/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003158-201603"},{"category":"","active_substances_in_scope_of_procedure":"Nabumetone","active_substance":"nabumetone","related_medicines":"","procedure_number":"PSUSA/00002101/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002101-201703"},{"category":"","active_substances_in_scope_of_procedure":"Nadifloxacin","active_substance":"nadifloxacin","related_medicines":"","procedure_number":"PSUSA/00002102/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002102-202105"},{"category":"","active_substances_in_scope_of_procedure":"Nadroparin","active_substance":"nadroparin","related_medicines":"","procedure_number":"PSUSA/00002104/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002104-201503"},{"category":"","active_substances_in_scope_of_procedure":"Nafarelin","active_substance":"nafarelin","related_medicines":"","procedure_number":"PSUSA/00002105/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002105-201502"},{"category":"","active_substances_in_scope_of_procedure":"Nafarelin","active_substance":"nafarelin","related_medicines":"","procedure_number":"PSUSA/00002105/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002105-201802"},{"category":"","active_substances_in_scope_of_procedure":"Naltrexone","active_substance":"naltrexone","related_medicines":"","procedure_number":"PSUSA/00002117/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002117-201511"},{"category":"","active_substances_in_scope_of_procedure":"Naltrexone","active_substance":"naltrexone","related_medicines":"","procedure_number":"PSUSA/00002117/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002117-201811"},{"category":"","active_substances_in_scope_of_procedure":"Naratriptan","active_substance":"naratriptan","related_medicines":"","procedure_number":"PSUSA/00002126/201702","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002126-201702"},{"category":"","active_substances_in_scope_of_procedure":"Naproxen","active_substance":"naproxen","related_medicines":"","procedure_number":"PSUSA/00002125/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002125-202008"},{"category":"","active_substances_in_scope_of_procedure":"Nebivolol","active_substance":"nebivolol","related_medicines":"","procedure_number":"PSUSA/00002129/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002129-201803"},{"category":"","active_substances_in_scope_of_procedure":"Nicardipine","active_substance":"nicardipine","related_medicines":"","procedure_number":"PSUSA/00002149/201605","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002149-201605"},{"category":"","active_substances_in_scope_of_procedure":"Nefopam","active_substance":"nefopam","related_medicines":"","procedure_number":"PSUSA/00002131/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002131-201903"},{"category":"","active_substances_in_scope_of_procedure":"Nifedipine","active_substance":"nifedipine","related_medicines":"","procedure_number":"PSUSA/00002156/201508","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002156-201508"},{"category":"","active_substances_in_scope_of_procedure":"Nifuroxazide","active_substance":"nifuroxazide","related_medicines":"","procedure_number":"PSUSA/00002160/202108","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002160-202108"},{"category":"","active_substances_in_scope_of_procedure":"Nifuroxazide","active_substance":"nifuroxazide","related_medicines":"","procedure_number":"PSUSA/00002160/201908","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002160-201908"},{"category":"","active_substances_in_scope_of_procedure":"Nicergoline","active_substance":"nicergoline","related_medicines":"","procedure_number":"PSUSA/00002150/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002150-202005"},{"category":"","active_substances_in_scope_of_procedure":"Nicergoline","active_substance":"nicergoline","related_medicines":"","procedure_number":"PSUSA/00002150/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002150-201505"},{"category":"","active_substances_in_scope_of_procedure":"Niclosamide","active_substance":"niclosamide","related_medicines":"","procedure_number":"PSUSA/00002151/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002151-202008"},{"category":"","active_substances_in_scope_of_procedure":"Nicorandil","active_substance":"nicorandil","related_medicines":"","procedure_number":"PSUSA-00002152-201902","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002152-201902"},{"category":"","active_substances_in_scope_of_procedure":"Nicorandil","active_substance":"nicorandil","related_medicines":"","procedure_number":"PSUSA/00002152/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002152-201602"},{"category":"","active_substances_in_scope_of_procedure":"Lorazepam","active_substance":"lorazepam","related_medicines":"","procedure_number":"PSUSA/00001909/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-202201"},{"category":"","active_substances_in_scope_of_procedure":"Nifedipine","active_substance":"nifedipine","related_medicines":"","procedure_number":"PSUSA/00002156/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002156-202008"},{"category":"","active_substances_in_scope_of_procedure":"Niflumic acid","active_substance":"niflumic acid","related_medicines":"","procedure_number":"PSUSA/00002157/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002157-201812"},{"category":"","active_substances_in_scope_of_procedure":"Niflumic","active_substance":"niflumic","related_medicines":"","procedure_number":"PSUSA/00002157/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002157-201512"},{"category":"","active_substances_in_scope_of_procedure":"Donepezil","active_substance":"donepezil","related_medicines":"","procedure_number":"PSUSA/00001160/202111","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001160-202111"},{"category":"","active_substances_in_scope_of_procedure":"Acetylsalicylic acid","active_substance":"acetylsalicylic acid","related_medicines":"","procedure_number":"PSUSA/00000039/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000039-202202"},{"category":"","active_substances_in_scope_of_procedure":"Nilutamide","active_substance":"nilutamide","related_medicines":"","procedure_number":"PSUSA/00002163/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002163-201807"},{"category":"","active_substances_in_scope_of_procedure":"Nimesulide (systemic formulations)","active_substance":"nimesulide","related_medicines":"","procedure_number":"PSUSA/00009236/202106","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009236-202106"},{"category":"","active_substances_in_scope_of_procedure":"Nimesulide (systemic formulations)","active_substance":"nimesulide","related_medicines":"","procedure_number":"PSUSA/00009236/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009236-201506"},{"category":"Human","active_substances_in_scope_of_procedure":"Nimesulide (systemic formulations)","active_substance":"nimesulide","related_medicines":"","procedure_number":"PSUSA/00009236/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009236-201806"},{"category":"","active_substances_in_scope_of_procedure":"Nimesulide (topical formulations)","active_substance":"nimesulide","related_medicines":"","procedure_number":"PSUSA/00002165/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002165-201506"},{"category":"","active_substances_in_scope_of_procedure":"","active_substance":"nitrofurantoin;nifurtoinol","related_medicines":"","procedure_number":"PSUSA/00002174/201802","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002174-201802"},{"category":"","active_substances_in_scope_of_procedure":"Nitrous oxide, nitrous oxide / oxygen","active_substance":"nitrous oxide;oxygen","related_medicines":"","procedure_number":"PSUSA/00010572/201706","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010572-201706"},{"category":"","active_substances_in_scope_of_procedure":"Nitrous oxide, nitrous oxide / oxygen","active_substance":"nitrous oxide;oxygen","related_medicines":"","procedure_number":"PSUSA/00010572/201806","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010572-201806"},{"category":"","active_substances_in_scope_of_procedure":"Nomegestrol","active_substance":"nomegestrol","related_medicines":"","procedure_number":"PSUSA/00002181/201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002181-201801"},{"category":"","active_substances_in_scope_of_procedure":"Nomegestrol","active_substance":"nomegestrol","related_medicines":"","procedure_number":"PSUSA/00002181/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002181-201501"},{"category":"","active_substances_in_scope_of_procedure":"Lisdexamfetamine","active_substance":"lisdexamfetamine","related_medicines":"","procedure_number":"PSUSA/00010289/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202202"},{"category":"","active_substances_in_scope_of_procedure":"Nimodipine","active_substance":"nimodipine","related_medicines":"","procedure_number":"PSUSA/00002166/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002166-201811"},{"category":"","active_substances_in_scope_of_procedure":"Nitrazepam","active_substance":"nitrazepam","related_medicines":"","procedure_number":"PSUSA/00002170/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002170-201503"},{"category":"","active_substances_in_scope_of_procedure":"Nitrazepam","active_substance":"nitrazepam","related_medicines":"","procedure_number":"PSUSA/00002170/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002170-201803"},{"category":"","active_substances_in_scope_of_procedure":"Nitrendipine","active_substance":"nitrendipine","related_medicines":"","procedure_number":"PSUSA/00002171/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002171-202103"},{"category":"","active_substances_in_scope_of_procedure":"Nitrendipine","active_substance":"nitrendipine","related_medicines":"","procedure_number":"PSUSA/00002171/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002171-201503"},{"category":"","active_substances_in_scope_of_procedure":"Nitrendipine","active_substance":"nitrendipine","related_medicines":"","procedure_number":"PSUSA/00002171/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002171-201803"},{"category":"","active_substances_in_scope_of_procedure":"Nitrofurantoin / nifurtoinol","active_substance":"nitrofurantoin;nifurtoinol","related_medicines":"","procedure_number":"PSUSA/00002174/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002174-201502"},{"category":"","active_substances_in_scope_of_procedure":"Nitrofurantoin, nifurtoinol","active_substance":"nitrofurantoin;nifurtoinol","related_medicines":"","procedure_number":"PSUSA/00002174/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002174-202102"},{"category":"","active_substances_in_scope_of_procedure":"Nitrous oxide, nitrous oxide / oxygen","active_substance":"nitrous oxide;oxygen","related_medicines":"","procedure_number":"PSUSA/00010572/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010572-202006"},{"category":"","active_substances_in_scope_of_procedure":"Nomegestrol","active_substance":"nomegestrol","related_medicines":"","procedure_number":"PSUSA/00002181/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002181-202101"},{"category":"","active_substances_in_scope_of_procedure":"Norethisterone","active_substance":"norethisterone","related_medicines":"","procedure_number":"PSUSA/00002188/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002188-201708"},{"category":"","active_substances_in_scope_of_procedure":"Nortriptyline","active_substance":"nortriptyline","related_medicines":"","procedure_number":"PSUSA/00002192/201803","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002192-201803"},{"category":"","active_substances_in_scope_of_procedure":"Numeta","active_substance":"alanine;arginine;aspartic acid;cysteine;glucose;glutamic acid;glycine;histidine;isoleucine;leucine;lysine monohydrate;methionine;ornithine hydrochloride;phenylalanine;proline;serine;taurine;threonine;tryptophan;tyrosine;valine;calcium chloride;magnesium acetate;potassium acetate;sodium chloride;sodium glycerophosphate;olive oil;soya bean oil","related_medicines":"","procedure_number":"EMEA/H/N/PSR/S/0017","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0017"},{"category":"","active_substances_in_scope_of_procedure":"Octenidine dihydrochloride / phenoxyethanol","active_substance":"phenoxyethanol;octenidine dihydrochloride","related_medicines":"","procedure_number":"PSUSA/00002199/201701","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002199-201701"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / atorvastatin","active_substance":"amlodipine;atorvastatin","related_medicines":"","procedure_number":"PSUSA/00000177/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000177-202201"},{"category":"","active_substances_in_scope_of_procedure":"Moxonidine","active_substance":"moxonidine","related_medicines":"","procedure_number":"PSUSA/00002095/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002095-202201"},{"category":"","active_substances_in_scope_of_procedure":"Ketoprofen (all formulations except topical)","active_substance":"ketoprofen","related_medicines":"","procedure_number":"PSUSA/00001809/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001809-202201"},{"category":"","active_substances_in_scope_of_procedure":"Glipizide","active_substance":"glipizide","related_medicines":"","procedure_number":"PSUSA/00001535/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001535-202201"},{"category":"","active_substances_in_scope_of_procedure":"Octenidine dihydrochloride 1-propanol 2-propanol","active_substance":"octenidine dihydrochloride;1-propanol;2-propanol","related_medicines":"","procedure_number":"PSUSA/00010417/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010417-201901"},{"category":"","active_substances_in_scope_of_procedure":"Octenidine","active_substance":"octenidine","related_medicines":"","procedure_number":"PSUSA/00010748/201907","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010748-201907"},{"category":"Human","active_substances_in_scope_of_procedure":"octenidine","active_substance":"octenidine","related_medicines":"","procedure_number":"PSUSA/00010748/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010748-202007"},{"category":"","active_substances_in_scope_of_procedure":"Octreotide","active_substance":"octreotide","related_medicines":"","procedure_number":"PSUSA/00002201/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002201-201706"},{"category":"","active_substances_in_scope_of_procedure":"Octreotide","active_substance":"octreotide","related_medicines":"","procedure_number":"PSUSA/00002201/202006","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002201-202006"},{"category":"Human","active_substances_in_scope_of_procedure":"Ofloxacin (systemic use)","active_substance":"ofloxacin","related_medicines":"","procedure_number":"PSUSA/00002203/202104","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-202104"},{"category":"","active_substances_in_scope_of_procedure":"Ofloxacin (systemic use)","active_substance":"ofloxacin","related_medicines":"","procedure_number":"PSUSA/00002203/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-201504"},{"category":"","active_substances_in_scope_of_procedure":"Ofloxacin (systemic use)","active_substance":"ofloxacin","related_medicines":"","procedure_number":"PSUSA/00002203/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-201804"},{"category":"","active_substances_in_scope_of_procedure":"Ofloxacin (topical use)","active_substance":"ofloxacin","related_medicines":"","procedure_number":"PSUSA/00002204/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002204-201504"},{"category":"Human","active_substances_in_scope_of_procedure":"Ofloxacin (topical use)","active_substance":"ofloxacin","related_medicines":"","procedure_number":"PSUSA/00002204/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002204-201804"},{"category":"","active_substances_in_scope_of_procedure":"Olmesartan","active_substance":"olmesartan","related_medicines":"","procedure_number":"PSUSA/00002207/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002207-202110"},{"category":"","active_substances_in_scope_of_procedure":"Olmesartan","active_substance":"olmesartan","related_medicines":"","procedure_number":"PSUSA/00002207/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002207-201610"},{"category":"","active_substances_in_scope_of_procedure":"","active_substance":"olodaterol;tiotropium","related_medicines":"","procedure_number":"PSUSA/00010489/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010489-201705"},{"category":"","active_substances_in_scope_of_procedure":"Olodaterol / tiotropium","active_substance":"olodaterol;tiotropium","related_medicines":"","procedure_number":"PSUSA/00010489/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010489-201805"},{"category":"","active_substances_in_scope_of_procedure":"Olodaterol","active_substance":"olodaterol","related_medicines":"","procedure_number":"PSUSA/00010245/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-202103"},{"category":"","active_substances_in_scope_of_procedure":"Olodaterol/tiotropium","active_substance":"olodaterol;tiotropium","related_medicines":"","procedure_number":"PSUSA/00010489/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010489-202105"},{"category":"","active_substances_in_scope_of_procedure":"Olodaterol","active_substance":"olodaterol","related_medicines":"","procedure_number":"PSUSA/00010245/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201509"},{"category":"","active_substances_in_scope_of_procedure":"Omega-3-acid-ethyl esters","active_substance":"omega-3-acid-ethyl esters","related_medicines":"","procedure_number":"PSUSA/00010312/201701","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010312-201701"},{"category":"","active_substances_in_scope_of_procedure":"Omeprazole","active_substance":"omeprazole","related_medicines":"","procedure_number":"PSUSA/00002215/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002215-201704"},{"category":"","active_substances_in_scope_of_procedure":"Opium","active_substance":"opium","related_medicines":"","procedure_number":"PSUSA/00010670/202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-202109"},{"category":"","active_substances_in_scope_of_procedure":"Opium","active_substance":"opium","related_medicines":"","procedure_number":"PSUSA/00010670/201909","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-201909"},{"category":"","active_substances_in_scope_of_procedure":"Opium","active_substance":"opium","related_medicines":"","procedure_number":"PSUSA/00010670/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-201808"},{"category":"","active_substances_in_scope_of_procedure":"Ondansetron","active_substance":"ondansetron","related_medicines":"","procedure_number":"PSUSA/00002217/202102","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002217-202102"},{"category":"","active_substances_in_scope_of_procedure":"Ondansetron","active_substance":"ondansetron","related_medicines":"","procedure_number":"PSUSA/00002217/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002217-201802"},{"category":"","active_substances_in_scope_of_procedure":"Ondansetron","active_substance":"ondansetron","related_medicines":"","procedure_number":"PSUSA/00002217/201502","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002217-201502"},{"category":"","active_substances_in_scope_of_procedure":"Omega-3-acid ethyl esters","active_substance":"omega-3-acid-ethyl esters","related_medicines":"","procedure_number":"PSUSA/00010312/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010312-202001"},{"category":"","active_substances_in_scope_of_procedure":"Olodaterol","active_substance":"olodaterol","related_medicines":"","procedure_number":"PSUSA/00010245/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201503"},{"category":"","active_substances_in_scope_of_procedure":"Olodaterol","active_substance":"olodaterol","related_medicines":"","procedure_number":"PSUSA/00010245/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201603"},{"category":"","active_substances_in_scope_of_procedure":"Olodaterol","active_substance":"olodaterol","related_medicines":"","procedure_number":"PSUSA/00010245/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201703"},{"category":"","active_substances_in_scope_of_procedure":"Olodaterol","active_substance":"olodaterol","related_medicines":"","procedure_number":"PSUSA/00010245/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201803"},{"category":"","active_substances_in_scope_of_procedure":"Olsalazine","active_substance":"olsalazine","related_medicines":"","procedure_number":"PSUSA/00002213/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002213-201705"},{"category":"","active_substances_in_scope_of_procedure":"Opium","active_substance":"opium","related_medicines":"","procedure_number":"PSUSA/00010670/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-202009"},{"category":"","active_substances_in_scope_of_procedure":"Oxcarbazepine","active_substance":"oxcarbazepine","related_medicines":"","procedure_number":"PSUSA/00002235/202108","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-202108"},{"category":"","active_substances_in_scope_of_procedure":"Labetalol","active_substance":"labetalol","related_medicines":"","procedure_number":"PSUSA/00001814/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001814-202002"},{"category":"","active_substances_in_scope_of_procedure":"Lacidipine","active_substance":"lacidipine","related_medicines":"","procedure_number":"PSUSA/00001815/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001815-202110"},{"category":"","active_substances_in_scope_of_procedure":"Lacidipine","active_substance":"lacidipine","related_medicines":"","procedure_number":"PSUSA/00001815/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001815-201610"},{"category":"","active_substances_in_scope_of_procedure":"Lactitol","active_substance":"lactitol","related_medicines":"","procedure_number":"PSUSA/00001819/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001819-201509"},{"category":"","active_substances_in_scope_of_procedure":"Oxcarbazepine","active_substance":"oxcarbazepine","related_medicines":"","procedure_number":"PSUSA/00002235/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-202008"},{"category":"","active_substances_in_scope_of_procedure":"Oxcarbazepine","active_substance":"oxcarbazepine","related_medicines":"","procedure_number":"PSUSA/00002235/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-201608"},{"category":"","active_substances_in_scope_of_procedure":"Oxatomide","active_substance":"oxatomide","related_medicines":"","procedure_number":"PSUSA/00002233/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002233-201701"},{"category":"","active_substances_in_scope_of_procedure":"Lactulose","active_substance":"lactulose","related_medicines":"","procedure_number":"PSUSA/00001821/202105","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001821-202105"},{"category":"","active_substances_in_scope_of_procedure":"Lactulose","active_substance":"lactulose","related_medicines":"","procedure_number":"PSUSA/00001821/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001821-201605"},{"category":"","active_substances_in_scope_of_procedure":"Lamotrigine","active_substance":"lamotrigine","related_medicines":"","procedure_number":"PSUSA/00001825/201711","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001825-201711"},{"category":"","active_substances_in_scope_of_procedure":"Oxaliplatin","active_substance":"oxaliplatin","related_medicines":"","procedure_number":"PSUSA/00002229/201804","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002229-201804"},{"category":"","active_substances_in_scope_of_procedure":"Oxaliplatin","active_substance":"oxaliplatin","related_medicines":"","procedure_number":"PSUSA/00002229/201504","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002229-201504"},{"category":"","active_substances_in_scope_of_procedure":"Landiolol","active_substance":"landiolol","related_medicines":"","procedure_number":"PSUSA/00010570/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-201708"},{"category":"","active_substances_in_scope_of_procedure":"Landiolol","active_substance":"landiolol","related_medicines":"","procedure_number":"PSUSA/00010570/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-201802"},{"category":"","active_substances_in_scope_of_procedure":"Landiolol","active_substance":"landiolol","related_medicines":"","procedure_number":"PSUSA/00010570/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-201808"},{"category":"","active_substances_in_scope_of_procedure":"Landiolol","active_substance":"landiolol","related_medicines":"","procedure_number":"PSUSA/00010570/201902","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-201902"},{"category":"","active_substances_in_scope_of_procedure":"Landiolol","active_substance":"landiolol","related_medicines":"","procedure_number":"PSUSA/00010570/202002","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-202002"},{"category":"","active_substances_in_scope_of_procedure":"Lanreotide","active_substance":"lanreotide","related_medicines":"","procedure_number":"PSUSA/00001826/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-202105"},{"category":"","active_substances_in_scope_of_procedure":"Lanreotide","active_substance":"lanreotide","related_medicines":"","procedure_number":"PSUSA/00001826/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-201705"},{"category":"","active_substances_in_scope_of_procedure":"Lanreotide","active_substance":"lanreotide","related_medicines":"","procedure_number":"PSUSA/00001826/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-202005"},{"category":"","active_substances_in_scope_of_procedure":"Lanthanum","active_substance":"lanthanum","related_medicines":"","procedure_number":"PSUSA/00003175/202103","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003175-202103"},{"category":"","active_substances_in_scope_of_procedure":"Oxaliplatin","active_substance":"oxaliplatin","related_medicines":"","procedure_number":"PSUSA/00002229/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002229-202104"},{"category":"","active_substances_in_scope_of_procedure":"Lanthanum","active_substance":"lanthanum","related_medicines":"","procedure_number":"PSUSA/00003175/201703","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003175-201703"},{"category":"","active_substances_in_scope_of_procedure":"Oxcarbazepinexcarbazepine","active_substance":"oxcarbazepine","related_medicines":"","procedure_number":"PSUSA/00002235/201908","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-201908"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost (except for products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001832/202104","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001832-202104"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost (except for products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001832/201604","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001832-201604"},{"category":"","active_substances_in_scope_of_procedure":"Oxycodone","active_substance":"oxycodone","related_medicines":"","procedure_number":"PSUSA/00002254/202104","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-202104"},{"category":"","active_substances_in_scope_of_procedure":"Oxycodone","active_substance":"oxycodone","related_medicines":"","procedure_number":"PSUSA/00002254/201804","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-201804"},{"category":"","active_substances_in_scope_of_procedure":"Oxymetazoline","active_substance":"oxymetazoline","related_medicines":"","procedure_number":"PSUSA/00002258/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002258-202008"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost (products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001834/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201704"},{"category":"","active_substances_in_scope_of_procedure":"Oxytocin","active_substance":"Oxytocin","related_medicines":"","procedure_number":"PSUSA/00002263/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002263-202006"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost (products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001834/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201504"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost (products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001834/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201510"},{"category":"","active_substances_in_scope_of_procedure":"Oxytocin","active_substance":"Oxytocin","related_medicines":"","procedure_number":"PSUSA/00002263/201706","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002263-201706"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost (products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001834/201604","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201604"},{"category":"","active_substances_in_scope_of_procedure":"Ozenoxacin","active_substance":"Ozenoxacin","related_medicines":"","procedure_number":"PSUSA/00010651/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-202105"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost (products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001834/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201610"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost (products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001834/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201710"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost (products with paediatric indication)","active_substance":"Latanoprost","related_medicines":"","procedure_number":"PSUSA/00001834/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201804"},{"category":"","active_substances_in_scope_of_procedure":"Latanoprost / timolol","active_substance":"Latanoprost;timolol","related_medicines":"","procedure_number":"PSUSA/00001833/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001833-201706"},{"category":"","active_substances_in_scope_of_procedure":"Ozenoxacin","active_substance":"Ozenoxacin","related_medicines":"","procedure_number":"PSUSA/00010651/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-201805"},{"category":"","active_substances_in_scope_of_procedure":"Ozenoxacin","active_substance":"Ozenoxacin","related_medicines":"","procedure_number":"PSUSA/00010651/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-201905"},{"category":"","active_substances_in_scope_of_procedure":"Ozenoxacin","active_substance":"Ozenoxacin","related_medicines":"","procedure_number":"PSUSA/00010651/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-201911"},{"category":"","active_substances_in_scope_of_procedure":"Ozenoxacin","active_substance":"Ozenoxacin","related_medicines":"","procedure_number":"PSUSA/00010651/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-202005"},{"category":"","active_substances_in_scope_of_procedure":"Paclitaxel","active_substance":"paclitaxel","related_medicines":"","procedure_number":"PSUSA/00002264/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002264-201512"},{"category":"","active_substances_in_scope_of_procedure":"Pamidronate","active_substance":"pamidronate","related_medicines":"","procedure_number":"PSUSA/00002269/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002269-202105"},{"category":"","active_substances_in_scope_of_procedure":"Pamidronate","active_substance":"pamidronate","related_medicines":"","procedure_number":"PSUSA/00002269/201505","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002269-201505"},{"category":"","active_substances_in_scope_of_procedure":"Pamidronate","active_substance":"pamidronate","related_medicines":"","procedure_number":"PSUSA/00002269/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002269-201805"},{"category":"","active_substances_in_scope_of_procedure":"Pancuronium","active_substance":"pancuronium","related_medicines":"","procedure_number":"PSUSA/00002275/201912","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002275-201912"},{"category":"","active_substances_in_scope_of_procedure":"Paracetamol (IV formulation)","active_substance":"paracetamol (IV formulation)","related_medicines":"","procedure_number":"PSUSA/00002311/202105","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-202105"},{"category":"","active_substances_in_scope_of_procedure":"Quetiapine","active_substance":"quetiapine","related_medicines":"","procedure_number":"PSUSA/00002589/201707","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002589-201707"},{"category":"","active_substances_in_scope_of_procedure":"Quetiapine","active_substance":"quetiapine","related_medicines":"","procedure_number":"PSUSA/00002589/202006","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002589-202006"},{"category":"","active_substances_in_scope_of_procedure":"Quinagolide","active_substance":"quinagolide","related_medicines":"","procedure_number":"PSUSA/00002590/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002590-201707"},{"category":"","active_substances_in_scope_of_procedure":"Quinapril","active_substance":"quinapril","related_medicines":"","procedure_number":"PSUSA/00002591/202104","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002591-202104"},{"category":"","active_substances_in_scope_of_procedure":"Quinapril","active_substance":"quinapril","related_medicines":"","procedure_number":"PSUSA/00002591/201604","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002591-201604"},{"category":"","active_substances_in_scope_of_procedure":"Quinine","active_substance":"quinine","related_medicines":"","procedure_number":"PSUSA/00002598/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002598-202111"},{"category":"","active_substances_in_scope_of_procedure":"Quinine","active_substance":"quinine","related_medicines":"","procedure_number":"PSUSA/00002598/201611","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002598-201611"},{"category":"","active_substances_in_scope_of_procedure":"Rabbit anti-human thymocyte (powder for solution for infusion)","active_substance":"rabbit anti-human thymocyte","related_medicines":"","procedure_number":"PSUSA/00010184/201412","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010184-201412"},{"category":"","active_substances_in_scope_of_procedure":"Rabbit anti-human thymocyte (powder for solution for infusion)","active_substance":"rabbit anti-human thymocyte","related_medicines":"","procedure_number":"PSUSA/00010184/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010184-201506"},{"category":"","active_substances_in_scope_of_procedure":"Rabbit anti-human T-lymphocyte immunoglobulin","active_substance":"rabbit anti-humanT-lymphocyte immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00010252/201806","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010252-201806"},{"category":"","active_substances_in_scope_of_procedure":"Rabbit anti-human T-lymphocyte immunoglobulin","active_substance":"rabbit anti-humanT-lymphocyte immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00010252/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010252-202106"},{"category":"","active_substances_in_scope_of_procedure":"Rabeprazole","active_substance":"rabeprazole","related_medicines":"","procedure_number":"PSUSA/00002601/202110","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002601-202110"},{"category":"","active_substances_in_scope_of_procedure":"Rabeprazole","active_substance":"rabeprazole","related_medicines":"","procedure_number":"PSUSA/00002601/201610","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002601-201610"},{"category":"","active_substances_in_scope_of_procedure":"Rabeprazole","active_substance":"rabeprazole","related_medicines":"","procedure_number":"PSUSA/00002601/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002601-201510"},{"category":"","active_substances_in_scope_of_procedure":"Rabies vaccine","active_substance":"rabies vaccine","related_medicines":"","procedure_number":"PSUSA/00009277/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009277-202103"},{"category":"","active_substances_in_scope_of_procedure":"Rabies vaccine","active_substance":"rabies vaccine","related_medicines":"","procedure_number":"PSUSA/00009277/201603","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009277-201603"},{"category":"","active_substances_in_scope_of_procedure":"Racecadotril","active_substance":"racecadotril","related_medicines":"","procedure_number":"PSUSA/00002602/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002602-202003"},{"category":"","active_substances_in_scope_of_procedure":"Racecadotril","active_substance":"racecadotril","related_medicines":"","procedure_number":"PSUSA/00002602/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002602-201703"},{"category":"","active_substances_in_scope_of_procedure":"Ranitidine","active_substance":"ranitidine","related_medicines":"","procedure_number":"PSUSA/00002610/202105","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002610-202105"},{"category":"","active_substances_in_scope_of_procedure":"Ranitidine","active_substance":"ranitidine","related_medicines":"","procedure_number":"PSUSA/00002610/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002610-201505"},{"category":"","active_substances_in_scope_of_procedure":"Ranitidine","active_substance":"ranitidine","related_medicines":"","procedure_number":"PSUSA/00002610/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002610-201805"},{"category":"","active_substances_in_scope_of_procedure":"Reboxetine","active_substance":"reboxetine","related_medicines":"","procedure_number":"PSUSA/00002615/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002615-202004"},{"category":"","active_substances_in_scope_of_procedure":"Reboxetine","active_substance":"reboxetine","related_medicines":"","procedure_number":"PSUSA/00002615/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002615-201504"},{"category":"","active_substances_in_scope_of_procedure":"Reviparin","active_substance":"reviparin","related_medicines":"","procedure_number":"PSUSA/00002634/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002634-201501"},{"category":"","active_substances_in_scope_of_procedure":"Ribavirin (aerosol application)","active_substance":"ribavirin","related_medicines":"","procedure_number":"PSUSA/00010003/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010003-201508"},{"category":"","active_substances_in_scope_of_procedure":"Rilmenidine","active_substance":"rilmenidine","related_medicines":"","procedure_number":"PSUSA/00002643/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002643-202108"},{"category":"","active_substances_in_scope_of_procedure":"Rilmenidine","active_substance":"rilmenidine","related_medicines":"","procedure_number":"PSUSA/00002643/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002643-201808"},{"category":"","active_substances_in_scope_of_procedure":"Rilmenidine","active_substance":"rilmenidine","related_medicines":"","procedure_number":"PSUSA/00002643/201508","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002643-201508"},{"category":"","active_substances_in_scope_of_procedure":"Rimexolone","active_substance":"rimexolone","related_medicines":"","procedure_number":"PSUSA/00002647/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002647-201510"},{"category":"","active_substances_in_scope_of_procedure":"Risedronate","active_substance":"risedronate","related_medicines":"","procedure_number":"PSUSA/00002648/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002648-202103"},{"category":"","active_substances_in_scope_of_procedure":"Risedronate","active_substance":"risedronate","related_medicines":"","procedure_number":"PSUSA/00002648/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002648-201603"},{"category":"","active_substances_in_scope_of_procedure":"Risperidone","active_substance":"risperidone","related_medicines":"","procedure_number":"PSUSA/00002649/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002649-201705"},{"category":"","active_substances_in_scope_of_procedure":"Rizatriptan","active_substance":"rizatriptan","related_medicines":"","procedure_number":"PSUSA/00002655/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002655-201806"},{"category":"","active_substances_in_scope_of_procedure":"Rocuronium","active_substance":"rocuronium","related_medicines":"","procedure_number":"PSUSA/00002656/201902","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002656-201902"},{"category":"","active_substances_in_scope_of_procedure":"Rocuronium","active_substance":"rocuronium","related_medicines":"","procedure_number":"PSUSA/00002656/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002656-201602"},{"category":"","active_substances_in_scope_of_procedure":"Ropinirole","active_substance":"ropinirole","related_medicines":"","procedure_number":"PSUSA/00002661/201607","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002661-201607"},{"category":"","active_substances_in_scope_of_procedure":"Ropinirole","active_substance":"ropinirole","related_medicines":"","procedure_number":"PSUSA/00002661/201907","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002661-201907"},{"category":"","active_substances_in_scope_of_procedure":"Ropivacaine","active_substance":"ropivacaine","related_medicines":"","procedure_number":"PSUSA/00002662/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002662-201709"},{"category":"","active_substances_in_scope_of_procedure":"Rosuvastatin","active_substance":"rosuvastatin","related_medicines":"","procedure_number":"PSUSA/00002664/201711","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002664-201711"},{"category":"","active_substances_in_scope_of_procedure":"Roxithromycin","active_substance":"roxithromycin","related_medicines":"","procedure_number":"PSUSA/00002669/201612","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-201612"},{"category":"","active_substances_in_scope_of_procedure":"Roxithromycin","active_substance":"roxithromycin","related_medicines":"","procedure_number":"PSUSA/00002669/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-201412"},{"category":"","active_substances_in_scope_of_procedure":"Roxithromycin","active_substance":"roxithromycin","related_medicines":"","procedure_number":"PSUSA/00002669/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-201812"},{"category":"","active_substances_in_scope_of_procedure":"Rubella vaccine (live, attenuated)","active_substance":"rubella vaccine","related_medicines":"","procedure_number":"PSUSA/00002670/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002670-201501"},{"category":"","active_substances_in_scope_of_procedure":"Rubidium chloride RB-82","active_substance":"rubidium (82Rb) chloride","related_medicines":"","procedure_number":"PSUSA/00010806/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010806-202010"},{"category":"","active_substances_in_scope_of_procedure":"Rubidium chloride RB-82","active_substance":"rubidium (82Rb) chloride","related_medicines":"","procedure_number":"PSUSA/00010806/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010806-202110"},{"category":"","active_substances_in_scope_of_procedure":"Rupatadine","active_substance":"rupatadine","related_medicines":"","procedure_number":"PSUSA/00002673/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-202012"},{"category":"","active_substances_in_scope_of_procedure":"Rupatadine","active_substance":"rupatadine","related_medicines":"","procedure_number":"PSUSA/00002673/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-201712"},{"category":"","active_substances_in_scope_of_procedure":"Rupatadine","active_substance":"rupatadine","related_medicines":"","procedure_number":"PSUSA/00002673/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-201506"},{"category":"","active_substances_in_scope_of_procedure":"Rupatadine","active_substance":"rupatadine","related_medicines":"","procedure_number":"PSUSA/00002673/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-201512"},{"category":"","active_substances_in_scope_of_procedure":"Rupatadine","active_substance":"rupatadine","related_medicines":"","procedure_number":"PSUSA/00002673/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-201612"},{"category":"","active_substances_in_scope_of_procedure":"Roxithromycin","active_substance":"roxithromycin","related_medicines":"","procedure_number":"PSUSA/00002669/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-202112"},{"category":"","active_substances_in_scope_of_procedure":"Permethrin","active_substance":"permethrin","related_medicines":"","procedure_number":"PSUSA/00002355/201707","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002355-201707"},{"category":"","active_substances_in_scope_of_procedure":"Permethrin","active_substance":"permethrin","related_medicines":"","procedure_number":"PSUSA/00002355/201808","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002355-201808"},{"category":"","active_substances_in_scope_of_procedure":"Perindopril","active_substance":"perindopril","related_medicines":"","procedure_number":"PSUSA/00002354/201510","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002354-201510"},{"category":"","active_substances_in_scope_of_procedure":"Perindopril","active_substance":"perindopril","related_medicines":"","procedure_number":"PSUSA/00002354/202010","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002354-202010"},{"category":"","active_substances_in_scope_of_procedure":"Pergolide","active_substance":"pergolide","related_medicines":"","procedure_number":"PSUSA/00002351/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002351-201612"},{"category":"","active_substances_in_scope_of_procedure":"Saccharomyces boulardii","active_substance":"saccharomyces boulardii","related_medicines":"","procedure_number":"PSUSA/00009284/202002","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009284-202002"},{"category":"","active_substances_in_scope_of_procedure":"Saccharomyces boulardii","active_substance":"saccharomyces boulardii","related_medicines":"","procedure_number":"PSUSA/00009284/201702","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009284-201702"},{"category":"","active_substances_in_scope_of_procedure":"peppermint oil (63557)","active_substance":"peppermint oil","related_medicines":"","procedure_number":"PSUSA/00010436/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010436-202005"},{"category":"","active_substances_in_scope_of_procedure":"Salmeterol","active_substance":"salmeterol","related_medicines":"","procedure_number":"PSUSA/00002681/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002681-202010"},{"category":"","active_substances_in_scope_of_procedure":"Salmeterol/fluticasone propionate","active_substance":"salmeterol;fluticasone propionate","related_medicines":"","procedure_number":"PSUSA/00001455/201410","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001455-201410"},{"category":"","active_substances_in_scope_of_procedure":"Pentoxyverine","active_substance":"pentoxyverine","related_medicines":"","procedure_number":"PSUSA/00002345/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002345-201812"},{"category":"","active_substances_in_scope_of_procedure":"Salmeterol","active_substance":"salmeterol","related_medicines":"","procedure_number":"PSUSA/00002681/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002681-201510"},{"category":"","active_substances_in_scope_of_procedure":"Pentamidine","active_substance":"pentamidine","related_medicines":"","procedure_number":"PSUSA/00002338/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002338-201706"},{"category":"","active_substances_in_scope_of_procedure":"Penciclovir","active_substance":"penciclovir","related_medicines":"","procedure_number":"PSUSA/00002333/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002333-201608"},{"category":"","active_substances_in_scope_of_procedure":"Sertindole","active_substance":"sertindole","related_medicines":"","procedure_number":"PSUSA/00002695/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201507"},{"category":"","active_substances_in_scope_of_procedure":"Penciclovir","active_substance":"penciclovir","related_medicines":"","procedure_number":"PSUSA/00002333/202108","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002333-202108"},{"category":"","active_substances_in_scope_of_procedure":"Pelargonium sidoides dc and/or pelargonium reniforme curt. / radix","active_substance":"pelargonium sidoides dc;pelargonium reniforme curt. / radix","related_medicines":"","procedure_number":"PSUSA/00002329/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002329-201806"},{"category":"","active_substances_in_scope_of_procedure":"Sertindole","active_substance":"sertindole","related_medicines":"","procedure_number":"PSUSA/00002695/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201601"},{"category":"","active_substances_in_scope_of_procedure":"Sertindole","active_substance":"sertindole","related_medicines":"","procedure_number":"PSUSA/00002695/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201701"},{"category":"","active_substances_in_scope_of_procedure":"Sertindole","active_substance":"sertindole","related_medicines":"","procedure_number":"PSUSA/00002695/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201801"},{"category":"","active_substances_in_scope_of_procedure":"Sertindole","active_substance":"sertindole","related_medicines":"","procedure_number":"PSUSA/00002695/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201901"},{"category":"","active_substances_in_scope_of_procedure":"Sertindole","active_substance":"sertindole","related_medicines":"","procedure_number":"PSUSA/00002695/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-202001"},{"category":"","active_substances_in_scope_of_procedure":"Pefloxacin","active_substance":"pefloxacin","related_medicines":"","procedure_number":"PSUSA/00002322/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002322-202008"},{"category":"","active_substances_in_scope_of_procedure":"Patent blue V sodium","active_substance":"patent blue V sodium","related_medicines":"","procedure_number":"PSUSA/00002320/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002320-201804"},{"category":"","active_substances_in_scope_of_procedure":"Sertraline","active_substance":"sertraline","related_medicines":"","procedure_number":"PSUSA/00002696/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002696-201703"},{"category":"","active_substances_in_scope_of_procedure":"Paroxetine","active_substance":"paroxetine","related_medicines":"","procedure_number":"PSUSA/00002319/201712","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002319-201712"},{"category":"","active_substances_in_scope_of_procedure":"Sevoflurane","active_substance":"sevoflurane","related_medicines":"","procedure_number":"PSUSA/00002698/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002698-201501"},{"category":"","active_substances_in_scope_of_procedure":"Paricalcitol","active_substance":"paricalcitol","related_medicines":"","procedure_number":"PSUSA/00002316/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002316-201608"},{"category":"","active_substances_in_scope_of_procedure":"Sevoflurane","active_substance":"sevoflurane","related_medicines":"","procedure_number":"PSUSA/00002698/202001","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002698-202001"},{"category":"","active_substances_in_scope_of_procedure":"Paricalcitol","active_substance":"paricalcitol","related_medicines":"","procedure_number":"PSUSA/00002316/201908","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002316-201908"},{"category":"","active_substances_in_scope_of_procedure":"Silver sulfadiazine","active_substance":"silver sulfadiazine","related_medicines":"","procedure_number":"PSUSA/00002702/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002702-202009"},{"category":"","active_substances_in_scope_of_procedure":"Simvastatin","active_substance":"simvastatin","related_medicines":"","procedure_number":"PSUSA/00002709/201704","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002709-201704"},{"category":"","active_substances_in_scope_of_procedure":"Simvastatin","active_substance":"simvastatin","related_medicines":"","procedure_number":"PSUSA/00002709/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002709-202004"},{"category":"","active_substances_in_scope_of_procedure":"Paraffin liquid","active_substance":"Paraffin liquid","related_medicines":"","procedure_number":"PSUSA/00009251/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009251-201510"},{"category":"","active_substances_in_scope_of_procedure":"Sodium benzoate / grindelia tincture / polygala syrup","active_substance":"sodium benzoate;grindelia tincture;polygala syrup","related_medicines":"","procedure_number":"PSUSA/00010543/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010543-201912"},{"category":"","active_substances_in_scope_of_procedure":"Sodium iodide (131i)","active_substance":"sodium iodide (131I)","related_medicines":"","procedure_number":"PSUSA/00002753/201703","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002753-201703"},{"category":"","active_substances_in_scope_of_procedure":"Sodium iron gluconate (parenteral preparations)","active_substance":"sodium iron gluconate (parenteral preparations)","related_medicines":"","procedure_number":"PSUSA/00010867/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010867-202101"},{"category":"","active_substances_in_scope_of_procedure":"Sodium oxybate (intravenous use)","active_substance":"sodium oxybate","related_medicines":"","procedure_number":"PSUSA/00010613/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010613-202110"},{"category":"","active_substances_in_scope_of_procedure":"Sodium oxybate (intravenous use)","active_substance":"sodium oxybate","related_medicines":"","procedure_number":"PSUSA/00010613/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010613-201710"},{"category":"","active_substances_in_scope_of_procedure":"Sodium oxybate (intravenous use)","active_substance":"sodium oxybate","related_medicines":"","procedure_number":"PSUSA/00010613/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010613-201810"},{"category":"","active_substances_in_scope_of_procedure":"Sodium tetradecyl sulphate","active_substance":"sodium tetradecyl sulfate","related_medicines":"","procedure_number":"PSUSA/00002767/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002767-201704"},{"category":"","active_substances_in_scope_of_procedure":"Solifenacin / tamsulosin","active_substance":"solifenacin;tamsulosin","related_medicines":"","procedure_number":"PSUSA/00010285/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010285-201807"},{"category":"","active_substances_in_scope_of_procedure":"Paracetamol/pseudoephedrine","active_substance":"paracetamol;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00002307/201806","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002307-201806"},{"category":"","active_substances_in_scope_of_procedure":"Solifenacin-tamsulosin","active_substance":"solifenacin;tamsulosin","related_medicines":"","procedure_number":"PSUSA/00010285/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010285-202107"},{"category":"","active_substances_in_scope_of_procedure":"Solifenacin/tamsulosin","active_substance":"solifenacin;tamsulosin","related_medicines":"","procedure_number":"PSUSA/00010285/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010285-201507"},{"category":"","active_substances_in_scope_of_procedure":"Paracetamol / tramadol","active_substance":"paracetamol;tramadol","related_medicines":"","procedure_number":"PSUSA/00002310/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002310-201808"},{"category":"","active_substances_in_scope_of_procedure":"Paracetamol / tramadol","active_substance":"paracetamol;tramadol","related_medicines":"","procedure_number":"PSUSA/00002310/201508","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002310-201508"},{"category":"","active_substances_in_scope_of_procedure":"Solifenacin","active_substance":"solifenacin","related_medicines":"","procedure_number":"PSUSA/00002769/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002769-201706"},{"category":"","active_substances_in_scope_of_procedure":"Solifenacin","active_substance":"solifenacin","related_medicines":"","procedure_number":"PSUSA/00002769/202006","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002769-202006"},{"category":"","active_substances_in_scope_of_procedure":"Paracetamol (IV formulation)","active_substance":"paracetamol","related_medicines":"","procedure_number":"PSUSA/00002311/201805","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-201805"},{"category":"","active_substances_in_scope_of_procedure":"Sotalol","active_substance":"sotalol","related_medicines":"","procedure_number":"PSUSA/00002774/201908","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002774-201908"},{"category":"","active_substances_in_scope_of_procedure":"Soybean phospholipids (oral use)","active_substance":"soybean phospholipids (oral use)","related_medicines":"","procedure_number":"PSUSA/00010707/202110","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010707-202110"},{"category":"","active_substances_in_scope_of_procedure":"Spironolactone","active_substance":"spironolactone","related_medicines":"","procedure_number":"PSUSA/00002780/201503","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002780-201503"},{"category":"","active_substances_in_scope_of_procedure":"Spironolactone","active_substance":"spironolactone","related_medicines":"","procedure_number":"PSUSA/00002780/202103","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002780-202103"},{"category":"","active_substances_in_scope_of_procedure":"Spironolactone","active_substance":"spironolactone","related_medicines":"","procedure_number":"PSUSA/00002780/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002780-201803"},{"category":"","active_substances_in_scope_of_procedure":"Strontium [89sr] chloride","active_substance":"strontium (89sr) chloride","related_medicines":"","procedure_number":"PSUSA/00002795/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002795-201705"},{"category":"","active_substances_in_scope_of_procedure":"Paracetamol (IV formulation)","active_substance":"paracetamol","related_medicines":"","procedure_number":"PSUSA/00002311/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-201705"},{"category":"","active_substances_in_scope_of_procedure":"Paracetamol (IV formulation)","active_substance":"paracetamol","related_medicines":"","procedure_number":"PSUSA/00002311/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-201605"},{"category":"","active_substances_in_scope_of_procedure":"Paracetamol (IV formulation)","active_substance":"paracetamol","related_medicines":"","procedure_number":"PSUSA/00002311/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-201505"},{"category":"","active_substances_in_scope_of_procedure":"Phenobarbital","active_substance":"phenobarbital","related_medicines":"","procedure_number":"PSUSA/00002370/202001","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002370-202001"},{"category":"","active_substances_in_scope_of_procedure":"Pethidine","active_substance":"pethidine","related_medicines":"","procedure_number":"PSUSA/00002357/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002357-202008"},{"category":"","active_substances_in_scope_of_procedure":"Permethrin","active_substance":"permethrin","related_medicines":"","procedure_number":"PSUSA/00002355/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002355-202008"},{"category":"","active_substances_in_scope_of_procedure":"Phenol","active_substance":"phenol","related_medicines":"","procedure_number":"PSUSA/00009256/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009256-202004"},{"category":"","active_substances_in_scope_of_procedure":"Phenylephrine (ophthalmic formulations)","active_substance":"phenylephrine (ophthalmic formulations)","related_medicines":"","procedure_number":"PSUSA/00010402/202001","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010402-202001"},{"category":"","active_substances_in_scope_of_procedure":"Sulbactam","active_substance":"sulbactam","related_medicines":"","procedure_number":"PSUSA/00002800/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002800-201611"},{"category":"","active_substances_in_scope_of_procedure":"Sulbactam","active_substance":"sulbactam","related_medicines":"","procedure_number":"PSUSA/00002800/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002800-201911"},{"category":"","active_substances_in_scope_of_procedure":"Sulfamethizole","active_substance":"sulfamethizole","related_medicines":"","procedure_number":"PSUSA/00010561/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010561-201706"},{"category":"","active_substances_in_scope_of_procedure":"Sulfametrole / trimethoprim, sulfadiazine / trimethoprim, sulfamethoxazole / trimethoprim (co-trimoxazole)","active_substance":"sulfametrole;trimethoprim;sulfadiazine;sulfamethoxazole","related_medicines":"","procedure_number":"PSUSA/00010593/201903","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010593-201903"},{"category":"","active_substances_in_scope_of_procedure":"Phenylephrine / tropicamide","active_substance":"phenylephrine;tropicamide","related_medicines":"","procedure_number":"PSUSA/00010430/202011","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010430-202011"},{"category":"","active_substances_in_scope_of_procedure":"Sulprostone","active_substance":"sulprostone","related_medicines":"","procedure_number":"PSUSA/00002828/201604","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002828-201604"},{"category":"","active_substances_in_scope_of_procedure":"Sultamicillin","active_substance":"sultamicillin","related_medicines":"","procedure_number":"PSUSA/00002829/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002829-201511"},{"category":"","active_substances_in_scope_of_procedure":"Sultamicillin","active_substance":"sultamicillin","related_medicines":"","procedure_number":"PSUSA/00002829/202011","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002829-202011"},{"category":"","active_substances_in_scope_of_procedure":"Sumatriptan","active_substance":"sumatriptan","related_medicines":"","procedure_number":"PSUSA/00002832/201409","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002832-201409"},{"category":"","active_substances_in_scope_of_procedure":"Sumatriptan","active_substance":"sumatriptan","related_medicines":"","procedure_number":"PSUSA/00002832/201909","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002832-201909"},{"category":"","active_substances_in_scope_of_procedure":"Suxamethonium","active_substance":"suxamethonium","related_medicines":"","procedure_number":"PSUSA/00002834/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002834-201708"},{"category":"","active_substances_in_scope_of_procedure":"Suxamethonium","active_substance":"suxamethonium","related_medicines":"","procedure_number":"PSUSA/00002834/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002834-202008"},{"category":"","active_substances_in_scope_of_procedure":"Urapidil","active_substance":"urapidil","related_medicines":"","procedure_number":"PSUSA/00003078/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003078-202107"},{"category":"","active_substances_in_scope_of_procedure":"Urapidil","active_substance":"urapidil","related_medicines":"","procedure_number":"PSUSA/00003078/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003078-201807"},{"category":"","active_substances_in_scope_of_procedure":"Urapidil","active_substance":"urapidil","related_medicines":"","procedure_number":"PSUSA/00003078/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003078-201507"},{"category":"","active_substances_in_scope_of_procedure":"Urofollitropin","active_substance":"urofollitropin","related_medicines":"","procedure_number":"PSUSA/00003082/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003082-201703"},{"category":"","active_substances_in_scope_of_procedure":"Ursodeoxycholic acid","active_substance":"ursodeoxycholic acid","related_medicines":"","procedure_number":"PSUSA/00003084/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003084-201611"},{"category":"","active_substances_in_scope_of_procedure":"Phenylephrine hydrochloride / tropicamide","active_substance":"tropicamide;phenylephrine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010430/201711","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010430-201711"},{"category":"","active_substances_in_scope_of_procedure":"Yellow fever vaccine (live)","active_substance":"yellow fever vaccine (live)","related_medicines":"","procedure_number":"PSUSA/00003135/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-201812"},{"category":"","active_substances_in_scope_of_procedure":"Yellow fever vaccine (live)","active_substance":"yellow fever vaccine (live)","related_medicines":"","procedure_number":"PSUSA/00003135/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-202012"},{"category":"","active_substances_in_scope_of_procedure":"Yellow fever vaccine (live)","active_substance":"yellow fever vaccine (live)","related_medicines":"","procedure_number":"PSUSA/00003135/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-201612"},{"category":"","active_substances_in_scope_of_procedure":"Zafirlukast","active_substance":"zafirlukast","related_medicines":"","procedure_number":"PSUSA/00003138/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003138-201512"},{"category":"","active_substances_in_scope_of_procedure":"Zaleplon","active_substance":"zaleplon","related_medicines":"","procedure_number":"PSUSA/00003140/201907","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003140-201907"},{"category":"","active_substances_in_scope_of_procedure":"Zanamivir","active_substance":"zanamivir","related_medicines":"","procedure_number":"PSUSA/00003141/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003141-201701"},{"category":"","active_substances_in_scope_of_procedure":"Zidovudine","active_substance":"zidovudine","related_medicines":"","procedure_number":"PSUSA/00003143/202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003143-202109"},{"category":"","active_substances_in_scope_of_procedure":"Zidovudine","active_substance":"zidovudine","related_medicines":"","procedure_number":"PSUSA/00003143/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003143-201703"},{"category":"","active_substances_in_scope_of_procedure":"Ziprasidone","active_substance":"ziprasidone","related_medicines":"","procedure_number":"PSUSA/00003146/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003146-202007"},{"category":"","active_substances_in_scope_of_procedure":"Ziprasidone","active_substance":"ziprasidone","related_medicines":"","procedure_number":"PSUSA/00003146/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003146-201507"},{"category":"","active_substances_in_scope_of_procedure":"Zolmitriptan","active_substance":"zolmitriptan","related_medicines":"","procedure_number":"PSUSA/00003150/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003150-201703"},{"category":"","active_substances_in_scope_of_procedure":"Phenylephrine","active_substance":"phenylephrine","related_medicines":"","procedure_number":"PSUSA/00002378/201501","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002378-201501"},{"category":"","active_substances_in_scope_of_procedure":"Phenylpropanolamine","active_substance":"phenylpropanolamine","related_medicines":"","procedure_number":"PSUSA/00010483/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010483-202106"},{"category":"","active_substances_in_scope_of_procedure":"Phenylpropanolamine","active_substance":"phenylpropanolamine","related_medicines":"","procedure_number":"PSUSA/00010483/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010483-201806"},{"category":"","active_substances_in_scope_of_procedure":"Phenytoin","active_substance":"phenytoin","related_medicines":"","procedure_number":"PSUSA/00002392/202008","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002392-202008"},{"category":"","active_substances_in_scope_of_procedure":"Phloroglucinol, phloroglucinol trimethylphloroglucinol","active_substance":"phloroglucinol;phloroglucinol trimethylphloroglucinol","related_medicines":"","procedure_number":"PSUSA/00010355/201809","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010355-201809"},{"category":"","active_substances_in_scope_of_procedure":"Phloroglucinol, phloroglucinol / trimethylphloroglucinol","active_substance":"phloroglucinol;trimethylphloroglucinol","related_medicines":"","procedure_number":"PSUSA/00010355/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010355-201509"},{"category":"","active_substances_in_scope_of_procedure":"Valaciclovir","active_substance":"valaciclovir","related_medicines":"","procedure_number":"PSUSA/00003086/201512","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003086-201512"},{"category":"","active_substances_in_scope_of_procedure":"Valaciclovir","active_substance":"valaciclovir","related_medicines":"","procedure_number":"PSUSA/00003086/201812","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003086-201812"},{"category":"","active_substances_in_scope_of_procedure":"Valganciclovir","active_substance":"valganciclovir","related_medicines":"","procedure_number":"PSUSA/00003089/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003089-202103"},{"category":"","active_substances_in_scope_of_procedure":"Valganciclovir","active_substance":"valganciclovir","related_medicines":"","procedure_number":"PSUSA/00003089/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003089-201603"},{"category":"","active_substances_in_scope_of_procedure":"Vinorelbine","active_substance":"vinorelbine","related_medicines":"","procedure_number":"PSUSA/00003124/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003124-201704"},{"category":"","active_substances_in_scope_of_procedure":"Vigabatrin","active_substance":"vigabatrin","related_medicines":"","procedure_number":"PSUSA/00003112/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003112-201709"},{"category":"","active_substances_in_scope_of_procedure":"Vigabatrin","active_substance":"vigabatrin","related_medicines":"","procedure_number":"PSUSA/00003112/201409","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003112-201409"},{"category":"","active_substances_in_scope_of_procedure":"Phloroglucinol, phloroglucinol/trimethylphloroglucinol","active_substance":"phloroglucinol;trimethylphloroglucinol","related_medicines":"","procedure_number":"PSUSA/00010355/202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010355-202109"},{"category":"","active_substances_in_scope_of_procedure":"Pholcodine / biclotymol / chlorphenamine maleate","active_substance":"Pholcodine;biclotymol;chlorphenamine maleate","related_medicines":"","procedure_number":"PSUSA/00010437/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010437-202104"},{"category":"","active_substances_in_scope_of_procedure":"Pholcodine / biclotymol / chlorphenamine maleate","active_substance":"Pholcodine;biclotymol;chlorphenamine maleate","related_medicines":"","procedure_number":"PSUSA/00010437/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010437-201804"},{"category":"","active_substances_in_scope_of_procedure":"Pholcodine","active_substance":"Pholcodine","related_medicines":"","procedure_number":"PSUSA/00002396/202105","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002396-202105"},{"category":"","active_substances_in_scope_of_procedure":"Pholcodine","active_substance":"Pholcodine","related_medicines":"","procedure_number":"PSUSA/00002396/201905","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002396-201905"},{"category":"","active_substances_in_scope_of_procedure":"Verapamil","active_substance":"verapamil","related_medicines":"","procedure_number":"PSUSA/00003105/202001","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003105-202001"},{"category":"","active_substances_in_scope_of_procedure":"Venlafaxine","active_substance":"venlafaxine","related_medicines":"","procedure_number":"PSUSA/00003104/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003104-201705"},{"category":"","active_substances_in_scope_of_procedure":"Vecuronium bromide","active_substance":"vecuronium bromide","related_medicines":"","procedure_number":"PSUSA/00003102/202011","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003102-202011"},{"category":"","active_substances_in_scope_of_procedure":"Vecuronium bromide","active_substance":"vecuronium bromide","related_medicines":"","procedure_number":"PSUSA/00003102/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003102-201611"},{"category":"","active_substances_in_scope_of_procedure":"Varicella zoster-immunoglobulin","active_substance":"varicella zoster-immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00010266/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010266-201912"},{"category":"","active_substances_in_scope_of_procedure":"Varicella zoster-immunoglobulin","active_substance":"varicella zoster-immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00010266/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010266-201612"},{"category":"","active_substances_in_scope_of_procedure":"Varicella vaccine (live)","active_substance":"varicella vaccine (live)","related_medicines":"","procedure_number":"PSUSA/00010473/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010473-201903"},{"category":"","active_substances_in_scope_of_procedure":"Vancomycin","active_substance":"vancomycin","related_medicines":"","procedure_number":"PSUSA/00003097/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003097-201501"},{"category":"","active_substances_in_scope_of_procedure":"Vancomycin","active_substance":"vancomycin","related_medicines":"","procedure_number":"PSUSA/00003097/202001","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003097-202001"},{"category":"","active_substances_in_scope_of_procedure":"Valsartan, hydrochlorothiazide / valsartan","active_substance":"valsartan;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00010396/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010396-201704"},{"category":"","active_substances_in_scope_of_procedure":"Valsartan, hydrochlorothiazide / valsartan","active_substance":"valsartan;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00010396/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010396-202004"},{"category":"","active_substances_in_scope_of_procedure":"Valsartan / rosuvastatin","active_substance":"valsartan;rosuvastatin","related_medicines":"","procedure_number":"PSUSA/00010735/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010735-201910"},{"category":"","active_substances_in_scope_of_procedure":"Valproic acid, sodium valproate, valproate pivoxil,  valproate semisodium, valpromide, valproate bismuth, calcium valproate, valproate magnesium","active_substance":"valproic acid;sodium valproate;valproate pivoxil;valproate semisodium;valpromide;valproate bismuth;calcium valproate;valproate magnesium","related_medicines":"","procedure_number":"PSUSA/00003090/201801","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003090-201801"},{"category":"","active_substances_in_scope_of_procedure":"Valproic acid, sodium valproate, valproate pivoxil,  valproate semisodium, valpriomide, valproate bismuth, calcium valproate, valproate magnesium","active_substance":"valproic acid;sodium valproate;valproate pivoxil;valproate semisodium;valpriomide;valproate bismuth;calcium valproate;valproate magnesium","related_medicines":"","procedure_number":"PSUSA/00003090/202101","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003090-202101"},{"category":"","active_substances_in_scope_of_procedure":"Valproic acid/sodium valproate/valproate pivoxil/valproate semisodium/valpromide/valproate bismuth/calcium valproate/valproate magnesium","active_substance":"valproic acid;sodium valproate;valproate pivoxil;valproate semisodium;valpromide;valproate bismuth;calcium valproate;valproate magnesium","related_medicines":"","procedure_number":"PSUSA/00003090/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003090-201501"},{"category":"","active_substances_in_scope_of_procedure":"Pholcodine","active_substance":"Pholcodine","related_medicines":"","procedure_number":"PSUSA/00002396/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002396-201505"},{"category":"","active_substances_in_scope_of_procedure":"Pilocarpine (non ophthalmic formulations)","active_substance":"pilocarpine","related_medicines":"","procedure_number":"PSUSA/00002409/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002409-201707"},{"category":"","active_substances_in_scope_of_procedure":"Pitavastatin","active_substance":"pitavastatin","related_medicines":"","procedure_number":"PSUSA/00010502/201907","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010502-201907"},{"category":"","active_substances_in_scope_of_procedure":"Piroxicam","active_substance":"piroxicam","related_medicines":"","procedure_number":"PSUSA/00002438/202004","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002438-202004"},{"category":"","active_substances_in_scope_of_procedure":"Pitavastatin","active_substance":"pitavastatin","related_medicines":"","procedure_number":"PSUSA/00010502/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010502-201807"},{"category":"","active_substances_in_scope_of_procedure":"Pitavastatin","active_substance":"pitavastatin","related_medicines":"","procedure_number":"PSUSA/00010502/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010502-201707"},{"category":"","active_substances_in_scope_of_procedure":"Piribedil","active_substance":"piribedil","related_medicines":"","procedure_number":"PSUSA/00002436/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002436-202003"},{"category":"","active_substances_in_scope_of_procedure":"Piribedil","active_substance":"piribedil","related_medicines":"","procedure_number":"PSUSA/00002436/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002436-201703"},{"category":"","active_substances_in_scope_of_procedure":"Piretanide","active_substance":"piretanide","related_medicines":"","procedure_number":"PSUSA/00002433/201810","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002433-201810"},{"category":"","active_substances_in_scope_of_procedure":"Piretanide","active_substance":"piretanide","related_medicines":"","procedure_number":"PSUSA/00002433/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002433-201510"},{"category":"","active_substances_in_scope_of_procedure":"Piretanide","active_substance":"piretanide","related_medicines":"","procedure_number":"PSUSA/00002433/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002433-202110"},{"category":"","active_substances_in_scope_of_procedure":"Piracetam","active_substance":"piracetam","related_medicines":"","procedure_number":"PSUSA/00002429/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002429-201704"},{"category":"","active_substances_in_scope_of_procedure":"Pipobroman","active_substance":"pipobroman","related_medicines":"","procedure_number":"PSUSA/00002427/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002427-201806"},{"category":"","active_substances_in_scope_of_procedure":"Piperacillin / tazobactam","active_substance":"tazobactam;piperacillin","related_medicines":"","procedure_number":"PSUSA/00002425/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002425-201709"},{"category":"","active_substances_in_scope_of_procedure":"Pimecrolimus","active_substance":"pimecrolimus","related_medicines":"","procedure_number":"PSUSA/00002411/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-201803"},{"category":"","active_substances_in_scope_of_procedure":"Pimecrolimus","active_substance":"pimecrolimus","related_medicines":"","procedure_number":"PSUSA/00002411/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-201703"},{"category":"","active_substances_in_scope_of_procedure":"Pimecrolimus","active_substance":"pimecrolimus","related_medicines":"","procedure_number":"PSUSA/00002411/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-201603"},{"category":"","active_substances_in_scope_of_procedure":"Pimecrolimus","active_substance":"pimecrolimus","related_medicines":"","procedure_number":"PSUSA/00002411/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-201503"},{"category":"","active_substances_in_scope_of_procedure":"Pilocarpine / timolol","active_substance":"pilocarpine;timolol","related_medicines":"","procedure_number":"PSUSA/00002408/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002408-201607"},{"category":"","active_substances_in_scope_of_procedure":"Pilocarpine / timolol","active_substance":"pilocarpine;timolol","related_medicines":"","procedure_number":"PSUSA/00002408/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002408-202107"},{"category":"","active_substances_in_scope_of_procedure":"Pilocarpine (ophthalmic formulation)","active_substance":"pilocarpine","related_medicines":"","procedure_number":"PSUSA/00002410/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002410-201608"},{"category":"","active_substances_in_scope_of_procedure":"Primidone","active_substance":"primidone","related_medicines":"","procedure_number":"PSUSA/00002525/202006","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002525-202006"},{"category":"","active_substances_in_scope_of_procedure":"Praziquantel","active_substance":"praziquantel","related_medicines":"","procedure_number":"PSUSA/00002503/202104","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002503-202104"},{"category":"","active_substances_in_scope_of_procedure":"Tafluprost / timolol","active_substance":"tafluprost;timolol","related_medicines":"","procedure_number":"PSUSA/00010324/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010324-202012"},{"category":"","active_substances_in_scope_of_procedure":"Tafluprost / timolol","active_substance":"tafluprost;timolol","related_medicines":"","procedure_number":"PSUSA/00010324/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010324-201712"},{"category":"","active_substances_in_scope_of_procedure":"Tafluprost","active_substance":"tafluprost","related_medicines":"","procedure_number":"PSUSA/00002843/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002843-202104"},{"category":"","active_substances_in_scope_of_procedure":"Tafluprost","active_substance":"tafluprost","related_medicines":"","procedure_number":"PSUSA/00002843/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002843-201804"},{"category":"","active_substances_in_scope_of_procedure":"Tafluprost","active_substance":"tafluprost","related_medicines":"","procedure_number":"PSUSA/00002843/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002843-201504"},{"category":"","active_substances_in_scope_of_procedure":"Praziquantel","active_substance":"praziquantel","related_medicines":"","procedure_number":"PSUSA/00002503/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002503-201804"},{"category":"","active_substances_in_scope_of_procedure":"Tamoxifen","active_substance":"tamoxifen","related_medicines":"","procedure_number":"PSUSA/00002846/202004","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002846-202004"},{"category":"","active_substances_in_scope_of_procedure":"Pravastatin","active_substance":"pravastatin","related_medicines":"","procedure_number":"PSUSA/00002500/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002500-201703"},{"category":"","active_substances_in_scope_of_procedure":"Pravastatin","active_substance":"pravastatin","related_medicines":"","procedure_number":"PSUSA/00002500/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002500-202003"},{"category":"","active_substances_in_scope_of_procedure":"Tamoxifen","active_substance":"tamoxifen","related_medicines":"","procedure_number":"PSUSA/00002846/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002846-201504"},{"category":"","active_substances_in_scope_of_procedure":"Pramiracetam","active_substance":"pramiracetam","related_medicines":"","procedure_number":"PSUSA/00002492/201909","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002492-201909"},{"category":"","active_substances_in_scope_of_procedure":"Tamsulosin","active_substance":"tamsulosin","related_medicines":"","procedure_number":"PSUSA/00002847/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002847-202107"},{"category":"","active_substances_in_scope_of_procedure":"Tamsulosin","active_substance":"tamsulosin","related_medicines":"","procedure_number":"PSUSA/00002847/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002847-201607"},{"category":"","active_substances_in_scope_of_procedure":"Pramiracetam","active_substance":"pramiracetam","related_medicines":"","procedure_number":"PSUSA/00002492/201409","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002492-201409"},{"category":"","active_substances_in_scope_of_procedure":"Potassium para aminobenzoate","active_substance":"potassium para aminobenzoate","related_medicines":"","procedure_number":"PSUSA/00010130/202002","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010130-202002"},{"category":"","active_substances_in_scope_of_procedure":"Potassium para aminobenzoate","active_substance":"potassium para aminobenzoate","related_medicines":"","procedure_number":"PSUSA/00010130/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010130-201502"},{"category":"","active_substances_in_scope_of_procedure":"Porfimer","active_substance":"porfimer","related_medicines":"","procedure_number":"PSUSA/00010332/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010332-202004"},{"category":"","active_substances_in_scope_of_procedure":"Tapentadol","active_substance":"tapentadol","related_medicines":"","procedure_number":"PSUSA/00002849/201711","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-201711"},{"category":"","active_substances_in_scope_of_procedure":"Tapentadol","active_substance":"tapentadol","related_medicines":"","procedure_number":"PSUSA/00002849/201811","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-201811"},{"category":"","active_substances_in_scope_of_procedure":"Porfimer","active_substance":"porfimer","related_medicines":"","procedure_number":"PSUSA/00010332/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010332-201704"},{"category":"","active_substances_in_scope_of_procedure":"Tapentadol","active_substance":"tapentadol","related_medicines":"","procedure_number":"PSUSA/00002849/202111","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-202111"},{"category":"","active_substances_in_scope_of_procedure":"Polystyrene sulfonate","active_substance":"polystyrene sulfonate","related_medicines":"","procedure_number":"PSUSA/00002472/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002472-202110"},{"category":"","active_substances_in_scope_of_procedure":"Polystyrene sulfonate","active_substance":"polystyrene sulfonate","related_medicines":"","procedure_number":"PSUSA/00002472/202010","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002472-202010"},{"category":"","active_substances_in_scope_of_procedure":"Poly (o-2-hydroxyethyl) starch","active_substance":"poly (o-2-hydroxyethyl) starch","related_medicines":"","procedure_number":"EMEA/H/N/PSR/S/0009","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0009"},{"category":"","active_substances_in_scope_of_procedure":"Tauroselcholic (75Se) acid","active_substance":"tauroselcholic (75Se) acid","related_medicines":"","procedure_number":"PSUSA/00010486/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010486-201801"},{"category":"","active_substances_in_scope_of_procedure":"Poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine","active_substance":"poliovirus type 1;poliovirus type 3 (oral, live, attenuated) vaccine","related_medicines":"","procedure_number":"PSUSA/00010339/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-201807"},{"category":"","active_substances_in_scope_of_procedure":"Poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine","active_substance":"poliovirus type 1 vaccine;poliovirus type 3 vaccine","related_medicines":"","procedure_number":"PSUSA/00002460/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002460-201507"},{"category":"","active_substances_in_scope_of_procedure":"Poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine","active_substance":"poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine","related_medicines":"","procedure_number":"PSUSA/00010642/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010642-201807"},{"category":"","active_substances_in_scope_of_procedure":"Technetium (99mTc) bicisate","active_substance":"technetium (99mTc) bicisate","related_medicines":"","procedure_number":"PSUSA/00002856/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002856-201610"},{"category":"","active_substances_in_scope_of_procedure":"Poliovirus type 1 / poliovirus type 2 / poliovirus type 3 vaccine (oral, live, attenuated)","active_substance":"poliovirus type 1;poliovirus type 2;poliovirus type 3","related_medicines":"","procedure_number":"PSUSA/00002458/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002458-201607"},{"category":"","active_substances_in_scope_of_procedure":"Podophyllotoxin","active_substance":"podophyllotoxin","related_medicines":"","procedure_number":"PSUSA/00002454/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002454-202009"},{"category":"","active_substances_in_scope_of_procedure":"Technetium (99mTc) hynic-octeotide","active_substance":"technetium (99mTc) hynic-octeotide","related_medicines":"","procedure_number":"PSUSA/00010521/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010521-201706"},{"category":"","active_substances_in_scope_of_procedure":"Plasma protein fraction","active_substance":"plasma protein fraction","related_medicines":"","procedure_number":"PSUSA/00002449/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002449-202104"},{"category":"","active_substances_in_scope_of_procedure":"Technetium (99mTc) pertechnetate","active_substance":"technetium (99mTc) pertechnetate","related_medicines":"","procedure_number":"PSUSA/00002866/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002866-201603"},{"category":"","active_substances_in_scope_of_procedure":"Technetium (99mTc) pertechnetate","active_substance":"technetium (99mTc) pertechnetate","related_medicines":"","procedure_number":"PSUSA/00002866/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002866-201703"},{"category":"","active_substances_in_scope_of_procedure":"Technetium (99mTc) tetrofosmin, tetrofosmin","active_substance":"technetium (99mTc) tetrofosmin;tetrofosmin","related_medicines":"","procedure_number":"PSUSA/00002870/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002870-201705"},{"category":"","active_substances_in_scope_of_procedure":"Technetium 99mtc sestamibi","active_substance":"technetium (99mTc) sestamibi","related_medicines":"","procedure_number":"PSUSA/00002868/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002868-201706"},{"category":"","active_substances_in_scope_of_procedure":"Technetium (99mtc) mebrofenin","active_substance":"technetium (99mtc) mebrofenin","related_medicines":"","procedure_number":"PSUSA/00002861/201511","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002861-201511"},{"category":"","active_substances_in_scope_of_procedure":"Promestriene (cream and vaginal capsules)","active_substance":"promestriene","related_medicines":"","procedure_number":"PSUSA/00009271/202103","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-202103"},{"category":"","active_substances_in_scope_of_procedure":"Promestriene (cream and vaginal capsules)","active_substance":"promestriene","related_medicines":"","procedure_number":"PSUSA/00009271/201703","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-201703"},{"category":"","active_substances_in_scope_of_procedure":"Propofol","active_substance":"propofol","related_medicines":"","procedure_number":"PSUSA/00002555/201711","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002555-201711"},{"category":"","active_substances_in_scope_of_procedure":"Prulifloxacin","active_substance":"prulifloxacin","related_medicines":"","procedure_number":"PSUSA/00002569/201410","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002569-201410"},{"category":"","active_substances_in_scope_of_procedure":"Prulifloxacin","active_substance":"prulifloxacin","related_medicines":"","procedure_number":"PSUSA/00002569/201710","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002569-201710"},{"category":"","active_substances_in_scope_of_procedure":"Pseudoephedrine, acetylsalicylic acid / pseudoephedrine","active_substance":"pseudoephedrine;acetylsalicylic acid","related_medicines":"","procedure_number":"PSUSA/00010667/201806","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010667-201806"},{"category":"","active_substances_in_scope_of_procedure":"Pseudoephedrine, triprolidine","active_substance":"pseudoephedrine;triprolidine","related_medicines":"","procedure_number":"PSUSA/00003047/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003047-201412"},{"category":"","active_substances_in_scope_of_procedure":"Pseudoephedrine / triprolidiner","active_substance":"pseudoephedrine;triprolidine","related_medicines":"","procedure_number":"PSUSA/00003047/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003047-201712"},{"category":"","active_substances_in_scope_of_procedure":"Pseudoephedrine / triprolidine","active_substance":"pseudoephedrine;triprolidine","related_medicines":"","procedure_number":"PSUSA/00003047/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003047-202012"},{"category":"","active_substances_in_scope_of_procedure":"Prulifloxacin","active_substance":"prulifloxacin","related_medicines":"","procedure_number":"PSUSA/00002569/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002569-202010"},{"category":"","active_substances_in_scope_of_procedure":"Teicoplanin","active_substance":"teicoplanin","related_medicines":"","procedure_number":"EMEA/H/N/PSR/S/0025","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0025"},{"category":"","active_substances_in_scope_of_procedure":"Teicoplanin","active_substance":"teicoplanin","related_medicines":"","procedure_number":"PSUSA/00002878/202111","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002878-202111"},{"category":"","active_substances_in_scope_of_procedure":"Teicoplanin","active_substance":"teicoplanin","related_medicines":"","procedure_number":"PSUSA/00002878/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002878-201611"},{"category":"","active_substances_in_scope_of_procedure":"Tenonitrozole","active_substance":"tenonitrozole","related_medicines":"","procedure_number":"PSUSA/00003185/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003185-201502"},{"category":"","active_substances_in_scope_of_procedure":"Tenoxicam","active_substance":"tenoxicam","related_medicines":"","procedure_number":"PSUSA/00002893/202102","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002893-202102"},{"category":"","active_substances_in_scope_of_procedure":"Tenoxicam","active_substance":"tenoxicam","related_medicines":"","procedure_number":"PSUSA/00002893/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002893-201802"},{"category":"","active_substances_in_scope_of_procedure":"Tenoxicam","active_substance":"tenoxicam","related_medicines":"","procedure_number":"PSUSA/00002893/201502","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002893-201502"},{"category":"","active_substances_in_scope_of_procedure":"Terazosin","active_substance":"terazosin","related_medicines":"","procedure_number":"PSUSA/00002895/201811","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002895-201811"},{"category":"","active_substances_in_scope_of_procedure":"Terazosin","active_substance":"terazosin","related_medicines":"","procedure_number":"PSUSA/00002895/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002895-201511"},{"category":"","active_substances_in_scope_of_procedure":"Terbinafine","active_substance":"terbinafine","related_medicines":"","procedure_number":"PSUSA/00002896/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002896-201709"},{"category":"","active_substances_in_scope_of_procedure":"Terbutaline","active_substance":"terbutaline","related_medicines":"","procedure_number":"PSUSA/00002897/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002897-201612"},{"category":"","active_substances_in_scope_of_procedure":"Terlipressin","active_substance":"terlipressin","related_medicines":"","procedure_number":"PSUSA/00002905/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002905-202104"},{"category":"","active_substances_in_scope_of_procedure":"Terlipressin","active_substance":"terlipressin","related_medicines":"","procedure_number":"PSUSA/00002905/201804","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002905-201804"},{"category":"","active_substances_in_scope_of_procedure":"Terlipressin","active_substance":"terlipressin","related_medicines":"","procedure_number":"PSUSA/00002905/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002905-201504"},{"category":"","active_substances_in_scope_of_procedure":"Testosterone (all formulations apart from topical use and testosterone undecanoate injection)","active_substance":"testosterone;testosterone undecanoate","related_medicines":"","procedure_number":"PSUSA/00002907/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002907-201512"},{"category":"","active_substances_in_scope_of_procedure":"Testosterone (all formulations apart from topical use)","active_substance":"testosterone","related_medicines":"","procedure_number":"PSUSA/00010631/201812","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010631-201812"},{"category":"","active_substances_in_scope_of_procedure":"Testosterone (all formulations apart from topical use)","active_substance":"testosterone","related_medicines":"","procedure_number":"PSUSA/00010631/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010631-202112"},{"category":"","active_substances_in_scope_of_procedure":"Testosterone (topical use)","active_substance":"testosterone","related_medicines":"","procedure_number":"PSUSA/00002908/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002908-202112"},{"category":"","active_substances_in_scope_of_procedure":"Testosterone (topical use)","active_substance":"testosterone","related_medicines":"","procedure_number":"PSUSA/00002908/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002908-201512"},{"category":"","active_substances_in_scope_of_procedure":"Testosterone (topical use)","active_substance":"testosterone","related_medicines":"","procedure_number":"PSUSA/00002908/201812","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002908-201812"},{"category":"","active_substances_in_scope_of_procedure":"Testosterone undecanoate (injection)","active_substance":"testosterone undecanoate","related_medicines":"","procedure_number":"PSUSA/00010161/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010161-201612"},{"category":"","active_substances_in_scope_of_procedure":"Testosterone undecanoate (injection)","active_substance":"testosterone undecanoate","related_medicines":"","procedure_number":"PSUSA/00010161/201512","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010161-201512"},{"category":"","active_substances_in_scope_of_procedure":"Testosterone undecylate (injection)","active_substance":"testosterone undecylat","related_medicines":"","procedure_number":"PSUSA/00010161/201411","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010161-201411"},{"category":"","active_substances_in_scope_of_procedure":"Tetanus vaccines","active_substance":"tetanus vaccine","related_medicines":"","procedure_number":"PSUSA/00002910/201501","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002910-201501"},{"category":"","active_substances_in_scope_of_procedure":"Tetanus vaccines","active_substance":"tetanus vaccine","related_medicines":"","procedure_number":"PSUSA/00002910/201801","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002910-201801"},{"category":"","active_substances_in_scope_of_procedure":"Tetrabenazine","active_substance":"tetrabenazine","related_medicines":"","procedure_number":"PSUSA/00002911/201410","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-201410"},{"category":"","active_substances_in_scope_of_procedure":"Tetrabenazine","active_substance":"tetrabenazine","related_medicines":"","procedure_number":"PSUSA/00002911/201510","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-201510"},{"category":"","active_substances_in_scope_of_procedure":"Tetrabenazine","active_substance":"tetrabenazine","related_medicines":"","procedure_number":"PSUSA/00002911/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-201610"},{"category":"","active_substances_in_scope_of_procedure":"Tetrabenazine","active_substance":"tetrabenazine","related_medicines":"","procedure_number":"PSUSA/00002911/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-202010"},{"category":"","active_substances_in_scope_of_procedure":"Promestriene (cream and vaginal capsules)","active_substance":"promestriene","related_medicines":"","procedure_number":"PSUSA/00009271/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-201503"},{"category":"","active_substances_in_scope_of_procedure":"Promestriene (cream and vaginal capsules)","active_substance":"promestriene","related_medicines":"","procedure_number":"PSUSA/00009271/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-201603"},{"category":"","active_substances_in_scope_of_procedure":"Promestriene (cream and vaginal capsules)","active_substance":"promestriene","related_medicines":"","procedure_number":"PSUSA/00009271/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-201803"},{"category":"","active_substances_in_scope_of_procedure":"Propafenone","active_substance":"propafenone","related_medicines":"","procedure_number":"PSUSA/00002550/202101","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002550-202101"},{"category":"","active_substances_in_scope_of_procedure":"Propafenone","active_substance":"propafenone","related_medicines":"","procedure_number":"PSUSA/00002550/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002550-201601"},{"category":"","active_substances_in_scope_of_procedure":"Tixocortol, chlorhexidine gluconate / tixocortol pivalate","active_substance":"tixocortol pivalate;chlorhexidine gluconate;tixocortol","related_medicines":"","procedure_number":"PSUSA/00010333/201611","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010333-201611"},{"category":"","active_substances_in_scope_of_procedure":"Tixocortol, chlorhexidine gluconate / tixocortol pivalate","active_substance":"tixocortol;chlorhexidine gluconate;tixocortol pivalate","related_medicines":"","procedure_number":"PSUSA/00010333/201911","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010333-201911"},{"category":"","active_substances_in_scope_of_procedure":"Tizanidine","active_substance":"tizanidine","related_medicines":"","procedure_number":"PSUSA/00002977/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002977-201412"},{"category":"","active_substances_in_scope_of_procedure":"Tizanidine","active_substance":"tizanidine","related_medicines":"","procedure_number":"PSUSA/00002977/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002977-201912"},{"category":"","active_substances_in_scope_of_procedure":"Tobramycin (nebuliser solution) (apart from centrally authorised product)","active_substance":"tobramycin","related_medicines":"","procedure_number":"PSUSA/00009316/201712","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009316-201712"},{"category":"","active_substances_in_scope_of_procedure":"Tobramycin (nebuliser solution)","active_substance":"tobramycin","related_medicines":"","procedure_number":"PSUSA/00009316/202012","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009316-202012"},{"category":"","active_substances_in_scope_of_procedure":"Tobramycin (nebuliser solution)","active_substance":"tobramycin","related_medicines":"","procedure_number":"SUSA/00009316/201412","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/susa-00009316-201412"},{"category":"","active_substances_in_scope_of_procedure":"Tobramycin (ophthalmic and otic use)","active_substance":"tobramycin","related_medicines":"","procedure_number":"PSUSA/00009317/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009317-202103"},{"category":"","active_substances_in_scope_of_procedure":"Tobramycin (ophthalmic and otic use)","active_substance":"tobramycin","related_medicines":"","procedure_number":"PSUSA/00009317/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009317-201603"},{"category":"","active_substances_in_scope_of_procedure":"Tobramycin (systemic use)","active_substance":"tobramycin","related_medicines":"","procedure_number":"PSUSA/00009318/202009","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009318-202009"},{"category":"","active_substances_in_scope_of_procedure":"Tolperisone","active_substance":"tolperisone","related_medicines":"","procedure_number":"PSUSA/00002991/201906","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002991-201906"},{"category":"","active_substances_in_scope_of_procedure":"Tolterodine","active_substance":"tolterodine","related_medicines":"","procedure_number":"PSUSA-00002993-202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002993-202109"},{"category":"","active_substances_in_scope_of_procedure":"Tolterodine","active_substance":"tolterodine","related_medicines":"","procedure_number":"PSUSA/00002993/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002993-201609"},{"category":"","active_substances_in_scope_of_procedure":"Topiramate","active_substance":"topiramate","related_medicines":"","procedure_number":"PSUSA/00002996/201701","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002996-201701"},{"category":"","active_substances_in_scope_of_procedure":"Topotecan","active_substance":"topotecan","related_medicines":"","procedure_number":"PSUSA/00002997/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002997-201505"},{"category":"","active_substances_in_scope_of_procedure":"Tramadol","active_substance":"tramadol","related_medicines":"","procedure_number":"PSUSA/00003002/201705","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003002-201705"},{"category":"","active_substances_in_scope_of_procedure":"Tramadol","active_substance":"tramadol","related_medicines":"","procedure_number":"PSUSA/00003002/202005","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003002-202005"},{"category":"","active_substances_in_scope_of_procedure":"Trandolapril / verapamil","active_substance":"trandolapril;verapamil","related_medicines":"","procedure_number":"PSUSA/00003005/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003005-202003"},{"category":"","active_substances_in_scope_of_procedure":"Trandolapril / verapamil","active_substance":"trandolapril;verapamil","related_medicines":"","procedure_number":"PSUSA/00003005/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003005-201503"},{"category":"","active_substances_in_scope_of_procedure":"Trandolapril","active_substance":"trandolapril","related_medicines":"","procedure_number":"PSUSA/00003004/201902","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003004-201902"},{"category":"","active_substances_in_scope_of_procedure":"Treosulfan","active_substance":"treosulfan","related_medicines":"","procedure_number":"PSUSA/00009319/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009319-201708"},{"category":"","active_substances_in_scope_of_procedure":"Tiludronic acid","active_substance":"tiludronic acid","related_medicines":"","procedure_number":"PSUSA/00002959/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002959-201502"},{"category":"","active_substances_in_scope_of_procedure":"Timolol (eye preparations)","active_substance":"timolol","related_medicines":"","procedure_number":"PSUSA/00010439/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010439-202107"},{"category":"","active_substances_in_scope_of_procedure":"Timolol (eye preparations)","active_substance":"timolol","related_medicines":"","procedure_number":"PSUSA/00010439/201607","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010439-201607"},{"category":"","active_substances_in_scope_of_procedure":"Timolol (systemic use)","active_substance":"timolol","related_medicines":"","procedure_number":"PSUSA/00010432/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010432-201610"},{"category":"","active_substances_in_scope_of_procedure":"Timolol (systemic use)","active_substance":"timolol","related_medicines":"","procedure_number":"PSUSA/00010432/201910","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010432-201910"},{"category":"","active_substances_in_scope_of_procedure":"Tioconazole, tioconazole / hydrocortisone","active_substance":"tioconazole;hydrocortisone","related_medicines":"","procedure_number":"PSUSA/00010382/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010382-201704"},{"category":"","active_substances_in_scope_of_procedure":"Tiotropium","active_substance":"tiotropium","related_medicines":"","procedure_number":"PSUSA/00002972/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002972-202110"},{"category":"","active_substances_in_scope_of_procedure":"Tiotropium","active_substance":"tiotropium","related_medicines":"","procedure_number":"PSUSA/00002972/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002972-201610"},{"category":"","active_substances_in_scope_of_procedure":"Tirofiban","active_substance":"tirofiban","related_medicines":"","procedure_number":"PSUSA/00002974/201605","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002974-201605"},{"category":"","active_substances_in_scope_of_procedure":"Tirofiban","active_substance":"tirofiban","related_medicines":"","procedure_number":"PSUSA/00002974/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002974-201905"},{"category":"","active_substances_in_scope_of_procedure":"Ticlopidine","active_substance":"ticlopidine","related_medicines":"","procedure_number":"PSUSA/00002952/202005","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002952-202005"},{"category":"","active_substances_in_scope_of_procedure":"Ticlopidine","active_substance":"ticlopidine","related_medicines":"","procedure_number":"PSUSA/00002952/201505","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002952-201505"},{"category":"","active_substances_in_scope_of_procedure":"Theophylline","active_substance":"theophylline","related_medicines":"","procedure_number":"PSUSA/00002921/201706","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002921-201706"},{"category":"","active_substances_in_scope_of_procedure":"Thiamphenicol","active_substance":"thiamphenicol","related_medicines":"","procedure_number":"PSUSA/00002925/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002925-201805"},{"category":"","active_substances_in_scope_of_procedure":"Thiamphenicol","active_substance":"thiamphenicol","related_medicines":"","procedure_number":"PSUSA/00002925/201505","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002925-201505"},{"category":"","active_substances_in_scope_of_procedure":"Thiocolchicoside","active_substance":"thiocolchicoside","related_medicines":"","procedure_number":"PSUSA/00002927/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002927-201507"},{"category":"","active_substances_in_scope_of_procedure":"Thiocolchicoside","active_substance":"thiocolchicoside","related_medicines":"","procedure_number":"EMEA/H/N/PSR/J/0008","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0008"},{"category":"","active_substances_in_scope_of_procedure":"Thiocolchicoside","active_substance":"thiocolchicoside","related_medicines":"","procedure_number":"EMEA/H/N/PSR/J/0023","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0023"},{"category":"","active_substances_in_scope_of_procedure":"Thiopental","active_substance":"thiopental","related_medicines":"","procedure_number":"PSUSA/00002929/201603","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002929-201603"},{"category":"","active_substances_in_scope_of_procedure":"Tiagabine","active_substance":"tiagabine","related_medicines":"","procedure_number":"PSUSA/00002942/202106","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002942-202106"},{"category":"","active_substances_in_scope_of_procedure":"Tiagabine","active_substance":"tiagabine","related_medicines":"","procedure_number":"PSUSA/00002942/201806","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002942-201806"},{"category":"","active_substances_in_scope_of_procedure":"Tiagabine","active_substance":"tiagabine","related_medicines":"","procedure_number":"PSUSA/00002942/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002942-201506"},{"category":"","active_substances_in_scope_of_procedure":"Tianeptine","active_substance":"tianeptine","related_medicines":"","procedure_number":"PSUSA/00002943/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002943-202106"},{"category":"","active_substances_in_scope_of_procedure":"Tianeptine","active_substance":"tianeptine","related_medicines":"","procedure_number":"PSUSA/00002943/201806","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002943-201806"},{"category":"","active_substances_in_scope_of_procedure":"Tianeptine","active_substance":"tianeptine","related_medicines":"","procedure_number":"PSUSA/00002943/201506","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002943-201506"},{"category":"","active_substances_in_scope_of_procedure":"Tiapride","active_substance":"tiapride","related_medicines":"","procedure_number":"PSUSA/00002944/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002944-202107"},{"category":"","active_substances_in_scope_of_procedure":"Tiapride","active_substance":"tiapride","related_medicines":"","procedure_number":"PSUSA/00002944/201807","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002944-201807"},{"category":"","active_substances_in_scope_of_procedure":"Tiapride","active_substance":"tiapride","related_medicines":"","procedure_number":"PSUSA/00002944/201507","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002944-201507"},{"category":"","active_substances_in_scope_of_procedure":"Tibolone","active_substance":"tibolone","related_medicines":"","procedure_number":"PSUSA/00002947/201912","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002947-201912"},{"category":"","active_substances_in_scope_of_procedure":"Tibolone","active_substance":"tibolone","related_medicines":"","procedure_number":"PSUSA/00002947/201612","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002947-201612"},{"category":"","active_substances_in_scope_of_procedure":"Tick-borne encephalitis vaccine (inactivated)","active_substance":"tick-borne encephalitis vaccine (inactivated)","related_medicines":"","procedure_number":"PSUSA/00002951/201701","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002951-201701"},{"category":"","active_substances_in_scope_of_procedure":"Treprostinil","active_substance":"treprostinil","related_medicines":"","procedure_number":"PSUSA/00003013/201711","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201711"},{"category":"","active_substances_in_scope_of_procedure":"Treprostinil","active_substance":"treprostinil","related_medicines":"","procedure_number":"PSUSA/00003013/201611","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201611"},{"category":"","active_substances_in_scope_of_procedure":"Treprostinil","active_substance":"treprostinil","related_medicines":"","procedure_number":"PSUSA/00003013/201511","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201511"},{"category":"","active_substances_in_scope_of_procedure":"Treprostinil","active_substance":"treprostinil","related_medicines":"","procedure_number":"PSUSA/00003013/201805","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201805"},{"category":"","active_substances_in_scope_of_procedure":"Treprostinil","active_substance":"treprostinil","related_medicines":"","procedure_number":"PSUSA/00003013/201905","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201905"},{"category":"","active_substances_in_scope_of_procedure":"Treprostinil","active_substance":"treprostinil","related_medicines":"","procedure_number":"PSUSA/00003013/201605","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201605"},{"category":"","active_substances_in_scope_of_procedure":"Typhoid vaccine (live, attenuated)","active_substance":"typhoid vaccine","related_medicines":"","procedure_number":"PSUSA/00003067/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003067-201707"},{"category":"","active_substances_in_scope_of_procedure":"Typhoid vaccine (live, attenuated)","active_substance":"typhoid vaccine","related_medicines":"","procedure_number":"PSUSA/00003067/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003067-202112"},{"category":"","active_substances_in_scope_of_procedure":"Typhoid polysaccharide vaccine","active_substance":"typhoid polysaccharide vaccine","related_medicines":"","procedure_number":"PSUSA/00003065/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003065-201708"},{"category":"","active_substances_in_scope_of_procedure":"Typhoid polysaccharide vaccine","active_substance":"typhoid polysaccharide vaccine","related_medicines":"","procedure_number":"PSUSA/00003065/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003065-202008"},{"category":"","active_substances_in_scope_of_procedure":"Tuberculin purified protein derivative","active_substance":"tuberculin purified protein derivative","related_medicines":"","procedure_number":"PSUSA/00003063/202109","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003063-202109"},{"category":"","active_substances_in_scope_of_procedure":"Tuberculin purified protein derivative","active_substance":"tuberculin purified protein derivative","related_medicines":"","procedure_number":"PSUSA/00003063/201609","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003063-201609"},{"category":"","active_substances_in_scope_of_procedure":"Triptorelin","active_substance":"triptorelin","related_medicines":"","procedure_number":"PSUSA/00003048/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003048-201703"},{"category":"","active_substances_in_scope_of_procedure":"Trimetazidine","active_substance":"trimetazidine","related_medicines":"","procedure_number":"PSUSA/00003043/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-201508"},{"category":"","active_substances_in_scope_of_procedure":"Trimetazidine","active_substance":"trimetazidine","related_medicines":"","procedure_number":"PSUSA/00003043/201608","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-201608"},{"category":"","active_substances_in_scope_of_procedure":"Trimetazidine","active_substance":"trimetazidine","related_medicines":"","procedure_number":"PSUSA/00003043/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-201708"},{"category":"","active_substances_in_scope_of_procedure":"Trimetazidine","active_substance":"trimetazidine","related_medicines":"","procedure_number":"PSUSA/00003043/202008","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-202008"},{"category":"","active_substances_in_scope_of_procedure":"Trimetazidine","active_substance":"trimetazidine","related_medicines":"","procedure_number":"EMEA/H/N/PSR/0001","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-0001"},{"category":"","active_substances_in_scope_of_procedure":"Trimetazidine","active_substance":"trimetazidine","related_medicines":"","procedure_number":"EMEA/H/N/PSR/J/0002","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0002"},{"category":"","active_substances_in_scope_of_procedure":"Trimetazidine","active_substance":"trimetazidine","related_medicines":"","procedure_number":"EMEA/H/N/PSR/J/0003","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0003-0"},{"category":"","active_substances_in_scope_of_procedure":"Triglyceride combinations (e.g. olive oil, soya bean oil, fish oil)/ with or without mineral compounds/electrolytes (i.v. application)","active_substance":"triglyceride combinations","related_medicines":"","procedure_number":"PSUSA/00010648/202106","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010648-202106"},{"category":"","active_substances_in_scope_of_procedure":"Triazolam","active_substance":"triazolam","related_medicines":"","procedure_number":"PSUSA/00003023/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003023-201707"},{"category":"","active_substances_in_scope_of_procedure":"Tretinoin (oral formulations)","active_substance":"tretinoin","related_medicines":"","procedure_number":"PSUSA/00003015/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003015-201703"},{"category":"","active_substances_in_scope_of_procedure":"Tretinoin (topical formulations)","active_substance":"tretinoin","related_medicines":"","procedure_number":"PSUSA/00003016/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003016-201708"},{"category":"","active_substances_in_scope_of_procedure":"Triamcinolone (tablets and injectables)","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00010137/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010137-202009"},{"category":"","active_substances_in_scope_of_procedure":"Triamcinolone (topical and nasal formulations)","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00003017/201707","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003017-201707"},{"category":"","active_substances_in_scope_of_procedure":"Triamcinolone (intraocular formulations)","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00010292/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-201903"},{"category":"","active_substances_in_scope_of_procedure":"Triamcinolone (intraocular formulations)","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00010292/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-201703"},{"category":"","active_substances_in_scope_of_procedure":"Triamcinolone (intraocular formulations)","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00010292/201603","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-201603"},{"category":"","active_substances_in_scope_of_procedure":"Triamcinolone (intraocular formulations)","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00010292/201503","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-201503"},{"category":"","active_substances_in_scope_of_procedure":"Lamivudine / tenofovir disoproxil","active_substance":"lamivudine;tenofovir disoproxil","related_medicines":"","procedure_number":"PSUSA/00010751/202003","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010751-202003"},{"category":"","active_substances_in_scope_of_procedure":"Lactitol","active_substance":"lactitol","related_medicines":"","procedure_number":"PSUSA/00001819/202009","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001819-202009"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (topical use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010376/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-202004"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (topical use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010376/201804","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201804"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (topical use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010376/202104","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-202104"},{"category":"","active_substances_in_scope_of_procedure":"Itraconazole","active_substance":"Itraconazole","related_medicines":"","procedure_number":"PSUSA/00001798/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001798-201703"},{"category":"","active_substances_in_scope_of_procedure":"Itopride","active_substance":"itopride","related_medicines":"","procedure_number":"PSUSA/00010606/201906","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010606-201906"},{"category":"","active_substances_in_scope_of_procedure":"Estradiol / norethisterone","active_substance":"estradiol;norethisterone","related_medicines":"","procedure_number":"PSUSA/00001278/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001278-201703"},{"category":"","active_substances_in_scope_of_procedure":"Estradiol, estradiol /prednisolone (only cream/balm/emulsion for application in the female genital area)","active_substance":"estradiol;prednisolone","related_medicines":"","procedure_number":"PSUSA/00010441/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010441-201704"},{"category":"","active_substances_in_scope_of_procedure":"Estradiol, estradiol /prednisolone (only cream/balm/emulsion for application in the female genital area)","active_substance":"estradiol;prednisolone","related_medicines":"","procedure_number":"PSUSA/00010441/202004","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010441-202004"},{"category":"","active_substances_in_scope_of_procedure":"Exametazime/technetium (99mTc) exametazime","active_substance":"exametazime;technetium (99mTc) exametazime","related_medicines":"","procedure_number":"PSUSA/00001344/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001344-201601"},{"category":"","active_substances_in_scope_of_procedure":"Everolimus (indicated for rejection of transplanted organs)","active_substance":"everolimus","related_medicines":"","procedure_number":"PSUSA/00010269/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010269-202107"},{"category":"","active_substances_in_scope_of_procedure":"Everolimus (indicated for rejection of transplanted organs)","active_substance":"everolimus","related_medicines":"","procedure_number":"PSUSA/00010269/201807","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010269-201807"},{"category":"","active_substances_in_scope_of_procedure":"Everolimus (indicated for rejection of transplanted organs)","active_substance":"everolimus","related_medicines":"","procedure_number":"PSUSA/00010269/201507","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010269-201507"},{"category":"","active_substances_in_scope_of_procedure":"Etoricoxib","active_substance":"etoricoxib","related_medicines":"","procedure_number":"PSUSA/00001334/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001334-201703"},{"category":"","active_substances_in_scope_of_procedure":"Etoposide","active_substance":"etoposide","related_medicines":"","procedure_number":"PSUSA/00001333/201602","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001333-201602"},{"category":"","active_substances_in_scope_of_procedure":"Etoposide","active_substance":"etoposide","related_medicines":"","procedure_number":"PSUSA/00001333/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001333-201708"},{"category":"","active_substances_in_scope_of_procedure":"Etonogestrel","active_substance":"etonogestrel","related_medicines":"","procedure_number":"PSUSA/00001331/202109","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001331-202109"},{"category":"","active_substances_in_scope_of_procedure":"Etonogestrel","active_substance":"etonogestrel","related_medicines":"","procedure_number":"PSUSA/00001331/201809","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001331-201809"},{"category":"","active_substances_in_scope_of_procedure":"Etonogestrel","active_substance":"etonogestrel","related_medicines":"","procedure_number":"PSUSA/00001331/201509","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001331-201509"},{"category":"","active_substances_in_scope_of_procedure":"Etomidate","active_substance":"etomidate","related_medicines":"","procedure_number":"PSUSA/00001330/201709","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001330-201709"},{"category":"","active_substances_in_scope_of_procedure":"Etifoxine","active_substance":"etifoxine","related_medicines":"","procedure_number":"PSUSA/00001321/202010","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001321-202010"},{"category":"","active_substances_in_scope_of_procedure":"Etifoxine","active_substance":"etifoxine","related_medicines":"","procedure_number":"PSUSA/00001321/201710","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001321-201710"},{"category":"","active_substances_in_scope_of_procedure":"Etifoxine","active_substance":"etifoxine","related_medicines":"","procedure_number":"PSUSA/00001321/201410","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001321-201410"},{"category":"","active_substances_in_scope_of_procedure":"Etidronate","active_substance":"etidronate","related_medicines":"","procedure_number":"PSUSA/00001320/201709","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001320-201709"},{"category":"","active_substances_in_scope_of_procedure":"Ethosuximide","active_substance":"ethosuximide","related_medicines":"","procedure_number":"PSUSA/00001316/202003","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001316-202003"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / norgestimate","active_substance":"ethinylestradiol;norgestimate","related_medicines":"","procedure_number":"PSUSA/00001313/202110","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001313-202110"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / norgestimate","active_substance":"ethinylestradiol;norgestimate","related_medicines":"","procedure_number":"PSUSA/00001313/201610","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001313-201610"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / norethisterone","active_substance":"ethinylestradiol;norethisterone","related_medicines":"","procedure_number":"PSUSA/00001312/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001312-201708"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / levonorgestrel","active_substance":"ethinylestradiol;levonorgestrel","related_medicines":"","procedure_number":"PSUSA/00001309/201604","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001309-201604"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / levonorgestrel","active_substance":"ethinylestradiol;levonorgestrel","related_medicines":"","procedure_number":"PSUSA/00001309/201904","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001309-201904"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / gestodene","active_substance":"ethinylestradiol;gestodene","related_medicines":"","procedure_number":"PSUSA/00001308/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001308-202103"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / gestodene (except for transdermal application)","active_substance":"ethinylestradiol;gestodene","related_medicines":"","procedure_number":"PSUSA/00001308/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001308-201603"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / etonogestrel","active_substance":"ethinylestradiol;etonogestrel","related_medicines":"","procedure_number":"PSUSA/00001307/202007","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001307-202007"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol, gestodene (transdermal application)","active_substance":"ethinylestradiol;gestodene","related_medicines":"","procedure_number":"PSUSA/00010145/201502","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201502"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / gestodene (transdermal application)","active_substance":"ethinylestradiol;gestodene","related_medicines":"","procedure_number":"PSUSA/00010145/201802","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201802"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / gestodene (transdermal application)","active_substance":"ethinylestradiol;gestodene","related_medicines":"","procedure_number":"PSUSA/00010145/201708","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201708"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / gestodene (transdermal application)","active_substance":"ethinylestradiol;gestodene","related_medicines":"","procedure_number":"PSUSA/00010145/201608","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201608"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / gestodene (transdermal application)","active_substance":"ethinylestradiol;gestodene","related_medicines":"","procedure_number":"PSUSA/00010145/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201508"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / gestodene (transdermal application)","active_substance":"ethinylestradiol;gestodene","related_medicines":"","procedure_number":"PSUSA/00010145/201702","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201702"},{"category":"","active_substances_in_scope_of_procedure":"Ethanol / orthophenylphenol","active_substance":"Ethanol;orthophenylphenol","related_medicines":"","procedure_number":"PSUSA/00010416/201902","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010416-201902"},{"category":"","active_substances_in_scope_of_procedure":"Interferon gamma","active_substance":"Interferon gamma","related_medicines":"","procedure_number":"PSUSA/00001760/201601","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001760-201601"},{"category":"","active_substances_in_scope_of_procedure":"Interferon gamma","active_substance":"Interferon gamma","related_medicines":"","procedure_number":"PSUSA/00001760/201901","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001760-201901"},{"category":"","active_substances_in_scope_of_procedure":"Interferon alpha-2a","active_substance":"interferon alpha-2a","related_medicines":"","procedure_number":"PSUSA/00009197/201706","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009197-201706"},{"category":"","active_substances_in_scope_of_procedure":"Insulin porcine","active_substance":"insulin porcine","related_medicines":"","procedure_number":"PSUSA/00001756/201410","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001756-201410"},{"category":"","active_substances_in_scope_of_procedure":"Inosine dimepranol acedoben","active_substance":"inosine dimepranol acedoben","related_medicines":"","procedure_number":"PSUSA/00010425/201808","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010425-201808"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated, virosome)","active_substance":"influenza vaccine","related_medicines":"","procedure_number":"PSUSA/00001746/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001746-201508"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated, virosome)","active_substance":"influenza vaccine","related_medicines":"","procedure_number":"PSUSA/00001746/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001746-201504"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201703"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201603"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/201508","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201508"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201504"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202103"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202003"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201903"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated, adjuvanted)","active_substance":"influenza vaccine (surface antigen, inactivated, adjuvanted)","related_medicines":"","procedure_number":"PSUSA/00010300/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201504"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated, adjuvanted)","active_substance":"influenza vaccine (surface antigen, inactivated, adjuvanted)","related_medicines":"","procedure_number":"PSUSA/00010300/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201508"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated, adjuvanted)","active_substance":"influenza vaccine (surface antigen, inactivated, adjuvanted)","related_medicines":"","procedure_number":"PSUSA/00010300/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201603"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated, adjuvanted)","active_substance":"influenza vaccine (surface antigen, inactivated, adjuvanted)","related_medicines":"","procedure_number":"PSUSA/00010300/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201703"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated, adjuvanted)","active_substance":"influenza vaccine (surface antigen, inactivated, adjuvanted)","related_medicines":"","procedure_number":"PSUSA/00010300/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201803"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated, adjuvanted)","active_substance":"influenza vaccine (surface antigen, inactivated, adjuvanted)","related_medicines":"","procedure_number":"PSUSA/00010300/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201903"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated, adjuvanted)","active_substance":"influenza vaccine (surface antigen, inactivated, adjuvanted)","related_medicines":"","procedure_number":"PSUSA/00010300/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-202003"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","active_substance":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","related_medicines":"","procedure_number":"PSUSA/00010299/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201504"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","active_substance":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","related_medicines":"","procedure_number":"PSUSA/00010299/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201508"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","active_substance":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","related_medicines":"","procedure_number":"PSUSA/00010299/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201603"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","active_substance":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","related_medicines":"","procedure_number":"PSUSA/00010299/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201703"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","active_substance":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","related_medicines":"","procedure_number":"PSUSA/00010299/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201803"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","active_substance":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","related_medicines":"","procedure_number":"PSUSA/00010299/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201903"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","active_substance":"Influenza vaccine (split virion, inactivated, prepared in cell cultures)","related_medicines":"","procedure_number":"PSUSA/00010299/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-202003"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/201504","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201504"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/201508","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201508"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/201603","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201603"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/201703","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201703"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/201803","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201803"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/201903","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201903"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/202003","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202003"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/202103","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202103"},{"category":"","active_substances_in_scope_of_procedure":"Indoramin","active_substance":"indoramin","related_medicines":"","procedure_number":"PSUSA/00001740/201809","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001740-201809"},{"category":"Human","active_substances_in_scope_of_procedure":"indometacin","active_substance":"indometacin","related_medicines":"","procedure_number":"PSUSA/00001738/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001738-202007"},{"category":"","active_substances_in_scope_of_procedure":"Indobufen","active_substance":"indobufen","related_medicines":"","procedure_number":"PSUSA/00001736/201705","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001736-201705"},{"category":"","active_substances_in_scope_of_procedure":"Indium (In-111) chloride, indium (In-111) oxine","active_substance":"indium (In-111) chloride;indium (In-111) oxine","related_medicines":"","procedure_number":"PSUSA/00001734/202107","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001734-202107"},{"category":"","active_substances_in_scope_of_procedure":"Indium (111In) pentetate","active_substance":"indium (111In) pentetate","related_medicines":"","procedure_number":"PSUSA/00009191/202007","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009191-202007"},{"category":"","active_substances_in_scope_of_procedure":"Piroxicam","active_substance":"piroxicam","related_medicines":"","procedure_number":"PSUSA/00002438/201704","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002438-201704"},{"category":"","active_substances_in_scope_of_procedure":"Ciclosporin (systemic use)","active_substance":"ciclosporin","related_medicines":"","procedure_number":"PSUSA/00000745/202112","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000745-202112"},{"category":"","active_substances_in_scope_of_procedure":"Terbutaline","active_substance":"terbutaline","related_medicines":"","procedure_number":"PSUSA/00002897/202112","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002897-202112"},{"category":"","active_substances_in_scope_of_procedure":"Valaciclovir","active_substance":"valaciclovir","related_medicines":"","procedure_number":"PSUSA/00003086/202112","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003086-202112"},{"category":"","active_substances_in_scope_of_procedure":"Botulinum toxin a","active_substance":"botulinum toxin a","related_medicines":"","procedure_number":"PSUSA/00000426/202112","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000426-202112"},{"category":"","active_substances_in_scope_of_procedure":"Bupropion","active_substance":"bupropion","related_medicines":"","procedure_number":"PSUSA/00000461/202112","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000461-202112"},{"category":"","active_substances_in_scope_of_procedure":"Dexketoprofen / tramadol","active_substance":"dexketoprofen;tramadol","related_medicines":"","procedure_number":"PSUSA/00010468/202201","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010468-202201"},{"category":"","active_substances_in_scope_of_procedure":"Botulinum neurotoxin type a (150 kD) free from complexing proteins","active_substance":"botulinum neurotoxin type a (150 kd) free from complexing proteins","related_medicines":"","procedure_number":"PSUSA/00009084/202112","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009084-202112"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxyethyl starch","active_substance":"hydroxyethyl starch","related_medicines":"","procedure_number":"PSUSA/00001694/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202203"},{"category":"","active_substances_in_scope_of_procedure":"Dexlansoprazole, lansoprazole","active_substance":"dexlansoprazole;lansoprazole","related_medicines":"","procedure_number":"PSUSA/00001827/202112","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001827-202112"},{"category":"","active_substances_in_scope_of_procedure":"Carbomers","active_substance":"carbomers","related_medicines":"","procedure_number":"PSUSA/00000557/202201","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000557-202201"},{"category":"","active_substances_in_scope_of_procedure":"Rocuronium","active_substance":"rocuronium","related_medicines":"","procedure_number":"PSUSA-00002656-202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002656-202202"},{"category":"","active_substances_in_scope_of_procedure":"Aviptadil / phentolamine mesilate","active_substance":"aviptadil;phentolamine mesilate","related_medicines":"","procedure_number":"PSUSA/00010814/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010814-202202"},{"category":"","active_substances_in_scope_of_procedure":"Alprazolam","active_substance":"alprazolam","related_medicines":"","procedure_number":"PSUSA/00000109/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000109-202203"},{"category":"","active_substances_in_scope_of_procedure":"fluticasone propionate","active_substance":"fluticasone propionate","related_medicines":"","procedure_number":"PSUSA/00001454/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001454-202202"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Phleum Pratense (oromucosal use, product authorised via mutually recognition procedure)","active_substance":"allergen for therapy: Phleum Pratense","related_medicines":"","procedure_number":"PSUSA/00010475/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010475-202203"},{"category":"","active_substances_in_scope_of_procedure":"amlodipine","active_substance":"amlodipine","related_medicines":"","procedure_number":"PSUSA/00000174/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000174-202203"},{"category":"","active_substances_in_scope_of_procedure":"cabergoline","active_substance":"cabergoline","related_medicines":"","procedure_number":"PSUSA/00000477/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000477-202203"},{"category":"","active_substances_in_scope_of_procedure":"Aprotinin","active_substance":"aprotinin","related_medicines":"","procedure_number":"PSUSA/00000230/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000230-202202"},{"category":"","active_substances_in_scope_of_procedure":"Nicorandil","active_substance":"nicorandil","related_medicines":"","procedure_number":"PSUSA/00002152/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002152-202202"},{"category":"","active_substances_in_scope_of_procedure":"Eplerenone","active_substance":"eplerenone","related_medicines":"","procedure_number":"PSUSA/00001236/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001236-202203"},{"category":"","active_substances_in_scope_of_procedure":"clodronic acid, clodronic acid / lidocaine","active_substance":"clodronic acid;lidocaine","related_medicines":"","procedure_number":"PSUSA/00010650/202202","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010650-202202"},{"category":"","active_substances_in_scope_of_procedure":"Naratriptan","active_substance":"naratriptan","related_medicines":"","procedure_number":"PSUSA/00002126/202202","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002126-202202"},{"category":"","active_substances_in_scope_of_procedure":"Chloroprocaine hydrochloride","active_substance":"chloroprocaine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010078/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010078-202203"},{"category":"","active_substances_in_scope_of_procedure":"Dorzolamide","active_substance":"dorzolamide","related_medicines":"","procedure_number":"PSUSA/00003168/202202","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003168-202202"},{"category":"","active_substances_in_scope_of_procedure":"Ketoprofen (topical use only)","active_substance":"ketoprofen","related_medicines":"","procedure_number":"PSUSA/00009205/202201","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009205-202201"},{"category":"","active_substances_in_scope_of_procedure":"Mesalazine","active_substance":"Mesalazine","related_medicines":"","procedure_number":"PSUSA/00001990/202202","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001990-202202"},{"category":"","active_substances_in_scope_of_procedure":"Carboplatin","active_substance":"carboplatin","related_medicines":"","procedure_number":"PSUSA/00000559/202201","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000559-202201"},{"category":"","active_substances_in_scope_of_procedure":"Frovatriptan","active_substance":"frovatriptan","related_medicines":"","procedure_number":"PSUSA/00001484/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001484-202203"},{"category":"","active_substances_in_scope_of_procedure":"Gabapentin","active_substance":"gabapentin","related_medicines":"","procedure_number":"PSUSA/00001499/202202","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001499-202202"},{"category":"","active_substances_in_scope_of_procedure":"Mesterolone","active_substance":"mesterolone","related_medicines":"","procedure_number":"PSUSA/00010551/202201","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010551-202201"},{"category":"","active_substances_in_scope_of_procedure":"Levothyroxine","active_substance":"levothyroxine","related_medicines":"","procedure_number":"PSUSA/00001860/202201","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001860-202201"},{"category":"","active_substances_in_scope_of_procedure":"Human rabies immunoglobulin","active_substance":"human rabies immunoglobulin","related_medicines":"","procedure_number":"PSUSA/00001639/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001639-202204"},{"category":"","active_substances_in_scope_of_procedure":"Itraconazole","active_substance":"Itraconazole","related_medicines":"","procedure_number":"PSUSA/00001798/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001798-202203"},{"category":"","active_substances_in_scope_of_procedure":"Linezolid","active_substance":"linezolid","related_medicines":"","procedure_number":"PSUSA/00001888/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001888-202204"},{"category":"","active_substances_in_scope_of_procedure":"Mupirocin","active_substance":"mupirocin","related_medicines":"","procedure_number":"PSUSA/00002096/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002096-202203"},{"category":"","active_substances_in_scope_of_procedure":"Gentamicin (implant)","active_substance":"gentamicin","related_medicines":"","procedure_number":"PSUSA/00010628/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010628-202203"},{"category":"","active_substances_in_scope_of_procedure":"Ozenoxacin","active_substance":"Ozenoxacin","related_medicines":"","procedure_number":"PSUSA/00010651/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-202205"},{"category":"","active_substances_in_scope_of_procedure":"Isotretinoin (oral formulations)","active_substance":"isotretinoin (oral formulations)","related_medicines":"","procedure_number":"PSUSA/00010488/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202205"},{"category":"","active_substances_in_scope_of_procedure":"Lidocaine / prilocaine (not centrally authorised product)","active_substance":"lidocaine;prilocaine","related_medicines":"","procedure_number":"PSUSA/00001867/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001867-202203"},{"category":"","active_substances_in_scope_of_procedure":"Tretinoin (oral formulations)","active_substance":"tretinoin","related_medicines":"","procedure_number":"PSUSA/00003015/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003015-202203"},{"category":"","active_substances_in_scope_of_procedure":"Glucosamine","active_substance":"glucosamine","related_medicines":"","procedure_number":"PSUSA/00001539/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001539-202203"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria / tetanus / pertussis (acellular, component) vaccine (adsorbed), diphtheria / tetanus / pertussis (acellular, component) vaccine (adsorbed) reduced antigens contents","active_substance":"pertussis (acellular, component) vaccine (adsorbed), diphtheria;tetanus;pertussis (acellular, component) vaccine (adsorbed) reduced antigens contents;diphtheria vaccine","related_medicines":"","procedure_number":"PSUSA/00001125/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001125-202203"},{"category":"","active_substances_in_scope_of_procedure":"Varicella vaccine (live)","active_substance":"varicella vaccine (live)","related_medicines":"","procedure_number":"PSUSA/00010473/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010473-202203"},{"category":"","active_substances_in_scope_of_procedure":"Methyl salicylate, menthol / methyl salicylate, menthol / methyl salicylate / camphor, methyl salicylate/ camphor, methyl salicylate / menthol / camphor / tocopherol, methyl salicylate / camphor / menthol / turpentine (essence, oil), methyl salicylate / menthol / camphor / hydroxyethyl salicylate, methyl salicylate / menthol / camphor / hydroxyethyl salicylate / benzyl nicotinate","active_substance":"methyl salicylate;menthol;camphor;tocopherol;turpentine (essence oil);hydroxyethyl salicylate;benzyl nicotinate","related_medicines":"","procedure_number":"PSUSA/00010658/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010658-202204"},{"category":"","active_substances_in_scope_of_procedure":"Etoricoxib","active_substance":"etoricoxib","related_medicines":"","procedure_number":"PSUSA/00001334/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001334-202203"},{"category":"","active_substances_in_scope_of_procedure":"Mometasone furoate/olopatadine","active_substance":"mometasone furoate;olopatadine hydrochloride","related_medicines":"","procedure_number":"PSUSA/00010957/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010957-202204"},{"category":"","active_substances_in_scope_of_procedure":"Nefopam","active_substance":"nefopam","related_medicines":"","procedure_number":"PSUSA/00002131/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002131-202203"},{"category":"","active_substances_in_scope_of_procedure":"Sertraline","active_substance":"sertraline","related_medicines":"","procedure_number":"PSUSA/00002696/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002696-202203"},{"category":"","active_substances_in_scope_of_procedure":"Epoprostenol","active_substance":"epoprostenol","related_medicines":"","procedure_number":"PSUSA/00001242/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001242-202203"},{"category":"","active_substances_in_scope_of_procedure":"Candesartan, candesartan / hydrochlorothiazide","active_substance":"Candesartan;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00000527/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000527-202204"},{"category":"","active_substances_in_scope_of_procedure":"Carvedilol","active_substance":"carvedilol","related_medicines":"","procedure_number":"PSUSA/00000575/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000575-202204"},{"category":"","active_substances_in_scope_of_procedure":"Certoparin","active_substance":"certoparin","related_medicines":"","procedure_number":"PSUSA/00000625/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000625-202204"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / olmesartan","active_substance":"amlodipine;olmesartan","related_medicines":"","procedure_number":"PSUSA/00002208/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002208-202204"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / levonorgestrel","active_substance":"ethinylestradiol;levonorgestrel","related_medicines":"","procedure_number":"PSUSA/00001309/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001309-202204"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine besilate / hydrochlorothiazide / olmesartan medoxomil","active_substance":"amlodipine besilate;hydrochlorothiazide;olmesartan medoxomil","related_medicines":"","procedure_number":"PSUSA/00002210/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002210-202204"},{"category":"","active_substances_in_scope_of_procedure":"Sulprostone","active_substance":"sulprostone","related_medicines":"","procedure_number":"PSUSA/00002828/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002828-202204"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / candesartan","active_substance":"amlodipine;Candesartan","related_medicines":"","procedure_number":"PSUSA/00010191/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010191-202204"},{"category":"","active_substances_in_scope_of_procedure":"Carvedilol / ivabradine","active_substance":"carvedilol;ivabradine","related_medicines":"","procedure_number":"PSUSA/00010883/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010883-202204"},{"category":"","active_substances_in_scope_of_procedure":"Estradiol / norethisterone","active_substance":"estradiol;norethisterone","related_medicines":"","procedure_number":"PSUSA/00001278/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001278-202203"},{"category":"","active_substances_in_scope_of_procedure":"Oxycodone","active_substance":"oxycodone","related_medicines":"","procedure_number":"PSUSA/00002254/202204","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-202204"},{"category":"","active_substances_in_scope_of_procedure":"Fexofenadine","active_substance":"fexofenadine","related_medicines":"","procedure_number":"PSUSA/00001388/202203","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001388-202203"},{"category":"","active_substances_in_scope_of_procedure":"Amoxicillin/clavulanate","active_substance":"amoxicillin;clavulanate","related_medicines":"","procedure_number":"PSUSA/00000188/202203","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000188-202203"},{"category":"","active_substances_in_scope_of_procedure":"Amoxicillin","active_substance":"amoxicillin","related_medicines":"","procedure_number":"PSUSA/00000187/202203","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000187-202203"},{"category":"","active_substances_in_scope_of_procedure":"Amoxicillin","active_substance":"erythromycin","related_medicines":"","procedure_number":"PSUSA/00010808/202203","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010808-202203"},{"category":"","active_substances_in_scope_of_procedure":"Macrogol 3350","active_substance":"Macrogol 3350","related_medicines":"","procedure_number":"PSUSA/00001924/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001924-202205"},{"category":"","active_substances_in_scope_of_procedure":"Macrogol 4000, macrogol 4000 combinations (oral use)","active_substance":"macrogol 4000;macrogol 4000 combinations","related_medicines":"","procedure_number":"PSUSA/00010392/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010392-202205"},{"category":"","active_substances_in_scope_of_procedure":"Fusidic acid (systemic use)","active_substance":"fusidic acid","related_medicines":"","procedure_number":"PSUSA/00010226/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010226-202205"},{"category":"","active_substances_in_scope_of_procedure":"Levofloxacin/dexamethasone (ocular use)","active_substance":"levofloxacin;dexamethasone","related_medicines":"","procedure_number":"PSUSA/00010881/202206","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010881-202206"},{"category":"","active_substances_in_scope_of_procedure":"Risperidone","active_substance":"risperidone","related_medicines":"","procedure_number":"PSUSA/00002649/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002649-202205"},{"category":"","active_substances_in_scope_of_procedure":"Alteplase","active_substance":"alteplase","related_medicines":"","procedure_number":"PSUSA/00000112/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000112-202205"},{"category":"","active_substances_in_scope_of_procedure":"Calcifediol","active_substance":"calcifediol","related_medicines":"","procedure_number":"PSUSA/00000491/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000491-202206"},{"category":"","active_substances_in_scope_of_procedure":"Tirofiban","active_substance":"tirofiban","related_medicines":"","procedure_number":"PSUSA/00002974/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002974-202205"},{"category":"","active_substances_in_scope_of_procedure":"Eprosartan hydrochlorothiazide","active_substance":"eprosartan;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00001244/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001244-202204"},{"category":"","active_substances_in_scope_of_procedure":"Eprosartan","active_substance":"eprosartan","related_medicines":"","procedure_number":"PSUSA/00001243/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001243-202204"},{"category":"","active_substances_in_scope_of_procedure":"Valsartan, hydrochlorothiazide / valsartan","active_substance":"valsartan;hydrochlorothiazide","related_medicines":"","procedure_number":"PSUSA/00010396/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010396-202204"},{"category":"","active_substances_in_scope_of_procedure":"latanoprost / timolol","active_substance":"Latanoprost;timolol","related_medicines":"","procedure_number":"PSUSA/00001833/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001833-202206"},{"category":"","active_substances_in_scope_of_procedure":"Olsalazine","active_substance":"olsalazine","related_medicines":"","procedure_number":"PSUSA/00002213/202205","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002213-202205"},{"category":"","active_substances_in_scope_of_procedure":"Cefuroxime axetil","active_substance":"cefuroxime axetil","related_medicines":"","procedure_number":"PSUSA/00009099/202204","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009099-202204"},{"category":"","active_substances_in_scope_of_procedure":"Tolperisone","active_substance":"tolperisone","related_medicines":"","procedure_number":"PSUSA/00002991/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002991-202206"},{"category":"","active_substances_in_scope_of_procedure":"Cefuroxime sodium (except for intracameral use)","active_substance":"cefuroxime sodium","related_medicines":"","procedure_number":"PSUSA/00000615/202204","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000615-202204"},{"category":"","active_substances_in_scope_of_procedure":"Omeprazole","active_substance":"omeprazole","related_medicines":"","procedure_number":"PSUSA/00002215/202204","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002215-202204"},{"category":"","active_substances_in_scope_of_procedure":"Lamivudine / tenofovir disoproxil","active_substance":"lamivudine;tenofovir disoproxil","related_medicines":"","procedure_number":"PSUSA/00010751/202203","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010751-202203"},{"category":"","active_substances_in_scope_of_procedure":"Ivermectin (systemic use)","active_substance":"ivermectin","related_medicines":"","procedure_number":"PSUSA/00010377/202204","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010377-202204"},{"category":"","active_substances_in_scope_of_procedure":"Fentanyl (transdermal patches, solution for injection - nationally authorised product only)","active_substance":"fentanyl","related_medicines":"","procedure_number":"PSUSA/00001370/202204","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-202204"},{"category":"","active_substances_in_scope_of_procedure":"Aprotinin / calcium chloride / human factor xiii / human  fibrinogen / human thrombin, aprotinin / fibrinogen / fibronectin / human  coagulation factor XIII / plasma protein fraction / plasminogen / thrombin,  aprotinin / human fibrinogen / thrombin / calcium chloride, aprotinin /  calcium chloride / factor xiii / human thrombin / human clottable protein  containing mainly fibrinogen and fibronectin, calcium chloride / human  fibrinogen / factor xiii / fibronectin / plasminogen / human thrombin","active_substance":"aprotinin;calcium chloride;human factor xiii;human fibrinogen;human thrombin, aprotinin;fibrinogen;fibronectin;human coagulation factor XIII;plasma protein fraction;plasminogen;thrombin, aprotinin;human fibrinogen;thrombin;calcium chloride, aprotinin;calcium chloride;factor XIII;human thrombin;human clottable protein containing mainly fibrinogen and fibronectin, calcium chloride;human fibrinogen;factor XIII;bovine aprotinin, calcium chloride;bovine aprotinin, human fibrinogen;calcium chloride dihydrate;plasma fibronectin;bovine aprotinin;human coagulation factor XIII, human fibrinogen;calcium chloride dihydrate;plasma protein fraction;plasminogen;human thrombin;bovine aprotinin;human coagulation factor XIII","related_medicines":"","procedure_number":"PSUSA/00010346/202111","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010346-202111"},{"category":"","active_substances_in_scope_of_procedure":"Vinorelbine","active_substance":"vinorelbine","related_medicines":"","procedure_number":"PSUSA/00003124/202204","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003124-202204"},{"category":"","active_substances_in_scope_of_procedure":"Lanreotide","active_substance":"lanreotide","related_medicines":"","procedure_number":"PSUSA/00001826/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-202205"},{"category":"","active_substances_in_scope_of_procedure":"Triptorelin","active_substance":"triptorelin","related_medicines":"","procedure_number":"PSUSA/00003048/202203","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003048-202203"},{"category":"","active_substances_in_scope_of_procedure":"Bleomycin","active_substance":"bleomycin","related_medicines":"","procedure_number":"PSUSA/00000422/202203","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000422-202203"},{"category":"","active_substances_in_scope_of_procedure":"Methoxyflurane","active_substance":"Methoxyflurane","related_medicines":"","procedure_number":"PSUSA/00010484/202205","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-202205"},{"category":"","active_substances_in_scope_of_procedure":"Betaxolol","active_substance":"betaxolol","related_medicines":"","procedure_number":"PSUSA/00000401/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000401-202205"},{"category":"","active_substances_in_scope_of_procedure":"Levonorgestrel (for emergency contraception only)","active_substance":"levonorgestrel","related_medicines":"","procedure_number":"PSUSA/00010827/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010827-202205"},{"category":"","active_substances_in_scope_of_procedure":"Moclobemide","active_substance":"moclobemide","related_medicines":"","procedure_number":"PSUSA/00002079/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002079-202204"},{"category":"","active_substances_in_scope_of_procedure":"Acamprosate","active_substance":"acamprosate","related_medicines":"","procedure_number":"PSUSA/00000016/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000016-202207"},{"category":"","active_substances_in_scope_of_procedure":"Amorolfine","active_substance":"amorolfine","related_medicines":"","procedure_number":"PSUSA/00000185/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000185-202206"},{"category":"","active_substances_in_scope_of_procedure":"Cilastatin / imipenem","active_substance":"cilastatin;imipenem","related_medicines":"","procedure_number":"PSUSA/00000748/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000748-202206"},{"category":"","active_substances_in_scope_of_procedure":"Ganciclovir","active_substance":"ganciclovir","related_medicines":"","procedure_number":"PSUSA/00001516/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001516-202206"},{"category":"","active_substances_in_scope_of_procedure":"Pentamidine","active_substance":"pentamidine","related_medicines":"","procedure_number":"PSUSA/00002338/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002338-202206"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for diagnostic and or therapy Vespula SPP. (802) (with or without adjuvant), Wasp venom","active_substance":"Vespula SPP. (802);wasp venom","related_medicines":"","procedure_number":"PSUSA/00010721/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010721-202207"},{"category":"","active_substances_in_scope_of_procedure":"Theophylline","active_substance":"theophylline","related_medicines":"","procedure_number":"PSUSA/00002921/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002921-202206"},{"category":"","active_substances_in_scope_of_procedure":"Methylaminolevulinate","active_substance":"methylaminolevulinate","related_medicines":"","procedure_number":"PSUSA/00002019/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002019-202206"},{"category":"","active_substances_in_scope_of_procedure":"Apis mellifera (801) (with or without adjuvant), Apis mellifera venom","active_substance":"Apis mellifera (801);Apis mellifera venom","related_medicines":"","procedure_number":"PSUSA/00010722/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010722-202207"},{"category":"","active_substances_in_scope_of_procedure":"Sulfamethizole","active_substance":"sulfamethizole","related_medicines":"","procedure_number":"PSUSA/00010561/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010561-202206"},{"category":"","active_substances_in_scope_of_procedure":"Nitrous oxide, nitrous oxide / oxygen","active_substance":"nitrous oxide;oxygen","related_medicines":"","procedure_number":"PSUSA/00010572/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010572-202206"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor XIII","active_substance":"human coagulation factor XIII","related_medicines":"","procedure_number":"PSUSA/00001622/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001622-202206"},{"category":"","active_substances_in_scope_of_procedure":"Germanium (68Ge) chloride / gallium (68Ga) chloride","active_substance":"germanium (68Ge) chloride;gallium (68Ga) chloride","related_medicines":"","procedure_number":"PSUSA/00010364/202203","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-202203"},{"category":"","active_substances_in_scope_of_procedure":"Ibuprofen / pseudoephedrine","active_substance":"Ibuprofen;pseudoephedrine","related_medicines":"","procedure_number":"PSUSA/00001711/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-202207"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: betula verrucosa (sublingual use)","active_substance":"allergen for therapy: betula verrucosa (sublingual use)","related_medicines":"","procedure_number":"PSUSA/00010815/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202207"},{"category":"","active_substances_in_scope_of_procedure":"Phentermine/ topiramate","active_substance":"phentermine;topiramate","related_medicines":"","procedure_number":"PSUSA/00010956/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010956-202207"},{"category":"","active_substances_in_scope_of_procedure":"Itopride","active_substance":"itopride","related_medicines":"","procedure_number":"PSUSA/00010606/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010606-202206"},{"category":"","active_substances_in_scope_of_procedure":"Flecainide","active_substance":"flecainide","related_medicines":"","procedure_number":"PSUSA/00001396/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001396-202206"},{"category":"","active_substances_in_scope_of_procedure":"Glimepiride","active_substance":"glimepiride","related_medicines":"","procedure_number":"PSUSA/00001534/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001534-202206"},{"category":"","active_substances_in_scope_of_procedure":"Piracetam","active_substance":"piracetam","related_medicines":"","procedure_number":"PSUSA/00002429/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002429-202204"},{"category":"","active_substances_in_scope_of_procedure":"Benserazide / levodopa","active_substance":"benserazide;levodopa","related_medicines":"","procedure_number":"PSUSA/000000330/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-000000330-202206"},{"category":"","active_substances_in_scope_of_procedure":"Ketotifen (ophthalmic formulations)","active_substance":"ketotifen","related_medicines":"","procedure_number":"PSUSA/00001812/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001812-202206"},{"category":"","active_substances_in_scope_of_procedure":"Mitoxantrone","active_substance":"mitoxantrone","related_medicines":"","procedure_number":"PSUSA/00002076/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002076-202206"},{"category":"","active_substances_in_scope_of_procedure":"Methadone","active_substance":"methadone","related_medicines":"","procedure_number":"PSUSA/00002004/202205","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002004-202205"},{"category":"","active_substances_in_scope_of_procedure":"Levomethadone","active_substance":"levomethadone","related_medicines":"","procedure_number":"PSUSA/00001855/202205","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001855-202205"},{"category":"","active_substances_in_scope_of_procedure":"Esomeprazole / naproxen","active_substance":"esomeprazole;naproxen","related_medicines":"","procedure_number":"PSUSA/00001270/202204","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001270-202204"},{"category":"","active_substances_in_scope_of_procedure":"Venlafaxine","active_substance":"venlafaxine","related_medicines":"","procedure_number":"PSUSA/00003104/202205","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003104-202205"},{"category":"","active_substances_in_scope_of_procedure":"Bemiparin","active_substance":"bemiparin","related_medicines":"","procedure_number":"PSUSA/00000312/202204","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000312-202204"},{"category":"","active_substances_in_scope_of_procedure":"Cefadroxil","active_substance":"cefadroxil","related_medicines":"","procedure_number":"PSUSA/00000584/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000584-202207"},{"category":"","active_substances_in_scope_of_procedure":"Diphtheria / tetanus / poliomyelitis (inactivated) vaccine (adsorbed, reduced antigens(s) content)","active_substance":"diptheria;tetanus;poliomyelitis (inactivated) vaccine (adsorbed, reduced antigens(s) content)","related_medicines":"","procedure_number":"PSUSA/00001127/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001127-202208"},{"category":"","active_substances_in_scope_of_procedure":"Fosfomycin (oral formulation)","active_substance":"fosfomycin","related_medicines":"","procedure_number":"PSUSA/00010326/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010326-202207"},{"category":"","active_substances_in_scope_of_procedure":"Fosfomycin (IV formulation)","active_substance":"fosfomycin","related_medicines":"","procedure_number":"PSUSA/00010336/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010336-202207"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor IX","active_substance":"human coagulation factor IX","related_medicines":"","procedure_number":"PSUSA/00001617/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001617-202207"},{"category":"","active_substances_in_scope_of_procedure":"Poliovirus type 1 / poliovirus type 2 / poliovirus type 3 vaccine (oral, live, attenuated), poliovirus type 1 / poliovirus type 3 vaccine (oral, live, attenuated), poliovirus type 1 (oral, live, attenuated) vaccine, poliovirus type 2 (oral, live, attenuated) vaccine, poliovirus type 3 (oral, live, attenuated) vaccine","active_substance":"poliovirus type 1 vaccine;poliovirus type 2 vaccine;poliovirus type 3 vaccine","related_medicines":"","procedure_number":"PSUSA/00010801/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010801-202207"},{"category":"","active_substances_in_scope_of_procedure":"Fludarabine","active_substance":"fludarabine","related_medicines":"","procedure_number":"PSUSA/00001406/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001406-202208"},{"category":"","active_substances_in_scope_of_procedure":"Amikacin (except for centrally authorised products)","active_substance":"amikacin","related_medicines":"","procedure_number":"PSUSA/00000143/202206","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000143-202206"},{"category":"","active_substances_in_scope_of_procedure":"Triazolam","active_substance":"triazolam","related_medicines":"","procedure_number":"PSUSA/00003023/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003023-202207"},{"category":"","active_substances_in_scope_of_procedure":"Fluvoxamine","active_substance":"fluvoxamine","related_medicines":"","procedure_number":"PSUSA/00001458/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001458-202207"},{"category":"","active_substances_in_scope_of_procedure":"Pilocarpine (non-ophthalmic formulations)","active_substance":"pilocarpine","related_medicines":"","procedure_number":"PSUSA/00002409/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002409-202207"},{"category":"","active_substances_in_scope_of_procedure":"Diclofenac / misoprostol","active_substance":"diclofenac;misoprostol","related_medicines":"","procedure_number":"PSUSA/00001040/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001040-202207"},{"category":"","active_substances_in_scope_of_procedure":"Triamcinolone topical and nasal formulations","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00003017/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003017-202207"},{"category":"","active_substances_in_scope_of_procedure":"Beclometasone formoterol (inhalative application)","active_substance":"beclometasone;formoterol","related_medicines":"","procedure_number":"PSUSA/00010068/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010068-202207"},{"category":"","active_substances_in_scope_of_procedure":"Alprostadil (indicated in peripheral arterial occlusive diseases)","active_substance":"alprostadil","related_medicines":"","procedure_number":"PSUSA/00000111/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000111-202207"},{"category":"","active_substances_in_scope_of_procedure":"Ethinylestradiol / norethisterone","active_substance":"ethinylestradiol;norethisterone","related_medicines":"","procedure_number":"EMA/131957/2023","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/ema-131957-2023"},{"category":"","active_substances_in_scope_of_procedure":"Ketorolac (ophthalmic formulations)","active_substance":"ketorolac","related_medicines":"","procedure_number":"PSUSA/00001810/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001810-202207"},{"category":"","active_substances_in_scope_of_procedure":"Diltiazem","active_substance":"diltiazem","related_medicines":"","procedure_number":"PSUSA/00001084/202205","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001084-202205"},{"category":"","active_substances_in_scope_of_procedure":"Clindamycin phosphate / tretinoin","active_substance":"clindamycin phosphate;tretinoin","related_medicines":"","procedure_number":"PSUSA/00010080/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010080-202207"},{"category":"","active_substances_in_scope_of_procedure":"Pitavastatin","active_substance":"pitavastatin","related_medicines":"","procedure_number":"PSUSA/00010502/202207","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010502-202207"},{"category":"","active_substances_in_scope_of_procedure":"Carbetocin","active_substance":"carbetocin","related_medicines":"","procedure_number":"PSUSA/00000546/202206","regulatory_outcome":"","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000546-202206"},{"category":"","active_substances_in_scope_of_procedure":"Procyanidolic oligomers","active_substance":"procyanidolic oligomers","related_medicines":"","procedure_number":"PSUSA/00002537/202205","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002537-202205"},{"category":"","active_substances_in_scope_of_procedure":"Norethisterone","active_substance":"norethisterone","related_medicines":"","procedure_number":"PSUSA/00002188/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002188-202208"},{"category":"","active_substances_in_scope_of_procedure":"Delapril / manidipine, delapril / indapamide","active_substance":"delapril;manidipine, delapril;Indapamide","related_medicines":"","procedure_number":"PSUSA/00010496/202206","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010496-202206"},{"category":"","active_substances_in_scope_of_procedure":"Sodium tetradecyl sulphate","active_substance":"sodium tetradecyl sulfate","related_medicines":"","procedure_number":"PSUSA/00002767/202204","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002767-202204"},{"category":"","active_substances_in_scope_of_procedure":"Ropinirole","active_substance":"ropinirole","related_medicines":"","procedure_number":"PSUSA/00002661/202207","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002661-202207"},{"category":"","active_substances_in_scope_of_procedure":"Minocycline","active_substance":"minocycline","related_medicines":"","procedure_number":"PSUSA/00002065/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002065-202208"},{"category":"","active_substances_in_scope_of_procedure":"Piperacillin / tazobactam","active_substance":"piperacillin;tazobactam","related_medicines":"","procedure_number":"PSUSA/00002425/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002425-202209"},{"category":"","active_substances_in_scope_of_procedure":"Dornase alpha","active_substance":"dornase alpha","related_medicines":"","procedure_number":"PSUSA/00001164/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001164-202209"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: dermatophagoides pteronyssinus / dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)","active_substance":"Dermatophagoides pteronyssinus;Dermatophagoides farina","related_medicines":"","procedure_number":"PSUSA/00010582/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-202209"},{"category":"","active_substances_in_scope_of_procedure":"Tretinoin (topical formulations)","active_substance":"tretinoin","related_medicines":"","procedure_number":"PSUSA/00003016/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003016-202208-0"},{"category":"","active_substances_in_scope_of_procedure":"Treosulfan (except for centrally authorised product)","active_substance":"treosulfan","related_medicines":"","procedure_number":"PSUSA/00009319/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009319-202208"},{"category":"","active_substances_in_scope_of_procedure":"Choline alfoscerate","active_substance":"choline alfoscerate","related_medicines":"","procedure_number":"PSUSA/00010599/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010599-202208"},{"category":"","active_substances_in_scope_of_procedure":"Dexamfetamine","active_substance":"dexamfetamine","related_medicines":"","procedure_number":"PSUSA/00000986/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202209"},{"category":"","active_substances_in_scope_of_procedure":"Biperiden","active_substance":"biperiden","related_medicines":"","procedure_number":"PSUSA/00000415/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000415-202208"},{"category":"","active_substances_in_scope_of_procedure":"Paricalcitol","active_substance":"paricalcitol","related_medicines":"","procedure_number":"PSUSA/00002316/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002316-202208"},{"category":"","active_substances_in_scope_of_procedure":"Fluoxetine","active_substance":"fluoxetine","related_medicines":"","procedure_number":"PSUSA/00001442/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001442-202209"},{"category":"","active_substances_in_scope_of_procedure":"Drospirenone / ethinylestradiol","active_substance":"drospirenone;ethinylestradiol","related_medicines":"","procedure_number":"PSUSA/00010217/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010217-202209"},{"category":"","active_substances_in_scope_of_procedure":"Fluvastatin","active_substance":"fluvastatin","related_medicines":"","procedure_number":"PSUSA/00001457/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001457-202208"},{"category":"","active_substances_in_scope_of_procedure":"Ketorolac (systemic formulations)","active_substance":"ketorolac","related_medicines":"","procedure_number":"PSUSA-00001811-202207","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001811-202207"},{"category":"","active_substances_in_scope_of_procedure":"Meloxicam","active_substance":"meloxicam","related_medicines":"","procedure_number":"PSUSA/00010474/202207","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010474-202207"},{"category":"","active_substances_in_scope_of_procedure":"Artemether / lumefantrin (apart from the dispersible tablet)","active_substance":"artemether;lumefantrin","related_medicines":"","procedure_number":"PSUSA/00000236/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000236-202210"},{"category":"","active_substances_in_scope_of_procedure":"Terbinafine","active_substance":"terbinafine","related_medicines":"","procedure_number":"PSUSA/00002896/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002896-202209"},{"category":"","active_substances_in_scope_of_procedure":"Bromhexine","active_substance":"bromhexine","related_medicines":"","procedure_number":"PSUSA/00000437/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000437-202209"},{"category":"","active_substances_in_scope_of_procedure":"Trifarotene","active_substance":"trifarotene","related_medicines":"","procedure_number":"PSUSA/00010929/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010929-202210"},{"category":"","active_substances_in_scope_of_procedure":"Lysine acetylsalicylate","active_substance":"lysine acetylsalicylate","related_medicines":"","procedure_number":"PSUSA/00001921/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001921-202209"},{"category":"","active_substances_in_scope_of_procedure":"Ambroxol","active_substance":"ambroxol","related_medicines":"","procedure_number":"PSUSA/00000130/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000130-202209"},{"category":"","active_substances_in_scope_of_procedure":"Ambroxol / clenbuterol","active_substance":"ambroxol;clenbuterol","related_medicines":"","procedure_number":"PSUSA/00000131/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000131-202209"},{"category":"","active_substances_in_scope_of_procedure":"EMA/223477/2023","active_substance":"aminosalicylic acid","related_medicines":"","procedure_number":"PSUSA/00000165/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000165-202210"},{"category":"","active_substances_in_scope_of_procedure":"Felbamate","active_substance":"felbamate","related_medicines":"","procedure_number":"PSUSA/00010155/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010155-202209"},{"category":"","active_substances_in_scope_of_procedure":"Etomidate","active_substance":"etomidate","related_medicines":"","procedure_number":"PSUSA/00001330/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001330-202209"},{"category":"","active_substances_in_scope_of_procedure":"Etidronate","active_substance":"etidronate","related_medicines":"","procedure_number":"PSUSA/00001320/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001320-202209"},{"category":"","active_substances_in_scope_of_procedure":"Dinoprostone","active_substance":"dinoprostone","related_medicines":"","procedure_number":"PSUSA/00001104/202209","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001104-202209"},{"category":"","active_substances_in_scope_of_procedure":"Midazolam (all pharmaceutical forms and indications apart from oromucosal solution indicated for the treatment of prolonged, acute, convulsive seizures)","active_substance":"midazolam","related_medicines":"","procedure_number":"PSUSA/00002057/202209","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002057-202209"},{"category":"","active_substances_in_scope_of_procedure":"Adenosine","active_substance":"adenosine","related_medicines":"","procedure_number":"PSUSA/00000062/202208","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000062-202208"},{"category":"","active_substances_in_scope_of_procedure":"Tixocortol, chlorhexidine gluconate / tixocortol pivalate","active_substance":"tixocortol;chlorhexidine gluconate;tixocortol pivalate","related_medicines":"","procedure_number":"PSUSA/00010333/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010333-202211"},{"category":"","active_substances_in_scope_of_procedure":"Atovaquone / proguanil","active_substance":"atovaquone;proguanil","related_medicines":"","procedure_number":"PSUSA/00000266/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000266-202210"},{"category":"","active_substances_in_scope_of_procedure":"Human coagulation factor VII","active_substance":"human coagulation factor VII","related_medicines":"","procedure_number":"PSUSA/00001619/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001619-202210"},{"category":"","active_substances_in_scope_of_procedure":"Epinastine","active_substance":"epinastine","related_medicines":"","procedure_number":"PSUSA/00001231/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001231-202210"},{"category":"","active_substances_in_scope_of_procedure":"Isoflurane","active_substance":"Isoflurane","related_medicines":"","procedure_number":"PSUSA/00001786/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001786-202211"},{"category":"","active_substances_in_scope_of_procedure":"Acitretin","active_substance":"acitretin","related_medicines":"","procedure_number":"PSUSA/00000051/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202210"},{"category":"","active_substances_in_scope_of_procedure":"Clevidipine","active_substance":"clevidipine","related_medicines":"","procedure_number":"PSUSA/00010288/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202211"},{"category":"","active_substances_in_scope_of_procedure":"Rubidium (82Rb) chloride","active_substance":"rubidium (82Rb) chloride","related_medicines":"","procedure_number":"PSUSA/00010806/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010806-202210"},{"category":"","active_substances_in_scope_of_procedure":"Lenograstim","active_substance":"lenograstim","related_medicines":"","procedure_number":"PSUSA/00001839/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001839-202210"},{"category":"","active_substances_in_scope_of_procedure":"Valsartan / rosuvastatin","active_substance":"valsartan;rosuvastatin","related_medicines":"","procedure_number":"PSUSA/00010735/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010735-202210"},{"category":"","active_substances_in_scope_of_procedure":"Ezetimibe","active_substance":"ezetimibe","related_medicines":"","procedure_number":"PSUSA/00001346/202210","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001346-202210"},{"category":"","active_substances_in_scope_of_procedure":"Clenbuterol","active_substance":"clenbuterol","related_medicines":"","procedure_number":"PSUSA/00000794/202209","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000794-202209"},{"category":"","active_substances_in_scope_of_procedure":"Famotidine","active_substance":"Famotidine","related_medicines":"","procedure_number":"PSUSA/00001350/202209","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001350-202209"},{"category":"","active_substances_in_scope_of_procedure":"Carbidopa / levodopa","active_substance":"carbidopa;levodopa","related_medicines":"","procedure_number":"PSUSA/00000548/202210","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000548-202210"},{"category":"","active_substances_in_scope_of_procedure":"Fenoterol (respiratory indications)","active_substance":"fenoterol","related_medicines":"","procedure_number":"PSUSA/00001366/202209","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001366-202209"},{"category":"","active_substances_in_scope_of_procedure":"Ropivacaine","active_substance":"ropivacaine","related_medicines":"","procedure_number":"PSUSA/00002662/202209","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002662-202209"},{"category":"","active_substances_in_scope_of_procedure":"Polystyrene sulfonate","active_substance":"polystyrene sulfonate","related_medicines":"","procedure_number":"PSUSA/00002472/202210","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002472-202210"},{"category":"","active_substances_in_scope_of_procedure":"Anti-T lymphocyte immunoglobulin for human use, horse","active_substance":"anti-T lymphocyte immunoglobulin for human use, horse","related_medicines":"","procedure_number":"PSUSA/00010433/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010433-202211"},{"category":"","active_substances_in_scope_of_procedure":"Propofol","active_substance":"propofol","related_medicines":"","procedure_number":"PSUSA/00002555/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002555-202211"},{"category":"","active_substances_in_scope_of_procedure":"Econazole, econazole nitrate / triamcinolone acetonide, econazole nitrate / zinc oxide","active_substance":"econazole;econazole nitrate;triamcinolone acetonide;econazole nitrate;zinc oxide","related_medicines":"","procedure_number":"PSUSA/00001195/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001195-202211"},{"category":"","active_substances_in_scope_of_procedure":"Bambuterol","active_substance":"bambuterol","related_medicines":"","procedure_number":"PSUSA/00000295/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000295-202212"},{"category":"","active_substances_in_scope_of_procedure":"Bacillus clausii multi-antibioresistant spores","active_substance":"bacillus clausii multi-antibioresistant spores","related_medicines":"","procedure_number":"PSUSA/00000284/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000284-202211"},{"category":"","active_substances_in_scope_of_procedure":"Caffeine / ergotamine","active_substance":"Caffeine;ergotamine","related_medicines":"","procedure_number":"PSUSA/00000485/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000485-202211"},{"category":"","active_substances_in_scope_of_procedure":"Cetirizine","active_substance":"cetirizine","related_medicines":"","procedure_number":"PSUSA/00000628/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000628-202211"},{"category":"","active_substances_in_scope_of_procedure":"Alfuzosin","active_substance":"alfuzosin","related_medicines":"","procedure_number":"PSUSA/00000084/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000084-202211"},{"category":"","active_substances_in_scope_of_procedure":"dutasteride, dutasteride / tamsulosine","active_substance":"dutasteride;tamsulosine","related_medicines":"","procedure_number":"PSUSA/00010506/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010506-202211"},{"category":"","active_substances_in_scope_of_procedure":"Brotizolam","active_substance":"brotizolam","related_medicines":"","procedure_number":"PSUSA/00000444/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000444-202212"},{"category":"","active_substances_in_scope_of_procedure":"naltrexone","active_substance":"naltrexone","related_medicines":"","procedure_number":"PSUSA/00002117/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002117-202211"},{"category":"","active_substances_in_scope_of_procedure":"Dienogest","active_substance":"Dienogest","related_medicines":"","procedure_number":"PSUSA/00003167/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"31/07/2023","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003167-202212"},{"category":"","active_substances_in_scope_of_procedure":"Levocabastine","active_substance":"levocabastine","related_medicines":"","procedure_number":"PSUSA/00001849/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001849-202211"},{"category":"","active_substances_in_scope_of_procedure":"Sodium fluoride (18F)","active_substance":"sodium fluoride (18F)","related_medicines":"","procedure_number":"PSUSA/00010706/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010706-202211"},{"category":"","active_substances_in_scope_of_procedure":"Bromperidol","active_substance":"bromperidol","related_medicines":"","procedure_number":"PSUSA/00000439/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000439-202211"},{"category":"","active_substances_in_scope_of_procedure":"Amlodipine / indapamide, amlodipine / indapamide / perindopril","active_substance":"amlodipine;Indapamide;perindopril","related_medicines":"","procedure_number":"PSUSA/00010358/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010358-202211"},{"category":"","active_substances_in_scope_of_procedure":"Hydroxycarbamide (except for centrally authorised product)","active_substance":"hydroxycarbamide","related_medicines":"","procedure_number":"PSUSA/00009182/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-202212"},{"category":"","active_substances_in_scope_of_procedure":"Yellow fever vaccine (live)","active_substance":"yellow fever vaccine (live)","related_medicines":"","procedure_number":"PSUSA/00003135/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-202212"},{"category":"","active_substances_in_scope_of_procedure":"Inactivated leptospire vaccine","active_substance":"inactivated leptospire vaccine","related_medicines":"","procedure_number":"PSUSA/00010813/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010813-202211"},{"category":"","active_substances_in_scope_of_procedure":"Yellow fever vaccine (live)","active_substance":"yellow fever vaccine (live)","related_medicines":"","procedure_number":"PSUSA/00003135/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-202212-0"},{"category":"","active_substances_in_scope_of_procedure":"Apomorphine","active_substance":"apomorphine","related_medicines":"","procedure_number":"PSUSA/00000227/202211","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-202211"},{"category":"","active_substances_in_scope_of_procedure":"Cisplatin","active_substance":"cisplatin","related_medicines":"","procedure_number":"PSUSA-00000778-202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000778-202212"},{"category":"","active_substances_in_scope_of_procedure":"Amisulpride","active_substance":"amisulpride","related_medicines":"","procedure_number":"PSUSA/00000167/202301","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000167-202301"},{"category":"","active_substances_in_scope_of_procedure":"Hypericum perforatum L., herba","active_substance":"hypericum perforatum L., herba","related_medicines":"","procedure_number":"PSUSA/00001701/202301","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001701-202301"},{"category":"","active_substances_in_scope_of_procedure":"Atracurium","active_substance":"atracurium","related_medicines":"","procedure_number":"PSUSA/00000267/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000267-202212"},{"category":"","active_substances_in_scope_of_procedure":"Codeine camphosulphonate / sodium benzoate, codeine camphosulphonate / sulfogaiacol / grindelia soft extract","active_substance":"codeine camphosulphonate / sodium benzoate, codeine camphosulphonate / sulfogaiacol / grindelia soft extract","related_medicines":"","procedure_number":"PSUSA/00010542/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010542-202212"},{"category":"","active_substances_in_scope_of_procedure":"Allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis L. (sublingual tablet)","active_substance":"allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis L. (sublingual tablet)","related_medicines":"","procedure_number":"PSUSA/00010465/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010465-202212"},{"category":"","active_substances_in_scope_of_procedure":"Cefprozil","active_substance":"cefprozil","related_medicines":"","procedure_number":"PSUSA/00000605/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000605-202212"},{"category":"","active_substances_in_scope_of_procedure":"Tetanus vaccines","active_substance":"tetanus vaccine","related_medicines":"","procedure_number":"PSUSA/00002910/202301","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002910-202301"},{"category":"","active_substances_in_scope_of_procedure":"5 fluorouracil (topical application)","active_substance":"5 fluorouracil (topical application)","related_medicines":"","procedure_number":"PSUSA/00010000/202301","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010000-202301"},{"category":"","active_substances_in_scope_of_procedure":"Flurbiprofen","active_substance":"flurbiprofen","related_medicines":"","procedure_number":"PSUSA/00001450/202211","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001450-202211"},{"category":"","active_substances_in_scope_of_procedure":"Sertindole","active_substance":"sertindole","related_medicines":"","procedure_number":"PSUSA/00002695/202301","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-202301"},{"category":"","active_substances_in_scope_of_procedure":"Levobupivacaine","active_substance":"levobupivacaine","related_medicines":"","procedure_number":"PSUSA/00001848/202212","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001848-202212"},{"category":"","active_substances_in_scope_of_procedure":"Lamotrigine","active_substance":"lamotrigine","related_medicines":"","procedure_number":"PSUSA/00001825/202211","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001825-202211"},{"category":"Human","active_substances_in_scope_of_procedure":"Calcium chloride dihydrate / magnesium chloride hexahydrate / malic acid / sodium acetate trihydrate / sodium chloride / potassium chloride, calcium chloride dihydrate / sodium chloride / sodium lactate / potassium chloride, calcium chloride / sodium chloride / potassium chloride","active_substance":"calcium chloride dihydrate;magnesium chloride hexahydrate;Malic acid;sodium acetate trihydrate;sodium chloride;potassium chloride;calcium chloride;sodium lactate","related_medicines":"","procedure_number":"PSUSA/00010622/202301","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010622-202301"},{"category":"","active_substances_in_scope_of_procedure":"Fenoterol / ipratropium","active_substance":"fenoterol;ipratropium","related_medicines":"","procedure_number":"PSUSA/00001367/202302","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001367-202302"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (surface antigen, inactivated)","active_substance":"influenza vaccine (surface antigen, inactivated)","related_medicines":"","procedure_number":"PSUSA/00001744/202303","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202303"},{"category":"","active_substances_in_scope_of_procedure":"Haemophilus type b and meningococcal group C conjugate vaccine","active_substance":"haemophilus type b and meningococcal group c conjugate vaccine","related_medicines":"","procedure_number":"PSUSA/00001583/202302","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001583-202302"},{"category":"","active_substances_in_scope_of_procedure":"Influenza vaccine (split virion, inactivated) (non centrally authorised products)","active_substance":"influenza vaccine (split virion, inactivated) (non centrally authorised products)","related_medicines":"","procedure_number":"PSUSA/00010298/202303","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202303"},{"category":"","active_substances_in_scope_of_procedure":"Ipratropium","active_substance":"ipratropium","related_medicines":"","procedure_number":"PSUSA/00001780/202301","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001780-202301"},{"category":"","active_substances_in_scope_of_procedure":"Ipratropium / salbutamol","active_substance":"ipratropium;salbutamol","related_medicines":"","procedure_number":"PSUSA/00001781/202301","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001781-202301"},{"category":"","active_substances_in_scope_of_procedure":"Haemophilus type b conjugate vaccines","active_substance":"haemophilus type b conjugate vaccines","related_medicines":"","procedure_number":"PSUSA/00001584/202302","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001584-202302"},{"category":"","active_substances_in_scope_of_procedure":"Saccharomyces boulardii","active_substance":"saccharomyces boulardii","related_medicines":"","procedure_number":"PSUSA/00009284/202302","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00009284-202302"},{"category":"","active_substances_in_scope_of_procedure":"Mefloquine","active_substance":"mefloquine","related_medicines":"","procedure_number":"PSUSA/00001955/202302","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001955-202302"},{"category":"","active_substances_in_scope_of_procedure":"Dacarbazine","active_substance":"dacarbazine","related_medicines":"","procedure_number":"PSUSA/00000919/202302","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000919-202302"},{"category":"Human","active_substances_in_scope_of_procedure":"Tauroselcholic [75Se] acid","active_substance":"tauroselcholic (75Se) acid","related_medicines":"","procedure_number":"PSUSA/00010486/202301","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010486-202301"},{"category":"Human","active_substances_in_scope_of_procedure":"paroxetine","active_substance":"paroxetine","related_medicines":"","procedure_number":"PSUSA/00002319/202212","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002319-202212"},{"category":"Human","active_substances_in_scope_of_procedure":"anastrozole","active_substance":"anastrozole","related_medicines":"","procedure_number":"PSUSA/00000210/202208","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000210-202208"},{"category":"Human","active_substances_in_scope_of_procedure":"idarubicin","active_substance":"idarubicin","related_medicines":"","procedure_number":"PSUSA/00001720/202211","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001720-202211"},{"category":"Human","active_substances_in_scope_of_procedure":"gemcitabine","active_substance":"gemcitabine","related_medicines":"","procedure_number":"PSUSA/00001519/202301","regulatory_outcome":"Variation","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001519-202301"},{"category":"Human","active_substances_in_scope_of_procedure":"ethosuximide","active_substance":"ethosuximide","related_medicines":"","procedure_number":"PSUSA/00001316/202303","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001316-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"Epinephrine / mepivacaine hydrochloride, mepivacaine / norepinephrine, mepivacaine","active_substance":"epinephrine;mepivacaine hydrochloride;mepivacaine;norepinephrine","related_medicines":"","procedure_number":"PSUSA/00001979/202303","regulatory_outcome":"Maintenance","first_published_date":"05/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001979-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"","active_substance":"enalapril","related_medicines":"","procedure_number":"PSUSA/00001211/202303","regulatory_outcome":"Maintenance","first_published_date":"04/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001211-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"Isotretinoin (oral formulations)","active_substance":"isotretinoin (oral formulations)","related_medicines":"","procedure_number":"PSUSA/00010488/202305","regulatory_outcome":"Maintenance","first_published_date":"04/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202305"},{"category":"Human","active_substances_in_scope_of_procedure":"Benzyl nicotinate / camphor / dimethyl sulfoxide / nonivamide / turpentine oil, Nicoboxil/ Nonivamide","active_substance":"benzyl nicotinate;camphor;Dimethyl sulfoxide;nonivamide;turpentine oil;nicoboxil","related_medicines":"","procedure_number":"PSUSA/00010584/202303","regulatory_outcome":"Maintenance","first_published_date":"04/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010584-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"Methylphenobarbital","active_substance":"methylphenobarbital","related_medicines":"","procedure_number":"PSUSA/00002025/202303","regulatory_outcome":"Maintenance","first_published_date":"04/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00002025-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"Triamcinolone (intraocular formulations)","active_substance":"triamcinolone","related_medicines":"","procedure_number":"PSUSA/00010292/202303","regulatory_outcome":"Maintenance","first_published_date":"04/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"Mometasone furoate/olopatadine","active_substance":"mometasone furoate;olopatadine","related_medicines":"","procedure_number":"PSUSA/00010957/202304","regulatory_outcome":"Maintenance","first_published_date":"04/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010957-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"Human plasma (pooled and treated for virus inactivation)","active_substance":"human plasma (pooled and treated for virus inactivation)","related_medicines":"","procedure_number":"PSUSA/00001635/202302","regulatory_outcome":"Maintenance","first_published_date":"04/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001635-202302"},{"category":"Human","active_substances_in_scope_of_procedure":"Deproteinised hemoderivative of calf blood, deproteinised hemoderivative of calf blood / macrogol 400","active_substance":"deproteinised hemoderivative of calf blood","related_medicines":"","procedure_number":"PSUSA/00010600/202303","regulatory_outcome":"Maintenance","first_published_date":"01/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010600-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"Hydroxyethyl starch","active_substance":"hydroxyethyl starch","related_medicines":"","procedure_number":"PSUSA/00001694/202303","regulatory_outcome":"Maintenance","first_published_date":"01/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"Furosemide","active_substance":"Furosemide","related_medicines":"","procedure_number":"PSUSA/00001491/202301","regulatory_outcome":"Maintenance","first_published_date":"01/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001491-202301"},{"category":"Human","active_substances_in_scope_of_procedure":"Enalapril / nitrendipine","active_substance":"enalapril;nitrendipine","related_medicines":"","procedure_number":"PSUSA/00001213/202301","regulatory_outcome":"Maintenance","first_published_date":"01/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001213-202301"},{"category":"Human","active_substances_in_scope_of_procedure":"Drospirenone","active_substance":"drospirenone","related_medicines":"","procedure_number":"PSUSA/00010853/202211","regulatory_outcome":"Maintenance","first_published_date":"01/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010853-202211"},{"category":"Human","active_substances_in_scope_of_procedure":"Ciprofloxacin (systemic use)","active_substance":"ciprofloxacin","related_medicines":"","procedure_number":"PSUSA/00000775/202304","regulatory_outcome":"Maintenance","first_published_date":"01/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000775-202304"},{"category":"Human","active_substances_in_scope_of_procedure":"BCG (bacillus calmette-gurin) for Immunotherapy","active_substance":"bacillus calmette-gurin (BCG)","related_medicines":"","procedure_number":"PSUSA/00000303/202303","regulatory_outcome":"Maintenance","first_published_date":"01/12/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000303-202303"},{"category":"Human","active_substances_in_scope_of_procedure":"omega-3-acid ethyl esters","active_substance":"omega-3-acid ethyl esters 90","related_medicines":"","procedure_number":"PSUSA-00010312-202301","regulatory_outcome":"Variation","first_published_date":"30/11/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010312-202301"},{"category":"Human","active_substances_in_scope_of_procedure":"etoposide","active_substance":"etoposide","related_medicines":"","procedure_number":"PSUSA/00001333/202302","regulatory_outcome":"","first_published_date":"29/11/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001333-202302"},{"category":"Human","active_substances_in_scope_of_procedure":"beta-alanine","active_substance":"beta-alanine","related_medicines":"","procedure_number":"PSUSA/10510/202301","regulatory_outcome":"Variation","first_published_date":"29/11/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-10510-202301"},{"category":"Human","active_substances_in_scope_of_procedure":"levosalbutamol, salbutamol","active_substance":"levosalbutamol;salbutamol","related_medicines":"","procedure_number":"PSUSA/000010330/202301","regulatory_outcome":"Variation","first_published_date":"28/11/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-000010330-202301"},{"category":"Human","active_substances_in_scope_of_procedure":"bicalutamide","active_substance":"bicalutamide","related_medicines":"","procedure_number":"PSUSA/00000407/202302","regulatory_outcome":"Maintenance","first_published_date":"28/11/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00000407-202302"},{"category":"Human","active_substances_in_scope_of_procedure":"lomustine","active_substance":"lomustine","related_medicines":"","procedure_number":"PSUSA/00001902/202301","regulatory_outcome":"Variation","first_published_date":"28/11/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00001902-202301"},{"category":"Human","active_substances_in_scope_of_procedure":"Landiolol","active_substance":"","related_medicines":"","procedure_number":"PSUSA/00010570/202302","regulatory_outcome":"Maintenance","first_published_date":"27/11/2023","last_updated_date":"","psusa_url":"https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-202302"}]